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Abstract 
 
The use of Crystal Structure Prediction (CSP) studies in the pharmaceutical industry is 
currently limited by computational cost, which scales badly with molecular size and 
flexibility. This thesis seeks to develop new methods that would allow to perform CSP 
studies on larger, more flexible pharmaceutical-like molecules.  
 First, a full CSP workflow was successfully used to predict the crystal structure 
of a large flexible molecule for the 6th Blind Test and in a joint computational-experimental 
study of the antihelminthic drug mebendazole. These CSP studies were integrated with 
three previously published computational analyses of flexible pharmaceuticals and used 
to benchmark the development of new methods. 
 Successively, knowledge-based conformational information retrieved from the 
Cambridge Structural Database (CSD) was used to facilitate the generation of candidate 
crystal structures of these five molecules. Millions of crystal structures were generated 
at a reduced computational cost, but with an equally effective coverage of the 
conformational search space, compared to the original CSP efforts.  
 The importance of treating conformational flexibility when optimising search-
generated crystal structures was then assessed. This led to using dispersion-corrected 
density functional tight-binding (DFTB-D) as an intermediate step to minimise all intra- 
and intermolecular degrees of freedom of several thousands of search-generated crystal 
structures. DFTB-D reduced the cost of the final lattice energy evaluations by providing 
better starting points, and results of similar quality to the original CSP studies were 
obtained after optimising only the intermolecular interactions with a higher quality wave-
function. 
 Finally, a CSD survey was performed to determine thresholds that can 
discriminate the great majority of polymorphs from duplicate determinations. These 
thresholds and comparison methods were implemented in a Python programme that can 
be used in CSP studies to perform clustering and to interpret the results more effectively. 
The prospects for expanding the use of CSP to pharmaceutical development are 
discussed.  
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Impact statement 
 
The work shown in this thesis can bring a variety of benefits both inside and outside 
academia. First, the development of new methods to cut down the computational cost of 
predicting the crystal structure/s of large and flexible molecules could be used by 
researchers interested in surveying the possible solid-state forms of a molecule. These 
methods could help drug development, as they are targeted to large and flexible 
pharmaceutical-like molecules. Faster predictions of the crystal structure/s of drug 
molecules could be undertaken concurrently with experimental solid form screening and 
could cover the search space more completely, reducing the experimental work needed 
to minimise the risk of the late appearance of a new polymorph. This is important as 
unpredicted changes in the solid-state form of a pharmaceutical molecule occurring in 
late stages of drug development or after it has been marketed can be disastrous both to 
manufacturers and to patients. 
 This thesis shows an example of a joint computational and experimental effort 
aimed at finding new crystalline forms of the antihelminthic drug mebendazole. The 
experimental study, which has yet to be completed, may find new forms with better 
properties than the currently marketed one, overcoming some of the difficulties in 
delivering this important drug to patients. This can impact all those industrial and 
academic researchers who are interested in leveraging both theory and experiments in 
solid form screening. 
Furthermore, criteria to discriminate the great majority of polymorphs from 
duplicates/redeterminations have been found. These criteria could be used both 
experimentally, to verify whether two crystal structures of the same molecule generated 
in different experiments are polymorphs, and computationally, to remove duplicates 
generated in crystal structures prediction studies.  
The benefits of this work are being realised in a variety of ways. Writing 
computational scripts was vital to effectively perform the research illustrated in this 
thesis. For example, an efficient Python clustering algorithm was produced, as well a 
Bash script to monitor a crystal structure search and interrupt it once a sufficient 
coverage of the potential energy surface has been achieved. All those tools have been 
put at the disposal of my group and are also being shared with collaborators in industry 
and in academia. 
Many of the methods and results developed in this thesis have been published in 
peer-reviewed scientific journals and have been disseminated through presentations at 
conferences or at specialised seminars, including the Gordon Research Conference on 
Crystal Engineering, the annual CCDC student days and the Bologna’s Convention on 
Crystal Forms. They can be utilised by members of my research group, possibly in 
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collaboration with industry. Some of these methods have already been successfully 
tested on succinic acid, increasing their credibility; the next step will be the expansion to 
larger and more flexible molecules, which may require further adaptions. 
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space group. 
Figure 1.2: Framework followed by successful CSP methodologies based on finding the most 
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Figure 1.3: Chemical diagram and average CPU cost of the successful predictions of the crystal 
structures of (left) molecule XXII (right) molecule XXVI in the 6th Blind Test of organic CSP. The 
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Figure 2.1:  A typical energy vs distance plot for two rigid molecules; σ represents the distance at 
which U=0, and ε is the depth of the energy well. 
Figure 2.2: Schematics of the dipole moment in water. 
Figure 2.3: Schematics of the quadrupole moment around a benzene ring. 
Figure 2.4: Schematics of LAMs of a molecule with two independent CDFs. Ab initio calculations 
are performed at the red LAM points, while the rectangles indicate the range of applicability of 
each LAM point. The energy at each point in the grid is calculated by a second order Taylor 
expansion from the closest LAM point. 
Figure 3.1: Chemical diagrams five target molecules for the 6th Blind Test of CSP. 
Figure 3.2: Chemical diagram of molecule XXVI. The arrows define the torsion angles considered 
as the flexible in the CSP study.  Φ1a and Φ1b (C2-C1-C7-O1 and C34-C29-28-O2) are 0° in the 
diagram above, Φ2a and Φ2b (O1-C7-N1-H21 and O2-C28-N2-H22) are 180°, Φ3a and Φ3b (H21-
N1-C8-C17 and H22-N2-C19-C20) are 180° and Φ4 (C10-C9-C18-C19) is 180°. 
Figure 3.3: Search fragments used in Conquest to perform the CSD surveys. Angles ξ1, ξ3 and ξ4 
were considered analogues of Φ1a and Φ1b, Φ3a and Φ3b and Φ4 respectively. Also all these 
fragments contain angle ξ2 that is an analogue of torsion angles Φ2a and Φ2b.  
Figure 3.4: Results of the isolated-molecule scans of torsion angle a) Φ1a from 0° to 360° in 30° 
steps; this is also valid for Φ1b b) Φ2a from 0° to 180° in 90° steps, this is also valid for Φ2b c) Φ3a 
from 0° to 360° in 30° steps; this is also valid for Φ3b d) Φ4 from -40° to -140° in 20° steps. The 
blue points indicate the relative conformational energy when the torsion angle took a certain value; 
at each point, all the CDFs were relaxed with the exception of the scanned torsion angle. All the 
calculations were performed at the PBE0 6-31G(d,p)  level of theory starting from the                   
PBE0 6-31G(d,p) optimised global minimum gas-phase conformer. The orange bars indicate the 
frequency of each value in the CSD. The black lines indicate the values taken by the torsion 
angles in the conformation of the target experimental crystal structure. 
Figure 3.5: Surrogate molecules used to calculate the ΔEintra grids of (left) Φ1a and Φ1b and (right) 
Φ3a, Φ3b and Φ4 of molecule XXVI.  
Figure 3.6: Lattice energy vs density plot obtained after the search with CrystalPredictor 1.6. 
ΔEintra was calculated from the ab initio grids, while Uinter was modelled with the atomic point 
charges and the FIT potential. The structure that ended up matching the experimental form is 
indicated in blue. Each point on the plot corresponds to a separate crystal structure. 
Figure 3.7: Overlay of the conformation in the experimental crystal structure of molecule XXVI 
(coloured by elements) and the closest gas-phase optimised conformer (in blue). The RMSD1 
calculated with the Crystal Packing Similarity tool is 0.624 Å. 
Figure 3.8: Overlay of the conformation of the experimental crystal structure of molecule XXVI 
(coloured by elements) and the conformation of search-generated structure 1600 (in blue). The 
RMSD1 calculated with the Crystal Packing Similarity tool is 0.282 Å. 
Figure 3.9: Lattice energy vs density plot obtained after the intermediate optimisations with a 
single-iteration of CrystalOptimizer. Each point on the plot corresponds to a separate crystal 
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structure, labelled according to its space group. The structure that ended up matching the 
experimental form is indicated. 
Figure 3.10: Lattice energy vs density plots showing (a) the 100 lowest energy crystal structures 
fully optimised with CrystalOptimizer submitted as a first list of predictions (b) the 100 lowest 
energy crystal structures after a rigid-body optimisation in a PCM with ε=3 and with the addition 
of the vibrational component to Helmholtz free energy at 298 K submitted as a second list of 
predictions. See Appendix Tables 3.3-3.4 for more details. Each point on the plots corresponds 
to a separate crystal structure, labelled according to its space group. The structures matching the 
target experimental form are indicated. 
Figure 3.11: Overlay between the hydrogen bonded dimer in the experimental crystal structure of 
molecule XXVI (coloured by elements) and predicted structure 1600 in the first list (in green). The 
hydrogen bonds are coloured in purple. The RMSD15 for the 15/15 overlay is 0.276 Å. 
Figure 3.12: (above) Lattice energy vs density plot of the 100 lowest energy structures submitted 
as a first list of predictions (below) free energy vs density plot the 100 lowest energy structures 
submitted as a second list of predictions. They are labelled on whether they form intra- or 
intermolecular hydrogen bonds. 
Figure 3.13: Overlay of the conformations of structures 1600 (coloured by elements), which 
matches the target experimental crystal structure, 675 (yellow), 421 (blue) and 2231 (red) (left) 
and the sheet common to all four structures (right). 
Figure 3.14: (left) Overlay of the conformation of structure 3525 (coloured by elements), the global 
minimum in Elatt in the first list, and the isolated-molecule global minimum of molecule XXVI (in 
blue) (right) and its crystal structure. 
Figure 3.15: Overlay of the conformations of structures 3104 (coloured by elements), 185 (blue), 
1391 (red) and 7559 (yellow) (left) and the packing motif common to those 4 structures (right). 
Figure 4.1: Chemical diagrams of (left) the A-tautomer of mebendazole (right) the C-tautomer of 
mebendazole 
Figure 4.2: Intermolecular hydrogen bond motif of (above) mebendazole form A, where each 
molecule uses two donors and two acceptors, forming both a NH···O hydrogen bond with the 
R2
2(14) graph set motif and a NH···N hydrogen bond with the R2
2(8) graph set motif, and (below) 
mebendazole form C, where each molecule uses one donor and one acceptor, forming a NH···N 
hydrogen bond with the R2
2(8) graph set motif. The hydrogen bonds are coloured in purple. 
Figure 4.3: Chemical diagram of the (above) A-tautomer (below) C-tautomer of mebendazole. 
The two tautomers are differentiated by where C14=O15 in the edge benzoyl substituent attaches 
to the central benzimidazole ring: in the A-tautomer it attaches three bonds away from the                
N1-H1a group, to atom C7, while in the C-tautomer it attaches four bonds away, to atom C8. The 
six torsion angles that wereconsidered in the initial analysis of conformational flexibility are 
indicated (see Appendix Table 4.1 for their definition). The scans were only performed on the C-
tautomer. 
Figure 4.4: Results of the angle scans of torsion angles a) Φ1 (x-axis) and Φ2 (y-axis) from 0° to 
360° in 30° steps; this is a contour plot of the conformational energy penalty surface as a function 
of the values of these two torsion angles b) Φ3 from 0° to 360° in 30° steps c) Φ4 from 0° (cis) to 
180° (trans) in 90° steps d) Φ5 from 0° to 360° in 30° steps and e) Φ6 from 0° to 360° in 30° steps. 
At each point on the plots, all the conformational degrees of freedom (CDFs) were relaxed with 
the exception of the scanned torsion angle/s. The optimisations were performed at the               
PBE0 6-31G(d,p) level of theory starting from the PBE0 6-31G(d,p) optimised global minimum 
gas-phase conformer. The red dots/lines indicate the values taken by the torsion angle/s in the 
conformation of form C of mebendazole, black dots/lines in the conformation of form A (see 
Appendix Table 4.2 for the actual values). 
Figure 4.5: Surrogate molecules used to calculate the ΔEintra grids of (left) Φ1 and Φ2 and (right) 
Φ3 and Φ5 of both tautomers of mebendazole. 
Figure 4.6: Chemical diagram and atomic numbering of (above) the A-tautomer (below) the                    
C-tautomer of mebendazole, showing the torsion angles (black arrows) and bond-angles (red 
arcs) treated as independent CDFs in the final refinement stage of this CSP study. Double arrows 
indicate that two definitions of torsion angles around the same central bond were treated as 
variables in the CrystalOptimizer optimisations. See Appendix Table 4.4 for the precise definition 
of the explicitly flexible torsion and bond-angles. 
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Figure 4.7: Plot summarising the combined crystal energy landscape of both tautomers of 
mebendazole. See Appendix Table 4.5 for more details. Some of the low-energy plausible 
structures are labelled 
Figure 4.8: 15-molecule overlay between (above) the experimental crystal structure of 
mebendazole form A, coloured by elements, and structure A788, in green, with an RMSD15 of 
0.300 Å and (below) the experimental crystal structure of mebendazole form C, coloured by 
elements, and structure C5, in green, with an RMSD15 of 0.276 Å. The hydrogen bonds are 
coloured in purple.  
Figure 4.9: Plot summarising the combined crystal energy landscape of both tautomers of 
mebendazole obtained after recalculating the lattice energy of structures in Figure 4.7 with PCM.  
See Appendix Table 4.5 for more details. Some of the low-energy plausible structures are 
labelled. 
Figure 4.10: Plot summarising the crystal energy landscape of the A-tautomer of mebendazole 
after the full optimisations with CrystalOptimizer, showing all the crystal structures within 20 
kJ·mol-1 of the global minimum in Elatt.  Each point on the landscape corresponds to a separate 
crystal structure, labelled according to its space group. The structure matching experimental form 
A is circled, and some of the most competitive structures are also labelled. The crystal energy 
landscape calculated with the PCM is summarised in Appendix Figure 4.2a, and more details can 
be found in Appendix Table 4.5. 
Figure 4.11: NH···N intermolecular hydrogen bond with (left) the R2
2(8) graph set motif common 
to 82 low-energy structures containing the A-tautomer of mebendazole (right) the C1
1(4) graph set 
motif common to 23 low-energy structures. 
Figure 4.12: Unique intermolecular hydrogen bond motif in A173. 
Figure 4.13: Plot summarising the crystal energy landscape of the C-tautomer of mebendazole 
after the full optimisations with CrystalOptimizer, showing all the crystal structures within 20 
kJ·mol-1 of the global minimum in Elatt. Each point on the landscape corresponds to a separate 
crystal structure, labelled according to its space group. The structure matching experimental form 
C is circled, and some of the lowest energy structures are also labelled. The crystal energy 
landscape calculated with the PCM is summarised in Appendix Figure 4.2b, and more details can 
be found in Appendix Table 4.5. 
Figure 4.14: Example of conformations belonging to the conformational energy wells of                            
C-conformer 1 (left) and C-conformer 2 (right). 
Figure 4.15: NH···H hydrogen bond with the R2
2(𝟖) graph set motif common to all low-energy 
crystal structures containing the C-tautomer of mebendazole. 
Figure 4.16: Hydrogen bond motif of the global minimum structure C27. 
Figure 4.17: Hydrogen bond motif common to C248, C115, C509, C908 and C244. 
Figure 4.18: Sheet common to 9/10 lowest energy structures, including the global minimum (C27) 
and the match to experimental form C (C5). 
Figure 4.19: Diffractograms of forms A (black), B (grey), C (red), D1 (dark blue), D2 (light blue), 
E (brown) and F (olive). These patterns are compared to the diffractograms of the THF and DMF 
solvates (shown in green and orange). 
Figure 4.20: Diffractogram of form G (black) obtained through a phase transition of form B after 
six months at ambient conditions. 
Figure 5.1: Chemical diagrams of the small molecules used to investigate the ability of CSD 
information on geometric preferences to define the conformational search space. 
Figure 5.2: Histograms (light purple bars) and Von Mises KDE PDFs (red lines) describing the 
torsion angle distributions of the dihedral angles indicated on each molecular diagram of (a) 5-
Formyluracil (0° in the diagram) (b) Tazofelone (0° in the diagram) (c) Fenamic acid (0° in the 
diagram), with an overlay of the PDF for tolfenamic acid in green, showing the effect of the 
additional methyl and Cl substituents. 
Figure 5.3: Overlays of the experimental conformations of the molecules in Figure 5.1 (coloured 
by elements) with their best matches produced by the CG (in blue). If the same CG conformation 
was the closest match of each molecule in the asymmetric unit of Z’>1 crystal structures, the other 
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experimental conformations are coloured in red or in yellow. Polymorphs with very similar 
conformations are shown only once. 
Figure 5.4: Chemical diagrams of the molecules used to test the applicability of CSD information 
to large and flexible targets, showing the torsion angles that are identified as flexible by the 
rotamer libraries and the number of distinct conformations generated by the CG. The additional 
angles not identified by the rotamers libraries are in green and define the position of polar 
hydrogen atoms. Atomic numbering can be found in Appendix Figure 5.1, and the definition of the 
torsion angles in Appendix Table 5.1. 
Figure 5.5: Overlays of the experimental conformations of the molecules in Figure 5.4 (coloured 
by elements) with their best matches produced by the CG (in blue). 
Figure 5.6: Visual comparison of the effects of changing by 30° (a) torsion angle Φ4 in molecule 
XXVI, which strongly affects molecular shape and (b) torsion angle Φ6 in molecule XXIII, which 
has a very small effect on the shape of the hydrogen bonded dimer, except in the proximity of the 
carboxylic acid functional groups. 
Figure 5.7: Decision tree used to discriminate between constrained and explicitly flexible torsion 
angles on the basis of the PDF f() values and the changes in shape associated with their 
variation. 
Figure 5.8: Decision tree used to choose the separation threshold of each torsion angle defining 
a separate CR from the PDF f()  and shape-matching characteristics. 
Figure 5.9: Chemical diagram and atomic numbering of succinic acid. The torsion angles identified 
as flexible by the CG are in black, while those in green define the position of polar hydrogen 
atoms. Their definition can be found in Appendix Table 5.8. 
Figure 5.10: Summary of the application of the workflow on the molecules in Figure 5.4. The 
torsion angles in red were treated as flexible in the searches, covering the ranges given in 
degrees. Torsion angles in black were constrained to a set of CG values, with the values used in 
at least one search indicated; note that many combinations of these values were eliminated as 
energetically unfeasible (see Appendix Tables 5.10-5.15).  Torsion angles in green were 
constrained to the indicated values having been determined from an ab initio conformational-
energy scan. The tautomers A and C of mebendazole were treated in the same way (the 
motivation for this assumption is illustrated in Chapter 4). 
Figure 5.11: Plots of the significant CSP-generated crystal structures found in previous studies, 
classified as to whether they were found by the search workflow, of (a) molecule XXVI, (b) 
GSK269984B, (c) molecule XX, (d) molecule XXIII and (e) mebendazole. Higher energy 
structures were included for molecule XXVI (a structure whose stability was very dependent on 
the energy model), molecule XX and mebendazole (a competitive crystal structure with a cis 
amide for both molecules). Structures matching the experimentally known forms are indicated by 
open diamonds. 
Figure 5.12: Summary of the application of the workflow to succinic acid. Torsion angles in black 
were constrained to a set of CG values, with the values used in at least one search indicated; 
many combinations of these values were eliminated as energetically unfeasible (see Appendix 
Table 5.21). Torsion angles in green were constrained to the indicated values having been 
determined from an ab initio conformational-energy scan. Since the two halves of the molecule 
are symmetric, only one combination 180°-0° values for the green torsion angles Φ1 and Φ5 was 
considered, as they would represent identical molecules upon switching.  
Figure 6.1: Chemical diagrams of the five molecules considered for this test. The black arrows 
indicate the CDFstorsion.  
Figure 6.2: Chemical diagram of the five molecules considered for this test, showing the torsion 
angles and bond-angles treated as independent in the CrystalOptimizer optimisation with the 
CDFsAUTODOF. Black arrows indicate the torsion angles that are also present in the CDFstorsion and 
that are selected according to chemical intuition, while red arrows and red arcs indicate the torsion 
and bond-angles added by AUTODOF as they include polar hydrogen atoms.  
Figure 6.3: Chemical diagrams of the five molecules considered for this test. The torsion angles 
indicated by black arrows and the bond-angles indicated by red arcs were present in the 
CDFsAUTODOF and varied significantly in at least one crystal structure optimised with 
CrystalOptimizer with the CDFsall. Green arrows and arcs indicate torsion and bond-angles not 
included in the CDFsAUTODOF but that varied significantly in at least one crystal structure, while 
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those in turquoise are included in the CDFsAUTODOF but did not vary significantly in any crystal 
structure. 
Figure 6.4: Chemical diagrams of the five molecules considered for this test, showing the torsion 
and bond-angles treated as independent in the CrystalOptimizer optimisation with the 
CDFsAUTODOF+. The torsion angles indicated by red and black arrows and bond-angles indicate by 
red arcs were present in the CDFsAUTODOF.  Blue arrows and arcs indicate the torsion and bond-
angles that were manually added as they belong to one of the three categories of intuitively rigid 
CDFs that varied significantly in the CrystalOptimizer minimisations performed with the CDFsall. 
Figure 6.5: Comparison between the lattice energies obtained after full optimisations with 
CrystalOptimizer with the various sets of independent CDFs and those with the CDFsall for the 20 
crystal structures of (a) molecule XXVI (b) molecule XXIII (c) the A-tautomer of mebendazole (d) 
the C-tautomer of mebendazole and (e) naproxen. For each molecule, the lattice energies are 
plotted as the difference with the Elatt value of the global minimum in the benchmark optimisations 
with the CDFsall. The black lines indicate the lattice energies obtained in the optimisations with 
the CDFsall, and the structures matching the experimentally-characterised forms are indicated. 
See Appendix Tables 6.6-6.10 for more detailed results. The presence of crystal structures with 
energies lower than those obtained with the CDFsall is probably due to the tolerances in the 
convergence criteria of the optimisations. 
Figure 6.6: Comparison between the lattice energies obtained after full optimisations with 
CrystalOptimizer with the various sets of independent CDFs and those with the CDFsall for the 20 
crystal structures of (a) molecule XXVI (b) molecule XXIII (c) the A-tautomer of mebendazole (d) 
the C-tautomer of mebendazole and (e) naproxen. For each crystal structure, the energy is shown 
as the difference with that obtained in the benchmark optimisations with the CDFsall for the same 
structure. The crystal structures that match experimentally-characterised forms are circled. See 
Appendix Tables 6.6-6.10 for more detailed results. The presence of crystal structures with 
energies lower than those obtained with the CDFsall is probably due to the tolerances in the 
convergence criteria of the optimisations. 
Figure 6.7: For each molecule, average CPU cost of the optimisations as a function of the number 
of independent CDFs. 
Figure 6.8: Fragments used to perform the CSD surveys with Conquest. The black arrow 
represents a torsion angle, red arcs bond-angles. Z indicates any non-H atom, while the ‘a’ 
subscript indicates that the atom is acyclic. Fragments (a), (b) and (c) represent categories 1-3 of 
intuitively rigid CDFs respectively (see section 6.2.5.2). 
Figure 6.9: Fragments used to perform the CSD surveys with Conquest, representing torsion and 
bond-angles in rigid rings in the absence of heavy substituents in the central atoms. The black 
arrow represents a torsion angle, the red arc a bond-angle. Z indicates any non-H atom, X any 
atom, while the ‘1’ subscript indicates that the atom forms only one bond. 
Figure 6.10: Histogram showing the CSD distribution of the values of the torsion angle in the 
fragment in Figure6.8a. 
Figure 6.11: Histogram showing the CSD distribution of the values of the torsion angle in the 
fragment in Figure6.9a. 
Figure 6.12: Histogram showing the CSD distribution of the values of the bond-angle in the 
fragment in Figure 6.8b. 
Figure 6.13: Histogram showing the CSD distribution of the values of the bond-angle in the 
fragment in Figure 6.9b. 
Figure 6.14: Histogram showing the CSD distribution of the values of the bond-angle in the 
fragment in Figure6.8c. 
Figure 7.1: Plots of the crystal energy landscapes obtained after the final optimisations with the 
Ψ𝑚𝑜𝑙
𝑃𝐵𝐸0+𝐹𝐼𝑇method of (a) molecule XXVI (b) GSK269984B (c) molecule XX (d) molecule XXIII and 
(e) mebendazole. Each point on the plots corresponds to a separate crystal structure, labelled 
according to its space group. The structures matching the known experimental forms are 
indicated. The relative energies of the Z’=2 polymorphs of XXIII (XAFPAY02 for form C and 
XAFPAY04 for form E), which were outside the scope of the searches performed in Chapter 5, 
were calculated independently and are only shown in Figure 7.3. 
Figure 7.2: For some key CSP-generated crystal structures of each molecule, the relative 
vibrational contributions ΔFvib, which can be added to Elatt to calculate the Helmholtz free energy 
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(A, see Equation 2.37). For each molecule, ΔFvib is calculated relative to the structure which is 
the Elatt global minimum after the Ψ𝑚𝑜𝑙
𝑃𝐵𝐸0+𝐹𝐼𝑇  optimisations, for which ΔFvib = 0. The structures 
matching the experimentally known forms are indicated in green. The rigid-body modes are pure 
lattice modes, calculated with the Ψ𝑚𝑜𝑙
𝑃𝐵𝐸0+𝐹𝐼𝑇 model using DMACRYS. Full details about the crystal 
structures and their energies can be found in Appendix Table 7.7. 
Figure 7.3: Relative energies of the five polymorphs of molecule XXIII calculated in this study 
compared with those reported by the participants of the 6th Blind Test. Note that values linked by 
dashed lines denote changes from adding free energy estimates. The number in parentheses 
corresponds to the group identifier, with R denoting participants who only optimised crystal 
structures generated by others.  
Figure 8.1: Comparison of the PXRD similarity and the number of molecules matched (out of 15) 
for the 3,925 pairs of crystal structures under consideration. 
Figure 8.2: Decision tree to discriminate whether two organic crystal structures characterised at 
similar pressures are duplicates or polymorphs. 
Figure 8.3: Schematics of the criteria used in the algorithm to decide whether two                       
computer-generated crystal structures are duplicates or belong to different clusters. The blue 
boxes indicate steps where the user can define the thresholds for success or failure, while the 
green boxes represent hard-coded criteria. 
Figure 8.4: Distribution of the number of molecules that could be overlaid for the 3,347 pairs of 
polymorphs. They correspond to the 3,371 pairs of crystal structures considered, excluding the 
24 identified as duplicates. 
Figure 8.5: 15-molecule overlay between the crystal structures of DIMETH01 (coloured by 
elements) and DIMETH06 (in green). The RMSD15 is 0.226 Å. The publication clearly states that 
they are different polymorphs.  
Figure 8.6: Comparison between the crystal structures of FORMAC (left) and FORMAC01 (right). 
Figure 8.7: Summary of the results of the analysis of the polymorph-flagged CSD crystal 
structures. The pairs of false polymorphs are listed in Appendix Table 8.3 and the pairs of false 
duplicates in Appendix Table 8.4. 
Figure 8.8: Summary of the results of the test on the polymorph-flagged CSD crystal structures 
for each step of the methodology in Figure 8.2. 
Figure 8.9: 1-molecule overlay of the crystal structures of DBEZLM01 (coloured by elements) and 
DBEZLM05 (in green). See Appendix Table 8.3 for details. 
Figure 8.10: Molecular conformations contained in (left) ANTCYB11 and (right) ANTCYB13. See 
Appendix Table 8.3 for details. The phenyl rings in ANTCYB11 are intuitively wrong. 
Figure 8.11: Molecule and symmetry elements of (right) BENZID04 and (left) BENZID08. See 
Appendix Table 8.3 for details. Those crystal structures are both in the P1̅ space group and a 
15/15 molecule overlay is possible with an RMSD15 of 0.181 Å. The yellow dots represent 
crystalline inversion centres, and in BENZID04 one of the inversion centre is located half the way 
through the central C-C bond. 
Figure 8.12: 15-molecule overlay of DXYLEN14 (coloured by elements) and DXYLEN15 (in 
green). See Appendix Table 8.3 for details. Despite a clearly excellent agreement, the tool returns 
an unrealistic RMSD15 of 2.335 Å. This has to be due to an error in the Crystal Packing Similarity 
tool. 
Figure 8.13: 15-molecule overlays of (above) BIZWAI01 and BIZWAI02, with an RMSD15 of just 
0.007 Å, despite being explicitly indicated as polymorphs in the publication (below) SUWMIG and 
SUWMIG03, which require looser 40% distance and 40° angle tolerances to obtain a 15/15 
overlay with an RMSD15 of 1.16 Å, despite being explicitly indicated as redeterminations in the 
publication. 
Figure 8.14: Histograms showing the simulated PXRD similarities of (above) the polymorphic 
pairs identified; the false duplicates are indicated by orange bars (below) the pairs of duplicates 
identified; false polymorphs are indicated by orange bars. 
Figure 8.15: Lattice energy vs density plot obtained after the search with CrystalPredictor of 
molecule XXVI (above) before and (below) after clustering. 
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Figure 8.16: Lattice energy vs density plot obtained after the search with CrystalPredictor of the 
A-tautomer of mebendazole (above) before and (below) after clustering. 
Figure 8.17: Lattice energy vs density plot obtained after the search with CrystalPredictor of the 
C-tautomer of mebendazole (above) before and (below) after clustering. 
Figure 8.18: Overlay of structures 2494 and 2495 (right) after the search, where it is possible to 
overlay 15/15 molecules with an RMSD15 of 0.006 (left) after the single-iteration of 
CrystalOptimizer, where it is only possible to overlay 5/15 molecules. Molecules of 2494 are 
coloured by elements, while for 2495 matched molecules are coloured in green, non-matched 
molecules in red. 
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Chapter 1: Introduction 
 
1.1 Polymorphism 
 
1.1.1 Definition and importance 
   
Polymorphism occurs when molecules with the same chemical composition, covalent 
bonding and stereochemistry form different crystal structures.1, 2 This definition excludes 
solvates and hydrates of a molecule, since they have different chemical compositions, as 
well as crystal structures containing different isomers and tautomers, since they have 
different covalent bonding and stereochemistry.3 Although several definitions have been 
proposed to include these as special cases of polymorphism,3, 4 in this thesis a strict 
demarcation is followed. 
  Polymorphism has been known for a long time. The first intuition of its existence 
dates back to 1822 when Mitscherlich noticed that different crystals of the same 
compounds displayed different chemical and physical properties.3, 5 Although McCrone in 
1965 famously stated that “every compound has different polymorphic forms and that, in 
general, the number of forms known is proportional to the time and money that has been 
spent in research on that compound”,6 polymorphism was considered just a scientific 
curiosity until the last few decades, a rare phenomenon that affected a minority of 
compounds, while monomorphism was considered the norm.7-9 
  However, the interest in polymorphism has dramatically increased from the 
1990s.10 This can be explained by several concurring factors. First of all, the increasing 
understanding of how much a change in the arrangement of molecules can affect solid-
state properties:5 polymorphs can differ in melting point, colour, solubility, conductivity, 
physical and chemical stability, reflective index and mechanical properties.2, 3, 11 ROY 
(from its red, orange, yellow crystals)  provides a striking example of how a change in the 
crystal structure can affect the properties of solids formed of molecules with identical 
covalent bonding,12, 13 as shown in Figure 1.1.12  
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Figure 1.1: Molecular diagram of ROY and photos of its 10 known crystal structures. For 
those that have been solved the space group and the value taken by torsion angle θ are 
also indicated. The crystal structure of polymorph R05 has recently been solved:14 it has 
two molecules in the asymmetric unit cell, with θ values of 44.9° and -34.0° respectively, 
and it crystallises in the P21 space group. 
  Secondly, the improvement in the experimental techniques to search for, 
characterise and compare polymorphs appears to confirm the validity of McCrone’s 
statement;5 polymorphism is now recognised as a prevalent phenomenon,8, 9 and the 
majority of molecules that are thoroughly screened are found to form more than one single-
component crystal structure.10 Finally, there have been some highly publicised cases 
where polymorphism has led to manufacturing failures or to patent litigation,5 which have 
upgraded this phenomenon from the subject of mere ‘academic’ scientific interest to an 
industrially relevant problem with important financial and legal implications.  
 
1.1.2 Relevance to the pharmaceutical industry 
 
Polymorphism is relevant for any industry that deals with solid-state products, such as 
agrochemicals, pigments, semiconductors and energy materials.2, 15 The pharmaceutical 
industry is the one for which polymorphism can have the most severe            
consequences,1, 3, 9, 16-18 and large sums of money and human time are invested to 
understand and analyse this phenomenon. The reason is that most drugs are formulated 
with the active pharmaceutical ingredients (APIs) in the crystalline state.3, 18 This is 
because APIs in the form of solid crystal structures are easier to manufacture and more 
stable (i.e. less prone to degradation and phase transformations) than when they are in 
solution or in the amorphous state.3, 18 Since the properties of a solid are dramatically 
affected by the ways molecules are arranged in space, when a candidate API moves from 
the discovery to the development stage the selection of an optimal crystalline form takes 
a fundamental importance.2, 3, 17 
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  The most important polymorph-dependent properties for an API are 
bioavailability and chemical and physical stability.3 Bioavailability is the proportion of a 
drug that has an effect on the patient, and it is related to solubility and dissolution           
rate.2, 3, 19 More thermodynamically stable polymorphs are less soluble,1, 3, 19 and the 
differences in solubility between different crystal structures can be large.3, 19 Chemical 
stability is related to the reactivity of a molecule; unstable solid forms are undesirable as 
they lead to a loss of drug product and possibly to the formation of toxic degradants.3 
Physical stability is related to the tendency of a crystalline API to undergo transformation 
to another form, such as a different polymorph, a hydrate or an amorphous solid;3 this is 
obviously undesirable as it alters the physical properties of the drug product. More 
thermodynamically stable solid forms generally have higher chemical and physical 
stability. Mechanical properties are also polymorph-dependent.1, 3, 17 They can be relevant 
as they affect the mechanical strength and the tableting behaviour of a drug, but they are 
not as important as stability and bioavailability as they can be overcome by the choice of 
appropriate excipients and by the formulation process.3 
  The implications of polymorphism are so important that regulatory agencies 
require an accurate understanding of the solid-state structural behaviour and to have 
robust processes to produce the correct form of an API.1, 3, 17 The risks of polymorphism 
for the pharmaceutical industry are well-known, and a review by Lee et al. written in 20113 
lists five cases in which a change in the crystal structure of an API created problems to 
industrial manufacturers: Tegretol (carbamazepine) in 1988,20 Norvir (ritonavir) in 1998,21 
Neupro (rotigotine) in 2008,22 Avalide (irbesartan-hydrochlorothiazide)23 and Coumadin 
(warfarin sodium 2-propanol solvate) in 2010.3 It is likely that several other cases have 
occurred, which have not been publicly reported.3 The most famous example is certainly 
the one of ritonavir, as it is emblematic in illustrating the financial, reputational and             
health-related risks that are associated with an incomplete understanding of the solid-state 
behaviour of an API.  Only form I was initially found during drug development at Abbott. 
This form was introduced on the market in 1996, but in 1998 another polymorph, form II, 
appeared.21 Form II contains a high-energy conformation, present in only 1% of the 
molecules in solution,24 but it has a more complete hydrogen bonding network than        
form I that makes it more thermodynamically stable.24 It became impossible to reliably 
produce the original form.3 This new polymorph was significantly less soluble than the one 
that had originally been marketed,24 compromising its oral bioavailability. Abbott had to 
withdraw ritonavir from the market,3 and after huge research efforts it eventually came 
back as a soft-gelatin capsule.25 
  Finally, polymorphs are considered patentable inventions,3 and the discovery of 
different solid forms can be exploited to extend the patent-life of a drug.26 
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1.1.3 Solid form screens 
 
Given the importance of understanding the solid-state behaviour of a molecule, solid form 
(or polymorph) screens are a fundamental component of the drug development 
processes.1-3, 17 The purpose of solid form screens is to identify all the possible solid-state 
forms of an API and to choose the one with the best balance of properties, which may 
eventually be marketed.3 
  Solid form screens rely on the principle that crystallising the target molecules 
under a comprehensive set of external conditions should produce all its polymorphs, as 
well as its solvates and hydrates and any amorphous form.1, 3, 17 The set of external 
conditions that can be adjusted is very broad. Crystallisation can be performed from a 
variety of solvents and solvent mixtures, which can promote different intermolecular 
interactions in the solid-state.2 Cooling rates, temperatures, pHs and degrees of 
supersaturation can also be varied to obtain different forms upon crystallisation from 
solution,2  and different seeds and/or impurities can be used to promote heterogeneous 
nucleation.2 Furthermore, crystallisation can be performed from the melt, from amorphous 
materials or from a slurry containing a solid-state form dissolved in a solvent.2 Heat, 
pressure or mechanical deformation (such as liquid-assisted grinding) can then be applied 
to promote solid-solid transformations.3 Finally, less conventional methods are often 
included in current solid form screening procedures, such as crystallisation in electrical or 
ultrasound fields, under laser beams or in nano-confined forms,1, 17 as size can stabilise 
different polymorphs because of the increasing importance of surface energy for smaller 
crystals.2, 27 
  However, a trial and error approach must be utilised since the set of conditions 
that permit to find all the possible solid forms cannot be known prior to the screen.1, 3, 17, 18 
All molecules are different, and there is no pre-defined ‘cookbook’ approach that is 
guaranteed to find all important forms for any target.1 Even high-throughput screening 
procedures that automatically test a multitude of different conditions can sometimes      
fail.1, 3 Hence, polymorph screens have no clear end-point and their extent is arbitrary.18 
Crystallisation experiments are generally performed well after the last solid form has been 
identified to minimise the risk of missing anything important.18 Because of the low success 
rate of drug development and the huge amount of money, time and human resources that 
are required to perform a comprehensive experimental solid form screen, this process is 
very costly to pharmaceutical manufacturers.3, 18 The impossibility of determining the 
optimal extent of a screen causes the waste of precious resources.18  
   As a consequence, the ability to predict how a molecule crystallises, ideally not 
just as a single component, but also as a hydrate, or with a co-crystal former, is of 
tremendous value to the pharmaceutical industry.1, 17, 18 Predictions could be used to 
confidently stop the polymorph screen once all important solid-state forms have been 
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found, as well as to direct the experimental effort towards those with the most desirable 
set of properties.1, 17, 18 Fast and reliable predictions have the potential to revolutionise 
drug development.18 
   
1.2 Crystal structure prediction (CSP) 
  
1.2.1 Background 
 
The prediction of the possible crystal structures a molecule could adopt, a very important 
goal for the pharmaceutical industry, requires programming in a computer code a model 
of what determines its crystallisation behaviour.1 The art of using computer models to 
predict how a molecule crystallises takes the name of crystal structure prediction      
(CSP).1, 7, 9, 16-18 The origins of CSP date back to the 1960s-1970s,18 with the first proper 
CSP study performed on benzene in 1983;28 however, the techniques were still immature, 
and in 1988 John Maddox famously stated that “One of the continuing scandals in the 
physical sciences is that it remains in general impossible to predict the structure of even 
the simplest crystalline solids from a knowledge of their chemical composition”.29 The 
progresses since that stimulating remark have been dramatic, thanks to the increasing 
power of computers and to improvements in CSP methodologies. However, scientific 
curiosity was still the main driving force for development, and CSP was considered a way 
to test the accuracy of theoretical models rather than as a technology to be applied to   
real-life problems.18 It was not until the 5th Blind Test of CSP in 2010 (see Chapter 3.1.1 
for details) that the pharmaceutical industry started to become interested in the 
commercial application of this technique;18, 30, 31 in that occasion two groups successfully 
predicted the crystal structure of molecule XX (see Figure 1.2),32, 33 whose size and level 
of flexibility are similar to those of small molecules in pharmaceutical development, giving 
CSP much needed credibility. 
  Since then, the commercial interest in CSP has drastically increased, to the point 
that most large pharmaceutical manufacturers are interested in including computational 
predictions in their drug development procedures.18 As the title of a recent article points 
out, “Crystal structure prediction is changing from basic science to applied technology”.18 
 
1.2.2 Overview of the methodologies 
   
The theoretical assumption behind all successful CSP methodologies is that molecules 
crystallise in thermodynamically stable crystal structures.1, 7, 9, 18 In general, CSP 
methodologies follow the framework shown in Figure 1.2. 
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Figure 1.2: Framework followed by successful CSP methodologies based on finding the 
most thermodynamically stable crystal structures. The Blind Tests CSP study of 
molecule XX32, 33 is taken as an example. 
  The input of a CSP methodology is only the chemical diagram of a molecule, 
while the output is the crystal energy landscape, which is the set of the computer-
generated crystal structures that can be considered as thermodynamically plausible 
polymorphs and their energies.1, 7, 17 A summary plot of a crystal energy landscape is 
shown in Figure 1.2, where each point represents a unique minimum on the potential 
energy surface (in this case modelled by lattice energy at 0 K, see Chapter 2 for details). 
Current CSP methodologies have become reliable at producing crystal energy 
landscapes, since known forms are in most cases found among the set of 
thermodynamically plausible crystal structures.7, 18  
  However, some problems remain. First of all, the potential energy surface is 
immense, and a severe limitation of the search space, in particular in the number of 
molecules in the asymmetric unit cell (i.e. Z’), is needed.1, 18 Most CSP methodologies are 
restricted to Z’=1,1, 7 with Z’=2 searches performed only rarely,9, 19 and so a large portion 
of the potential energy surface with non-integer or large Z’ values is not accessible by 
CSP. It is also common to introduce limitations in the range of molecular conformations, 
which may cause the missing of crystal structures containing strained conformations.9, 18 
Furthermore, CSP studies can only produce crystal structures with perfect infinite static 
lattices,1, 16 excluding disordered (although disorder can be anticipated in some        
cases)34, 35 and defective forms from its reach.7, 18  
  Nevertheless, despite these sources of under-prediction, CSP methodologies 
actually tend to over-predict polymorphism.8, 18 One possible explanation is that 
temperature effects are not accurately modelled, and many of the crystal structures that 
are predicted as distinct minima at 0 K would not survive under real-life experimental 
conditions.8, 18 However the main reason of this over-prediction is that it is not yet fully 
understood which of the thermodynamically plausible crystal structures are actually 
kinetically accessible via crystal nucleation and growth or via phase transition.8, 18 Many of 
the predicted forms may simply not be accessible experimentally, or be so kinetically hard 
30 
 
to crystallise that they can only be produced with a very complicated set of       
experiments.8, 18, 19, 36 Hence CSP can only produce a set of plausible but not necessarily 
accessible polymorphs.18  
  This information is extremely helpful in drug development, but a close 
collaboration between computational and experimental scientists is required, as well as a 
good level of understanding about what a crystal energy landscape can or cannot say 
about the crystallisation behaviour of a molecule.1, 17, 18 Although there are some examples 
of CSP directing experimentalists towards the production of new polymorphs,36-39 this 
remains a rarity.18 Only once crystallisation kinetics is fully understood, and limitations to 
the search space are no longer required, CSP will become the definitive tool to design 
crystal structures with desired properties.7, 18 Until then it will remain an important tool for 
the pharmaceutical industry, but subject to ongoing developments. 
 
1.2.3 Molecular size and flexibility: effect on the computational cost of CSP 
 
Another problem that hinders a more routine use of organic CSP studies as a complement 
to polymorph screening is computational cost.1, 17 CSP studies are very computationally 
expensive, and the main reason is that the crystalline behaviour of organic molecules is 
dominated by weak intermolecular interactions,40 whose accurate modelling requires 
costly electronic structure calculations.1, 7, 9, 17 
  The computational cost of CSP studies is strongly dependent on molecular size 
and flexibility.1, 17, 41 As molecules get larger and more flexible the number of degrees of 
freedom that need to be modelled increases, causing an increment in the computational 
expense.1, 17, 42, 43 Figure 1.3 shows how in the 6th Blind Test of CSP the successful 
predictions of the crystal structure of large and flexible molecule XXVI were on average 
more than one order of magnitude more computationally expensive those of small and 
rigid molecule XXII.9 
 
Figure 1.3: Chemical diagram and average CPU cost of the successful predictions of the 
crystal structures of (left) molecule XXII (right) molecule XXVI in the 6th Blind Test of 
organic CSP. The average is for the 13 successful predictions of molecule XXII and two 
of molecule XXVI for which the computational expense is reported in the Blind Test 
publication.9  
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  Accurate CSP studies on molecules like XXVI require hundreds of thousands of 
CPU hours, which translates to weeks or months of use of computer clusters, depending 
on their size.1, 9 This is problematic for the pharmaceutical industry: since drug molecules 
are chosen for their biological activity, they tend to be very conformationally flexible.17, 44 
High-quality CSP studies are simply unaffordable for many molecules in drug 
development, and using current methods with standard computational resources it would 
not be possible to perform a CSP study on a molecule like ritonavir.17  Hence, a routine 
use of computational predictions in drug development requires more cost-effective CSP 
methodologies.  
 
1.3 Signposting contents of the thesis 
 
This thesis aims to develop ways to expand CSP studies towards larger and more flexible 
molecules of pharmaceutical interest, by reducing the computational cost of each portion 
of a CSP workflow and improving the analysis of the generated crystal structures to more 
effectively identify plausible polymorphs and separate them from duplicates. 
  Chapter 2 illustrates the theoretical and informatics methods used in this thesis 
to perform CSP and to compare and analyse crystal structures and molecular 
conformations. The functioning of the main computer algorithms is also described. In 
Chapter 3 the successful CSP study on large and flexible molecule XXVI that was 
undertaken in the context of the 6th Blind Test is discussed,9 while Chapter 4 illustrates a 
computational study on the antihelminthic drug mebendazole that was carried out as part 
of an academic solid form screening effort. These studies were both performed with 
traditional CSP workflows, and some issues related to computational cost, limitation of 
search space and the effect of molecular size and flexibility are examined. Following from 
these studies, Chapter 5 discusses how a methodology to use conformational information 
retrieved from the Cambridge Structural Database (CSD)45 to cut down the computational 
cost of CSP searches was developed and tested on molecule XXVI, mebendazole and 
three further flexible pharmaceutical molecules with previously published studies.41 
Chapter 6 analyses the importance of selecting which torsion and bond-angles are 
optimised as a function of solid-state interactions in the final minimisations of the crystal 
structures generated in CSP searches. This leads to Chapter 7, which examines the use 
of the semi-empirical quantum-mechanical method DFTB-D46 to reduce the computational 
cost of the final refinement of the crystal structures that had been generated in the 
searches described in Chapter 5.44 Chapter 8 then discusses how the CSD was mined to 
determine structural and crystallographic differences that can separate polymorphs from 
duplicates/redeterminations, and how a programme to cluster more efficiently                         
CSP-generated crystal structures was developed and tested. Finally, in Chapter 9 the 
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main conclusions that can be drawn from this thesis are illustrated and future steps in this 
area of research are suggested. 
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Chapter 2: Existing crystal structure prediction 
and informatics methods 
 
2.1 Introduction 
 
As mentioned in Chapter 1, successful crystal structure prediction (CSP) methodologies 
aim to determine which packing arrangements are the most thermodynamically stable. 
The thermodynamic stability of a crystal structure is determined by its free energy at 
given temperature and pressure conditions.1-3 In most CSP applications the 
thermodynamic stability is however approximated by lattice energy (Elatt), i.e. the energy 
required separate all the molecules in a static lattice at 0 K to an infinite distance in their 
lowest energy conformation.2, 4, 5 Although free energy estimates are becoming more 
established (see Chapter 2.3.3) they are generally performed only on some of the most 
promising crystal structures at the end of CSP workflows entirely based on Elatt 
minimisation.2  
 The accurate computation of Elatt requires a thorough understanding of the           
non-bonded interactions that occur between the molecules in the solid-state, as well as 
within the molecules themselves. Furthermore, an effective CSP study requires an 
accurate analysis and comparison of the generated crystal structures and their 
differences. This chapter outlines the methods that were used in this thesis to generate, 
rank, compare and analyse crystal structures of organic molecules. 
 
2.2 Intermolecular forces 
 
The presence of forces between the molecules that constitute matter is evident.6 The 
existence of solid and liquid phases shows that there are attractive forces between the 
molecules they are constituted of, as otherwise they would not remain confined. On the 
other hand, the difficulty in compressing solid and liquid phases to smaller volumes 
demonstrates that at short-ranges molecules repel each other. These observations are 
summarised in Figure 2.1, which shows how the potential energy between two spherical 
rigid molecules (U) changes as a function of their distance (R). The forces between 
molecules are related to the potential energy by:6  
 𝐹 = −
𝑑𝑈
𝑑𝑅
   2.1 
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Figure 2.1:  A typical energy vs distance plot for two rigid molecules; σ represents the 
distance at which U=0, and ε is the depth of the energy well. 
 Figure 2.1 shows that at long-range the forces between the molecules are 
attractive, as the derivative of U with respect to R is positive and F is negative, and at 
short-range they are repulsive. At equilibrium (the minimum in the curve), the forces 
acting on the molecules are null, and 𝑈 = −𝜀. 
 Intermolecular energy and forces are essentially of quantum-mechanical (QM) 
origin.6  Out of the four fundamental forces, strong and weak nuclear interactions are not 
relevant for objects of the size of molecules, while gravitational forces are present but so 
much weaker than electromagnetic forces that they can safely be ignored.7 Furthermore, 
magnetic interactions are extremely weak between closed-shell molecules and can also 
usually be neglected.6 Finally, resonance effects only arise for molecules in a degenerate 
electronic state, so they are not relevant for the ground state closed-shell molecules this 
thesis is focused on.6  
 Several distinct contributions to intermolecular forces exist, which are commonly 
separated into short- and long-range, depending on where they are the most relevant. 
 
  2.2.1 Long-range forces 
 
Long-range intermolecular forces are easily described when molecules are at long 
distances from one another, i.e. their wave-functions do not overlap.6 However, these 
forces act also at shorter distances, in a modified form that is more complex to describe 
(see Chapter 2.2.2.2). They decay as a function of an inverse power of distance, R-n.6  
 Intermolecular forces can be understood in terms of perturbation theory, which 
finds the approximate solution to a problem from the exact solution to another problem.8 
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 For two infinitely separated molecules A and B, their time independent 
Schrödinger’s equations can be written as: 
 𝐻𝐴
0𝛹𝐴
0 = 𝐸𝐴
0𝛹𝐴
0  2.2 
 𝐻𝐵
0𝛹𝐵
0 = 𝐸𝐵
0𝛹𝐵
0  2.3 
and for the combined system: 
 𝐻𝐴𝐵
0 𝛹𝐴𝐵
0 = 𝐸𝐴𝐵
0 𝛹𝐴𝐵
0   2.4 
 𝐻𝐴𝐵
0 = 𝐻𝐴
0 +  𝐻𝐵
0  2.5 
 𝐸𝐴𝐵
0 = 𝐸𝐴
0 + 𝐸𝐵
0  2.6 
 where H0 indicates the Hamiltonian of the unperturbed ground state, E0 the 
corresponding energy and Ψ0 the unperturbed wave-function, which corresponds for the 
combined system corresponds to:6 
 𝛹𝐴𝐵
0 = 𝛹𝐴
0𝛹𝐵
0  2.7 
 Note that at long-range this wave-function does not require anti-symmetrisation, 
as there is no overlap of the wave-functions of molecules A and B (i.e. the electrons 
clearly belong to either A and B).6 This complicates the theory at short-ranges, where 
anti-symmetrisation is instead required (see Chapter 2.2.2). 
 The perturbation from the ground state derives from the electrostatic interactions 
between the electrons and nuclei of molecules A and B. The perturbed Hamiltonian for 
the combined system can then be written as:6 
  𝐻𝐴𝐵 = 𝐻𝐴𝐵
0 + 𝐻′ = 𝐻𝐴
0 + 𝐻𝐵
0  + 𝐻′  2.8 
 the perturbation term H’ corresponds to: 
  𝐻′ = ∑ ∑
𝑒𝑎𝑒𝑏
4𝜋𝜀0𝑅𝑎𝑏
𝑏∈𝐵𝑎∈𝐴   2.9 
 where a and b are the electrons and nuclei in molecules A and B respectively, ea 
and eb are their charges, Rab their distance and ε0 is the permittivity of free space.  
 Using Rayleigh-Schrödinger perturbation theory,9 the overall energy of the 
perturbed system can be expanded as: 
 𝐸𝐴𝐵 = 𝐸𝐴𝐵
0 + 𝐸𝐴𝐵
′ + 𝐸𝐴𝐵
′′ +. ..   2.10 
 the first order term (𝐸𝐴𝐵
′ ) describes the classical electrostatic interactions between 
molecules A and B, and the second order term (𝐸𝐴𝐵
′′ ) describes the induction and 
dispersion interactions.6 Higher order terms are neglected as the series converges 
rapidly and so they have a negligible contribution to EAB.6 
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2.2.1.1 Electrostatics 
 
Electrostatic interactions are the classical Coulombic interactions between the 
unperturbed molecular charge densities. Using the first order term in equation 2.10, the 
electrostatic energy can be defined as:6 
 𝑈𝑒𝑙𝑒𝑐 = 𝐸𝐴𝐵
′ = ⟨𝛹𝐴
0𝛹𝐵
0|𝐻′|𝛹𝐴
0𝛹𝐵
0⟩ = ∫
𝜌𝐴(𝑟)𝜌𝐵(𝑟
′)
4𝜋𝜖0|𝑟−𝑟′|
𝑑3𝑟 𝑑3𝑟′  2.11 
 where ρ is the charge density around molecules A and B and points in space r 
and r’ respectively. Uelec can be either attractive (i.e. Uelec < 0) or repulsive (i.e Uelec >0) 
depending on the orientation of ρA and ρB. As a classical Coulombic interaction, Uelec is 
strictly pairwise additive.6 This means that for three molecules A, B and C: 
 𝑈𝑒𝑙𝑒𝑐
𝐴𝐵𝐶 = 𝑈𝑒𝑙𝑒𝑐
𝐴𝐵 + 𝑈𝑒𝑙𝑒𝑐
𝐴𝐶 + 𝑈𝑒𝑙𝑒𝑐
𝐵𝐶   2.12 
 the same would be true for any number of molecules, and this property makes 
the computation of electrostatic interactions relatively simple. The charge density around 
molecules can be modelled in terms of isotropic atomic point charges (see Chapter 
2.3.1.2.1). However, a more accurate approach that is used throughout most of this 
thesis is to model ρ in terms of a distributed multipole expansion around atomic sites; 
this is explained in detail in Chapter 2.3.1.2.2. In a multipole expansion of the charge 
density, the leading term describes the interaction between two ground-state charges 
and decays with R-1.6, 10 
 
2.2.1.2 Induction 
 
Induction (also known as polarisation) interactions are a component of the second order 
term in Equation 2.10.6 Continuing with the example of two molecules A and B, induction 
describes the interaction between the unperturbed charge density of A and the charge 
density of B modified by the presence of A, and vice-versa. Hence: 
𝑈𝑖𝑛𝑑
𝐴𝐵 =𝑈𝑖𝑛𝑑
𝐴 + 𝑈𝑖𝑛𝑑
𝐵 = − ∑
⟨𝛹𝐴
0𝛹𝐵
0
|𝐻′|𝛹𝐴
𝑚𝛹𝐵
0
⟩⟨𝛹𝐴
𝑚𝛹𝐵
0
|𝐻′|𝛹𝐴
0𝛹𝐵
0
⟩
𝐸𝐴
𝑚−𝐸𝐴
0𝑚≠0  
 − ∑
⟨𝛹𝐴
0𝛹𝐵
0
|𝐻′|𝛹𝐴
0𝛹𝐵
𝑛
⟩⟨𝛹𝐴
0𝛹𝐵
𝑛
|𝐻′|𝛹𝐴
0𝛹𝐵
0
⟩
𝐸𝐵
𝑛−𝐸𝐵
0𝑛≠0   2.13 
 where m and n are excited states of molecules A and B respectively. In the first 
term of Equation 2.13 the charge density of molecule B modifies the one of molecule A, 
which interacts with the electric field of molecule B, and vice-versa for the second term. 
 Induction interactions are always attractive and are not pairwise addictive.6 The 
reason is that in the presence of multiple molecules, each has its charge density modified 
by the electric field caused by the presence of all the other molecules. The charge density 
around each molecule will then feel the changed electric field of its neighbours, and get 
modified as a consequence; the effect goes on until induction is completely converged.11 
In a multipole expansion, the leading term (charge-induced dipole) decays with R-4.6 
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 The strength of Uind depends on the ease of distortion of the molecular charge 
density under the effect of an external electric field, or polarizability. For non-spherical 
molecules polarizabilities are very anisotropic, and they are defined by a tensor 
describing how much a molecular charge distribution can be modified by an electric field 
in the x, y and z directions.6, 12 Polarizabilities can be calculated quantum-mechanically, 
making it possible for a many-body system like a crystal structure to calculate Uind 
through an iterative process.6 However, this is very computationally demanding, since 
high quality basis sets and wave-functions are required to compute accurate 
polarizabilities.12 For this reason, in this thesis induction was not modelled explicitly. 
However, for some calculations its effect was estimated with a polarisable continuum 
model (PCM),13 which is described in Chapter 2.3.1.4. 
 
2.2.1.3 Dispersion 
 
Dispersion is a universal attractive interaction of exclusive QM origin, and is a component 
of the second order term in Equation 2.10.6 It derives from the constant fluctuation of the 
molecular electron densities, which creates instantaneous dipoles (as well as higher 
order multipoles, see Chapter 2.3.1.2.2) in a molecule. These dipoles induce dipoles in 
other molecules, creating an instantaneous correlation of their charge densities, which 
lowers the overall energy.6 Without dispersion spherical neutral molecules could not form 
condensed states.14 While induction is a static interaction, dispersion is frequency 
dependent. In terms of perturbation theory as, it is described as: 
 𝑈𝑑𝑖𝑠𝑝 = − ∑ ∑
⟨𝛹𝐴
0𝛹𝐵
0
|𝐻′|𝛹𝐴
𝑚𝛹𝐵
𝑛
⟩⟨𝛹𝐴
𝑚𝛹𝐵
𝑛
|𝐻′|𝛹𝐴
0𝛹𝐵
0
⟩
𝐸𝐴
𝑚+𝐸𝐵
𝑛−𝐸𝐴
0−𝐸𝐵
0𝑛≠0𝑚≠0   2.14 
 dispersion interactions are approximately pairwise addictive, although many-
body terms can have important effects.6 The leading term in a multipole expansion 
(induced dipole-induced dipole) decays with R-6.6 
 Similarly to induction, the molecule-specific dispersion coefficients can be 
calculated from the polarizabilities. However, in this thesis dispersion was modelled 
through empirically-fitted parameters;3, 15 more details can be found in Chapter 2.3.1.2.3. 
 
2.2.2 Short-range forces 
 
Short-range interactions arise when molecules are at short distances from one another, 
so that their wave-functions overlap. They decay with the exponential e-αR.6 
 The perturbation theory for intermolecular forces at short distances is strongly 
complicated by the need to anti-symmetrise the wave-function in Equation 2.7,6 and 
contrary to their long-range counterparts short-range interactions cannot be computed 
analytically. 
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2.2.2.1 Exchange-repulsion 
 
Exchange-repulsion interactions derive from the overlap of the molecular electron 
clouds. The exchange term is attractive, and is due to electrons being free to occupy the 
orbitals over both molecules.6 The repulsion term is, as the word suggests, repulsive, 
and derives from the Pauli exclusion principles: electrons try to occupy the same area of 
space, but they are forbidden to be in the same orbitals unless they have opposite spin.6 
Overall, the repulsion term dominates, which makes exchange-repulsion interactions 
increasingly repulsive at short-ranges (this explains the short-range wall in Figure 2.1): 
 𝑈𝑒𝑟 = 𝑈𝑒𝑥𝑐ℎ + 𝑈𝑟𝑒𝑝 > 0  2.15 
 Uer is approximately pairwise additive,6 and is generally expressed in the form of 
a repulsive atom-atom potential parametrised from experimental data or ab initio 
calculations. Parametrisation to ab initio data is more accurate but more computationally 
demanding,16, 17 and in this thesis short-range interactions were modelled with an 
empirically-fitted potential (see Section 2.3.1.2.3). 
 
2.2.2.2 Other short-range terms 
 
As mentioned in Chapter 2.2.1, the long-range interactions are also present at small 
distances, but they are modified by the overlap of the electron clouds around the 
molecules.  
 Charge-penetration is a short-range modification of the electrostatic energy. 
Where the electron densities overlap, the nuclei of one molecule are no longer 
completely shielded from the electrons of the other molecule.18 Charge-penetration is 
generally attractive, although it becomes repulsive at very short distances, and is 
pairwise additive.19 
 Charge-transfer is a short-range modification of the induction energy, due to the 
interaction between donors and acceptors. Electrons are transferred from the high 
energy occupied orbitals of the donor to the low energy unoccupied orbitals of the 
acceptor. Charge-transfer interactions are attractive and are not pairwise addictive.6 
 Finally, damping is a correction to account for exchange-induction and exchange-
dispersion, which are the modifications to induction and dispersion interactions due to 
the anti-symmetrisation of the wave-functions.6 
 Overall, the net effect of these interactions is small compared to Uer ,6 and it is 
assumed they are absorbed in the parametrisation of the short-term repulsive potential. 
 
2.3 Determining the thermodynamic stability of crystal structures 
 
A realistic description of the interactions between molecules in organic crystalline solids, 
which are the subjects of this thesis, requires an accurate understanding of the electronic 
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structure. Since the exclusive use of standard transferable force-fields that consider only 
nuclear positions has proven unreliable in CSP,15, 20, 21 at least some ab initio electronic 
structure calculations are required. In this section the two most common ways to model 
the energy of crystal structures in CSP are described, which are referred to as the Ψmol 
and the Ψcrys methods. 
 
2.3.1 The Ψmol method 
 
In Chapter 2.2 intermolecular interactions were described through perturbation theory. It 
requires firstly to solve the Schrödinger’s equation of the individual molecules, and then 
to calculate the intermolecular interactions as a perturbation of their ground-state 
molecular wave-functions. In most of this thesis, an approach based on this theory was 
used to determine the thermodynamic stability of crystal structures was utilised, and it 
can be referred to as the Ψmol method.4, 22-24 After calculating the individual molecular 
wave-functions (i.e. the Ψmol), the intermolecular interactions are computed as the sum 
of the interactions between the atoms of different molecules. Crystalline symmetry 
simplifies the problem, since costly ab initio calculations are required only for molecules 
that are not related by symmetry operations20 (symmetry related molecules have the 
same nuclear positions and so by definition the same ground-state wave-functions). 
Within the Ψmol formalism, Elatt can be defined as:10, 15, 25 
 𝐸𝑙𝑎𝑡𝑡 = 𝑈𝑖𝑛𝑡𝑒𝑟 + ∆𝐸𝑖𝑛𝑡𝑟𝑎  2.16 
 where the intermolecular energy term, Uinter, is the sum of all the interactions 
between molecules, and ΔEintra is defined as the intramolecular energy penalty. Note that 
Elatt must be negative in a crystal structure, otherwise it would not form.  
 
 2.3.1.1 Intramolecular energy penalty (ΔEintra) 
 
In the Ψmol method intermolecular interactions do not directly change the molecular 
conformation/s, as they are calculated from ground-state wave-functions.6 
Conformational distortions are negligible for very rigid molecules (e.g. benzene), for 
which Elatt ≈ Uinter.15, 26 However, flexible molecules can adopt different configurations that 
allow to minimise Uinter (and consequently Elatt) in Equation 2.16.26, 27 Within the Ψmol 
framework, this is accounted for by the ΔEintra term, which is the difference between the 
conformational energy of a molecule with a configuration corresponding to that in a 
crystal structure and that of the lowest energy conformer/s of the isolated molecule/s 
(also referred to as gas-phase energy).15, 28, 29 If the conformational energy of the 
isolated-molecule global minimum is known, ΔEintra can be calculated from the molecular 
wave-function; this calculation allows to also determine how the charge density varies 
for different conformations, which can be used to compute Uinter: 
 ∆𝐸𝑖𝑛𝑡𝑟𝑎 = 𝐸𝑐𝑟𝑦𝑠𝑡𝑎𝑙𝑙𝑖𝑛𝑒 𝑚𝑜𝑙𝑒𝑐𝑢𝑙𝑎𝑟 𝑐𝑜𝑛𝑓𝑜𝑟𝑚𝑎𝑡𝑖𝑜𝑛
𝑔𝑎𝑠−𝑝ℎ𝑎𝑠𝑒 − 𝐸𝑔𝑙𝑜𝑏𝑎𝑙 𝑚𝑖𝑛𝑖𝑚𝑢𝑚
𝑔𝑎𝑠−𝑝ℎ𝑎𝑠𝑒   2.17 
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 ΔEintra values are very dependent on the level of theory chosen for the calculation 
of the molecular wave-function.30 In this thesis, density functional theory with the hybrid 
PBE0 6-31G(d,p) functional was utilised. PBE0 has proven to be successful in several 
high-quality CSP studies and provides a good balance between quality and 
computational cost.2, 31-33  All the wave-function calculations with the Ψmol methods were 
performed with the Gaussian code.34, 35 
 As the name ‘penalty’ suggest, ΔEintra is always a positive number. Despite being 
negligible for rigid molecules, no crystalline conformation is completely undistorted from 
an isolated-molecule conformer.27 In most experimentally known crystal structures ΔEintra 
is small, generally below 5-10 kJ·mol-1 and very rarely above 20-25 kJ·mol-1,27, 36, 37 as 
improvements in intermolecular interactions cannot generally compensate for large 
conformational energy penalties. However, crystal structures with large ΔEintra values 
exist, and this is often associated with a competition between intra- and intermolecular 
hydrogen bonds27 or between folded and extended conformations.36 In the presence of 
several torsion angles (or dihedral angles; in this thesis these two terms are used 
interchangeably) with low-energy barriers to rotation a wide range of low-energy 
conformations can exist, which adds to the complexity of the CSP problem. 
 In their review on conformational polymorphism, Cruz Cabeza and Bernstein27 
distinguished between conformational adjustment and conformational change. 
Conformational adjustment is defined as a slight change from a gas-phase conformer 
that a molecule undergoes in the crystal to minimise Uinter, but still within the same 
isolated-molecule conformational energy well (i.e. the crystalline geometry, when 
isolated, optimises to the same gas-phase minimum in conformational energy). On the 
other hand, conformational change requires that the molecule in the crystal structure 
belongs to a different conformational energy well (i.e. the crystalline geometry, when 
isolated, does not optimise to the same gas-phase minimum in conformational energy). 
Polymorphs related by conformational change can be classified as conformational 
polymorphs, while those related by adjustment simply as polymorphs.27 
 
2.3.1.2 Intermolecular energy (Uinter) 
 
In the Ψmol method Uinter is modelled with a potential that calculates the intermolecular 
interactions of the molecules, treated as rigid-bodies,10, 29 using some of the long- and 
short-range terms that have been listed in Chapter 2.2. There are several potentials that 
can be used to model Uinter within the Ψmol formalism. The most accurate ones are 
completely non-empirical and require ab initio calculations of polarizability to model 
induction and dispersion interactions analytically, as well as a parametrisation of the 
short-range interactions from electronic structure data.16, 17 However, producing these 
accurate and theoretically compelling potentials is computationally expensive and by no 
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means routine, in particular for large and flexible molecules. Hence the potential utilised 
in this thesis to model Uinter contains a mixture of empirically-fitted and ab initio-derived 
terms: 
 𝑈𝑖𝑛𝑡𝑒𝑟 = 𝑈𝑒𝑙𝑒𝑐 + 𝑈𝑟𝑒𝑝−𝑑𝑖𝑠𝑝  2.18 
 where Uelec is the electrostatic energy calculated from atomic point charges or 
from distributed multipoles expanded around atom sites, which are derived from the ab 
initio wave-functions, and Urep-disp is a transferable empirically-fitted potential that 
describes repulsion and dispersion interactions; note that induction is not explicitly 
modelled in Equation 2.18.  
 
2.3.1.2.1 Uelec from point charges 
 
Electrostatic interactions are a fundamental component of intermolecular forces, and of 
very limited transferability.38 The potential in Equation 2.18 is an atom-atom potential. 
Hence the calculation of Uelec requires to partition the molecular charge density into atom 
sites to allow the pairwise summation of the electrostatic interactions between each 
molecule under consideration.  
 The simplest and computationally cheapest way to partition the charge density is 
a division into isotropic (i.e. spherical) point-charges placed around each atom.6 Within 
this model, the electrostatic energy between two atoms i, j in two molecules A and B can 
be written as: 
 𝑈𝑒𝑙𝑒𝑐
𝑖𝑗 =
1
4𝜋𝜀0
𝑞𝑖𝑞𝑗
𝑅𝑖𝑗
  2.19 
 Where qi and qj are the point charges at atoms i and j and Rij is the distance 
between these atoms. This model is very simple and broadly independent of molecular 
conformation.6 In this thesis, atomic point charges were used to compute the electrostatic 
component of intermolecular energy in the crystal structure searches, which were 
performed with CrystalPredictor (see Chapter 2.4.1.2 for details). However, this 
approach has the weakness of describing the charge density around each atom as a 
sphere, and as such it cannot describe directional features such as lone pairs and π 
electrons.6, 15 This is particularly important for molecules that are close to one another, 
as they often are in crystals, while at longer-ranges the model becomes more adequate 
since higher order non-spherical terms decay more quickly with distance.6  Additional 
expansion sites can be added to overcome some of the directionality problems, but this 
is an arbitrary correction that also increases the computational expense of the fitting.6 
 There are several methods to partition the charge density into atomic point 
charges. In this thesis is the CHELPG method (CHarges from Electrostatic Potential 
using a Grid based method)39 was utilised. Atomic charges are fitted via a least-square 
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procedure from the ab initio calculated charge density evaluated on a grid of points 
around the molecule, guaranteeing that the total molecular charge is correct.39 
 
2.3.1.2.2 Uelec from distributed multipoles 
 
A more accurate way to represent the charge density is through multipole expansion.6 
The zeroth order (i.e. l=0) multiple moment is the total charge (q), which is independent 
of direction:  
 𝑞 = ∑ 𝑒𝑎𝑎   2.20 
 where ea is the charge on each electron and nucleus. No integration is required 
to calculate q. The first order moment (l=1) is the dipole (μ), which describes the 
separation of equal and opposite charges along a linear vector:6 
 𝜇𝛼 = ∫ 𝜌(𝒓)𝑟𝛼𝑑
3𝒓  2.21 
 where ρ(r) is the charge density at point r and α stands for either x, y or z. A 
typical example of a dipole is the one formed by water, as shown in Figure 2.2. 
 
Figure 2.2: Schematics of the dipole moment in water. 
 The second order term (l=2) arises when two equal dipoles are located nearby 
so that their net dipole moment is zero, but as their positive charges overlap they have 
net non-zero moment called quadrupole (θ):6 
 𝜃𝛼𝛽 = ∫ 𝜌(𝒓)(
3
2
𝑟𝛼𝑟𝛽 −
1
2
𝑟𝛼𝛿𝛼𝛽)𝑑
3𝒓  2.22 
  where α and β stand for either x, y or z and δ is the Kronecker delta. The θαβ 
matrix is traceless (i.e. θxx+θyy+θzz=0), and symmetric with permutation of indices (i.e. 
θxz=θzx), meaning that only five independent quadrupole moments exist.6 An example is 
the quadrupole moment around a benzene ring, shown in Figure 2.3. 
 
Figure 2.3: Schematics of the quadrupole moment around a benzene ring. 
 The third order term (l=3) is the octopole, which represents the overlap of the 
positive charges of four dipoles in a three-dimensional array, the fourth order term (l=4) 
is the hexadecapole and so on.6 
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 In a multipole expansion, Uelec decays with the negative n
th power of distance 
between two multipoles a and b, where:6 
 𝑛 = 𝑙𝑎 + 𝑙𝑏 + 1  2.23 
 hence Uelec between two charges decays with 𝑅𝐴𝐵
−1, between a dipole and a charge 
with 𝑅𝐴𝐵
−2 and so on. Note that since multipole moments with 𝑙 > 0 are orientation 
dependent, their interaction leads to torques and non-central forces.10 
 Although multipoles could be expanded around a single site for a whole molecule, 
better convergence is obtained when they are expanded around several specific sites, 
which are often atomic nuclei. This approach is called ‘distributed multipole expansion’.6 
There are several ways of partitioning the molecular charge density to define the 
multipole expansion around each atom; the one that was utilised in this thesis is the 
Distributed Multipole Analysis (DMA) developed by Stone.40 It requires that the molecular 
wave-function is calculated using a Gaussian basis set, i.e. that the basis set consists of 
a series of Gaussian orbitals around each atom. The DMA uses the properties of 
Gaussian orbitals to fit multipole moments at specific sites around each atom.40 In this 
thesis, the programme Gaussian Distributed Multipole Analysis (GDMA)41 was used to 
fit distributed multipoles from molecular wave-functions calculated with Gaussian up to 
fourth order terms (i.e. charges, dipoles, quadrupoles, octopoles and hexadecapoles). 
  This approach solves the lack of directionality of the point charge model, as 
multipoles around each atom are highly anisotropic; for example dipole moments can 
naturally represent lone pairs, and quadrupole moments can represent π electrons.6, 15 
Distributed multipoles have been proven to provide more accurate energy rankings in 
CSP studies than point charges.42 
 
2.3.1.2.3 Urep-disp 
 
The remaining intermolecular interactions in Equation 2.18 were modelled in this thesis 
with an isotropic Buckingham atom-atom exp-6 potential.3, 15, 29, 43 For two molecules A 
and B: 
 𝑈𝑟𝑒𝑝−𝑑𝑖𝑠𝑝
𝐴𝐵 =  𝑈𝑟𝑒𝑝
𝐴𝐵 + 𝑈𝑑𝑖𝑠𝑝
𝐴𝐵 = ∑ 𝐴𝜄𝜅 𝑒𝑥𝑝(−𝐵𝜄𝜅𝑅𝜄𝜅) −
𝐶𝜄𝜅
𝑅𝜄𝜅
6𝑖∈𝐴,𝑘∈𝐵   2.24 
 where ι is the type of atom i, κ the type of atom k, and Rικ is the distance between 
these two atoms. The positive term in Equation 2.24 describes the short-range repulsive 
interactions, while the negative term the long-range attractive dispersion interactions. 
Other intermolecular interactions are assumed to be absorbed in the fitting. 
 A, B and C are the empirically fitted parameters, and they are specific to the 
atomic species and sometimes also to the atomic connectivity, e.g. an H atom bonded 
to N has different parameters from when it is bonded to C. Parameters for each pair of 
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atoms are not always fitted explicitly. Combining rules can be used to calculate the 
missing parameters,44 as: 
 𝐴𝜄𝜅 = √𝐴𝜄𝜄 + 𝐴𝜅𝜅;  𝐵𝜄𝜅 =
1
2
(𝐵𝜄𝜄 + 𝐵𝜅𝜅); 𝐶𝜄𝜅 = √𝐶𝜄𝜄 + 𝐶𝜅𝜅  2.25 
 although combining rules can lead to some inaccuracies,43 they are generally 
found to be broadly applicable.6 In this thesis, the FIT parameters45 were used to model 
Urep-disp. They were fitted to a variety of crystal structures: apolar hydrogen, carbon and 
nitrogen were fitted to azahydrocarbon crystal structures,46 oxygen to oxohydrocarbon 
crystal structures,47 and polar hydrogen to a set of azabenzenes, nitrobenzenes and 
other simple molecules that contain intermolecular hydrogen bonds.45 Parameters were 
also fitted separately for chlorine48 and fluorine.49 In the FIT potential each atomic species 
is treated in the same way irrespective of the connectivity, with the exception of polar 
and apolar hydrogens.  
 The FIT potential has some shortcomings. First of all, induction interactions are 
not explicitly modelled, but their effect is absorbed in the empirical fitting. This increases 
the risk of double counting if induction were to be included in Uinter.10, 12 The dispersion 
interactions are also not damped, which can lead to inaccurate short-term behaviours.17 
Furthermore, its parameters are fitted to crystal structures at room temperature, so they 
are not entirely consistent with a CSP procedure that calculates Elatt at 0 K, as they will 
have absorbed thermal expansion effects. The FIT parameters are also completely 
isotropic (i.e. each atom is treated as a sphere), and do not include many-body effects 
and higher order dispersion terms. Finally the FIT parameters were fitted in combination 
of Uelec values calculated from a wave-function determined at the HF/ 6-31G(d,p) level of 
theory,45 and this complicates their transferability when charge densities are computed 
with different models. For these reasons new A, B and C parameters are being 
developed, either empirically-fitted with charge densities computed at specific levels of 
theory43, 44 or in the form of non-empirical potentials.16, 17  
 However, fitting these more accurate potentials is not routine and very 
computationally demanding. Furthermore, the FIT potential has proven to be very 
effective in CSP, and has recently been found capable to reproduce absolute energies 
as accurately as some more complex and computationally expensive Ψcrys (see Chapter 
2.3.2) models.50 Hence it was confidently used in this thesis to calculate Uinter within the 
Ψmol formalism. 
 
2.3.1.2.4 The polarisable continuum model (PCM) 
 
As already mentioned, the Uinter model in Equation 2.18 ignores induction interactions. 
However, induction can play a significant role in both absolute and relative energies of 
crystal structures, especially when they have different hydrogen bond patterns.12, 51 
Although induction can be modelled in the Ψmol method,10 this was not done in this thesis.  
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 An alternative way to estimate the effect of polarisation on Elatt is calculating the 
molecular wave-function/s with a polarisable continuum model (PCM). The polarisable 
continuum is generally used to study solvation of a solvent around a solute of interest 
(i.e. the electrostatic interactions that stabilise the solute losing a H+ ion in a solvent).13 
PCM calculations can be performed with Gaussian, where a polarisable continuum 
surrounds a cavity defined by the solvent-excluded surface of the molecule (the solvent 
is assumed to be water). The cavity is calculated by atomic or group spheres plus extra 
spheres to smoothen the surface.34 By calculating the wave-function in a PCM, the effect 
of induction on Elatt should be modelled without the need of introducing an explicit 
intermolecular term. However, the exact dielectric constant (ε) of the solid-state 
environment around the molecule is not exactly known, and the PCM simply introduces 
an average polarisation effect that is independent of the specific crystal structure.52 
Furthermore, there is a risk of double counting induction effects modelled by the PCM 
with those that have been accidentally included in the empirical fitting of Urep-disp. 
Nevertheless, Cooper et al. showed how the inclusion of a PCM helps to improve the 
relative ranking of crystal structures matching experimental forms relative to other 
predicted but unfound alternatives.52 Their suggested dielectric constant of ε=3 for 
neutral organic molecules,52 which seems to be typical for this kind of crystals,51 was 
used in Chapters 3 and 4 to recalculate Elatt values after the completion of the CSP 
workflow, with the aim of estimating the changes in relative stability that may arise from 
including induction. Note that the polarisable continuum was not used to fully-optimise 
crystal structures, but only to calculate polarised molecular wave-function/s and use 
them to recalculate ΔEintra and to re-optimise Uinter with DMACRYS. Details of the 
functioning of DMACRYS can be found in Chapter 2.4.2.1. 
 
2.3.2 The Ψcrys method 
 
The Ψmol method is based on separating intra- and intermolecular interactions. However, 
the crystal structure itself can be modelled as an assembly of nuclei and electrons, on 
which to perform ab initio calculations.6  This can be referred to as the ‘supermolecule’ 
method, or Ψcrys, as crystalline and not molecular wave-functions are calculated.6 Within 
this formalism, the lattice energy of can be calculated as:  
 𝐸𝑙𝑎𝑡𝑡 =
𝐸𝑐𝑟𝑦𝑠
𝑍
− 𝐸𝑔𝑙𝑜𝑏𝑎𝑙 𝑚𝑖𝑛𝑖𝑚𝑢𝑚
𝑔𝑎𝑠−𝑝ℎ𝑎𝑠𝑒   2.26 
 where Ecrys is the energy of the crystalline ‘supermolecule’ and Z is the number 
of molecules in the primitive unit cell.  
 There are several methods that can be used to perform calculations with the Ψcrys 
method, ranging from periodic MP2 algorithms to Diffusion Monte Carlo and fragment 
based approaches.53 However, successful CSP workflows have to perform Ψcrys 
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calculations on hundreds, if not thousands, crystal structures and so they currently use 
cost-effective periodic density functional theory (DFT).2  
 
2.3.2.1 Periodic density functional theory 
 
Periodic DFT methods were not directly used in this thesis, mainly because of their 
relatively high computational expense. However, introducing them is fundamental as 
they are becoming increasingly prevalent in CSP: in the latest Sixth Blind Test of organic 
CSP (see Chapter 3.1.1), 12 groups used periodic DFT,2 while only two groups had done 
the same in the Fifth Blind Test,54 where Ψmol methods were still the norm.  
 With the Born-Oppenheimer approximation55 (i.e. the position of nuclei is fixed), 
DFT calculates the energy as a functional of the electron density ρ(r), using the method 
proposed by Kohn and Sham:56 
 𝐸𝐷𝐹𝑇[𝜌] = 𝐸𝑁𝐸[𝜌(𝑟)] + 𝑇𝑠[𝜌(𝑟)] + 𝐽[𝜌(𝑟)] + 𝐸𝑋𝐶[𝜌(𝑟)]  2.27 
Hohenberg and Kohn proved that EDFT is in principle exact.57 The terms ENE (the 
potential energy between nuclei and electrons), Ts (the non-interacting component of the 
kinetic energy of the electrons) and J (the classic Coulombic repulsion between 
electrons) can be calculated exactly. However, EXC (the exchange and correlation 
functional), which describes non-classical interactions between electrons, is not known 
exactly and must be approximated.53, 58 Several EXC functionals have been developed. 
In CSP generalised gradient approximation (GGA) functionals are commonly used, 
which are dependent on ρ(r) and its gradient.58 
 There are several reasons why periodic DFT is becoming increasingly prevalent 
in CSP.  First of all, despite being more computationally demanding than Ψmol methods, 
periodic DFT is still relatively cheap compared to other Ψcrys approaches such as periodic 
correlated wave-functions methods, while being more accurate, in principle, than 
periodic HF methods, because it includes some description of electron correlation.53, 59 
The increase in the power of computers and the presence of several high-quality,          
well-maintained and optimised codes60-63 to perform periodic DFT is decreasing the          
cost-barrier for use in CSP. Also periodic DFT is generally more accurate than Ψmol 
methods.50 There are several reasons: first of all, calculating the wave-function for a 
whole crystal structure does not require the somewhat artificial separation of inter- and 
intermolecular interactions, and all crystalline degrees of freedom can be optimised at 
the same time. On the other hands, Ψmol methods can only afford to optimise some 
selected molecular conformational degrees of freedom (CDFs) in response to solid-state 
interactions (the limitations of this approach are discussed in details in Chapter 6).64 
Furthermore, periodic DFT naturally calculates intra- and intermolecular interactions, 
including repulsion, electrostatics and induction, without needing any parametrisation to 
ab initio or experimental data, as well as approximations like the truncation of the 
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multipole series and pairwise additivity. This eliminates the need of selecting a potential 
that is adequate for the system of interest. 
 However, periodic DFT has some weaknesses. First of all, there is no systematic 
way to improve the quality of the wave-function,65 and hence no guarantee that the 
quality of the calculations for one system would be the same if identical methods were 
applied to another. Energies of sub-kJ·mol-1 accuracy can only be obtained with 
extremely expensive periodic correlated wave-function methods such as coupled 
cluster.66 Furthermore, most periodic DFT methods in CSP use plane-wave basis sets 
to compute the molecular wave-function,2 which makes the use of functionals that include 
exact exchange, such as PBE0 or B3LYP, very computationally inefficient.67, 68 In 
general, Ψmol methods can afford to compute wave-functions at higher levels of theory 
than Ψcrys methods. Finally, the functionals used in periodic DFT to calculate exchange 
and correlation interactions depend on the local charge density. Hence they do not model 
dispersion interactions that derive from non-local electron correlation, and periodic DFT 
tends to be severely under-binding.69 The most common solution is the use of  
dispersion-corrected DFT (DFT-D),2, 70 where a dispersion correction is added to EDFT in 
Equation 2.27: 
 𝐸𝐷𝐹𝑇−𝐷 = 𝐸𝐷𝐹𝑇 + 𝐸𝑑𝑖𝑠𝑝  2.28 
 all common forms of Edisp are composed of an attractive asymptotic –Cn/R
n term, 
where n is the order of the dispersion correction (often n=6 for dipole-dipole interactions, 
but sometimes higher order terms are included), and a damping parameter to limit the 
effect of the correction at short-ranges where the correlation functionals are      
sufficient.70, 71 Older dispersion corrections are empirically fitted to experimental       
data,72, 73 while in more state-of-the-art ones like XDM,74 D371 and TS75 the Cn parameters 
are geometry-dependent or calculated from ab initio polarizabilities. These corrections 
are all pairwise, and a more recent many-body dispersion (MBD) correction proposed by 
Tkatchenko et al. seems to improve the results even further.76 
 
2.3.2.2 Semi-empirical quantum-mechanical methods 
 
Although accurate, periodic DFT methods are computationally demanding, in particular 
for CSP studies of large and flexible molecules where the spectrum of possible packings 
is enormous and thousands crystal structures often need to be optimised.77 As already 
mentioned, completely transferrable force-fields are not a suitable alternative.                
Semi-empirical QM methods could be a solution to affordably yet accurately optimise 
thousands of crystal structures in CSP workflows.24, 77, 78 They start from standard ab 
initio methods and apply a minimal basis set and substantial systematic 
approximations.79 The lowering in the quality of the wave-function is compensated by a 
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reduction of the computational expense of several orders of magnitude compared to 
standard periodic Ψcrys methods.79 Semi-empirical QM methods have been applied to 
large chemical and biochemical systems,79 but they have never been used in CSP. There 
are several kinds of semi-empirical methods, but they can be broadly divided into two 
families: those derived from molecular orbital theory, and those derived from DFT, which 
take the name of density functional tight-binding (DFTB).78, 79 DFTB methods were used 
in this thesis. 
  
2.3.2.2.1 Density functional tight-binding 
 
DFTB represents the DFT energy in Equation 2.27 as a Taylor expansion around a 
reference electron density ρ0, which is calculated for neutral atoms.79 Hence, the total 
energy is written in terms of a deviation δρ from this reference: 
 𝐸[𝜌] = 𝐸0[𝜌0] + 𝐸
1[𝜌0, 𝛿𝜌] + 𝐸
2[𝜌0, (𝛿𝜌)
2] + 𝐸3[𝜌0, (𝛿𝜌)
3] + ⋯  2.29 
 DFTB1 only expands E to the first order term, DFTB2 to the second order and 
DFTB3, which was used in this thesis, to the third order.79  
 All terms in Equation 2.29 are subject to approximations. E0[ρ0]  represents the 
superimposition of the charge density of neutral atoms, and as such it is independent of 
the chemical environment and can be parametrised to DFT or experimental data.79, 80 In 
DFTB, the zeroth order term takes the form of an atom-atom potential that describes 
short-range repulsive interactions between nearest-neighbours:79 
 𝐸0[𝜌0]~𝐸𝑟𝑒𝑝 =
1
2
∑ 𝑉𝐴𝐵
𝑟𝑒𝑝
𝐴𝐵   2.30 
 where V is the parametrised element and A and B are two atoms. The first order 
term E1[ρ1] represents the energy of all the occupied orbitals:79 
 𝐸1[𝜌0, 𝛿𝜌] = ∑ ⟨𝜓𝑖|𝐻0|𝜓𝑖⟩𝑖 = ∑ ∑ ∑ 𝑛𝑖𝐶𝜇𝑖𝐶𝜈𝑖𝐻𝜇𝜈
0
𝜈∈𝐵𝜇∈𝐴𝑖𝐴𝐵   2.31 
 where Ψi represents the molecular orbitals described by a minimal basis set 
constituted only of valence electrons, with occupancy ni, μ and ν are atomic orbitals on 
atoms A and B respectively, C the basis set coefficients and H0 the Hamiltonian of the 
zeroth order density.80 The diagonal element of the Hamiltonian matrix (i.e. 𝐻𝜇𝜇
0 ) describe 
the energy level of the free atoms; all the off-diagonal Hamiltonian matrix elements are 
2-centred, as the 3 and 4-centred elements are neglected.79 The Hamiltonian elements 
depend only on the atomic pairs, and so they are calculated in advance with DFT and 
tabulated for use in DFTB.80 
 In the second order term, deviations of charge density from the reference are 
approximated as interactions between atomic monopoles:79, 80 
 𝐸2[𝜌0, (𝛿𝜌)
2] =
1
2
∑ 𝛥𝑞𝐴𝛥𝑞𝐵𝛾𝐴𝐵𝐴𝐵   2.32 
 where γAB is an analytical function that models the decay of coulombic 
interactions and replaces the charge-charge integrals. At long distances γAB approaches 
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1/RAB, while at short distances it includes the electron-electron interactions and so it 
deviates from 1/RAB,79 while  the on-site values γAA and γBB represent Hubbard 
parameters UA and UB, which are related to the atomic hardness.79 The γAB function works 
poorly for hydrogen, and a modified version 𝛾𝐴𝐵
ℎ  is used in DFTB3.79, 80 The charges are 
iterated to self-consistency, which allows to estimate polarisation effects.24  
 Finally the third order term describes the change of the atomic hardness with 
respect to the charge state:80 
 𝐸3[𝜌0, (𝛿𝜌)
3] =
1
3
∑ (𝛥𝑞𝐴)
2𝛥𝑞𝐵𝛤𝐴𝐵𝐴𝐵   2.33 
 where ΓAB is the derivative of γAB with respect to atomic charge.80 
 The main advantage of DFTB3 is that it can calculate all the properties that can 
be determined by DFT calculations, including energies, dipole moments, atomic forces 
and charge densities, at a computational cost up to three orders of magnitude lower.79  
 However, DFTB3 has some limitations that must be taken into account. First of 
all it inherits from DFT the lack of long-range dispersion, which in this work was adjusted 
by adding the D3 dispersion correction to the DFTB3 energies:79 
 𝐸𝐷𝐹𝑇𝐵3−𝐷3 = 𝐸𝐷𝐹𝑇𝐵3 + 𝐸𝑑𝑖𝑠𝑝
𝐷3  2.34 
 the damping of the D3 dispersion parameters has to be specifically fitted for use 
in DFTB3.77 Secondly, the zeroth-order term in Equation 2.30 is approximated as a 
repulsive potential that is only a function of nearest neighbour distances: as a 
consequence, other long-range interactions are neglected, and so further corrections 
have to be included.79 Furthermore, the neglect of three and four-centred integrals in the 
Hamiltonian matrix reduces the accuracy of the first order term in the expansion, and 
approximating the interactions of long-range charge densities by monopoles (Equation 
2.32), excluding dipoles, quadrupoles etc., worsens the description of intermolecular 
interactions.79 Finally, the minimal basis set causes an underestimate of both 
polarizability and Pauli repulsion, which can lead to unrealistically short intermolecular 
distances.79 
 Despite these weaknesses, DFTB has been shown to perform reasonably well 
for molecular crystals. For example, DFTB3-D3 was capable to reproduce the absolute 
energies of the crystal structures in the X23 benchmark set to a good degree of 
accuracy.77 Also, it has been shown that DFTB3-D3 can be an effective tool to estimate 
the vibrational energy component to free energy of carbamazepine.81 Given these 
promising results, DFTB3-D3 was applied in Chapter 7 to test whether it could be 
integrated in CSP workflows. All DFTB3-D3 calculations were performed with the 
programme dftb+.82 
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2.3.3 Calculation of free energies 
 
All methods that have been discussed so far calculate Elatt of static crystal structures. 
However, real crystals are not static, and their vibrations have fundamental effects on 
many crystalline properties: they expand crystal structures and can induce polymorphic 
phase transitions.25, 83 Nyman and Day have calculated that for a sample of 475 
polymorphic pairs, approximately 21% had their Elatt stability ranking reversed by 
vibrational effects at temperatures below their melting points. 83 
 What determines the thermodynamic stability of crystal structures at given 
temperature and pressure conditions is the Gibbs free energy, G, defined as: 
 𝐺(𝑝, 𝑇) = 𝑈 + 𝑝𝑉 − 𝑇𝑆   2.35 
 where U is the internal energy of the system, p the pressure applied to the 
system, V its volume, T the temperature and S the entropy. Pressure effects can be 
easily included in CSP and in some cases calculations under pressure are performed to 
target specific polymorphic forms.84 However, in most CSP studies the pV term is ignored 
as it only has an effect at high p values.28 If the volume is kept constant, the 
thermodynamic stability can then be approximated by the Helmholtz free energy, A: 
 𝐴(𝑇) = 𝑈 − 𝑇𝑆  2.36 
 to calculate A in CSP, it is common practice to divide A into Elatt and Fvib, defined 
as the vibrational component to free energy:25 
 𝐴(𝑇) = 𝐸𝑙𝑎𝑡𝑡  + 𝐹𝑣𝑖𝑏(𝑇)  2.37 
 Where: 
 𝐹𝑣𝑖𝑏(𝑇) = 𝑍𝑃𝐸 + 𝑈𝑡ℎ𝑒𝑟𝑚𝑎𝑙 (𝑇) + 𝑇𝑆  2.38 
 ZPE represent the zero point energy (i.e. the lattice vibrations that occur at 0 K) 
and Uthermal is the thermal component of internal energy.83 
 In this thesis, free energies were modelled using the rigid-body harmonic 
approximation, where Fvib is computed from the vibrational frequencies of harmonic 
phonons, which are collective non-interacting QM excitations of the lattice.25, 85 Phonon 
frequencies (ω) can be calculated from the second derivatives of the energy with respect 
to the atomic displacements, and an accurate computation requires that the crystal 
structure is at an energy minimum (i.e. the forces are equal to zero, see Equation      
2.1).86, 87 Phonons repeat periodically within the reciprocal space, k, and their frequency 
varies at different points in the Brillouin zone, the smallest repeating unit in the reciprocal 
lattice.85  
  The quasi-harmonic approximation can be used to optimise A as a function of 
volume, and it allows to estimate the effect of thermal expansion.1, 68, 83 This 
approximation was not utilised in this thesis, and its contribution to A is generally small.83 
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2.3.3.1 Calculation on free energies with the Ψmol model 
 
In this thesis the calculation of Fvib values with the Ψmol method was performed with 
DMACRYS.10 It determines the ω values by the analytical calculation of a matrix of 
second derivatives;10 care must be taken that the lattice energy optimisation is complete, 
so that no imaginary frequency values are present.87 Only low-frequency intermolecular 
phonon modes can be calculated with the Ψmol model, since the molecular conformation 
is held rigid in DMACRYS.10 High-frequency intramolecular phonon modes are assumed 
to have a negligible effect on the relative energy ranking between crystal structures.25 
 DMACRYS only calculates the phonon modes at the Γ point, i.e. at the origin of 
the Brillouin zone (where k=0).86 This decreases the accuracy of the results: only optical 
phonon modes can be found at the Γ-point, while acoustic modes, which can have a 
large effect on Fvib, are zero at the origin.85 Accurate calculations of phonon frequencies 
requires the sampling of several k-points to guarantee that the phonon modes are 
converged.25, 68 Nyman and Day have proposed a method to calculate more accurate Fvib 
values based on building several linear supercells of the same crystal structure.25 This 
makes sure that a sufficient number of k-points is sampled. Relative free energies have 
been found to converge well if a k-point distance of at least 0.12 Å−1 is guaranteed.25 In 
Chapter 3, the standard DMACRYS approach to calculate Fvib from ω values at the            
Γ-point was utilised, while in Chapter 7 the linear supercell method was employed. 
 
2.3.3.2 Calculation on free energies with the Ψcrys model 
 
Phonon vibrations calculated with Ψcrys are more complete, as both molecular and lattice 
modes can be coupled.24 Since the energy expression is much more complex than the 
intermolecular potential used with the Ψmol method (see Equation 2.18), the second 
derivatives are not computed analytically but from finite displacement: the position of the 
atoms are slightly perturbed and a reaction force is calculated.87 A matrix of second 
derivatives is then computed form these reaction forces. Values of ω at different k-points 
can be calculated by integration of the Brillouin zone,22 and supercells with minimum 
unit-cell lengths can be built to guarantee that the phonon modes are converged.88 In 
this thesis, Ψcrys phonon modes calculated with DFTB3-D3 were utilised in Chapter 7 to 
estimate the free energies of some crystal structures, which were compared to those 
calculated with DMACRYS using the linear supercell method. 
   
2.4 Crystal structure prediction: methods and codes 
 
CSP methodologies use various computational tools to explore the crystalline Elatt 
surface of molecules. This surface is multidimensional, and it is a function of the lattice 
lengths and angles of the unit cell (i.e. the smallest repeating unit in the crystalline lattice), 
the position of the centre of mass and the orientation of the molecules for a given space 
54 
 
group symmetry and number of molecules in the asymmetric unit, and the CDFs of all 
the symmetry independent molecules.28, 29 The Elatt surface is immense, in particular for 
large molecules as each CDF increases its dimensionality, and cannot be fully explored 
with very accurate but computationally expensive methods. Hence, CSP algorithms 
require some approximations. Broadly speaking, all successful CSP methodologies use 
a hierarchical approach: an initial crystal structure search aimed at finding the most 
important local Elatt minima is followed by a refinement of the generated crystal structures 
performed with higher quality models.2 Searches are generally carried out with potentials 
that can be empirically-fitted89 or parametrised to reproduce ab initio data,90 while the 
final refinement is performed either with periodic Ψcrys methods or with Ψmol methods 
where a high-quality wave-function is calculated for each molecular conformation.20  
 In this section, the CSP workflow used in this thesis and the main algorithms are 
described. 
 
2.4.1 Crystal structure search 
 
2.4.1.1 Definition of conformational flexibility 
 
Most (but not all)91, 92 CSP methodologies require an initial assessment of conformational 
flexibility before performing a search,2 to determine what conformations a molecule could 
realistically take in a crystal structure. Since the search space increases with the number 
of conformations that are considered,29 limiting them to a set of the most relevant ones 
can keep the overall cost of CSP manageable. Furthermore, in a search the only CDFs 
that need to be considered are the most flexible torsion angles (e.g. those around acyclic 
bonds), as they can separate the important local minima in Elatt.28  
 A variety of methods to define the conformational flexibility of a molecule exists. 
They are generally based either on calculating the energies of different gas-phase 
configurations with ab initio methods or on using existing information on the 
conformational preferences of molecules in crystal structures, which are often retrieved 
from the Cambridge Structural Database (CSD).93 Both approaches can be useful, and 
in Chapter 5 of this thesis an attempt to find an optimal balance between these two 
methods is discussed. 
 In general, molecules do not crystallise in conformations that have high-energies 
compared to the isolated-molecule global minimum in conformational energy (see 
Chapter 2.3.1.1). However, for flexible molecules the range of plausible conformations 
can be very broad. In this thesis ab initio calculations to define the search space were 
carried out in Chapters 3, 4 and 5 with Gaussian at the PBE0 6-31G(d,p) level of theory. 
The main shortcoming of this method is the high computational expense, in particular for 
very flexible molecules. 
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 CSD surveys can also be helpful, as they provide information on the 
conformational preferences of molecules in actual crystal structures, not just in the       
gas-phase. However, care must be taken, as these preferences are deduced from 
molecules that contain similar fragments but could have a different balance of intra- and 
intermolecular interactions. Furthermore, a blind reliance on CSD data could bias CSP 
studies towards the ‘already-known’94 and prevent to access unusual but possibly 
relevant conformations and crystal structures.  
 
2.4.1.2 Generating crystal structures: CrystalPredictor 
 
In this thesis, CrystalPredictor95, 96 was used to perform the crystal structure searches. 
This algorithm uses a deterministic low-discrepancy Sobol sequence97 to perform an 
efficient search through the multidimensional Elatt surface, which is a function of the unit-
cell lengths and angles, the position and orientation of the molecules (as allowed by the 
space group and number of molecules in the asymmetric unit) and a set of user-defined 
torsion angles that are treated as independent CDFs.29, 95, 96 The Sobol sequence is used 
to generate the initial crystal structures and guarantees a better coverage of the search 
space compared to uniform or random (stochastic) samplings.29  
 The initial crystal structures are then automatically optimised with the Ψmol model 
(see Equation 2.16). Uinter is modelled as in Equation 2.18: Uelec is calculated from atomic 
point charges (Equation 2.19), as they are cheaper to compute and less dependent on 
conformation than distributed multipoles, while Urep-disp is calculated with the exp-6 
potential in Equation 2.24. The atomic point charges can either be fixed at the values of 
the input conformation or calculated as a function of the values of the independent CDFs. 
In this thesis fixed point charges were used. 
  Two versions of CrystalPredictor exist, which differ only in the way they treat 
ΔEintra and conformational flexibility (i.e. they work identically for rigid searches). In this 
thesis only CrystalPredictor 1 was used. It models ΔEintra through a Hermite interpolation 
over a grid of intramolecular energies covering the flexibility ranges of the CDFs treated 
as search variables. The ΔEintra values in the grid are calculated before the search 
through a set of ab initio optimisations of the isolated molecules, in which the 
independent CDFs are fixed at some user-defined values while the other CDFs are 
allowed to relax to the closest local minimum in conformational energy. The size of the 
ΔEintra grid increases very rapidly with the number of independent CDFs. This problem 
can be limited by dividing a molecule into smaller more manageable surrogate molecules 
containing a subset of the independent CDFs. This convenient approximation allows a 
significant reduction in computational cost, and it was used in all the searches performed 
in Chapters 3, 4 and 5. The possibility of using surrogate models is indeed the main 
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reason why only CrystalPredictor 1 was used in this thesis. When surrogate molecules 
are used, ΔEintra is then calculated as:28 
 𝛥𝐸𝑖𝑛𝑡𝑟𝑎 = ∑ 𝛥𝐸𝑖𝑛𝑡𝑟𝑎
𝑎𝑁
𝑎=1   2.39 
 where N is the number of subsets. This approximation can be used only when it 
is reasonable to assume that the energy penalty for varying a subset of torsion angles is 
not affected by the rest of the molecule. In CrystalPredictor 1, only the independent CDFs 
are varied in the search, while the other dependant CDFs (bond-lengths, bond-angles 
and torsion angles treated as rigid) are kept at their input value (generally the lowest 
energy gas-phase conformer).  
 During the course of this thesis, a new version of this programme has been 
developed: CrystalPredictor 2, which models ΔEintra using local approximate models 
(LAMs).29, 64, 95 The intramolecular energy of each conformation is calculated by a 
second-order Taylor expansion from some pre-calculated points within the flexibility 
range of the independent CDFs; an example of LAMs is shown in Figure 2.4. LAMs are 
calculated in the same way as the grids in CrystalPredictor 1, but an expensive 
calculation of the second derivatives of conformational energy is also required. These 
LAMs can be stored and re-utilised in subsequent optimisations of Elatt with 
CrystalOptimizer (see Chapter 2.4.2.2), reducing the overall computational cost.29 
 
Figure 2.4: Schematics of LAMs of a molecule with two independent CDFs. Ab initio 
calculations are performed at the red LAM points, while the rectangles indicate the range 
of applicability of each LAM point. The energy at each point in the grid is calculated by a 
second order Taylor expansion from the closest LAM point.  
 A finer LAM spacing increases the accuracy of the model, but also the 
computational cost. Recently, improvements in the code to guide the user towards an 
optimal LAMs sampling have been added, which were partially inspired by the outcome 
of the Blind Test CSP study of molecule XXVI (see Chapter 3).98 An advantage of 
CrystalPredictor 2 is that each LAM point corresponds to an optimised configuration, 
meaning that the CDFs that are not treated as search variables are not fixed at the values 
of the input conformation but can respond to changes of the independent CDFs, allowing 
a more accurate description of the molecular geometries. However, it is not currently 
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possible to utilise the approximation in Equation 2.39, meaning that for flexible molecules  
large multi-dimensional LAMs are required; also LAMs are specific to a certain input 
conformation, and have to be recalculated if a different input is used (e.g. two searches 
with cis and trans carboxyl groups), which is not required for the grids. These factors 
made CrystalPredictor 2 unaffordable for the large and flexible molecules that were 
studied in this thesis.  
 
2.4.2 Crystal structure refinement 
 
Since crystal structure searches are performed with approximate models, the generated 
crystal structures need to be refined to obtain more accurate geometries, as well as 
absolute and relative energies. The main crystal structure refinement programmes that 
were used in this thesis were DMACRYS, which optimises only the intermolecular 
interactions, and CrystalOptimizer, which minimises Elatt coupling DMACRYS with ab 
initio calculations on the molecular conformation/s.64 
 
2.4.2.1 Optimisation of Uinter: DMACRYS 
 
In this thesis, the optimisations of the intermolecular interactions were performed with 
DMACRYS. DMACRYS uses the Ψmol method: it treats the molecules in a crystal 
structure as rigid, and models Uinter as a sum of some of the terms described in Chapter 
2.2. Uinter was modelled as in Equation 2.18, with Uelec calculated from distributed 
multipoles up to hexadecapoles (rank 4) fitted with GDMA (see Chapter 2.3.1.2.2) from 
the wave-function computed with Gaussian, and Urep-disp calculated with the exp-6 
potential in Equation 2.24.  
 In DMACRYS, long-range electrostatic interactions (charge-charge, charge-
dipole and dipole-dipole) are calculated using the Ewald summation method, and the 
remaining interactions are summed in real space up to a user-defined cut-off distance.10 
A Newton-Raphson scheme minimises the structure to the closest minimum in Uinter.10 
However, if the second-derivative matrix contains any negative eigenvalue DMACRYS 
warns the user that the crystal structure has converged to a saddle point. The crystalline 
symmetry can then be reduced to a sub-group of the initial space group, finding a lower-
energy true Elatt minimum.10 
 DMACRYS can be sufficient as a final refinement tool in CSP only for very rigid 
molecules or if the molecular conformations have already been optimised with other 
methods (e.g. in Chapter 7 with DFTB3-D3). For flexible molecules DMACRYS is often 
not sufficient, and coupling with ab initio programmes is required to optimise both the 
intra- and intermolecular components of Elatt at the same time.10 
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2.4.2.2 Optimisation of Elatt: CrystalOptimizer 
 
In this thesis, CrystalOptimizer was the main programme that was used to perform full 
Elatt optimisations of the generated crystal structures. This algorithm uses the Ψmol 
method, and it optimises both components of Elatt (Equation 2.16) as a function of a set 
of user-defined independent CDFs. Since bond-lengths are not affected by the solid-
state environment,64 generally only the most flexible torsion and bond-angles are treated 
as independent CDFs. However, the choice of the independent CDFs is generally 
arbitrary, as there are no defined rules that allow an optimal selection of the torsion and 
bond-angles that need to be treated as variables in CrystalOptimizer minimisations. This 
issue is discussed in detail in Chapter 6. 
 CrystalOptimizer works by performing a two-level optimisation:64 
 𝑚𝑖𝑛 𝐸𝑙𝑎𝑡𝑡(𝐶𝐷𝐹𝑠𝑖𝑛𝑑𝑒𝑝𝑒𝑛𝑑𝑒𝑛𝑡) = 𝑚𝑖𝑛 [𝛥𝐸𝑖𝑛𝑡𝑟𝑎 + 𝑚𝑖𝑛(𝑈𝑖𝑛𝑡𝑒𝑟)]  2.40 
  in the outer-optimisation the independent CDFs are varied. For a given set of 
values of the independent CDFs Gaussian is called to relax the rest of the molecule/s to 
the closest local minimum in gas-phase energy, and ΔEintra is calculated. Then, the       
inner-optimisation takes place: distributed multipoles are derived from the charge density 
of the optimised conformation with GDMA, and Uinter is minimised with DMACRYS.64 The 
process is repeated until the outer-optimisation problem is complete; a quasi-Newton 
scheme is used to converge Elatt as a function of the independent CDFs.64 
 In principle, this scheme requires to perform expensive ab initio optimisations and 
charge density calculations at each point within the outer-optimisation scheme. However, 
the process is made more computationally efficient by using LAMs,64 which have already 
been described in Chapter 2.4.1.2. Ab initio calculations are stored in LAMs databases, 
containing conformational energy values, their first and second derivatives with respect 
to the CDFs, and distributed multipoles.64 If at any point in the outer-optimisation a similar 
set of independent CDF values in is present in the LAMs databases, within a user-
defined tolerance, then the results of previous calculations are re-utilised. Otherwise, 
new ab initio calculations are performed on-the-fly and stored in the databases.29, 64 This 
procedure is very efficient, as re-utilising ab initio calculations reduces the overall 
computational cost without decreasing accuracy.64 This possibility of re-utilising previous 
calculations is indeed an advantage of the Ψmol method: the overall computational cost 
does not scale with the number of crystal structures that are optimised like for the Ψcrys 
method, since as more optimisations are performed the LAMs databases cover a larger 
portion of the conformational space and less costly ab initio calculations are required. 
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2.5 Comparison of crystal structures and of molecular conformations  
 
Since CSP studies tend to predict many more polymorphs than they are actually 
experimentally determined (as mentioned in Chapter 1.2.2),99 it is necessary to 
determine whether structures matching known forms are present among those that have 
been computationally predicted and to find common motifs that can define structural 
trends20 or hint to the presence of disorder.100, 101 Furthermore, CSP methods tend to 
generate several duplicates of the same Elatt minima,2, 15 and crystal structure comparison 
tools can be used to determine which forms are unique and which are just duplicates 
corresponding to a different definition of the same unit cell. Determining a degree of 
dissimilarity that experimental or computer-generated crystal structures must possess to 
be classified as polymorphs is a non-trivial task;102, 103 this issue is discussed in Chapter 
8. In this section, the tools that were used in this thesis for comparing crystal structures 
and molecular conformations are described. 
 
2.5.1 The Crystal Packing Similarity tool 
 
The Crystal Packing Similarity tool has developed from COMPACK, a programme written 
by the Cambridge Crystallographic Data Centre (CCDC) to quantify the similarity 
between crystal structures for use by both experimentalists and those involved in 
computational studies.104 Crystal Packing Similarity is available through Mercury,105 a 
programme developed by the CCDC that was used in this thesis mainly as a visualisation 
tool, and recently also through the CSD Python API (see Chapter 2.6.5). The idea behind 
the Crystal Packing Similarity tool (and COMPACK) is that relying on visual analyses to 
determine the similarity between crystal structures is a slow and arbitrary process, and 
quantitative parameters are key to achieve realistic comparisons.104 
 The Crystal Packing Similarity tool performs crystal structures comparisons 
based exclusively on the position of the atoms, and so it is independent of symmetry and 
unit cell information. It represents a crystal structure as a cluster of N molecules, where 
N is user-defined, built from a central reference molecule and the nearest (N-1) ones. 
This cluster is then used as a reference sub-structure search query, which is overlaid 
with another crystal structure to find the three-dimensional coordinates that lead to 
highest possible number of molecules matching. Two molecules are considered to match 
if the distances and the angles of the triangles in the reference cluster and in the 
comparison structure differ by no more than user-defined tolerances; the default values 
are 20% distance and 20° angle tolerances.104 The level of structural similarity is then 
quantified in terms of the root-mean-square-deviation (RMSDx), which is a measure of 
the average distance between the atoms of the x molecules that can be matched. This 
value is calculated as: 
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 𝑅𝑀𝑆𝐷𝑥 = √
∑ 𝛿𝑖
𝑀
𝑖=1
𝑀
  6672.41 
 where M is the total number of atoms of the x molecules that can be matched 
and δ is the distance between these atoms. The user can decide whether or not to 
account for the position of hydrogen atoms, which are generally neglected when 
comparing experimental crystal structures since they are very weak X-ray scatterers. 
When x = N, each molecule can be overlaid with the reference cluster. If the RMSDx 
value is very low, within numerical noise, the two clusters can be considered to be 
identical, while large values can indicate more significant differences, e.g. thermal 
expansion for crystal structures determined at different temperatures. 
 The choice of N depends on the purpose of the comparison. If N=1, only one 
molecule between two crystal structures is compared; for crystal structures with only one 
molecule in the asymmetric unit cell (i.e. Z’=1) this is equivalent to performing a 
comparison of the molecular conformations. On the other hand, larger values of N mean 
that wider portions of the crystal structures are compared, which could better capture 
differences and similarities. The default value of N=15 is commonly used, as in the 
original testing of COMPACK it was found sufficient to discriminate between polymorphs 
and duplicates of crystal structures containing only one molecular species, which are the 
subject of this thesis.104 The analyses in Chapter 8 confirm these results. 
 
2.5.2 Simulated powder X-ray diffraction (PXRD) pattern similarity 
 
Another way to obtain a single quantitative measure of structural similarity is to compare 
simulated powder X-ray diffraction (PXRD) patterns. PXRD patterns depend only on the 
distances between atoms.106 They consist of a 1-dimensional function that simulates the 
diffraction patterns of a crystal structure for a specific X-ray wavelength and for a given 
range of 2θ values. There are several ways to quantify the similarity between powder 
patterns. Point-by-point measures that calculate the differences in peak intensity at 
identical 2θ values are extremely sensitive to peak positions.106 Since the position of 
peaks in a simulated PXRD patterns depends on the unit cell dimensions, a small 
difference, e.g. due to variations in pressure or temperature, can give poor similarities 
for two determinations of identical crystal structures.106 Hence, the CCDC tool used in 
this thesis calculates PXRD similarity with a weighted cross-correlation function 
developed by de Gelder,107 which is less sensitive to peak shifts.  PXRD similarities are 
quantified in terms of a number that goes from 0 to 1, where 1 indicates identical 
simulated patterns. This measure used to be common in CSP, and it is still utilised to 
compile lists of unique polymorphs within the Cambridge Structural Database (CSD).108 
However, further studies have shown that PXRD similarities are sometimes insensitive 
to certain crystalline modifications, as they can be close to 1 for different crystal 
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structures;109 their inadequacy was also shown in the analyses in Chapter 8. Hence, in 
this thesis PXRD similarities were never used on their own but only as a preliminary 
method to filter out very dissimilar crystal structures. The Crystal Packing Similarity tool 
(or its earlier version COMPACK) was always used to perform realistic comparisons. 
 
2.5.3 Ultrafast shape recognition (USR) 
 
Recognising the shape similarity between molecules is a vital part of drug discovery, as 
shape differences can hinder the interaction between a drug molecule and its target.110 
Ultrafast shape recognition (USR) was developed to perform a fast quantitative shape 
comparison of large databases of molecules, using simple descriptors that to do not rely 
on slow molecular overlays (e.g. calculating the RMSD1 with the Crystal Packing 
Similarity tool, see Chapter 2.5.1), which can also be the source of several errors.110 USR 
characterises the shape of a molecule as a set of 1-dimensional parameters that carry 
3-dimensional information. Twelve moments are computed: they are the average, the 
variance and the skewness of the distribution of the distances of the atoms to four 
locations, namely “the molecular centroid (ctd), the closest atom to ctd (cst), the farthest 
atom to ctd (fct) and the farthest atom to fct (ftf)”.110 This method provides a good balance 
between accuracy and computational cost. A unique percentage similarity score (S%) 
between two molecules A and B can then be calculated as:110 
 𝑆𝐴𝐵
% = (
1
1+
1
12
∑ 𝑀𝑖
𝐴−𝑀𝑖
𝐵12
𝑖=1
) · 100  2.42 
 where Mi represents the i
th moment. In Chapter 5, USR was used to quantify the 
effect of varying a torsion angles on the overall shape of the molecule. The programme 
USRCAT111 was employed for this purpose. 
 
 2.6 Crystal structure informatics  
 
CSP methods use calculations to predict the packing possibilities of a molecule, without 
any prior knowledge. However, we possess an enormous amount of information on real 
crystal structures, which can be used to validate and possibly integrate CSP workflows.  
 Any experimentally-determined crystal structure is a source of information on the 
intra- and intermolecular interactions that occur in the solid-state.112 Analysing samples 
of crystal structures can provide knowledge about the packing preferences of molecules 
with certain characteristics, such as hydrogen bond donors and acceptors, size, 
functional groups, etc. Fast and efficient search and analysis tools allow to retrieve and 
analyse information from large datasets. In the context of this thesis, the most useful 
database is the CSD, which currently contains more than 900,000                           
experimentally-determined organic crystal structures. The predictive power of CSD 
information is proven by how it has been recently used to perform ‘healthchecks’ on 
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pharmaceutical crystal structures and assess the likelihood of more stable polymorphs 
existing,112 and even to perform full CSP studies.113 In this section, the main tools that 
can be used to extract information from the CSD are described, and the ways this 
information was utilised in this thesis are indicated.  
 
2.6.1 ConQuest 
 
ConQuest is the primary programme for mining the CSD.112, 114 It allows to search crystal 
structures based on several factors, including compound name, molecular formula, 
crystalline properties and/or literature reference. It can also perform searches based on 
chemical substructures, which can easily be drawn. Data of interest on crystal structures 
that meet the search criteria can be extracted, e.g. specific torsion angle distributions, 
distributions of bond-lengths and of hydrogen bond or other non-bonded contacts. 
Furthermore ConQuest allows the restriction of searches using parameters like R-factor 
or disorder and to consider only structures in specific CSD-subsets, such as lists of 
unique polymorphs.  
 ConQuest is a very flexible tool, and it was used in Chapters 3, 6 and 8 to find 
crystal structures with specific molecular and packing characteristics as well as to extract 
the distributions of some key torsion and bond-angles. 
 
2.6.2 Mogul 
 
Mogul is a programme for extracting conformational information from the CSD and 
analysing geometrical preferences.112, 115 It takes a fragment of interest as input and 
mines the CSD for molecules containing the same fragment in a comparable chemical 
environment. It finally outputs distributions of observed values of the bond-lengths, bond-
angles and/or torsion angles in the form of histograms. Mogul classifies the value of a 
CDF as usual or unusual depending on its CSD frequency, and this has been used within 
the ‘healthchecks’ to evaluate the likelihood of polymorphism: an unusual molecular 
geometry indicates that alternate crystal structures with more common values for the 
conformation may exist.112 
 In this thesis, Mogul was used in Chapter 5 to assess the ranges of 
conformational flexibility for generating the ΔEintra grids (see Chapter 2.4.1.2) of some 
torsion angles to be treated as flexible in CrystalPredictor searches.  
 
2.6.3 CSD knowledge-based conformational libraries 
 
Recently, an approach has been developed by the CCDC for analysing the geometrical 
preferences of organic molecules using knowledge-based conformational libraries, 
which contain information about the CSD distributions of bond-lengths, bond-angles and 
dihedrals.116 These libraries are derived from Mogul, but have some significant 
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differences from their parent programme that make them more suited for the rapid and 
fully automatized analysis of conformational preferences that is required in applications 
such as generating key molecular conformations (see Chapter 2.6.4) and geometrical 
optimisations. First of all, key conformational features are automatically identified, and 
then a “cascade” search approach is used to extract the distribution of their values from 
the CSD; this approach is faster than the one used by Mogul.116 A first search is 
performed for libraries that match precisely the chemical environment of the fragment of 
interest, and if enough entries are not found the search is repeated for libraries that 
describe it less accurately and so on. If no library remains, the search fails, otherwise 
the most chemically precise library containing a sufficient number of entries is utilised. 
Furthermore the CSD conformational libraries do not provide information about each 
definition of flexible torsion angles, but they consider rotamers, selecting one specific 
‘reference torsion angle’ around each rotatable bond to avoid redundancies.116 Finally, 
the rotamer distributions cover the full 0-360° range, accounting for chirality.116 There are 
also other changes compared to Mogul in the way flexible rings are handled, but none of 
the molecules explored in this thesis contained this kind of feature. 
 The CSD knowledge-based conformational libraries were used in Chapter 5 to 
assess the ranges of conformational flexibility of the main flexible torsion angles to 
choose their treatment in the crystal structures searches. 
 
2.6.3.1 Kernel density estimation (KDE) 
 
Conformational information is generally analysed through histograms. However, 
histograms have weaknesses, as they are not smooth, non-differentiable and depend 
strongly on the bin size. Hence, despite the ease of visualisation, histograms are not 
well-suited to perform quantitative analysis of conformational distributions.117 A statistical 
density estimator on the other hand can generate probability density functions (PDFs), 
which are smooth functions that are related to the frequency of a given value in a 
distribution. In particular, kernel density estimation (KDE) is a very general approach for 
the generation of PDFs, which does not require parameters like mean or standard 
deviation of the distribution and depends only on the data points.117 It is important that 
the kernel is suited to the conformational data at hand. In Chapter 5 KDE was used to 
generate PDFs of torsion angle distributions, which are circular in nature, and the Von 
Mises kernel was chosen, following the method used by McCabe et al.117 With the Von 
Mises kernel, the probability density function f is calculated as: 
 𝑓(𝜃) =
1
2𝜋𝐼0(𝜈)
∑ 𝑒𝑥𝑝 [𝜈 𝑐𝑜𝑠(𝜃 − 𝜃𝑖)]
𝑛
𝑖=1  2.43 
 where θ is a torsion angle value ranging from 0 to 2π, n is the size of the sample, 
I0 is the zeroth order modified Bessel function of the first kind, θi represents the i
th 
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observed value, and ν is a shape parameter that is related to the level of smoothing of 
the PDF. The ν parameter was calculated via a set of equations proposed by Fisher,118 
which optimise the level of smoothing depending on the shape of the distribution.  
 
2.6.4 The CSD Conformer Generator 
 
The CSD Conformer Generator (CG) produces plausible conformations for an input 
molecule, using the information in the CSD knowledge-based conformational libraries to 
guide this selection.119 It was originally developed for use in life-science modelling 
applications such as protein-ligand-docking and pharmacophoric shape matching.  
 As a first step the CG optimises bond-lengths and bond-angles of the molecular 
input conformation using a modified version of the Tripos force field. Successively, the 
distributions of each rotamer and flexible ring (if present) in the molecule are retrieved 
from the CSD conformational libraries. Through sampling these distributions, a diverse 
set of conformations is generated, each having a different combination of rotamer and 
flexible ring values, if present. Similar conformations are clustered using a combination 
of a torsion dissimilarity coefficient and atomic root-mean-squared deviations. In 
addition, structures that feature unphysical close contacts or more than a specified 
number of unusual rotamer values are removed. For each generated conformation, the 
CG assigns a probability score, on which the conformations are ranked:119 
 𝑠𝑐𝑜𝑟𝑒 =
𝑙𝑛(𝑝𝑚𝑎𝑥)−𝑙𝑛(𝑝)
𝑙𝑛(𝑝𝑚𝑎𝑥)−𝑙𝑛(𝑝𝑚𝑖𝑛)
  2.44 
 where p is the probability of the conformation, and pmax and pmin are the 
probabilities of the most and least probable conformations respectively. These p values 
are calculated as: 
 𝑝 = ∏ 𝑝𝑖
𝑛
𝑖=1   2.45 
 where pi is the probability assigned to each of the n parameters (rotamers and 
flexible rings) that the CG uses to produce the conformations. Despite some 
weaknesses, such as the use of a heuristic clash term and the lack of any electrostatic 
interaction like internal hydrogen bonds, the CG has been found to perform well when it 
was compared to competitors on identical sets of molecules.119 In this thesis, the CG was 
used in Chapter 5 to aid the selection of the conformational regions that were searched 
with CrystalPredictor. 
 
2.6.5 The CSD Python API 
 
Although the CSD contains an enormous amount of information, which can be 
systematically retrieved and analysed, it was not until recently that it could be used in 
programming. The release of the CSD Python API has brought an enormous advance, 
as it allows to access data more quickly and effectively, and to interface the retrieved 
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information with other tools and to build workflows.93 Almost all CCDC informatics tools 
can be accessed through the Python API. The CSD Python API was used throughout 
this thesis to perform a variety of analyses and to interface information retrieved from the 
CSD with external programmes. 
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Chapter 3: Successful prediction of molecule 
XXVI for the 6th Blind Test of Crystal Structure 
Prediction 
 
3.1 Introduction 
 
3.1.1 The CCDC Blind Tests of crystal structure prediction methods 
 
CSP studies are rarely carried out without any previous experimental knowledge. This 
makes the real quality of an apparently effective CSP methodology dubious, since a user 
may be inclined to tweak the study to reproduce the known form as a low energy one. 
The Blind Tests periodically organised by the Cambridge Crystallographic Data Centre 
(CCDC)1, 2 are an invaluable tool to test the credibility of CSP techniques, as well as to 
stimulate the development of new methodologies.2 Their main purpose is to verify the 
reliability of CSP methods in predicting unknown crystal structures.  
 Crystallographers are asked in advance to provide some unpublished, high-quality 
crystal structures without disorder of molecules that meet certain criteria in terms of size, 
flexibility, atom type and number of molecules in the asymmetric unit (Z’). After selecting 
a set of molecules, the CCDC keeps the experimental crystal structures confidential. The 
molecular diagrams and the crystallisation conditions are released to the participating 
computational groups at the beginning of the challenge, together with a deadline to 
submit the predictions. At the end of the challenge, the predictions are evaluated and 
compared with the experimental forms, and a workshop is held, which results in a joint 
publication summarising the state-of-the-art of CSP.2 
 Six Blind Tests have been held so far. The first three, held in 1999,3 20014 and 
2004,5 were open only to invited participants, while the following three, held in 2007,6 
20107 and 2014-152 were open to anyone who was interested in the challenge. The 
results of the first three challenges were of mixed quality, but in general they showed the 
immaturity of CSP methods, with no approach being consistently reliable; the results for 
the more flexible systems were particularly discouraging. The 4th Blind Test6 saw the first 
substantial success, although limited to small molecules: GRACE,8 developed by 
Neumann et al., was the first method to correctly predict all the target crystal structures. 
The 5th Blind Test7 was another important step forward: two groups successfully 
predicted the crystal structure of molecule XX, whose size (55 atoms) and flexibility are 
comparable to those of small molecules in drug development.9 These successes 
drastically increased industrial interest in CSP, leading to several collaborations between 
computational groups and pharmaceutical manufacturers.10, 11 
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 Almost all successful CSP methodologies used in the Blind Tests aim to determine 
which crystal structures are the most thermodynamically stable.12 A problem inherent 
with the Blind Tests is that there is no guarantee that the molecules are monomorphic, 
let alone that the target crystal structures are the most stable forms. Indeed, there have 
been instances of polymorphs being found during or after the completion of the Blind 
Tests, in some cases more stable than the target form,3, 13 in others metastable.14 If the 
target crystal structure is metastable, there is a high chance that it could be missed or 
ranked poorly by the participating groups. Hence, a proper assessment of the possible 
crystalline forms of the target molecules prior to the start of the Blind Test considerably 
improves the scientific conclusiveness of the challenge. 
  This chapter discusses how the crystal structure of one of the target molecules of 
the 6th Blind Test was successfully predicted, as a validation of the CSP methodology 
utilised throughout most of this thesis. It also illustrates some of the challenges that can 
be encountered when performing CSP on large and flexible molecules, which need to be 
addressed to make computational studies a routine component of industrial polymorph 
screens. The information on the experimental forms that is outlined in this chapter was 
not known when the CSP study was carried out; all comparisons with experimental data 
were performed after the release of the target crystal structures at the end on the Blind 
Test. 
 
3.1.2 The 6th Blind Test 
 
The 6th Blind Test took place between September 2014 and August 2015. The five target 
molecules are shown in Figure 3.1. 
 
Figure 3.1: Chemical diagrams five target molecules for the 6th Blind Test of CSP. 
 This set of molecules reflects the progress undertaken by CSP methods, with the 
addition of targets with unprecedented complexities for Blind Tests, such as the first three 
component salt (XXIV) and the largest Blind Test molecule to date (XXVI). Particularly 
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interesting is moderately flexible molecule XXIII, for which participants were challenged 
to predict five polymorphs, two of which were Z’=2. 
 Acknowledging that polymorphism is a very prevalent phenomenon in organic 
solids, the submission criteria for this 6th Blind Test were changed compared to the 
previous challenges: participants were no longer invited to submit three unique 
predictions, but two lists of up to 100 structures, ranked in terms of a scoring function 
(energy, in most cases).2 This gave participants greater flexibility, allowing the 
submission of predictions obtained with more than one model, for example with or 
without the inclusion of thermal effects. The Price group sent predictions for all five 
molecules, with each group member dedicated to a different target. A set of 1,000 
putative crystal structures for each molecule was also sent for optimisation and ranking 
by other groups developing accurate periodic DFT-D methods, but who did not have the 
tools for generating candidate crystalline forms. This chapter is focused on the molecule 
I worked on: large and flexible molecule XXVI. Details about the CSP studies of the other 
molecules can be found in the Blind Test publication.2  
 
3.1.3 Molecule XXVI 
 
3.1.3.1 Molecule and crystallisation conditions 
 
Figure 3.2: Chemical diagram of molecule XXVI. The arrows define the torsion angles 
considered as the flexible in the CSP study.  Φ1a and Φ1b (C2-C1-C7-O1 and C34-C29-28-
O2) are 0° in the diagram above, Φ2a and Φ2b (O1-C7-N1-H21 and O2-C28-N2-H22) are 
180°, Φ3a and Φ3b (H21-N1-C8-C17 and H22-N2-C19-C20) are 180° and Φ4 (C10-C9-C18-
C19) is 180°. 
 N,N’-([1,1’-Binaphthalene]-2,2’-diyl)bis(2-chlorobenzamide) (C34H22C12N2O2) has 
two halves (C1-C17 and C18-C34) that are related by symmetry. Although                               
1,1'-binaphthyl compounds can be axially chiral, this molecule was crystallised as a 
racemic mixture.2 Hence, it was not possible to assume it could only crystallise in the 
chiral space groups. It was crystallised by slow evaporation from a 1:1 mixture of 
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hexanes and dichloromethane; this information was not used as part of the CSP process 
by any participant.2 
 The main challenges for performing CSP on molecule XXVI were the large size, 
the numerous flexible rotatable bonds,15 which drastically increase the search space, 
and the bulky congested shape that can hinder the formation of directional intermolecular 
interactions. 
 
3.1.3.2 The experimental forms 
 
The only fully-solved single-component crystal structure of molecule XXVI was the target 
of this Blind Test study. This crystal structure is stable at room temperature, has one 
molecule in the asymmetric unit cell and it is in the triclinic P1̅ space group; it was later 
deposited in the CSD1 with refcode XAFQIH.2 A polymorph screen performed by 
Johnson Matthey (Pharmorphix) revealed that the only solved crystal structure (form 1) 
undergoes a phase transition to another crystalline polymorph, referred to as form 11, 
taking place at 428 K; form 11 was characterised through high-resolution powder 
diffraction, but the crystal structure has not been solved yet.2 Nine solvates of molecule 
XXVI, referred to as forms 2-10, were also found in the polymorph screen.2 These 
solvates are currently not deposited in the CSD. 
 
3.2 Methods 
 
3.2.1 Analysis of conformational flexibility 
 
3.2.1.1 Torsion angle scans 
 
The first step of this CSP study was the determination of a plausible range of solid-state 
conformations. The seven torsion angles shown in Figure 3.2 were identified as flexible 
through chemical intuition and a set of isolated molecule optimisations. To determine the 
range of values that each torsion angle could realistically take in the solid-state, the 
conformational energy penalty for varying torsion angles Φ1a, Φ2a, Φ3a and Φ4 was 
calculated via constrained 1-dimensional angle scans performed with Gaussian 0316 at 
the PBE0 6-31G(d,p) level of theory. In each angle scan, one of these torsion angles 
was fixed at one value, while the other conformational degrees of freedom (CDFs) were 
relaxed to minimise conformational energy. Once the conformation was fully optimised, 
the same torsion angle was fixed at another value and the rest of the molecule was 
relaxed; the process was repeated until the entire range of the scan was covered.  
 The ranges and size steps of the scans were chosen from chemical intuition and 
an analysis of possible CSD values (see Section 3.2.1.2). Angles Φ1b, Φ2b and Φ3b were 
not explicitly scanned since this would have given the same results as their symmetry-
related counterparts; the energy profile of angle Φ4 was assumed to be symmetric about 
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0° and so it was only scanned in the -180 to 0° range. Each scan was initiated from the 
lowest energy isolated-molecule conformation at the PBE0 6-31G(d,p) level of theory, 
since this has been shown to be the most suitable starting point for performing angle 
scans on flexible molecules.17 
  
3.2.1.2 CSD surveys 
 
The relaxed angle scans were complemented by a CSD survey of all molecules 
containing the fragments shown in Figure 3.3. 
 
Figure 3.3: Search fragments used in Conquest to perform the CSD surveys. Angles ξ1, ξ3 
and ξ4 were considered analogues of Φ1a and Φ1b, Φ3a and Φ3b and Φ4 respectively. Also 
all these fragments contain angle ξ2 that is an analogue of torsion angles Φ2a and Φ2b.  
 As already mentioned in Chapter 2, CSD surveys can integrate the analysis of 
conformational flexibility, by highlighting any weakness in the chosen level of theory17 
and determining the solid-state geometrical preference.18 The                                 
experimentally-determined crystal structures of molecules containing the fragments 
shown in Figure 3.3, which mimic the functional groups of molecule XXVI, were retrieved 
with Conquest.19 When more than one entry belonged to the same refcode family, the 
structures were checked manually. If they were redeterminations, only the one with the 
lowest R-factor was considered, while polymorphs were all kept.  
 The fragment in Figure 3.3a was found in 99 unique crystal structures, the one in 
Figure 3.3b in 67 and the one in Figure 3.3c in 33. The values taken by ξ1, ξ2, ξ3 and ξ4 in 
the CSD-retrieved crystal structures were extracted with Mercury.20 
 The results of the angle scans and of the CSD surveys are summarised in Figure 
3.4, where the values taken by each dihedral in the conformation of target experimental 
form of molecule XXVI are also indicated (see Appendix Table 3.1 for the specific 
values). 
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Figure 3.4: Results of the isolated-molecule scans of torsion angle a) Φ1a from 0° to 360° 
in 30° steps; this is also valid for Φ1b b) Φ2a from 0° to 180° in 90° steps, this is also valid 
for Φ2b c) Φ3a from 0° to 360° in 30° steps; this is also valid for Φ3b d) Φ4 from -40° to -140° 
in 20° steps. The blue points indicate the relative conformational energy when the torsion 
angle took a certain value; at each point, all the CDFs were relaxed with the exception of 
the scanned torsion angle. All the calculations were performed at the PBE0 6-31G(d,p)  
level of theory starting from the PBE0 6-31G(d,p) optimised global minimum gas-phase 
conformer. The orange bars indicate the frequency of each value in the CSD. The black 
lines indicate the values taken by the torsion angles in the conformation of the target 
experimental crystal structure. 
 The constrained angle scans and the CSD surveys provided consistent results. 
With the exception of Figure 3.4a, it is clear that low-energy regions are the most 
populated in the CSD, and only a few torsion angle values with a calculated 
conformational energy penalty exceeding 20 kJ·mol-1 can be found in solid-state 
conformations. The main inconsistency is for Φ1a-1b, where few solid-state conformations 
can be found in the apparently low-energy region between 150 and 210°; this may be 
due to the specific characteristics and interactions of molecule XXVI. It is interesting to 
note that the scans for angles Φ1a and Φ3a are not exactly symmetric around 180°: this is 
due to the interactions between the scanned torsion angles and the rest of the molecule, 
including the other symmetric half. 
 In summary, Figure 3.4 shows that the isolated-molecule scans could be 
confidently used to limit the conformational search space in this CSP study. The 
effectiveness of this initial analysis is confirmed by all torsion angles of the target 
crystalline conformation taking values with calculated energy penalties smaller than       
20 kJ·mol-1 and found in at least some crystal structures of similar molecules. 
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3.2.2 Crystal structure generation 
 
After analysing the torsion angle scans and the CSD distributions shown in Figure 3.4, a 
flexible crystal structure search was performed, with only five torsion angles (Φ1a, Φ1b, 
Φ3a, Φ3b and Φ4) treated as explicitly flexible CDFs. This was done because the scan of 
amide torsion angles Φ2a and Φ2b showed the presence of a large energy barrier for 
moving away from the trans configuration (i.e. 180°), with the competitive cis 
configuration (i.e. 0°) being approximately 24 kJ·mol-1 higher in energy. Furthermore, all 
the retrieved solid-state conformations had the amide group (torsion angle ξ2 in Figure 
3.3a-c) in the trans configuration. Hence, it was decided to constrain both amide torsion 
angles Φ2a and Φ2b to their values in the isolated-molecule global minimum in 
conformational energy (181.21° and 180.59° respectively) during the search, and no 
crystal structure was generated with cis amides. However, both amide torsion angles 
were treated as independent CDFs in the final refinement stage (see Chapter 3.2.3) to 
allow them to take the most suitable configuration in the crystalline environment.  
 The search was performed with CrystalPredictor 1.6, which estimates ΔEintra with 
a crude model based on the interpolation of a grid of ab initio calculated intramolecular 
energies for each CDF treated as an explicit search variable (for details of the 
methodology, see Chapter 2.4.1.2).21  The other CDFs, including Φ2a and Φ2b, were 
constrained at the values in the isolated-molecule global minimum in conformational 
energy. This version of CrystalPredictor was used because an immense 
multidimensional grid would have been required to produce the local approximate 
models (LAMs) utilised by CrystalPredictor 222 for estimating ΔEintra, drastically increasing 
the computational expense, as explained in Chapter 2.4.1.2. On the other hand, 
CrystalPredictor 1.6 allows the grids to be constructed more cheaply by dividing a 
molecule into several appropriate surrogate molecule each containing a subset of the 
torsion angles. Note that this assumption is realistic only for torsion angles that define 
the positions of groups that do not interact strongly with one another.24 
 Molecule XXVI was broken down into three surrogate molecules, shown in Figure 
3.5, and two grids of ΔEintra values were produced: one for the central portion of the 
molecule, including angles Φ3a, Φ3b and Φ4, and one for the two identical edge portions 
containing angles Φ1a and Φ1b. Methyl groups were added at the extremities of each 
surrogate molecule to avoid the presence of unphysical free bonds.  
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Figure 3.5: Surrogate molecules used to calculate the ΔEintra grids of (left) Φ1a and Φ1b 
and (right) Φ3a, Φ3b and Φ4 of molecule XXVI.  
 The good agreement between the energy penalty for varying the torsion angles 
in the surrogate molecules and in the whole molecule (see Appendix Figure 3.1) 
indicates that this was a sensible approximation.  
 The two grids for each surrogate molecule were calculated with Gaussian 03 at 
the PBE0 6-31G(d,p) level of theory. The grid ranges shown in Table 3.1 were selected 
from the analysis of the angle scans and the CSD surveys (see Figure 3.4). The values 
of the torsion angles in the conformation of the target experimental crystal structures 
(see Figure 3.4 and Appendix Table 3.2) are all within the ranges covered by the grids. 
Table 3.1: Dimensionality of the ΔEintra grids used to perform the crystal structure search 
with CrystalPredictor. The grids were calculated from the surrogate molecules in Figure 
3.5. 
Central surrogate molecule 
Torsion angle 
label 
Torsion Angle Definition 
Minimum 
of search 
range/° 
Maximum 
of search 
range/° 
Step Size/° 
Number of 
grid points 
Φ3a H21-N1-C8-C17 120 300 20 10 
Φ3b H22-N2-C19-C20 120 300 20 10 
Φ4 C19-C18-C9-C8 -130 -70 20 4 
        
Number of 
Grid Points 
400 
Edge surrogate molecule 
Torsion angle 
label 
Torsion Angle Definition 
Minimum 
of search 
range/° 
Maximum 
of search 
range/° 
Step Size/° 
Number of 
grid points 
Φ1a and Φ1b C2-C1-C7-O1 and C30-C29-C28-O2  20 340 20 17 
 
 In the search, ΔEintra was calculated from the grids, while Uinter was modelled as 
the sum of an electrostatic component from fixed point charges calculated at the PBE0 
6-31G(d,p) level of theory on the isolated-molecule global minimum conformer and a 
repulsion-dispersion component calculated with the empirically-fitted FIT potential.25 A 
total of 1,000,000 crystal structures were generated in the 59 most common space 
groups, listed in Appendix Table 3.1. Although the challenge stated that the molecule 
could have crystallised in Z’=2, it was decided to limit the study to structures with only 
one molecule in the asymmetric unit to limit the overall computational cost. This seemed 
to be a sensible assumption since molecule XXVI does not possess the characteristics 
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that correlate with a higher likelihood of crystallisation with Z’>1, which were determined 
in a recent survey of the crystal structures in the CSD with more than one molecule in 
the asymmetric unit (~10% of the total), as it is large, flexible and not crystallised as 
homo-chiral.26  
 
3.2.3 Refinement of the generated crystal structures  
 
The final stage of this CSP study was the optimisation and re-ranking of the most 
promising generated crystal structures. The 9,400 generated structures with Elatt up to 40 
kJ·mol-1 of the global minimum in CrystalPredictor energy were taken to this final stage. 
A large energy window was necessary because of the simple and relatively inaccurate 
model used in the search. The flexible nature of molecule XXVI meant that both ΔEintra 
and Uinter had to be optimised for each crystal structure, and CrystalOptimizer27 (see 
Chapter 2.4.2.2) was used to carry out the all the Elatt minimisations. However, in order 
to limit the computational cost, not all the 9,400 generated crystal structures were fully 
optimised, but a hierarchal approach was used. Firstly, an intermediate optimisation and 
re-ranking step was performed with a single iteration of CrystalOptimizer, and only the 
most promising candidates were then fully optimised. This same approach has been 
used in other successful CSP studies.11, 28 
 
3.2.3.1 Intermediate optimisation of the generated crystal structures 
 
A single-iteration of CrystalOptimizer does not produce fully converged crystal 
structures, but improves their geometries and the energy ranking because of the greater 
accuracy of the CrystalOptimizer Ψmol model compared to the CrystalPredictor one.11  
 All the  9,400 generated crystal structures within 40 kJ·mol-1 of the global 
minimum in CrystalPredictor energy underwent this intermediate optimisation step. 
ΔEintra was improved optimising the molecular conformation with Gaussian03 at the 
PBE0 6-31G(d,p) level of theory as a function of the seven torsion angles in Figure 3.2, 
which were treated as independent CDFs. Uinter was also improved by optimising the 
intermolecular interactions with a more accurate distributed multipoles electrostatic 
model with GDMA 2.229 and DMACRYS (see Chapter 2.4.2.1).30 All the                        
electronic-structure calculations performed in this intermediate step to calculate ΔEintra 
and the multipoles were stored into LAMs databases to be re-utilised for further 
CrystalOptimizer optimisations, reducing in this way the computational cost of the 
successive CSP stage.23, 27 When all the single iterations of CrystalOptimizer were 
completed, duplicates were removed with COMPACK.31 Crystal structures were 
considered as duplicates if they had an energy difference smaller than 2.5 kJ·mol-1, a 
density difference smaller than 0.05 g·cm-3, and if it was possible to overlay 20/20 
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molecules, with 20% distance and 20° angle tolerances, with a root mean square 
deviation (RMSD20) smaller than 0.65 Å.  
 
3.2.3.2 Final optimisation of the most promising crystal structures 
 
The 1,322 unique crystal structures within 30 kJ·mol-1 of the global minimum after the 
single iteration of CrystalOptimizer were taken forward. All these structures were fully 
optimised with CrystalOptimizer at the PBE0 6-31G(d,p) level of theory; the seven torsion 
angles in Figure 3.2 were once again treated as independent CDFs, and were optimised 
under the influence of packing forces. A few structures were found not to be true Elatt 
minima, and their symmetry was reduced to lower energy Z’=2 structures. The fully 
optimised crystal structures were finally clustered with COMPACK to remove any 
duplicate. This time, crystal structures were considered as duplicates if they had an 
energy difference smaller than 2.85 kJ·mol-1, a density difference smaller than 0.05  
g·cm-3, and if it was possible to overlay 30/30 molecules, with 20% distance and 20° 
angle tolerances, with a root mean square deviation (RMSD30) smaller than 0.65 Å.  
 
3.2.4 Estimate of the effect of polarisation on lattice energies and calculation of free 
energies at 298 K 
 
The final step of the CSP study was the estimate of the effect of polarisation and 
temperature on the energies of the predicted crystal structures. The effect of polarisation 
on Elatt was estimated by re-calculating ΔEintra and the charge density of the fully 
optimised crystal structures in a PCM with ε=3 (see Chapter 2.3.1.2.4), a value typical of 
organic solids, and then performing a rigid-body optimisation of the intermolecular 
interactions with DMACRYS32. The same level of theory, PBE0 6-31G(d,p), and 
repulsion-dispersion potential, FIT, as for the CrystalOptimizer optimisations were used. 
Temperature effects were then estimated with DMACRYS by calculating the vibrational 
component (Fvib) of the Helmholtz free energy (A) at 298 K from the rigid-body k=0 
phonon modes (see Chapter 2.3.3.1).30, 33  
 
3.2.5 The two submitted lists 
 
Each group taking part in this Blind Test challenge was allowed to submit two lists 
containing up to 100 crystal structures. For molecule XXVI, the first list (see Appendix 
Table 3.3) contained the 100 lowest energy crystal structures after the full optimisations 
with CrystalOptimizer. This list covered an energy range of approximately 16.1 kJ·mol-1, 
larger than the typical polymorphic energy range of 10 kJ·mol-1.34, 35 
 The second list (see Appendix Table 3.4) was constituted by the 100 structures 
that were considered as the most likely to crystallise at room temperature. They were 
ranked on the Helmholtz free energy at 298 K, whose Elatt component (see Equation 
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2.37) was calculated with the PCM. Starting from the bottom of the energy ranking, 
structures that upon human judgment looked too similar to nucleate and grow 
independently without transforming into lower-energy forms were removed. This process 
continued until 100 individual crystal structures were found, which covered an energy 
range of approximately 22.2 kJ·mol-1. 
 
3.3 Results and Discussion 
 
Both submitted lists contained a close match to the target experimental crystal structure 
of molecule XXVI.2  
 
3.3.1 Crystal structure search 
 
 
Figure 3.6: Lattice energy vs density plot obtained after the search with CrystalPredictor 
1.6. ΔEintra was calculated from the ab initio grids, while Uinter was modelled with the 
atomic point charges and the FIT potential. The structure that ended up matching the 
experimental form is indicated in blue. Each point on the plot corresponds to a separate 
crystal structure. 
 The computer-generated structures were named according to their ranking after 
the CrystalPredictor search. The structure that ended up matching the experimental form 
is structure 1600, i.e. the structure that was ranked 1600th at the search stage.  
 Treating the most flexible torsion angles as flexible in the search was key to the 
success of this CSP study. Rigid searches performed only on the isolated-molecule 
global minimum or on a set of local minima in conformational energy would have failed 
to generate crystal structures that could have optimised to the target experimental form. 
Figure 3.7 shows an overlay between the experimental conformation and the closest 
isolated-molecule local minimum conformer optimised at a PBE0 6-31G(d,p) level of 
theory. The overlay is poor, with an RMSD1 of 0.624 Å and a noticeable difference in the 
orientation of the edge groups. 
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Figure 3.7: Overlay of the conformation in the experimental crystal structure of molecule 
XXVI (coloured by elements) and the closest gas-phase optimised conformer (in blue). 
The RMSD1 calculated with the Crystal Packing Similarity tool is 0.624 Å. 
 The experimental conformation has one amide group distorted from planarity with 
the naphthalene group, which Figure 3.4c shows being a relatively high-energy 
configuration. This illustrates how improved intermolecular interactions can distort a 
crystalline conformation from optimised gas-phase geometries.35, 36 The selection of the 
search space for the flexible search (see Table 3.1) was effective: both amide groups 
are in their trans configuration, and the experimental values of the five torsion angles 
that were treated as independent variables in the search (see Figure 3.4 and Appendix 
Table 3.2) are all within the grid ranges. 
 The CrystalPredictor energies were poor, as shown by the ranking of structure 
1600, ~29 kJ·mol-1 above the global minimum. Furthermore, an overlay of                          
search-generated structure 1600 and the target experimental form performed with the 
Crystal Packing Similarity tool31 (see Chapter 2.5.1) with its standard settings only 
matches 9/15 molecules. Nonetheless, the conformations are much more similar, as 
shown in Figure 3.8, proving how vital the correct treatment of molecular flexibility in the 
search was for the success of this CSP study. 
 
Figure 3.8: Overlay of the conformation of the experimental crystal structure of molecule 
XXVI (coloured by elements) and the conformation of search-generated structure 1600 (in 
blue). The RMSD1 calculated with the Crystal Packing Similarity tool is 0.282 Å. 
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3.3.2 Refinement of the generated crystal structures 
 
3.3.2.1 Intermediate optimisation of the generated crystal structures 
 
Figure 3.9: Lattice energy vs density plot obtained after the intermediate optimisations 
with a single-iteration of CrystalOptimizer. Each point on the plot corresponds to a 
separate crystal structure, labelled according to its space group. The structure that 
ended up matching the experimental form is indicated. 
The intermediate optimisation with a single-iteration of CrystalOptimizer improved the 
energies and geometries substantially, as expected given the more accurate and 
expensive energy model. The energy ranking was drastically modified, and the global 
minimum in Figure 3.9 was ranked 675th by CrystalPredictor. Structure 1600 came down 
to the 45th place, ~12 kJ·mol-1 less stable than the global minimum. Its geometry was 
also improved: after the intermediate optimisation structure 1600 had a 15/15 molecule 
match with the target experimental crystal structure, with an RMSD15 of just 0.422 Å. The 
conformation was also improved by the single iteration of CrystalOptimizer, with an 
RMSD1 with its experimental counterpart of 0.206 Å. 
 This intermediate step was key to the success of the CSP study, since it allowed 
a drastic reduction in the number of structures requiring full optimisations and provided 
a more accurate starting point for further calculations. Although not exactly cheap (see 
Table 3.3), it made the CSP study feasible within its time and resource constraints. This 
underlines how important an intermediate step bridging the gap between the search and 
the final optimisation can be for screening several thousands of computer-generated 
crystal structures, a topic explored more in depth in Chapter 7. 
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3.3.3.2 The two submitted lists 
 
 
Figure 3.10: Lattice energy vs density plots showing (a) the 100 lowest energy crystal 
structures fully optimised with CrystalOptimizer submitted as a first list of predictions (b) 
the 100 lowest energy crystal structures after a rigid-body optimisation in a PCM with ε=3 
and with the addition of the vibrational component to Helmholtz free energy at 298 K 
submitted as a second list of predictions. See Appendix Tables 3.3-3.4 for more details. 
Each point on the plots corresponds to a separate crystal structure, labelled according to 
its space group. The structures matching the target experimental form are indicated. 
 A total of 1,322 unique crystal structures were fully optimised with 
CrystalOptimizer, and the ones in Figure 3.10a were submitted as the first list of 
predictions. The re-ranking was once again drastic. Structure 1600 ranked 2nd, only ~0.5 
kJ·mol-1 above the global minimum, structure 3525. A high-quality 15/15 molecule 
overlay with the target experimental crystal structure was achieved, with an RMSD15 of 
0.276 Å and an RMSD1 of 0.126 Å. The importance of allowing the amide torsion angles 
to respond to packing forces in the final optimisation is outlined by Φ2b taking a value of 
167.4°, as opposed to 180.6° in the input conformation for the search. This illustrates the 
importance of carefully analysing the conformational space before a search is performed, 
and that CSD analyses can be an effective tool to guide the process of determining the 
most relevant conformations. 
(a) 
(b) 
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  The crystal energy landscape obtained after estimating the effect of polarisation 
and temperature (Figure 3.10b) is remarkably different. Structure 1600 was now clearly 
the most favourable form in terms of free energy, with a ~8.3 kJ·mol-1 gap with the second 
most competitive one. Most of the re-ranking was due the inclusion of polarisation, which 
was the main stabilising factor for structure 1600. This stabilisation was mainly due to 
the presence of an intermolecular hydrogen bond in structure 1600: when calculating the 
molecular wave-function in a PCM, the charge distribution of the molecule polarises the 
dielectric continuum, which in turn induces a change in the molecular electron density 
compared to the gas-phase in a way that stabilises strong intermolecular electrostatic 
interactions (e.g. strengthening the dipole moments, which reinforces hydrogen 
bonds);37 the same phenomenon occurred for other low-energy predicted crystal 
structures (see Chapter 3.3.4.2). The rigid-body vibrational contribution to free energy 
was much smaller, and the low-energy crystal structures had small variations in terms of 
Fvib, usually in the order of 2-4 kJ·mol-1, indicating that Elatt differences dominated the 
free energy ranking.33, 38 Structure 1600 in the second list is nearly identical to its 
counterpart in the first list, with an RMSD15 of just 0.019 Å. 
 Although both crystal energy landscapes contain the target experimental form as 
a low-energy crystal structure, they provide very different insights in terms of the possible 
polymorphism of molecule XXVI and show how sensitive energy differences are on 
theoretical models. While Figure 3.10a suggests that the known form is one of the most 
promising structures within several competitive putative polymorphs (PPMs), Figure 
3.10b shows a typical monomorphic crystal energy landscape,39 which indicates that the 
known crystal structure is much more stable than any competitor. The monomorphic 
landscape in Figure 3.10b seems to be refuted by molecule XXVI undergoing a                    
high-temperature phase transition to another polymorph (form 11) at 428 K. The crystal 
structure of form 11 is currently unknown. If form 11 were a different crystal structure 
from form 1 and found as a separate minimum in this study, then the energy gap in Figure 
3.10b would be incorrect, since the vibrational component of free energy is unlikely to 
cause a sufficient re-ranking even at high temperatures33 for any other predicted crystal 
structures to become more stable. However, these calculations of the free energy did 
not account for thermal expansion40, 41 and/or the coupling of lattice and molecular 
vibrations42 (see Chapter 2.3.3 for details). On the other hand, if form 11 were a distinct 
polymorph missed in this study or outside of its boundaries (for example with Z’>1), then 
it would mean the CSP search was not complete enough. The energy of form 11 would 
have to be calculated with both models to understand which one provides a more 
accurate picture of the solid-state behaviour of molecule XXVI. It is also possible that the 
phase transition from form 1 to form 11 is associated with no significant change in crystal 
structure, meaning that form 11 is an isostructural polymorph of the known form43 (a topic 
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discussed in Chapter 8); in this case, CSP methods would not be capable to predict form 
11, and the existence of this polymorph would not disprove the monomorphic energy 
landscape in Figure 3.10b. Finally, it is unlikely that form 11 is higher symmetry phase 
averaging over lower symmetry Elatt minima, since both crystal energy landscapes do not 
reveal the presence of groups of crystal structures with similar energies and common 
motifs. 
 
3.3.3 Analysis of the generated crystal structures 
 
3.3.3.1 Reproduction of the experimental form 
 
The structural and crystallographic parameters of the experimental form and structure 
1600 in both lists are compared in Table 3.2. The overlay between the experimental form 
and predicted structure 1600 optimised with the model used to compile the first list is 
shown in Figure 3.11. 
Table 3.2: Comparison between the crystallographic and structural parameters in the 
experimental crystal structure of XXVI and in predicted structure 1600. 
Structure 
Density
/g·cm3 
Packing 
coefficient/
% 
Space 
group 
Z' a/Å b/Å c/Å α/° β/° γ/° 
XAFQIH 1.346 65.5 P1̅ 1 10.40 11.03 14.18 76.83 73.33 63.47 
1600 (1st list) 1.343 67.4 P1̅ 1 10.26 11.17 14.23 78.54 73.53 62.86 
1600 (2nd list) 1.347 67.7 P1̅ 1 10.26 11.17 14.20 78.59 73.40 62.87 
 
 
Figure 3.11: Overlay between the hydrogen bonded dimer in the experimental crystal 
structure of molecule XXVI (coloured by elements) and predicted structure 1600 in the 
first list (in green). The hydrogen bonds are coloured in purple. The RMSD15 for the 15/15 
overlay is 0.276 Å. 
 Table 3.2 shows an excellent agreement between the structural and 
crystallographic parameters of the experimental crystal structure and the forms predicted 
with both models, well within the margin of error of the CSP methodology. This is 
confirmed by the good match shown in Figure 3.11. Although the experimental form is 
denser than structure 1600 in the first list, it has a smaller calculated packing coefficient. 
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This shows the limitation of the grid-based method used to estimate the packing 
coefficient of crystal structures. 
 This analysis confirms that CrystalOptimizer was accurate at reproducing the 
target experimental crystal structure and at ranking it relative to its predicted competitors. 
The success of this CSP study was due to the quality of the CrystalOptimizer Ψmol model, 
which accurately balanced intra- and intermolecular interactions, even if only seven 
CDFs were explicitly optimised under the influence of packing forces. However, the 
generation of a similar enough crystal structure in the search was equally as 
fundamental.  
 
3.3.3.2 Other competitive low-energy crystal structures 
 
Although only one experimental single-component form is known, an analysis of the 
other predicted low-energy crystal structures of molecule XXVI reveals interesting 
information about the crystallisation possibilities of this molecule. Beside structure 1600, 
27 other predicted crystal structures could be found within the typical  polymorphic energy 
range of 10 kJ·mol-1 in the first list and 3 in the second list. Only 5 of the structures in the 
first list and 6 in the second list had their symmetry reduced to Z’=2, the lowest energy 
one being structure 4201, ranked 18th in the first list and 19th in the second list.   
 XXVI seems to struggle to pack well with itself: most low-energy predicted crystal 
structures have packing coefficients of 67-68% and even the densest PPMs do not 
exceed 70.6%. This is probably due to the awkward shape of the molecule, which hinders 
the formation of dense packings. The polymorph screen that found nine solvates (forms 
2-10) seems to confirm this hypothesis: the presence of many solvated forms is often 
associated with the inability of a molecule to pack densely.2, 44  
 Conformational flexibility is also a clear feature of the low-energy forms. There is 
no dominating conformation: using the criteria proposed by Cruz Cabeza and Bernstein 
for determining whether two crystal structures are related by conformational change (see 
Chapter 2.3.1.1),36 the 100 crystal structures in the first and second list can be grouped 
into 40 and 44 clusters of conformational polymorphs respectively. 
 Hydrogen bonds are a fundamental feature of organic crystals, when hydrogen 
bond donor and acceptors are present.  Figure 3.12 shows which structures in the two 
lists form intra or intermolecular hydrogen bonds. 
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Figure 3.12: (above) Lattice energy vs density plot of the 100 lowest energy structures 
submitted as a first list of predictions (below) free energy vs density plot the 100 lowest 
energy structures submitted as a second list of predictions. They are labelled on whether 
they form intra- or intermolecular hydrogen bonds. 
 A comparison between these two plots reveals that the most important effect of 
the PCM with ε=3 was to stabilise structure 1600, but it also stabilised other crystal 
structures that formed hydrogen bonds, either intra- or intermolecular, relative to the 
ones that did not form any.  
 Although the target experimental form forms an intermolecular NH···O hydrogen 
bond, few predicted crystal structures share this feature. The reason is the bulky shape 
of molecule XXVI, with steric effects preventing the formation of an extensive hydrogen 
bond network.2 The formation of hydrogen bonds requires that the amide groups are not 
co-planar with the naphthalene groups, which leads to a high conformational energy 
penalty, as shown in Figure 3.4c. Structure 1600 has a high relative ΔEintra of ~17.5 
kJ·mol-1 for the PBE0 6-31G(d,p) isolated molecule, while the inclusion of the PCM with 
ε=3 decreases the energy penalty to ~12.7 kJ·mol-1.  
 Three interesting PPMs forming intermolecular hydrogen bonds are structures 
675 (ranked 3rd in the first list and 2nd in the second), 421 (ranked 5th in the first list, and 
removed from the second list because considered similar to structure 675) and 2231 
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(ranked 14th in the first list, and removed from the second list because considered similar 
to structure 675). They all contain similar conformations to structure 1600 and form the 
same hydrogen bonded and π-π stacked sheet, as shown in Figure 3.13. As expected, 
these structures are all characterised by high ΔEintra values of 13 to 20 kJ·mol-1 in the first 
list, compensated by favourable intermolecular interactions. 
 
Figure 3.13: Overlay of the conformations of structures 1600 (coloured by elements), 
which matches the target experimental crystal structure, 675 (yellow), 421 (blue) and 
2231 (red) (left) and the sheet common to all four structures (right). 
 On the other hand the global minimum in Elatt in the first list (ranked 3rd in the 
second list), structure 3525, contains a conformation similar to the isolated-molecule 
global minimum, with a low ΔEintra value of ~1.2 kJ·mol-1 in the first list and ~2.2 kJ·mol-1 
in the second list. Its crystal structure is characterised by sheets of π-π stacked 
chlorobenzene rings with Cl atoms oriented in opposite directions, as shown in Figure 
3.14. This π-π stacking motif is present in 46 of the 100 structures in the first list of 
predictions.  
 
Figure 3.14: (left) Overlay of the conformation of structure 3525 (coloured by elements), 
the global minimum in Elatt in the first list, and the isolated-molecule global minimum of 
molecule XXVI (in blue) (right) and its crystal structure. 
 Other structures form intramolecular hydrogen bonds: structure 3104 (ranked 6th 
in both lists), 185 (ranked 17th in the first list and 5th in the second list), 1391 (ranked 59th 
in the first list and 48th in the second list) and 7559 (ranked 77th in the first list, and 
removed from the second list because considered similar to structure 3104). They all 
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have high ΔEintra values of ~17-19 kJ·mol-1 in the first list, while in the second list they are 
slightly stabilised by the PCM with ΔEintra values of ~13-14 kJ·mol-1. The reason for these 
high conformational energies is that the stabilisation provided by the internal hydrogen 
bond does not fully compensate for the penalty of distorting both amide groups from co-
planarity with naphthalene. However, their densities are the highest among all the low-
energy crystal structures, and so they are stabilised by dispersion.39 These four structure 
have similar conformations and share a similar stacking, shown in Figure 3.15.  
 
Figure 3.15: Overlay of the conformations of structures 3104 (coloured by elements), 185 
(blue), 1391 (red) and 7559 (yellow) (left) and the packing motif common to those 4 
structures (right). 
 In summary, this CSP study has shown that this molecule could form several 
alternative crystal structures, although the two lists give a very different picture of their 
relative competitiveness. The energetic and structural characteristics of these crystal 
structures provide several insights about this molecule and its possible solid-state 
behaviour. 
 
3.3.4 Overall computational cost 
 
The overall computational cost of this CSP study is broken down in Table 3.3. 
Table 3.3: Breakdown of the computational cost of the Blind Test prediction of the crystal 
structure of molecule XXVI. 
  CPU time (hours) % of total time 
Flexibility analysis 11,000 4.2 
Grid Generation 11,000 4.2 
Crystal structure search with CrystalPredictor 1.6 5,300 2.0 
Single iterations with CrystalOptimizer 138,000 52.6 
Full optimisations with CrystalOptimizer 96,000 36.6 
Estimate of polarisation and temperature effects 1,100 0.4 
Total time 262,400 100.0 
 The most expensive steps were the ones involved in the refinement of the search-
generated crystal structures (see Chapter 3.2.3), which combined accounted for almost 
90% of the overall computational cost. Although the flexibility analysis and the search 
accounted for slightly more than 10% of the overall CPU cost, those steps required the 
largest amount of human effort. The CPU cost shown in Table 3.3 is lower than the one 
given in the Blind Test publication, since in this more accurate estimate only the 
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calculations that led to the final predictions are accounted for.2 However, the overall 
expense for predicting the crystal structure of this molecule remains rather large, 
highlighting an important problem related to performing CSP on large and flexible 
molecules. Some solutions to tackle the high computational cost of CSP studies of large 
and flexible molecules are proposed in Chapters 5 and 7. 
 
3.3.5 DFT-D optimisation of the structures generated in this study 
 
The 1,000 lowest energy crystal structures after the single-iteration of CrystalOptimizer 
were sent to two groups that did not have the codes to generate candidate structures, in 
order to give them the opportunity to use their high-quality Ψcrys DFT-D methods (see 
Chapter 2.3.2.1) to optimise and re-rank them. As mentioned in Chapter 3.3.3.1, this list 
contained structure 1600 as the 45th structures in the Elatt ranking, which was already a 
close match to the target experimental form, as it was possible to match 15/15 molecules 
with an RMSD15 of 0.422 Å. 
 Tkatchenko et al. did not send predictions for molecule XXVI due to time and 
resource constraints. In their post-analysis, they performed periodic DFT-D calculation 
with the PBE functional, first with a single-point Elatt calculation on each structure using 
the pairwise Tkatchenko-Scheffler (TS)45 dispersion correction, then fully optimising 20 
the lowest energy ones at the PBE+TS level of theory, and finally re-calculating the 
energies using the many-body dispersion (MBD)46 correction. Structure 1600 was found 
to be the global minimum in Elatt, confirming the results of my CSP study, although with 
a small gap of just 0.7 kJ·mol-1 from the second lowest energy predicted form.  
 Brandenburg and Grimme used a multi-stage hierarchical approach, from 
cheaper semi-empirical methods (see Chapter 2.3.2.2) to more accurate electronic 
structure calculations. The first list was purely based on semi-empirical methods, while 
in the second one the structures were further optimised at the TPSS+D347, 48 level of 
theory. Structure 1600 was not present in either submitted list. Post-analysis revealed it 
was lost because it was slightly above the ranking cut-off that was adopted after one of 
the intermediate stages with semi-empirical methods; if it had been kept, it would have 
been the ranked 18th in the first list and 1st in the second (and more accurate) list, 
consistently with the post-analysis by Tkatchenko et al. 
 These high-quality calculations confirm that structure 1600 is one of the most 
stable computer-generated crystal structures in terms of Elatt. It is promising how the less 
sophisticated and cheaper Ψmol method employed in this study gave similar answers to 
more expensive Ψcrys methods. The relative ranking of the other predicted structures is 
different, but an objective assessment of the quality of different crystal energy 
landscapes is impossible because of the absence of any other solved experimental 
polymorph of molecule XXVI. The fact that these very accurate methodologies failed to 
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provide a successful prediction for the Blind Test because of cost and resource 
constraints reinforces the idea that any effective CSP methodology must combine 
accuracy with cost feasibility. 
 
3.4 Comparison with submissions by other groups 
 
3.4.1 Molecule XXVI 
 
Because of its complexity, only 12 out of the 25 participants submitted predictions for 
molecule XXVI. Only three of these 12 groups, including ours, successfully predicted the 
target crystal structure in their lists. Many of the failures were due to the inclusion of 
assumptions and/or limitations that were needed to keep the computational cost 
manageable.2  
 Both other groups that included the experimental crystal structure of XXVI in their 
predicted lists had it ranked very competitively. Neumann et al. used the well-known and 
successful GRACE method.8 A tailor-made force field (TMFF)49 was parametrised from 
DFT-D calculations, which was used to evaluate the energies of both bonded and                
non-bonded interactions. A Monte-Carlo parallel tempering algorithm was utilised to 
generate a set of crystal structure from the TMFF Elatt surface, in order to keep the 
computational cost manageable. The most promising candidates were then optimised 
and re-ranked with DFT-D, using the PBE functional and the empirically-fitted             
Neumann-Perrin dispersion correction. The DFT-D minimisations were performed firstly 
with more loose convergence criteria, forming the first list of predictions, and then with 
more stringent ones, forming the second list. The structure matching the experimental 
form was ranked first in both lists. The computational cost of their successful CSP study 
was larger than the one shown in Table 3.3 (~356,000 vs ~262,000 CPU hours); 
however, the cost of the methodologies is hardly comparable since GRACE produced 
some structures with Z’=2, although within a less complete search.  
 Elking and Fust-Molnar used a multi-step procedure in their CSP study. Their 
method consisted in the random generation of crystal structures in 32 space groups with 
1 or 2 molecules in the asymmetric unit, the most promising of which were then optimised 
and re-ranked with DFT-D methods. The random generation was based on an estimate 
of Elatt in which ΔEintra was calculated with the Merck Molecular Force Field,50 while Uinter 
was estimated as the sum of an electrostatic component modelled with distributed 
multipoles calculated with GAMESS51 and an repulsion-dispersion component calculated 
from an empirically fitted potential.52 Several rigid searches were performed fom isolated-
molecule conformers. After the crystal structure generation, the distributed multipoles of 
the top 2,000 lowest energy generated structures were re-calculated, and used to 
perform a flexible optimisation and energy re-ranking using the same Elatt model as in 
the search. The 50 lowest energy structures after this intermediate optimisation were 
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then fully minimised and re-ranked with DFT-D at the PBE+XDM53 level of theory with 
Quantum Espresso.54 The computational cost of their study and the criteria to produce 
the two lists are unknown. A structure matching the experimental form was ranked eighth 
in their first list and first in the second. 
  The other methods were not successful at predicting the target experimental 
form. Pantelides, Adjiman et al. used a similar method to the one utilised in this CSP 
study. CrystalPredictor (although version 2 rather than 1.6) was used to perform the 
search and CrystalOptimizer was utilised for the final refining the generated crystal 
structures. Post-analysis revealed that the failure to find a match to the experimental 
form was caused by the value of torsion angle Φ3b (see Appendix Table 3.2) being 
outside the flexibility range in the search. After extending the search space in their post-
analysis, a crystal structure matching the experimental form was found.55 This shows 
that an accurate and comprehensive assessment of the conformational search space is 
vital to successful CSP studies. 
 Another interesting example is that of Day et al., who performed a set of rigid 
searches with the crystal structure generation engine GLEE.56 The searches were 
performed from conformers generated via a low-mode conformational search57 using the 
OPLS2005 force field58 and then optimised in the gas-phase with Gaussian0959 at the 
B3LYP 6-311G(d,p)+D3 level of theory. The rigid searches were limited to the distinct 
isolated-molecule energy minima with a relative conformational energy lower than 30 
kJ·mol-1. No match to the target experimental form was found, because it is highly 
distorted from the closest isolated-molecule conformational energy minimum (as shown 
in Figure 3.7). This hints to the need of not limiting the search space to isolated-molecule 
minima, since intermolecular forces can cause significant conformational adjustment. 
 
3.4.2 Other molecules 
 
The overall results of the Blind Test were quite promising. All molecules had at least one 
correct prediction, with the exception of the Z’=2 form E of molecule XXIII. The 
methodology used in our group was successful for most molecules, and the only Z’=1 
crystal structure that was not present in either list was form A of molecule XXIII. Also, 
the two Z’=2 polymorphs of molecule XXIII (forms C and E) and the crystal structure of 
the three component salt XXIV were not found. The GRACE commercial methodology 
utilised by Neumann et al. was also very successful, since it only missed form E of 
molecule XXIII, and it was the only method that performed better than our simpler Ψmol 
alternative. This Blind Test has been considered a big advance in CSP,60 which is 
becoming a procedure for understanding the solid form landscapes of organic molecules. 
However, the computational cost currently hinders a larger-scale applicability of CSP, 
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particularly on large and flexible molecules of pharmaceutical interest. Hence, it is worth 
to develop CSP methods to make them more widely applicable. 
 
3.5 Conclusion 
 
The CSP methodology discussed in this chapter successfully predicted the crystal 
structure of molecule XXVI in both lists submitted for the Blind Test. In the first list, ranked 
purely on Elatt, the structure matching the experimental form was ranked second, only 
0.5 kJ·mol-1 above the global minimum, and was one among several competitive PPMs. 
In the second list, in which estimates of polarisation and temperature effects were 
included in the energy ranking, the structure matching the experimental form was ranked 
first, with a large energy gap from its closest competitor. Although the existence of a 
high-temperature polymorph of molecule XXVI may suggest that this large gap is 
incorrect, this cannot really be confirmed until this form is fully characterised, since it may 
be a structure not present in the crystal energy landscape or very similar to the known 
form. 
 The results from this study illustrate some points that are very important in the 
overall context of this thesis. First of all, the experimental form contains a strained               
high-energy conformation, which is stabilised by intermolecular hydrogen bonds. This 
shows how important the initial assessment of the conformational space is: trying to limit 
the computational cost of a flexible search by excluding conformational ranges that are 
relatively high in energy can often lead to incomplete searches, as shown by the CSP 
study by Pantelides, Adjiman et al. On the other hand, limiting the cost just by performing 
rigid searches on a set of isolated-molecule local minima is not adequate, as shown by 
the study by Day et al., since molecules can crystallise in distorted conformations that 
must be explicitly included in the searches. Hence a balance between computational 
cost and coverage of the conformational space must be found.24 
 Another important point is that for large and flexible molecules the final refinement 
procedure requires a cost-effective methodology. Since the search is bound to use 
approximate models, the energy ranking it provides is often poor. Hence hundreds or 
even thousands of structures often need to be considered, and it is currently impossible 
to minimise each of them with the most accurate models. An accurate method that 
cannot optimise a sufficient number of structures can be ineffective for use in CSP for 
large and flexible molecules, as illustrated by the failure of both groups that re-ranked 
crystal structures with DFT-D to submit a correct prediction for molecule XXVI despite 
being provided with a set of structures containing a close match to the target 
experimental form. Hence, accurate but cost effective optimisation and re-ranking 
methods are desirable.42 
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 Finally, this study proves how sensitive energy differences are to the theoretical 
models. However, the quality of any energy ranking is difficult to judge in the absence of 
an experimental benchmark.61 Overall, the 6th Blind Test showed that several CSP 
methods can predict and rationalise the crystallisation behaviour of organic molecules 
that are similar in terms of size and flexibility to the smaller ones in pharmaceutical 
development. The trade-off between computational cost and accuracy remains an 
important problem, and the expansion of CSP to even larger and more flexible molecules 
requires a limitation of the expense without a decrease in the quality of the predictions. 
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3.7 Appendix 
 
Appendix Figure 3.1: Comparison of the energy penalties for varying torsion angles (a) 
Φ1a and Φ1b (b) Φ3a and Φ3b (c) Φ4 in the whole molecule and in the surrogate molecules 
used to calculate the ΔEintra grids. All the calculations were performed at the PBE0           
6-31G(d,p) level of theory starting from the PBE0 6-31G(d,p) optimised gas-phase 
conformations of both the whole molecule and the surrogate molecules. Φ1b and Φ3b were 
not scanned explicitly, as their energy profile would be identical to their symmetry 
related counterparts.  
 
Appendix Table 3.1: List of the 59 space groups considered in the crystal structure 
search performed with CrystalPredictor 1.6. 
P1 P1̅ P21 P21/c P21212 P212121 Pna21 Pca21 Pbca Pbcn 
C2/c Cc C2 Pc Cm P21/m C2/m P2/c C2221 Pmn21 
Cmc21 Aba2 Fdd2 Iba2 Pnna Pccn Pbcm Pnnm Pmmn Pnma 
Cmcm Cmca Fddd Ibam P41 P43 I4̅ P4/n P42/n I4/m 
I41/a P41212 P43212 P4̅21c I4̅2d P31 P32 R3 P3̅ R3̅ 
P3121 P3221 R3c R3̅C P61 P63 P63/m P213 PA3̅  
 
Appendix Table 3.2: Values taken by the seven torsion angles in Figure 3.2 in the 
conformation of the target experimental crystal structure of molecule XXVI. 
Torsion angle label Torsion Angle Definition Experimental conformer value 
Φ1a C2-C1-C7-O1 145.6 
Φ1b C30-C29-C28-O2 124.1 
Φ2a O1-C7-N1-H21 179.9 
Φ2b O2-C28-N2-H22 167.4 
Φ3a H21-N1-C8-C17 194.3 
Φ3b H22-N2-C19-C20 140.9 
Φ4 C19-C18-C9-C8 -78.4 
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Appendix Table 3.3: Lattice energies, structural and crystallographic parameters of the 
100 crystal structures of molecule XXVI that were submitted as a first list of prediction for 
the 6th Blind Test. The structure matching the experimental form is highlighted in orange. 
Structure  
Elatt  
/kJ·mol-1 
Density  
/g·cm3 
Packing 
coefficient/
% 
Space 
group Z' a/Å b/Å c/Å α/° β/° γ/° 
3525 -206.86 1.351 68.3 P1̅ 1 10.55 10.84 14.97 71.52 69.52 61.07 
1600 -206.37 1.343 67.4 P1̅ 1 10.26 11.17 14.23 78.54 73.53 62.86 
675 -204.25 1.352 68.7 P21/c 1 11.67 14.21 16.91 90.00 100.2
8 
90.00 
38 -202.70 1.341 67.5 I41/a 1 10.90 23.24 23.24 86.85 76.43 76.43 
421 -201.43 1.352 68.6 P21/c 1 11.56 14.34 16.91 90.00 100.2
1 
90.00 
3104 -201.20 1.394 70.5 P1̅ 1 10.50 10.95 13.72 105.0
6 
100.5
8 
112.3
2 615 -200.58 1.321 66.8 P21/c 1 10.42 14.26 20.19 90.00 90.00 109.7
3 239 -200.48 1.342 68.0 P21/c 1 10.78 13.75 18.95 98.39 90.00 90.00 
2930 -200.30 1.351 68.7 P1̅ 1 10.74 10.83 14.64 88.66 70.78 60.44 
354 -199.98 1.325 67.0 P21/c 1 10.21 15.69 19.12 113.2
0 
90.00 90.00 
851 -199.81 1.322 66.7 P1̅ 1 11.16 11.18 11.94 86.52 73.76 80.74 
6460 -199.74 1.310 65.8 P1̅ 1 10.89 11.46 13.66 72.83 69.52 64.82 
6335 -199.41 1.335 67.6 C2/c 1 10.69 10.90 28.19 78.98 79.07 60.65 
221 -199.40 1.313 66.4 P1̅ 1 11.09 11.22 13.90 69.59 89.40 63.01 
2231 -199.29 1.356 68.6 P1̅ 1 10.61 10.87 14.39 74.95 73.13 61.12 
2496 -198.93 1.323 67.4 P21/c 1 10.53 13.85 19.65 100.2
1 
90.00 90.00 
185 -198.75 1.391 70.7 P21/c 1 11.95 13.74 17.80 90.00 90.00 113.5
5 4201 -198.65 1.344 67.9 P21 2 9.95 10.20 29.41 90.00 90.00 111.6
5 314 -198.63 1.307 65.8 P21/c 1 10.84 14.31 19.45 90.00 90.00 108.9
8 508 -198.56 1.353 68.5 P21/c 1 11.12 13.20 18.84 90.00 94.36 90.00 
4946 -198.48 1.354 68.8 P1̅ 1 10.56 11.10 14.39 103.8
9 
98.13 118.1
8 6879 -198.35 1.314 66.3 C2/c 1 10.69 10.69 28.58 94.89 96.61 117.7
1 506 -198.23 1.332 67.8 P1̅ 1 10.85 11.39 14.01 85.79 67.59 61.94 
4842 -198.03 1.336 67.8 P21/c 1 10.85 14.66 17.79 90.00 99.49 90.00 
43 -197.84 1.372 69.5 P21/c 1 8.84 16.17 19.01 90.00 90.60 90.00 
1236 -197.71 1.355 68.3 C2/c 1 14.93 14.93 15.87 103.4
5 
107.0
2 
116.2
0 1537 -197.69 1.341 67.8 P1̅ 1 10.38 10.43 14.40 94.31 91.70 116.3
2 188 -197.46 1.349 68.3 P1̅ 1 9.00 10.75 16.26 104.9
5 
94.63 111.8
6 5126 -196.81 1.288 65.1 Pbca 1 13.54 19.66 21.75 90.00 90.00 90.00 
444 -196.75 1.379 69.7 P1̅ 1 10.38 10.43 14.27 101.3
0 
101.3
5 
111.0
0 544 -196.57 1.318 66.8 P1̅ 1 11.15 11.22 11.98 73.18 86.57 80.28 
686 -196.52 1.327 67.4 C2/c 1 13.14 15.37 15.41 92.81 90.00 115.3
1 89 -196.42 1.315 66.3 I41/a 1 19.93 19.93 19.93 91.50 119.1
4 
119.1
4 20 -196.16 1.320 67.0 P1̅ 1 10.12 11.07 13.39 88.56 80.15 72.88 
83 -196.04 1.355 68.4 P21/c 1 10.85 15.53 16.34 90.00 90.09 90.00 
3075 -195.96 1.361 69.0 Pbca 1 14.44 17.91 21.20 90.00 90.00 90.00 
4199 -195.83 1.337 67.6 P1̅ 1 9.97 10.80 14.41 95.32 94.86 114.2
5 1249 -195.77 1.345 68.2 P21/c 1 12.26 15.21 15.39 90.00 105.0
7 
90.00 
177 -195.67 1.331 67.1 P1̅ 1 10.84 11.20 12.19 107.2
2 
92.98 95.99 
2012 -195.49 1.339 67.3 P1̅ 1 9.60 11.00 14.73 94.10 96.01 114.8
0 3860 -195.43 1.322 66.8 C2/c 1 10.93 11.66 25.21 95.63 90.00 117.9
3 1237 -195.43 1.351 68.3 P21/c  1 11.25 13.71 17.91 90.00 91.44 90.00 
579 -194.83 1.323 66.6 P21/c 1 10.64 13.84 19.74 90.00 90.00 104.0
6 361 -194.40 1.345 67.9 P21/c 1 11.81 14.27 16.70 90.00 99.87 90.00 
985 -194.35 1.337 67.4 P1̅ 1 10.08 11.15 14.01 82.16 83.35 63.63 
371 -194.35 1.334 67.4 P21/c 2 16.71 17.04 21.10 90.00 111.4
2 
90.00 
694 -194.34 1.322 66.9 P21/c 1 10.81 14.41 18.24 90.00 96.90 90.00 
102 -194.08 1.319 66.8 Pbca 1 16.24 18.32 19.02 90.00 90.00 90.00 
5147 -193.98 1.329 67.2 Cc 2 10.62 11.08 27.22 92.41 90.00 118.6
3 8917 -193.91 1.316 66.5 P21/c 1 10.65 14.36 19.50 90.00 90.00 108.0
2 1098 -193.86 1.328 67.1 P21/c 1 11.06 14.00 18.14 90.00 90.00 90.38 
1378 -193.62 1.310 66.6 P21/c 1 10.34 13.72 21.02 90.00 90.00 107.2
7 1662 -193.60 1.304 66.3 P21/c 1 10.97 13.22 20.06 100.6
0 
90.00 90.00 
1369 -193.52 1.333 66.9 P1̅ 1 10.50 11.01 13.15 72.81 74.73 88.80 
1019 -193.40 1.301 65.8 P21 2 10.50 10.84 28.40 90.00 90.00 117.4
4 6282 -193.32 1.320 66.6 P21/c 1 10.70 14.40 19.30 90.00 90.00 108.1
4 
101 
 
88 -193.22 1.341 67.9 C2/c 1 13.50 13.50 15.62 96.37 96.37 98.03 
125 -193.20 1.348 68.2 P21/c 1 11.47 13.42 18.62 90.00 90.00 105.2
8 1391 -193.19 1.389 70.4 Cc 1 10.76 10.76 13.89 103.9
8 
103.9
8 
112.0
5 6915 -193.15 1.336 67.2 P1̅ 1 10.55 10.76 14.02 83.48 69.50 69.46 
203 -193.14 1.345 68.1 P1̅ 
 
1 10.83 11.36 12.96 78.29 83.03 62.67 
1749 -193.13 1.307 65.6 C2/c 1 10.75 10.75 29.06 90.95 99.79 119.6
8 2339 -193.12 1.314 66.0 P1̅ 1 10.59 10.91 14.59 106.1
8 
97.43 114.1
0 277 -193.08 1.335 67.4 C2/c 1 13.51 13.51 17.30 71.19 71.19 75.97 
8620 -192.92 1.304 66.2 P1̅ 1 10.89 11.46 11.74 92.43 98.87 98.31 
485 -192.82 1.340 67.8 P21/c 1 13.67 14.24 14.30 90.00 91.30 90.00 
576 -192.77 1.334 67.5 P21/c 1 11.12 15.67 16.04 90.00 90.98 90.00 
709 -192.69 1.330 67.3 P21/c 1 11.85 13.03 18.49 90.00 100.8
4 
90.00 
1275 -192.59 1.312 66.1 P21/c 1 10.59 14.21 19.74 90.00 90.00 106.9
0 3196 -192.51 1.333 67.7 P21/c 1 11.55 13.83 17.96 90.00 102.6
2 
90.00 
1881 -192.49 1.284 65.1 P21/c 1 10.56 13.36 21.66 90.00 90.00 108.0
5 595 -192.35 1.299 65.7 C2/c 1 14.42 14.42 14.60 103.0
7 
103.0
7 
91.58 
4822 -192.34 1.284 64.7 P1̅ 1 9.80 11.21 14.07 75.37 81.15 77.82 
833 -192.25 1.312 66.2 C2/c 1 11.10 11.10 24.42 87.75 87.75 71.17 
692 -192.02 1.361 69.0 P21 1 9.98 11.23 12.23 92.28 90.00 90.00 
2129 -191.99 1.306 66.2 C2/c 1 10.73 10.73 28.49 80.19 80.19 62.78 
7559 -191.98 1.382 69.9 P1̅ 1 10.68 11.13 13.64 103.5
8 
103.6
5 
113.0
6 1244 -191.94 1.322 67.0 P212121 1 10.39 11.56 23.50 90.00 90.00 90.00 
7458 -191.74 1.316 66.5 P1̅ 1 11.36 11.53 13.52 84.72 65.88 62.13 
2763 -191.68 1.327 67.1 P21/c  1 11.44 13.98 17.62 90.00 94.12 90.00 
3441 -191.68 1.317 66.1 P21/c 1 11.17 14.77 17.17 90.00 90.00 91.86 
500 -191.64 1.297 65.6 P21/c 1 10.42 14.70 18.78 90.00 90.27 90.00 
545 -191.60 1.336 67.5 P21/c 1 10.92 14.77 17.62 100.7
5 
90.00 90.00 
174 -191.52 1.339 67.7 P21/c 1 10.95 14.97 18.05 90.00 90.00 109.8
0 4800 -191.50 1.319 66.8 P1̅ 1 10.47 10.95 14.96 69.21 77.70 61.98 
4000 -191.47 1.307 65.8 P1̅ 1 11.21 11.55 12.37 104.4
5 
93.42 111.1
0 5656 -191.47 1.340 67.5 P1̅ 1 11.35 11.78 12.08 95.99 117.6
5 
97.74 
119 -191.46 1.337 67.8 C2/c 1 10.51 10.51 25.56 96.10 96.10 92.56 
1825 -191.41 1.322 66.9 P21 2 10.87 11.08 26.56 90.00 90.00 118.1
9 455 -191.35 1.299 65.8 P21/c 1 12.84 14.90 16.14 111.5
8 
90.00 90.00 
3136 -191.28 1.306 66.3 P21/c 1 10.71 14.98 17.82 90.00 90.00 92.33 
4915 -191.28 1.340 67.9 P21/c 1 11.18 12.93 19.31 90.00 94.41 90.00 
779 -191.24 1.290 65.3 Pbca 1 14.66 19.82 19.91 90.00 90.00 90.00 
1377 -191.21 1.331 67.5 P21/c 1 10.81 14.98 18.05 106.6
9 
90.00 90.00 
201 -191.16 1.326 67.0 P21/c 1 10.70 16.31 16.72 90.00 105.5
2 
90.00 
4638 -191.14 1.315 66.1 P1̅ 1 10.01 10.27 15.57 97.28 100.5
3 
112.5
7 1920 -191.13 1.324 66.9 P21/c 1 10.58 13.60 19.96 90.00 90.00 101.3
0 1684 -191.04 1.325 67.1 Pbca 1 14.01 18.77 21.41 90.00 90.00 90.00 
31 -190.89 1.328 67.4 P21/c 1 8.71 16.36 20.61 106.9
3 
90.00 90.00 
4958 -190.75 1.330 67.3 C2/c 1 14.44 14.44 16.50 107.0
7 
107.4
7 
108.7
7  
Appendix Table 3.4: Free energies, structural and crystallographic parameters of the 100 
structures of molecule XXVI that were submitted as a second list of prediction for the 6th 
Blind Test. The structure matching the experimental form is highlighted in orange. 
Structure  
A  
/kJ·mol-1 
Density 
/g·cm3 
Packing 
coefficient/
% 
Space 
group Z' a/Å b/Å c/Å α/° β/° γ/° 
1600 -237.40 1.347 67.7 P1̅ 1 10.2
6 
16.24 11.17 59.0
1 
117.13 93.6
6 675 -229.09 1.353 68.8 P21/c 1 16.9
0 
14.17 11.69 90.0
0 
79.90 90.0
0 3525 -227.85 1.354 68.5 P1̅ 1 10.8
3 
10.86 29.89 59.6
1 
69.36 121.
83 2591 -227.59 1.324 67.4 P1̅ 1 11.8
1 
10.79 11.54 90.0
0 
106.74 90.0
0 185 -227.32 1.389 70.6 P21/c 1 11.9
8 
17.81 13.73 90.0
0 
113.55 90.0
0 3104 -227.04 1.392 70.4 P1̅ 1 10.5
5 
22.34 10.93 117.
40 
67.73 62.5
3 851 -226.49 1.321 66.7 P1̅ 1 11.1
8 
11.16 11.95 73.5
4 
86.55 80.8
6 2496 -226.41 1.323 67.3 P21/c 1 13.8
3 
10.54 19.64 90.0
0 
79.80 90.0
0 239 -226.30 1.343 68.0 P21/c 1 18.9
3 
10.80 13.73 90.0
0 
81.69 90.0
0 314 -226.15 1.307 65.8 P21/c 1 10.8
3 
19.49 14.86 90.0
0 
65.49 90.0
0 
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354 -225.61 1.325 67.0 P21/c 1 15.7
2 
10.20 19.35 90.0
0 
65.08 90.0
0 38 -225.46 1.341 67.5 I41/a 1 31.9
6 
31.96 10.89 90.0
0 
90.00 90.0
0 221 -224.93 1.314 66.5 P1̅ 1 11.2
2 
13.91 11.08 89.2
7 
117.09 110.
47 5126 -224.86 1.291 65.3 Pbca 1 21.7
2 
13.53 19.66 90.0
0 
90.00 90.0
0 615 -224.84 1.319 66.7 P21/c 1 10.4
4 
20.21 14.53 90.0
0 
67.25 90.0
0 4946 -224.71 1.354 68.9 P1̅ 1 10.5
6 
14.54 11.11 100.
75 
61.92 76.8
3 8620 -224.26 1.304 66.1 P1̅ 1 10.8
9 
11.75 11.45 87.3
5 
81.92 98.8
5 6335 -224.01 1.337 67.7 C2/c 1 28.2
2 
10.68 18.99 90.0
0 
77.15 90.0
0 4201 -223.99 1.344 67.9 P1̅ 2 11.3
2 
29.46 9.95 90.0
0 
123.25 90.0
0 686 -223.08 1.326 67.4 C2/c 1 27.7
9 
13.14 15.42 90.0
0 
87.25 90.0
0 1019 -222.86 1.302 65.9 P21 2 11.0
8 
28.43 10.50 90.0
0 
60.08 90.0
0 1881 -222.84 1.286 65.2 P21/c 1 13.3
4 
21.66 10.56 90.0
0 
71.82 90.0
0 1236 -222.73 1.355 68.3 C2/c 1 25.3
6 
15.77 19.09 90.0
0 
133.86 90.0
0 43 -222.28 1.373 69.6 P21/c 1 18.9
6 
16.21 8.84 90.0
0 
89.26 90.0
0 6879 -221.90 1.314 66.3 C2/c 1 18.3
1 
11.04 29.66 90.0
0 
71.16 90.0
0 1537 -221.88 1.342 67.9 P1̅ 1 10.3
7 
14.43 10.41 85.6
2 
63.78 91.8
9 508 -221.58 1.352 68.5 P21/c 1 18.8
4 
13.21 11.11 90.0
0 
85.69 90.0
0 3075 -221.55 1.363 69.1 Pbca 1 17.8
5 
21.22 14.45 90.0
0 
90.00 90.0
0 4842 -221.33 1.339 68.0 P21/c 1 10.8
5 
14.62 19.29 90.0
0 
114.50 90.0
0 83 -221.22 1.353 68.2 P21/c 1 10.8
4 
15.49 19.64 90.0
0 
56.76 90.0
0 694 -221.05 1.324 67.0 P21/c 1 10.8
0 
14.41 18.22 90.0
0 
83.14 90.0
0 361 -220.97 1.347 68.0 P21/c 1 11.8
0 
14.25 18.77 90.0
0 
118.65 90.0
0 506 -220.92 1.333 67.9 P1̅ 1 15.2
9 
11.39 11.47 123.
28 
118.89 61.5
7 188 -220.88 1.347 68.2 P1̅ 1 9.00 11.17 16.65 68.2
1 
76.71 63.3
2 803 -220.85 1.336 67.8 P21 2 10.6
5 
28.86 9.82 90.0
0 
67.66 90.0
0 1244 -220.78 1.323 67.1 P212121 1 11.5
6 
10.40 23.46 90.0
0 
90.00 90.0
0 203 -220.68 1.343 67.9 P1̅ 1 12.9
7 
11.58 10.78 119.
03 
96.89 94.6
2 20 -220.65 1.320 67.0 P1̅ 1 13.4
0 
10.12 11.06 72.8
4 
88.52 80.1
5 1237 -220.58 1.351 68.3 P21/c 1 17.9
1 
13.70 11.25 90.0
0 
88.60 90.0
0 177 -220.56 1.329 67.1 P1̅ 1 11.2
0 
10.85 12.20 93.0
6 
72.60 84.1
5 7902 -220.55 1.321 67.0 P1̅ 1 11.1
8 
10.98 13.23 104.
08 
83.73 67.0
4 8917 -220.54 1.319 66.6 P21/c 1 10.6
5 
19.49 14.98 90.0
0 
65.44 90.0
0 455 -220.41 1.301 65.9 P21/c 1 14.8
7 
12.83 17.47 90.0
0 
120.69 90.0
0 1369 -219.94 1.337 67.1 P1̅ 1 13.0
5 
10.54 11.01 91.4
2 
72.71 105.
06 4273 -219.73 1.327 67.3 P21/c 1 13.1
1 
11.35 20.74 90.0
0 
65.60 90.0
0 1098 -219.51 1.329 67.1 P21/c 1 11.0
4 
18.17 13.99 90.0
0 
89.50 90.0
0 1249 -219.45 1.344 68.0 P21/c 1 12.2
5 
15.23 15.41 90.0
0 
74.93 90.0
0 1391 -219.18 1.387 70.3 Cc 1 12.0
3 
17.84 13.89 90.0
0 
115.58 90.0
0 89 -219.17 1.316 66.3 I41/a 1 20.2
1 
20.21 27.76 90.0
0 
90.00 90.0
0 6909 -219.16 1.279 65.0 Pbca 1 18.9
3 
21.26 14.50 90.0
0 
90.00 90.0
0 709 -219.01 1.330 67.3 P21/c 1 11.8
5 
13.02 18.51 90.0
0 
79.03 90.0
0 1662 -218.84 1.304 66.3 P21/c 1 20.0
3 
10.98 13.22 90.0
0 
79.68 90.0
0 1378 -218.76 1.313 66.7 P21/c 1 10.3
2 
21.05 14.49 90.0
0 
64.43 90.0
0 595 -218.69 1.301 65.7 C2/c 1 20.1
3 
20.67 14.57 90.0
0 
71.15 90.0
0 1786 -218.69 1.278 64.9 Pbca 1 14.5
8 
18.91 21.17 90.0
0 
90.00 90.0
0 3860 -218.62 1.323 66.9 C2/c 1 25.2
1 
10.93 20.59 90.0
0 
83.51 90.0
0 576 -218.56 1.334 67.5 P21/c 1 16.0
8 
15.64 11.12 90.0
0 
88.79 90.0
0 4199 -218.54 1.338 67.6 P1̅ 1 16.8
0 
10.80 9.94 65.8
7 
121.28 108.
64 6915 -218.35 1.336 67.3 P1̅ 1 10.7
6 
14.01 10.56 110.
55 
69.33 96.6
3 371 -218.32 1.335 67.4 P21/c 2 16.6
9 
17.04 21.09 90.0
0 
68.67 90.0
0 4822 -218.27 1.286 64.8 P1̅ 1 15.8
6 
9.80 11.21 102.
34 
84.44 61.2
3 2763 -218.18 1.330 67.2 P21/c 1 11.4
6 
13.94 17.60 90.0
0 
86.11 90.0
0 5110 -218.11 1.269 63.9 P21/c 1 10.8
7 
19.66 15.56 90.0
0 
117.87 90.0
0 779 -217.92 1.292 65.5 Pbca 1 19.8
0 
19.90 14.65 90.0
0 
90.00 90.0
0 5656 -217.89 1.344 67.7 P1̅ 1 11.3
1 
11.78 12.10 84.4
4 
62.03 97.8
2 1377 -217.65 1.332 67.6 P21/c 1 14.9
9 
10.81 19.85 90.0
0 
60.47 90.0
0 5147 -217.59 1.329 67.2 Cc 2 19.4
4 
10.62 27.22 90.0
0 
87.27 90.0
0 1850 -217.59 1.339 67.9 P21/c 1 13.4
0 
18.60 11.63 90.0
0 
74.10 90.0
0 444 -217.46 1.374 69.5 P1̅ 1 10.4
1 
10.41 14.29 101.
29 
78.72 69.0
8 9156 -217.27 1.264 64.3 P1̅ 1 11.3
5 
10.49 14.61 89.9
5 
83.63 121.
24 3196 -217.00 1.332 67.6 P21/c 1 11.5
6 
13.84 17.94 90.0
0 
77.35 90.0
0 2002 -216.91 1.316 66.7 P1̅ 1 10.9
9 
10.14 14.78 85.4
8 
98.04 119.
66 844 -216.87 1.326 67.0 Pbca 1 28.5
4 
11.98 16.46 90.0
0 
90.00 90.0
0 
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7450 -216.85 1.312 66.4 P21/c 1 13.1
9 
11.05 19.60 90.0
0 
84.18 90.0
0 1666 -216.73 1.328 67.3 P21/c 1 8.87 31.28 11.02 90.0
0 
66.71 90.0
0 2656 -216.62 1.320 66.8 I2/c 1 17.5
5 
18.26 18.09 90.0
0 
76.95 90.0
0 3124 -216.49 1.332 67.6 P212121 1 24.0
1 
11.42 10.21 90.0
0 
90.00 90.0
0 3937 -216.40 1.330 67.6 P21/c 1 18.8
1 
10.59 15.23 90.0
0 
67.62 90.0
0 3136 -216.38 1.310 66.5 P21/c 1 10.7
0 
17.82 14.95 90.0
0 
87.64 90.0
0 3892 -216.35 1.264 64.5 P21/c 1 20.7
2 
13.35 10.74 90.0
0 
83.14 90.0
0 4171 -216.34 1.336 67.6 Pbca 1 18.3
2 
27.77 10.97 90.0
0 
90.00 90.0
0 1833 -216.24 1.304 66.1 C2/c 1 30.3
5 
9.92 19.53 90.0
0 
76.56 90.0
0 833 -216.23 1.311 66.2 C2/c 1 18.0
6 
12.90 24.46 90.0
0 
92.90 90.0
0 2384 -216.16 1.307 66.1 P21/c 1 10.8
6 
11.93 22.23 90.0
0 
82.31 90.0
0 31 -216.03 1.329 67.4 P21/c 1 20.6
3 
8.72 16.32 90.0
0 
73.11 90.0
0 4819 -216.01 1.300 66.1 P1̅ 1 10.1
4 
10.46 15.45 95.8
4 
78.13 66.0
3 8710 -215.94 1.330 67.2 P212121 1 11.4
1 
10.89 22.57 90.0
0 
90.00 90.0
0 773 -215.91 1.340 67.5 P21/c 1 12.1
5 
14.14 16.47 90.0
0 
79.74 90.0
0 102 -215.91 1.321 67.0 Pbca 1 18.9
9 
18.32 16.23 90.0
0 
90.00 90.0
0 882 -215.85 1.310 66.1 C2/c 1 16.4
8 
11.62 33.17 90.0
0 
63.68 90.0
0 119 -215.85 1.335 67.7 C2/c 1 14.5
2 
15.20 25.60 90.0
0 
81.25 90.0
0 316 -215.80 1.347 68.1 P21/c 12
1/c 
23.2
2 
16.37 9.06 90.0
0 
53.52 90.0
0 1825 -215.76 1.320 66.8 P21 2 10.8
9 
26.55 11.09 90.0
0 
118.27 90.0
0 9140 -215.73 1.307 66.2 P1̅ 1 10.0
6 
10.86 15.46 74.4
9 
78.41 61.5
7 7458 -215.52 1.317 66.6 P1̅ 1 15.0
3 
11.51 11.36 62.1
6 
88.19 119.
79 12 -215.50 1.334 67.0 P21/c 1 13.7
6 
17.09 12.80 90.0
0 
68.24 90.0
0 911 -215.38 1.282 64.8 P21/c 1 10.7
6 
12.28 22.01 90.0
0 
89.53 90.0
0 836 -215.32 1.314 66.0 P21/c 1 10.4
4 
15.05 20.99 90.0
0 
120.60 90.0
0 1798 -215.28 1.305 66.1 P21/c 1 17.2
0 
11.64 14.30 90.0
0 
86.65 90.0
0 1246 -215.19 1.318 66.5 P21/c 1 10.8
3 
21.88 11.98 90.0
0 
94.28 90.0
0  
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Chapter 4: Crystal Structure Prediction of 
mebendazole 
 
4.1 Introduction 
 
4.1.1 CSP as a complement to pharmaceutical solid form screening 
 
In the previous chapter, the ability of CSP methodologies to predict the crystal structure 
of organic molecules under Blind Test1 conditions was assessed. However, CSP studies 
on pharmaceuticals do not generally take place under these conditions, as their main 
purpose is to aid experimental solid form screens that are performed in parallel with 
computational analyses.2-4 Solid form screens are by their nature limited, as they cannot 
cover any possible crystallisation condition;2, 4-6 a detailed discussion on this subject can 
be found in Chapter 1.1.3. Computational modelling can effectively complement 
experimental studies in several ways. The most intuitive contribution of CSP is to 
reassure manufacturers that the most thermodynamically stable form is known,5, 7-9 
minimising the risk of ritonavir-like catastrophes.10 In some cases other competitive 
polymorphs can be proposed, ideally with desirable properties (solubility, morphology, 
porosity, etc.) either stable or metastable with the respect to the known form/s. Strategies 
to crystallise further polymorphs can sometimes be identified, e.g. seeding,11 
templating,12, 13 crystallisation under pressure4 or from solvents.14 Furthermore, in the 
absence of single crystals, CSP data can help solve crystal structures from powder           
X-ray diffraction (PXRD) data,15-17 nuclear magnetic resonance (NMR)18-20 or electron 
diffraction.21 Finally, a joint analysis of the findings of a CSP study and of an experimental 
polymorph screen can enhance the understanding of the crystallisation behaviour of a 
molecule: it can rationalise the presence of disorder, establish a link between its              
single-component behaviour and the formation of solvates and salts, or explain the role 
of kinetics in the formation of metastable crystal structures.2, 5 All these applications are 
of extreme value to pharmaceutical manufacturers,2, 3 and this is leading to an increasing 
industrial interest in CSP (see also Chapter 1.2.1) and to the development of several           
in-house CSP methodologies, e.g. the one in ref.3.3 
  This chapter describes a CSP study undertaken with the purpose of aiding an 
academic experimental solid form screen by two UCL collaborators (Merina Corpinot and 
Dr. Krešo Bučar) on the drug molecule mebendazole.  
 
4.1.2 Properties of mebendazole and of its known experimental forms 
 
Mebendazole (C16H13N3O3),22 trade name Vermox,23 is an antihelminthic (i.e. against 
worms) drug molecule used to treat infestations by a broad range of parasites (ascaris, 
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threadworms, hookworms, whipworms, pinworms, roundworms, tapeworms, etc.).24-26 
Recently, it has also shown some interesting anti-cancer properties against various 
forms of tumours.22 Infestations by parasites are a major problem in poor countries with 
lower hygiene standards. First synthesised in 1971,27 it is included in the WHO list of 
essential medicines28 and produced for the international market by generic 
manufacturers. It is taken in the form of oral capsules, and it has a low bioavailability 
(only 10%)25 due to the poor solubility of its single-component forms. There have been 
some successful attempts to improve its solubility via co-crystallisation,25 formation of a 
nitrate salt,29 promoieties30 and dispersion in oils.31   
 Three single-component crystal structures were known at the beginning of this joint 
experimental-computational study: forms A, B and C.24, 25, 29, 30, 32 Only forms A and C 
have solved crystal structures deposited in the CSD,33 with refcodes TUXPEJ24 and 
YULGIW34 respectively. These two forms are not polymorphs since they are constituted 
of two different tautomers of mebendazole32 (from now on the A-tautomer and                        
C-tautomer respectively, see Figure 4.1), as the protons in the imidazole rings are 
bonded to different nitrogen atoms. Defining crystal structures containing different 
isomers as polymorphs is incorrect, although some ambiguity does exist for tautomers 
as they can rapidly interconvert in solution or in the melt.35 Indeed, form C of 
mebendazole is known to convert to more stable form A in the solid-state, implying that 
the tautomers are closely related and can easily interconvert.36 However, as mentioned 
in Chapter 1.1.1, in this thesis a strict definition of polymorphism, which is also used in 
the CSD,37 is utilised. This strict discrimination is necessary in this chapter as CSP 
methods do not allow tautomeric interconversion.  
                        
Figure 4.1: Chemical diagrams of (left) the A-tautomer of mebendazole (right) the            
C-tautomer of mebendazole 
 The crystal structure of form A (TUXPEJ) was determined via synchrotron PXRD 
on a commercial sample at room temperature (~300K).24 Form A has one molecule in 
the asymmetric unit cell (i.e. Z’=1), it is in the P1̅ space group, it has a density of 1.402 
g/cm3 and a 70.7% packing coefficient. Form C (YULGIW) was characterised via single-
crystal X-ray diffraction at 150 K, and it was crystallised from a methanolic solution.34 It 
is a Z’=1 crystal structure in the P1̅ space group, with a density of 1.444 g/cm3 and a 
71.9% packing coefficient.   
 The two fully-characterised crystal structures of mebendazole have different 
intermolecular hydrogen bond motifs. In form C each molecule uses one hydrogen bond 
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donor and one acceptor (N acceptor in the imidazole group and NH in the amide group, 
with the R2
2(8) graph set motif), while in form A two donors and two acceptors per 
molecule are utilised, as there is an additional hydrogen bond between the O acceptor 
in the benzophenone group and NH in the imidazole ring with the R2
2(14) graph set motif. 
The two intermolecular hydrogen bond motifs of forms A and C are shown in Figure 4.2. 
 
Figure 4.2: Intermolecular hydrogen bond motif of (above) mebendazole form A, where 
each molecule uses two donors and two acceptors, forming both a NH···O hydrogen 
bond with the 𝐑𝟐
𝟐(𝟏𝟒) graph set motif and a NH···N hydrogen bond with the 𝐑𝟐
𝟐(𝟖) graph 
set motif, and (below) mebendazole form C, where each molecule uses one donor and 
one acceptor, forming a NH···N hydrogen bond with the 𝐑𝟐
𝟐(𝟖) graph set motif. The 
hydrogen bonds are coloured in purple. 
 Form B has only been characterised via PXRD and no solved crystal structure of 
this form exists.38 The most soluble form is B, followed by C and A.24, 36 This, combined 
with the well-known tendency of form C to transform into form A36 and with DSC data 
showing that B has the lowest melting temperature and A the highest,39 indicates that A 
is the most thermodynamically stable single-component form of mebendazole (probably 
because of its more extensive hydrogen bonding network, which compensates the lower 
density), followed by C and B.  Metastable form C is the commercial form because it has 
the best trade-off between solubility and stability;39, 40 form B is known to be toxic, while 
the solubility of A is so low that it has no antihelminthic effects when it is alone or when 
it is present in concentrations above 30% in mixtures with different forms.36, 40 Hence, the 
transformation of tablets of form C into thermodynamically more stable form A at the 
environmental conditions typical of poor tropical countries is an important problem as it 
decreases the shelf-life and the efficacy of this drug.36 
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4.1.3 Reasons for this joint computational-experimental solid form screen 
 
This CSP study was undertaken in parallel to the experimental effort, with the aim of 
determining whether the most stable form of mebendazole was known and if additional 
forms were plausible. This could prove important as the known forms possess                     
sub-optimal properties. The hoped outcome was to find a more soluble polymorph of 
mebendazole that is stable under environmental conditions. Furthermore, this study also 
aimed at finding and solving the crystal structure of form B of mebendazole, to determine 
whether it is a different unique form or mixture of various phases. Finally, the polymorph 
screen also aimed at improving the understanding of the overall solid-state behaviour of 
mebendazole. 
 The most thermodynamically stable computer-generated crystal structures were 
provided to the experimental collaborators to complement their effort in some of the ways 
described in Chapter 4.1.1. Furthermore, the results of this additional CSP study on a 
flexible pharmaceutical molecule were used to benchmark alternative methods in 
Chapters 5-7.  
  
 4.2 Methods 
 
4.2.1 Analysis of conformational flexibility 
   
 
Figure 4.3: Chemical diagram of the (above) A-tautomer (below) C-tautomer of 
mebendazole. The two tautomers are differentiated by where C14=O15 in the edge 
benzoyl substituent attaches to the central benzimidazole ring: in the A-tautomer it 
attaches three bonds away from the N1-H1a group, to atom C7, while in the C-tautomer it 
attaches four bonds away, to atom C8. The six torsion angles that were considered in the 
initial analysis of conformational flexibility are indicated (see Appendix Table 4.1 for their 
definition). The scans were only performed on the C-tautomer. 
The first step of this CSP study was to determine the range of conformations that the two 
tautomers of mebendazole are likely to take in the solid-state. A set of isolated molecule 
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optimisations combined with chemical intuition led to the identification of the six torsion 
angles in Figure 4.3 as those that are the most flexible and so could deviate the most in 
the crystal structure/s from the isolated molecule conformational energy minima.  
 For the purpose of analysing conformational flexibility only the C-tautomer was 
considered. This is because the two tautomers are distinguished only by the position of 
the edge benzoyl substituent (C14-C21) relative to proton H1a, as explained in the 
caption to Figure 4.3. Since the flexible torsion angles in the benzoyl substituent are well-
separated from the remaining ones, the fragments they define can be assumed not 
interact strongly with one another. Hence in the methodology used in this CSP study, 
where most torsion angles were analysed independently in the initial assessment of the 
conformational flexibility and surrogate molecules were used to estimate ΔEintra values in 
the searches (see Chapter 4.2.2), the main torsion angles could be assumed to have 
indistinguishable energy profiles in the two tautomers. This assumption is confirmed by 
the gas-phase minimum conformer of the A-tautomer being only ~0.5 kJ·mol-1 higher in 
energy than that of the C-tautomer. Note that the definitions of the torsion angles in 
Figure 4.3 (see Appendix Table 4.1) differ only for Φ1 and Φ2, and this is due to the 
different position of the benzoyl substituent. 
 The conformational energy penalties for varying torsion angles Φ1-Φ6 relative to 
the isolated-molecule global minimum were calculated on the C-tautomer via constrained 
1-dimensional angle scans at the PBE0 6-31G(d,p) level of theory performed with 
Gaussian09.41 The values that were obtained were deemed to be valid also for the                   
A-tautomer. The procedure for performing angle scans is described in Chapter 3.2.1.1. 
All torsion angles were optimised from 0° to 360° in 30° steps, with the exception of the 
amide torsion angle Φ4 that was scanned in 90° steps from 0° (i.e. its cis configuration) 
to 180° (i.e. its trans configuration). Each scan started from the global minimum in 
isolated-molecule conformational energy determined at the PBE0 6-31G(d,p) level of 
theory, since this is the most suitable starting point for angle scans on flexible 
molecules.42 Angles Φ1 and Φ2 were scanned together since they are adjacent and 
strongly interacting. The results of the torsion angle scans are shown in Figure 4.4. 
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Figure 4.4: Results of the angle scans of torsion angles a) Φ1 (x-axis) and Φ2 (y-axis) from 
0° to 360° in 30° steps; this is a contour plot of the conformational energy penalty surface 
as a function of the values of these two torsion angles b) Φ3 from 0° to 360° in 30° steps 
c) Φ4 from 0° (cis) to 180° (trans) in 90° steps d) Φ5 from 0° to 360° in 30° steps and e) Φ6 
from 0° to 360° in 30° steps. At each point on the plots, all the conformational degrees of 
freedom (CDFs) were relaxed with the exception of the scanned torsion angle/s. The 
optimisations were performed at the PBE0 6-31G(d,p) level of theory starting from the 
PBE0 6-31G(d,p) optimised global minimum gas-phase conformer. The red dots/lines 
indicate the values taken by the torsion angle/s in the conformation of form C of 
mebendazole, black dots/lines in the conformation of form A (see Appendix Table 4.2 for 
the actual values). 
 The results of the constrained angle scans indicate the geometric preferences of 
mebendazole. No CSD survey was performed, as the plots in Figure 4.4 were deemed 
sufficient to confidently limit the conformational search space. However, the analysis of 
the CSD conformational preferences of dihedrals Φ1-Φ5 was performed in Chapter 5. 
 The confidence in these results was enhanced by both experimentally known 
forms taking values in low-energy regions, with conformational energy penalties lower 
than 10 kJ·mol-1. The scan of the torsion angle describing the rotation of the methyl group 
(i.e. angle Φ6, Figure 4.4e) shows that its variation has a negligible effect on 
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conformational energy, which confirms the findings of previous analyses on this 
functional group.43 
 
4.2.2 Crystal structure generation 
 
An analysis of the isolated molecule angle scans suggested that the most effective way 
to generate crystal structures for mebendazole was to perform flexible searches on both 
tautomers. In particular, it was decided to treat only torsion angles Φ1, Φ2, Φ3 and Φ5 as 
explicitly flexible in the searches. On the other hand, the amide torsion angle Φ4 was 
constrained in both tautomers at two values corresponding to its cis (i.e. 0°) and trans 
(i.e. 180°) configurations, while the methyl torsion angle Φ6 was constrained at the values 
of the respective isolated-molecule minima in conformational energy because of its 
negligible effect on energy and intermolecular interactions (this is a common practice in 
CSP).43-45  
 Hence four searches were carried out: for each tautomer two searches were 
performed with the amide torsion angle Φ4 in the cis and trans configurations 
respectively. The searches were performed with CrystalPredictor 1.8, which estimates 
ΔEintra interpolating grids of ab initio calculated energies for the four explicitly flexible 
CDFs (see Chapter 2.4.1.2).46 The reason why this older version of CrystalPredictor was 
utilised was the same as for the Blind Test (see Chapter 3.2.2), i.e. the immense local 
approximate models (LAMs) that would need to be built for use with CrystalPredictor 2.47 
Also, for mebendazole this problem was exacerbated by the fact that the LAMs would 
have had to be calculated separately for each tautomer, further increasing the 
computational cost, while the ΔEintra grids required in CrystalPredictor 1.8 could be 
assumed to be valid for both tautomers since the energy differences for varying the main 
torsion angles were deemed to be indistinguishable, as explained in Chapter 4.2.1. 
 In order to produce the grids at a reasonable computational cost mebendazole 
was broken down into surrogate molecules. This assumption is generally accurate as 
long as the torsion angles that define the position of strongly interacting groups are 
scanned together.43, 48, 49 Hence, the two surrogate molecules shown in Figure 4.5, which 
were deemed to be valid for both tautomers, were considered. One contains torsion 
angles Φ1 and Φ2, and the other one contains torsion angles Φ3 and Φ5. Hydrogen atoms 
were added at the edges of each group to avoid the presence of unphysical free bonds. 
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Figure 4.5: Surrogate molecules used to calculate the ΔEintra grids of (left) Φ1 and Φ2 and 
(right) Φ3 and Φ5 of both tautomers of mebendazole. 
 For each surrogate molecule, the ΔEintra grids were calculated with Gaussian09 
at the PBE0 6-31G(d,p) level of theory; for the surrogate molecule containing torsion 
angles Φ3 and Φ5 two separate grids were calculated, one with the amide group in the 
cis configuration and one in the trans. The grid ranges are shown in Table 4.1, and they 
include all values of the four torsion angles with a conformational energy penalty smaller 
than 25 kJ·mol-1 (see Figure 4.4).  
Table 4.1: Dimensionality of the ΔEintra grids used to perform the crystal structure 
searches with CrystalPredictor. The grids were calculated from the surrogate molecules 
in Figure 4.5. 
First surrogate molecule 
Torsion angle 
label 
Torsion Angle 
Definition 
Minimum search 
range/° 
Maximum 
search range/° 
Step Size/° 
Steps 
Number 
Φ1 C18-C17-C14-C7 90 270 20 10 
Φ2 O15-C14-C7-C8 0 340 20 18 
        
Number of Grid 
Points 
180 
Second surrogate molecule 
Torsion angle 
label 
Torsion Angle 
Definition 
Minimum search 
range/° 
Maximum 
search range/° 
Step Size/° 
Steps 
Number 
Φ3 N1-C2-N10-C11 285 85 20 9 
Φ5 N10-C11-O12-C13 125 245 20 7 
        
Number of Grid 
Points 63 x 2 
 
 Each of the four searches generated 1,000,000 structures with Z`=1, in the 59 
most common space groups in the CSD (listed in the Appendix Table 4.3), for a total of 
4,000,000 generated structures. In the searches, Uinter was estimated as the sum of an 
electrostatic component calculated from fixed point charges computed at the                        
PBE0 6-31G(d,p) level of theory on the isolated-molecule conformers of both tautomers 
and an exp-6 repulsion-dispersion component from the empirically fitted FIT potential.50 
No search was performed with Z’>1 to keep the overall cost manageable. This seemed 
a sensible approximation as both known forms are Z’=1 and mebendazole does not have 
characteristics that correlate with a tendency of forming crystal structures with more than 
one molecule in the asymmetric unit cell, as it is a relatively large and flexible achiral 
molecule.51 
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4.2.3 Refinement of the generated crystal structures  
 
The final refinement was performed on all the crystal structures within 15 kJ·mol-1 of the 
global minimum in CrystalPredictor Elatt for each tautomer. This relatively small energy 
window was utilised as the CrystalPredictor energy model, albeit simple, successfully 
located both known forms as global minima in Elatt for each tautomer, suggesting that the 
atomic point charges+FIT model produced a reliable energy ranking. A total of 1,819 
crystal structures were present within this energy window: 855 for the A-tautomer with 
the trans amide group, 932 for the C-tautomer with trans amide and 32 for the C-tautomer 
with cis amide; no generated crystal structure with the A-tautomer and the cis amide was 
low enough in energy to be taken forward. As mebendazole is a flexible molecule, both 
Uinter and ΔEintra had to be optimised in the final refinement stage of CSP, and 
CrystalOptimizer52 (see Chapter 2.4.2.2) was used for this purpose. Following the 
success of the Blind Test CSP study, the same hierarchal approach was utilised to limit 
the overall computational expense: first structures underwent an intermediate 
optimisation and re-ranking with a single iteration of CrystalOptimizer, and the most 
stable ones were then fully optimised.  
  
4.2.3.1 Determination of the independent CDFs 
 
In order to guarantee an accurate final refinement of the generated crystal structures, it 
is important to treat as explicitly flexible not only those torsion angles that are treated as 
such in the searches (either as explicitly flexible, i.e. Φ1-Φ3 and Φ5 for mebendazole, or 
as defining separate conformational regions, i.e. Φ4), but also other torsion and bond-
angles that can impact the balance between intra- and intermolecular                      
interactions.43, 49, 53 On the other hand, bond-lengths can generally be safely ignored, as 
they are not significantly affected by the crystalline environment.54 Ideally, all 
conformational CDFs should be treated as independent in a fully atomistic optimisation, 
but this is often too computationally expensive as the cost of CrystalOptimizer 
minimisations increases drastically with the number of explicitly flexible CDFs.54 Hence, 
a limitation is required (all these issues are discussed in detail in Chapter 6). 
 In the Blind Test (see Chapter 3.2.2), the independent CDFs were limited to the 
seven torsion angles of molecule XXVI that are intuitively flexible. Although this approach 
was effective, it is not ideal, because it can lead to neglect some CDFs that can improve 
the balance between ΔEintra and Uinter. Hence a more comprehensive approach was 
utilised for determining the independent CDFs of mebendazole, which was affordable 
because of its smaller size compared to XXVI: for each tautomer, the 20 most 
competitive crystal structures in CrystalPredictor Elatt were fully optimised with 
CrystalOptimizer considering each torsion and bond-angle as an independent CDF. 
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Those torsion and bond-angles whose values changed by more than 5º and 1º 
respectively in one or more optimisation were considered to be sensitive to packing 
forces and so were selected for treatment as independent CDFs in the final refinement 
stage of this CSP study. It is interesting to note that although the selected CDFs are very 
similar for the two tautomers, there are some differences, as shown in Figure 4.6. These 
differences are probably due to the different point at which C14=O15 in the edge benzoyl 
group attaches to the benzimidazole rings, causing variations in intermolecular 
interactions that change the degree to which each CDF is affected by the crystalline 
environment. 
  
    
Figure 4.6: Chemical diagram and atomic numbering of (above) the A-tautomer (below) 
the C-tautomer of mebendazole, showing the torsion angles (black arrows) and bond-
angles (red arcs) treated as independent CDFs in the final refinement stage of this CSP 
study. Double arrows indicate that two definitions of torsion angles around the same 
central bond were treated as variables in the CrystalOptimizer optimisations. See 
Appendix Table 4.4 for the precise definition of the explicitly flexible torsion and               
bond-angles. 
 
4.2.3.2 Intermediate optimisation of the generated crystal structures 
 
The 855 crystal structures within 15 kJ·mol-1 of the CrystalPredictor lattice energy global 
minimum of the A-tautomer of mebendazole, and the 964 of the C-tautomer, underwent 
the intermediate optimisation with the single-iteration of CrystalOptimizer. ΔEintra was 
calculated optimising the molecular conformations at the PBE0 6-31G(d,p) level of theory 
with Gaussian09 as a function of the torsion and bond-angles shown in Figure 4.6, while 
Uinter was determined with DMACRYS,55 modelling it as a sum of electrostatic component 
from distributed multipoles calculated with GDMA 2.256 and a repulsion-dispersion 
component calculated with the empirically fitted FIT potential. All the ab initio calculations 
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were stored in local approximate models (LAMs) databases of both tautomers, and re-
utilised in later stages of the CSP procedure to limit the computational expense.  
 Once the single-iterations were complete, COMPACK57 was used to remove 
duplicates. Structures were considered as duplicates if they had an energy difference 
smaller than 2.5 kJ·mol-1, a density difference smaller than 0.05 g·cm-3, and if it was 
possible to overlay 30/30 molecules, with a 20% distance tolerance and a 20° angles 
tolerance, with a root mean square deviation (RMSD30) below 0.65 Å. 
 
 4.2.3.3 Final optimisation of the most promising crystal structures  
 
All unique structures within 20 kJ·mol-1 of the Elatt global minimum for each tautomer after 
the intermediate minimisations were then fully optimised. A larger energy window was 
applied than the 15 kJ·mol-1 one after the searches. This was done because the                
single- iterations of CrystalOptimizer and the successive clustering step had spread-out 
the energy values: a smaller number of low-energy crystal structures were present after 
the intermediate optimisations than after the searches, making the consideration of a 
larger energy window feasible. Furthermore, after all the minimisations were completed 
the variation in Elatt between the intermediate and the full optimisations was analysed in 
order to verify whether the 20 kJ·mol-1 window was sufficient. Since the maximum 
change in energy was ~15 kJ·mol-1 for structures with the C-tautomer and                               
~17.5 kJ·mol-1 for those with the A-tautomer, the 20 kJ·mol-1 threshold was deemed to 
be appropriate. 
 A total of 198 crystal structures with the A-tautomer and 155 with the C-tautomer 
were fully optimised with CrystalOptimizer at the PBE0 6-31G(d,p) level of theory for both 
ΔEintra and charge density calculations, treating all torsion and bond-angles in Figure 4.6 
as independent CDFs. A few structures were not true Elatt minima, and their symmetry 
was reduced to more stable Z’=2 structures. Only one crystal structure with the amide 
group in its cis configuration was taken to this final optimisation stage: this indicates that 
these structures were not competitive, mainly because cis amides are associated with 
large conformational energy penalties (~17 kJ·mol-1, see Figure 4.4c). 
 Once again, COMPACK was used to cluster the fully optimised crystal structures 
of both tautomers and remove duplicates. The clustering parameters were identical to 
those used after the intermediate optimisations (see Chapter 4.2.3.2), with the exception 
that a maximum energy difference of 2.85 rather than 2.5 kJ·mol-1 was allowed for two 
structures to be considered as duplicates. After the single-iterations of CrystalOptimizer 
a smaller energy difference had been permitted to avoid the removal of structures that 
could have converged to different minima at later stages of the CSP process. 
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4.2.4 Estimate of the effect of polarisation 
 
After all the optimisations were completed, the effect of polarisation on the energy 
ranking of the crystal structures was estimated. In order to do so, the Elatt values of the 
fully optimised unique crystal structures were re-determined calculating both ΔEintra and 
the charge density in a PCM with ε=3,58 and then optimising Uinter with DMACRYS. The 
same level of theory, PBE0 6-31G(d,p), and repulsion-dispersion potential, FIT, as for 
the CrystalOptimizer optimisations were utilised. 
 In this CSP study, no estimate of free energy was performed, as this generally 
has a small effect on relative rankings. Indeed in Chapter 7 free energies were calculated 
for a few low energy crystal structures of mebendazole, and they were shown to have a 
very limited effect on the relative thermodynamic stabilities. 
 
4.3 Results and Discussion 
 
4.3.1 Crystal structure search and intermediate optimisation of the generated structures 
 
The CSP-generated crystal structures were named depending on the tautomer they 
contained and on the ranking after the CrystalPredictor search. For example, structure 
A70 was the 70th crystal structure in CrystalPredictor Elatt ranking for the A-tautomer. The 
few crystal structures containing cis amide groups for the C-tautomer that were taken to 
the refinement stage are named CisC followed by their ranking in the respective search. 
 The Elatt global minima of both tautomers after the searches (i.e. structures A1 
and C1) were close matches to the two known experimental forms. Using the Crystal 
Packing Similarity tool with its standard settings, for A1 it is possible to overlay 15/15 
molecules with experimental form A (refcode TUXPEJ), with an RMSD15 of 0.458 Å, while 
for C1 and form C (refcode YULGIW) the same overlay produces an RMSD15 of           
0.367 Å. This result was much better than that obtained at the search stage for molecule 
XXVI (see Chapter 3.3.1), and this was probably due to both known forms having 
conformations with low-energy values for all the torsion angles that were considered as 
independent CDFs (see Figure 4.4). Indeed, both experimental conformations are very 
similar to the closest optimised isolated-molecule minima, as shown in Appendix Figure 
4.1. Although limiting the search to isolated-molecule minima would have probably 
produced both known forms, this would have also limited the range of predicted 
polymorphs. Several duplicates of A1 and C1, matching the known experimental forms, 
were also generated at higher energies. This suggests that these wells on the lattice 
energy surface are very broad, with several minima corresponding to almost identical 
crystal structures.59 Indeed, Chapter 8.3.3 shows how clustering search-generated 
structures would have removed several duplicates. 
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 The intermediate optimisation produced similar results, although some of the 
duplicates mentioned above optimised to energies lower than those of A1 and C1. Since 
the clustering procedure only keeps the lowest energy crystal structure among those that 
are deemed to belong to the same cluster, both A1 and C1 were removed as duplicates. 
However, a structure matching experimental form A, A14, was ranked 1st for the crystal 
structures containing the A-tautomer, and it had a 15/15 molecule overlay with TUXPEJ 
with an RMSD15 of 0.285 Å. A structure matching experimental form C, C5, was ranked 
2nd for the for the crystal structures containing C-tautomer (only 0.4 kJ·mol-1 above the 
global minimum at this stage, C248), having a 15/15 molecule overlay with YULGIW with 
and RMSD15 of 0.282 Å. The improvements in the overlays were due to the more 
accurate energy model of CrystalOptimizer compared to CrystalPredictor. The 
intermediate optimisations spread-out the relative Elatt values, which led to the exclusion 
of many non-competitive crystal structures, limiting the overall computational expense. 
 
4.3.2 Combined crystal energy landscape of both tautomers  
 
4.3.2.1 Crystal energy landscape obtained after the full optimisations 
 
A total of 353 crystal structures were fully optimised with CrystalOptimizer, which 
converged to 220 distinct minima. The 211 crystal structures within 20 kJ·mol-1 of the 
global minimum are plotted in Figure 4.7, which summarises the combined crystal energy 
landscapes of both tautomers of mebendazole; more details can be found in Appendix 
Table 4.5. All the ΔEintra values were calculated relative to the gas-phase minimum 
energy of the C-tautomer, which is lower than that of the A-tautomer by ~0.5 kJ·mol-1. 
 
Figure 4.7: Plot summarising the combined crystal energy landscape of both tautomers 
of mebendazole. See Appendix Table 4.5 for more details. Some of the low-energy 
plausible structures are labelled, and those matching the known forms are indicated. 
A788 
A19 
C27 C5, C10 
A50 
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     The combined crystal energy landscape shows that structure A788, a match to 
form A, was the global minimum in Elatt, ~1 kJ·mol-1 more stable than the closest 
competitor (A19). On the other hand structure C5, a match to form C, was ranked 4th, 
~2.5 kJ·mol-1 above A788 and ~0.4 kJ·mol-1 above C27, the lowest energy predicted 
crystal structure among those containing the C-tautomer. The overlay between A788 and 
form A is accurate, with an RMSD15 of 0.300 Å and an RMSD1 of 0.113 Å. The overlay 
between C5 and form C is also very good, with an RMSD15 of 0.276 Å and an RMSD1 of 
0.052 Å. Both overlays are shown in Figure 4.8. 
 
 
Figure 4.8: 15-molecule overlay between (above) the experimental crystal structure of 
mebendazole form A, coloured by elements, and structure A788, in green, with an 
RMSD15 of 0.300 Å and (below) the experimental crystal structure of mebendazole form C, 
coloured by elements, and structure C5, in green, with an RMSD15 of 0.276 Å. The 
hydrogen bonds are coloured in purple.  
 These data confirm that form A of mebendazole is more thermodynamically 
stable than form C, and suggest that it is unlikely that a lower energy single-component 
crystal structure than form A exists. Although the existence of a lower energy as yet 
unfound form cannot be completely ruled out, given the presence of several competitive 
crystal structures within the margin of error of the model,  it is unlikely than it would be 
significantly more stable than the known ones, showing that there is little risk of a 
ritonavir-like phenomenon. 
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4.3.2.2 Estimate of the effect of polarisation on lattice energy 
 
The results of recalculating the lattice energy of the fully minimised unique crystal 
structures of both tautomers (see Figure 4.7) with a PCM with ε=3 are shown in Figure 
4.9. More details can once again be found in Appendix Table 4.5. 
 
Figure 4.9: Plot summarising the combined crystal energy landscape of both tautomers 
of mebendazole obtained after recalculating the lattice energy of structures in Figure 4.7 
with PCM.  See Appendix Table 4.5 for more details. Some of the low-energy plausible 
structures are labelled. 
 The global minimum was now structure C27, ~0.8 kJ·mol-1 lower in energy than 
A788, which ranked second. A788 remained more energetically favourable than C5, 
although the application of the PCM decreased the energy difference to ~0.3 kJ·mol-1. 
Structure C5 ranked 3rd among the structures containing from the C-tautomer, ~0.2 
kJ·mol-1 less stable than structure C10 and ~1.0 kJ·mol-1 than structure C27. 
 Including an estimate of polarisation slightly stabilised the predicted crystal 
structures containing the C-tautomer with respect to those with the A-tautomer, while the 
relative rankings within the same tautomer remained very similar (this can also be 
observed by comparing Figure 4.10 with Appendix Figure 4.2a and Figure 4.13 with 
Appendix Figure 4.2b). Overall, the re-ranking caused by the application of the PCM was 
much smaller than in the Blind Test CSP study on molecule XXVI (see Chapter 3.3.3.2). 
Although these results were more at odds with experimental evidence than those shown 
in Figure 4.7, as the Elatt global minimum was an unfound crystal structure and not a 
match to form A, the energy differences remained well within the margins of error of the 
models, confirming that the existence of a significantly more stable polymorph is unlikely. 
C27 
C5, C10 
A788 
A19 
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The correct experimental energy ranking of the two known forms was also maintained. 
Since the relative stability of the CSP-generated crystal structures was not drastically 
affected by the inclusion of the PCM, except a slight stabilisation of those with the C-
tautomer, these calculations increased the confidence in the results.  
 
4.3.3 Analysis of the low energy predicted crystal structures after the full optimisations 
 
Although the results shown in Chapter 4.3.2 show that the two experimentally known 
forms are thermodynamically stable relative to competitors, both Figure 4.7 and Figure 
4.9 indicate that there is a large number of alternative crystal structures that are plausible 
candidates for crystallisation if the right experimental conditions were to be obtained. 
Hence, an analysis of the low energy forms is very important to understand the packing 
behaviour of mebendazole as well as the possible range of crystalline conformations.  
 
4.3.3.1 Crystal structures containing the A-tautomer 
 
 
Figure 4.10: Plot summarising the crystal energy landscape of the A-tautomer of 
mebendazole after the full optimisations with CrystalOptimizer, showing all the crystal 
structures within 20 kJ·mol-1 of the global minimum in Elatt.  Each point on the landscape 
corresponds to a separate crystal structure, labelled according to its space group. The 
structure matching experimental form A is circled, and some of the most competitive 
structures are also labelled. The crystal energy landscape calculated with the PCM is 
summarised in Appendix Figure 4.2a, and more details can be found in Appendix Table 
4.5. 
 The crystal structures that contain the A-tautomer and are within 20 kJ·mol-1 of 
the global minimum in Elatt do not differ much in terms of molecular conformations. In 
particular, the only really flexible conformational degrees of freedom appear to be Φ1, Φ2 
A788 
A19 
A50 
A37 
A53 
A173 A72 
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and Φ6, but Φ6 is a methyl rotation that has a minor effect on ΔEintra and on the overall 
molecular shape. Using the criteria developed by Cruz-Cabeza and Bernstein for 
identifying conformational polymorphs (see Chapter 2.3.1.1),60 the 112 crystal structures 
containing the A-tautomer in Figure 4.10 can be grouped into just three clusters of 
conformational polymorphs. The low-energy crystal structures tend to have low ΔEintra 
values, with none exceeding 8.5 kJ·mol-1. In all the low-energy crystal structures, the 
conformations have the benzophenone carbonyl group (C14-O15 in Figure 4.3) on the 
same side as the NH imidazole group (N1-H1a in Figure 4.3). 
 The A-tautomer of mebendazole seems to be able to pack well: all the structures 
within 20 kJ·mol-1 of the global minimum have packing coefficients between ~67% and 
~73% (see Appendix Table 4.5). This means that the A-tautomer of mebendazole should 
not have a problem to form stable single-component crystal structures.44 
 The global minimum for the A-tautomer (A788) matches the experimental crystal 
structure of mebendazole form A, as shown in Figure 4.8. In experimental form A two 
hydrogen bond acceptors and two hydrogen bond donors are utilised (see Figure 4.2). 
This intermolecular hydrogen bonding motif is shared by A788 other 3 low energy 
structures: A90, ranked 10th among the crystal structures containing the A-tautomer in 
Figure 4.10, A291, ranked 11th, and A143, ranked 14th. 
 A total of 105/112 crystal structures in Figure 4.10 form an intermolecular 
hydrogen bond between the N donor in the imidazole group and the NH in the amide 
group, including all 26 structures in the lowest 10 kJ·mol-1. In particular, 82 of these 
structures form this hydrogen bond with the R2
2(8) graph set motif. The remaining 23 
structures, including A72, ranked 7th, form this hydrogen bond with the C1
1(4) graph set 
motif, with each donor and acceptor bonding to two different molecules.  These motifs 
are shown in Figure 4.11. 
  
Figure 4.11: NH···N intermolecular hydrogen bond with (left) the 𝐑𝟐
𝟐(𝟖) graph set motif 
common to 82 low-energy structures containing the A-tautomer of mebendazole (right) 
the 𝐂𝟏
𝟏(𝟒) graph set motif common to 23 low-energy structures . 
 Although all three oxygen atoms in mebendazole are potential hydrogen bond 
acceptors, they are only used only in 47/112 low-energy crystal structures. The oxygen 
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atoms that are most commonly used as hydrogen bond acceptors are those in the amide 
and benzophenone C=O groups (i.e. atoms O15 and 16, see Figure 4.3); atom O12 is 
only utilised as an acceptor in three low-energy CSP-generated crystal structures.  
 Two structures were found after symmetry reduction to be Z`=2, in the P21 space 
group. A173, ranked 6th, is very interesting, because of its competitiveness and the 
unique intermolecular hydrogen bond pattern: on top of the usual NH···N hydrogen bond 
with the R2
2(8) graph set motif (see Figure 4.11), the imidazole NH group in one molecule 
in the asymmetric unit forms an intermolecular hydrogen bond with the benzophenone 
O acceptor of the other. This motif is shown in Figure 4.12. 
 
Figure 4.12: Unique intermolecular hydrogen bond motif in A173. 
 In summary, it is unlikely that the crystal structures containing the A-tautomer of 
mebendazole could form conformational polymorphs. The conformations in the low-
energy crystal structures are all broadly similar, and have low ΔEintra values.  
 In terms of intermolecular interactions, the most common feature of the crystal 
structures containing the A-tautomer of mebendazole is the NH···N intermolecular 
hydrogen bond, as it is present in almost all the low-energy CSP-generated structures 
(including A788). However, the spectrum of low-energy structures suggests that packing 
polymorphs of this tautomer are possible. The NH···N hydrogen bond is in fact formed 
with two possible graph set motifs, R2
2(8) and C1
1(4), and other hydrogen bonds using 
any of the three O atoms as acceptors are also present among the thermodynamically 
competitive crystal structures. 
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4.3.3.2 Crystal structures containing the C-tautomer 
 
Figure 4.13: Plot summarising the crystal energy landscape of the C-tautomer of 
mebendazole after the full optimisations with CrystalOptimizer, showing all the crystal 
structures within 20 kJ·mol-1 of the global minimum in Elatt. Each point on the landscape 
corresponds to a separate crystal structure, labelled according to its space group. The 
structure matching experimental form C is circled, and some of the lowest energy 
structures are also labelled. The crystal energy landscape calculated with the PCM is 
summarised in Appendix Figure 4.2b, and more details can be found in Appendix Table 
4.5. 
All the 99 CSP-generated crystal structures containing the C-tautomer that were not 
removed as duplicates are within the bottom 20 kJ·mol-1 in Elatt. The lowest 10 kJ·mol-1 
is more populated than for the A-tautomer, as 61 structures are present rather than 26. 
Five of these low-energy structures were found to be Z’=2 after symmetry reduction, 
though the two independent molecules did not differ much in their conformations and 
intermolecular interactions. They include C23, ranked 4th among the crystal structures 
containing the C-tautomer in Figure 4.13, C73, ranked 5th and C406, ranked 6th.  
 The only crystal structure with cis amide taken to this stage, CisC32, ranks 98th, 
~16 kJ·mol-1 above the global minimum. Hence, putative crystal structures with cis amide 
seem not to be viable candidates for polymorphs, although CisC32 has favourable 
intermolecular interactions that compensate for a high ΔEintra value of ~18 kJ·mol-1. If the 
cis conformation were to be produced in the synthesis, CisC32 would become a serious 
candidate. 
 The predicted low energy crystal structures containing the C-tautomer of 
mebendazole can also pack well, with packing coefficients ranging from ~66.5 to ~74.3% 
C27 
C5, C10 
C406 
C23 C73 
C248 
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(see Appendix Table 4.5). For this tautomer the main torsional degrees of freedom are 
once again Φ1, Φ2 and Φ6 (i.e. methyl rotation). In terms of conformations, the criteria 
developed by Cruz-Cabeza and Bernstein produce three possible clusters of 
conformational polymorphs. One cluster contains only CisC32, with the cis amide 
configuration. In 37/98 of the low-energy crystal structures with trans amide the 
benzophenone C=O group (C14-O15 in Figure 4.3) is on the same side as the imidazole 
NH (N1-H1a in Figure 4.3), while in 61/98 it is in the opposite side. From now on they 
will be called C-conformers 1 and 2 respectively. Although C-conformer 2 is more 
frequent, the lowest energy structures contain C-conformer 1. However, these 
geometries do not differ drastically in terms of conformational energy: no low-energy 
crystal structure with trans amide has ΔEintra values above 10 kJ·mol-1. Figure 4.14 shows 
one example for each of these two conformers. 
 
Figure 4.14: Example of conformations belonging to the conformational energy wells of 
C-conformer 1 (left) and C-conformer 2 (right). 
 Structure C5, which matches experimental form C of mebendazole (see Figure 
4.8) is ranked 2nd in energy, ~0.4 kJ/mol above the global minimum C27. Both contain 
C-conformer 1.  
 In terms of intermolecular hydrogen bonding motifs, all the 99 structures within 
20 kJ·mol-1 of the global minimum form an intermolecular hydrogen bond between the N 
acceptor in imidazole group and the NH in the amide group with the R2
2(8) graph set. 
This motif is shown in Figure 4.15. 
 
Figure 4.15: NH···H hydrogen bond with the 𝐑𝟐
𝟐(𝟖) graph set motif common to all low-
energy crystal structures containing the C-tautomer of mebendazole. 
 Note that this motif is identical to the one that dominates the most competitive 
CSP-generated structures containing the A-tautomer (Figure 4.11), with the edge 
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benzoyl substituent attached four rather than three bonds away from the imidazole NH 
group. Structure C5 only forms this hydrogen bond (see also Figure 4.2).  
 Although three oxygen atoms could be used as intermolecular hydrogen bond 
acceptors, this only happens in 17/99 low-energy structures; the global minimum C27 is 
one of them, as it combines the hydrogen bond shown in Figure 4.15 with another one 
between the amide O acceptor and imidazole NH with the R2
2(12) graph set motif, as 
shown in Figure 4.16. 
 
Figure 4.16: Hydrogen bond motif of the global minimum structure C27.  
 This hydrogen bonding pattern is shared by other five low-energy structures, 
including C406, ranked 6th, C46, ranked 10th and C24, ranked 11th. All these structures 
contain C-conformer 1. Five other low-energy structures, in this case containing                 
C-conformer 2, utilise the same donors and acceptors, but the amide O acceptor and the 
imidazole NH are hydrogen bonded to two different molecules, forming the C1
1(6) graph 
set motif: C248, ranked 9th, C115, ranked 12th, C509, ranked 13th, C908, ranked 16th and 
C244, ranked 17th. This motif is shown in Figure 4.17. 
 
Figure 4.17: Hydrogen bond motif common to C248, C115, C509, C908 and C244. 
 Many low-energy structures contain a common sheet formed by several 
molecules with C-conformer 1 connected by the NH···N hydrogen bond motif shown in 
Figure 4.15. Nine out of the ten lowest energy crystal structures (including structure C5 
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and the global minimum) contain this sheet, which is shown in Figure 4.18. This could 
hint to the possibility of static disorder.53, 61 
 
 
 
Figure 4.18: Sheet common to 9/10 lowest energy structures, including the global 
minimum (C27) and the match to experimental form C (C5).  
 In summary, the crystal structures containing the C-tautomer of mebendazole 
could form conformational polymorphs, as two distinct groups of conformations are 
present among low energy structures. Furthermore, packing polymorphs are also a 
possibility: although all thermodynamically competitive crystal structures form an 
intermolecular NH···H hydrogen bond with the R2
2(8) graph set motif, other additional 
motifs using any of the three O atoms as acceptors are present. Finally, the presence of 
a common sheet in several of the lowest computer-generated energy crystal structures 
hints to the possibility of disorder. 
 
4.3.4 Computational cost and importance of molecular flexibility 
 
A breakdown of the computational expense for undertaking this CSP study is shown in 
Table 4.2. 
Table 4.2: Breakdown of the computational cost of the CSP study of mebendazole. 
  
CPU time 
(hours) 
% of total 
time 
Flexibility analysis 700 5.2 
Grid Generation 200 1.5 
Crystal structure search with CrystalPredictor 
1.8 
5,800 43.3 
Single iterations with CrystalOptimizer 1,800 13.5 
Full optimisations with CrystalOptimizer 4,800 35.9 
Estimate of polarisation 80 0.6 
Total time 13,380 100.0 
  
 The computational cost of this study was much smaller than the one of molecule 
XXVI (see Chapter 3.3.5), despite the need of performing separate searches for the two 
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tautomers of mebendazole and the consideration of both cis and trans amide 
configurations (for molecule XXVI only trans amide configurations were considered, see 
Chapter 3.2.2). Compared to the Blind Test CSP study, the search contributed more to 
the overall computational cost (43.3 vs 2%), while the refinement had a smaller role (49.4 
vs 89.2%). Both the smaller overall computational cost and the lower relative contribution 
of final refinement stage were due to the limited size of mebendazole compared to 
molecule XXVI (35 vs 62 atoms, and 22 vs 40 non-hydrogenic atoms). Optimising smaller 
molecules is inherently cheaper,47 and fewer competitive crystal structures that required 
refinement with expensive methods were generated, both because the conformational 
search space was smaller and the CrystalPredictor energies were deemed to be more 
realistic. 
 Although mebendazole has only one less intuitively flexible torsion angle than 
molecule XXVI, only two dihedrals (Φ1 and Φ2 in Figure 4.3) show a significant degree 
of flexibility and affect the overall shape of the molecule; torsion angle Φ6 is very flexible 
but describes a methyl rotation with a negligible effect on molecular shape and packing 
capabilities. The high energy penalty for distorting torsion angles Φ3-Φ5 away 0° and/or 
180° (see Figure 4.4b-d) makes mebendazole a very planar molecule both when isolated 
and in the energetically plausible computer-generated crystal structures: there is no 
trade-off between intramolecular dispersion favouring folded conformers in the gas-
phase and intermolecular dispersion favouring planar conformations in the solid-state,62 
and no need of distorting the molecule to obtain an extensive hydrogen bond network 
(differently from molecule XXVI,1 see Chapter 3). This drastically reduced the 
conformational search space of mebendazole. Only three clusters of conformational 
polymorphs were present among the low-energy predicted crystal structures of each 
tautomer, while more than 40 could be found for molecule XXVI. Furthermore most             
low-energy CSP-generated crystal structures of both tautomers have low ΔEintra values, 
indicating that the degree of conformational adjustment that occurs in the 
thermodynamically competitive structures is limited. 
 This is very important in the overall context of this thesis, as it shows that level of 
molecular flexibility cannot be easily understood from the molecular diagram but it has a 
drastic effect on the computational expense. Hence it is important to develop new 
approaches that speed up the analysis of conformational flexibility, which will be 
discussed in Chapter 5. 
 
4.4 Experimental polymorph screen 
 
The experimental polymorph screen was carried out by Corpinot and Bučar. 
Mebendazole was purchased 98% pure from Cambridge Bioscience.  
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 Unfortunately no single crystals of mebendazole could be produced, and 
characterisations could only be performed with PXRD. Qualitative PXRD data were 
collected using a Stoe StadiP diffractometer in transmission geometry using 
monochromated CuKα1 radiation (λ = 1.54056 Å) generated at 40 kV and 30 mA. Data 
were collected at room temperature using a 2-60° 2θ range. Rietveld refinements were 
performed with the TOPAS academic programme. 
 A brief outline of the experimental work and its results is reported. 
 
4.4.1 Solvent-mediated phase transformation 
  
Mebendazole (m ≈ 200 mg) was suspended in a variety of solvents (V ≈ 2 mL) and 
slurried for 7-14 days. The solutions were then filtered and the obtained solids were dried 
on filter paper for several minutes. Solvent-mediated phase transformation experiments 
yielded predominantly phase pure powders consisting of form A. Two exceptions were 
noted where physical mixtures were obtained. In particular, the experiment involving 
nitromethane yielded a mixture of form A and an unidentified phase, while the experiment 
involving hexane yielded a mixture of forms A and C.  The results of the slurry 
experiments suggest that form A is the thermodynamically most stable, consistently with 
the outcome of the CSP study.  
 
4.4.2 Crystallisation by slow solvent evaporation 
 
Mebendazole (m ≈ 200 mg,) was dissolved under reflux conditions in a variety of solvents 
(V ≈ 5-23 mL) for 10-30 min in glass vials. The mixtures were filtered through a Millex® 
syringe filter and let evaporate at ambient conditions for 1-14 days. The results obtained 
from crystallisation by slow solvent evaporation were more varied, and yielded a complex 
solid form landscape. 
 The outcome of these experiments is summarised in Table 4.3, and the powder 
patterns are shown in Figure 4.19 and Figure 4.20. Note that two studies by Swanepoel 
et al.39 and Kumar et al.63 published distinct powder patterns for what they defined as 
mebendazole form B; the diffractograms were in both cases of poor quality and no 2θ 
values were reported. Some crystallisation experiments yielded a solid that resembles 
the form B powder pattern reported by Kumar et al., while others resulted in the formation 
of a solid that exhibits a diffractogram similar to that reported by Swanepoel et al. The 
comparison between the two diffractograms is shown in Appendix Figure 4.3: they 
correspond to two different forms, and so they are hereafter (tentatively) referred to as 
forms B (grey) and D (blue). Furthermore, there are two variations of form D that have 
similar powder patterns, meaning they could be structurally related: they are (tentatively) 
referred to as forms D1 and D2. 
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Table 4.3: Overview of all mebendazole crystal forms and the solvents that were used in 
their preparation. 
 
 
Figure 4.19: Diffractograms of forms A (black), B (grey), C (red), D1 (dark blue), D2 (light 
blue), E (brown) and F (olive). These patterns are compared to the diffractograms of the 
THF and DMF solvates (shown in green and orange).   
Single-component 
forms 
Solvent 
A ethanol, xylene 
B dichloroethane, chloroform, acetonitrile 
C 2-propanol, 2-butanol 
D1 ethyl acetate, chloroethanol, 2-propanol 
D2 methanol, dichloromethane 
E acetone 
F dioxane, pyridine 
G dichloroethane (phase transition from form B within 6 month) 
Solvates Solvent 
THF THF 
DMF DMF 
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Figure 4.20: Diffractogram of form G (black) obtained through a phase transition of form 
B after six months at ambient conditions. 
 Mebendazole does not appear to possess a strong tendency to form solvates, 
which is consistent with the results of the CSP study showing that both the A and the     
C-tautomers can easily form dense packings (see Chapters 4.3.3.1 and 4.3.3.2). 
 It has not yet been possible to solve the crystal structures of form B, the five new 
single component forms and the two solvates. Only the powder pattern of form G could 
be indexed and several different unit cells were proposed; the best fit is a mixture of two 
orthorhombic phases. 
 The 211 CSP-generated crystal structures in the crystal energy landscape (see 
Figure 4.7, Figure 4.9, and Appendix Table 4.5 for more details) were used to try to refine 
the PXRD patterns of form B and the five new single-component forms. However, no 
match could be found.  
 
4.4.3 Comparison with the computational results 
 
From a computational viewpoint, it is worrying that none of the PXRD patterns of the five 
new single-components forms of mebendazole and previously known but unsolved form 
B could be matched with the crystal structures in the crystal energy landscape. However, 
until the crystal structures of these experimental forms are solved, allowing the 
determination of the atomic positions, the space groups and Z’ values, it will not be 
possible to know why they were missed.  
 Nonetheless, a number of reasons can be anticipated. These forms might be 
outside the scope of the searches: they may have Z’>1, contain mixtures of tautomers, 
or contain other tautomers of mebendazole (Martins et al.34 listed three other possible 
tautomers on top of the A- and C- ones, see Appendix Figure 4.4) that were not included 
in the searches. This would be the least concerning scenario, as it would indicate that 
the CSP procedure did not miss any experimental form that was within its reach. 
However, this would be a reminder that the CSP algorithms must be improved to allow 
a broader coverage of the Elatt surface, such has high Z’ values or tautomeric mixtures, 
without making the computational cost unmanageable. A more worrying possibility would 
be that structures matching form B and/or the five new single-component forms were lost 
during the CSP process because they were outside the thresholds used to decide which 
structures to carry forward, they were not found because they contain strained 
conformations not included in the conformational search space or the searches 
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themselves were interrupted before they could completely explore the Elatt surface. This 
would mean that the CSP study was incomplete, and that its parameters should be 
corrected in the future. Form B and the five new forms appear to be metastable, and this 
increases the chance that they were missed because of an incomplete coverage of the 
search space or limitations in the number of crystal structures optimised with the most 
accurate methods. Chapters 5 and 7 propose new workflows that could solve some of 
these problems. 
 Finally, these forms might be disordered or not phase pure (this appears to be 
the case for form G): in such cases, they would be outside the reach of the adopted CSP 
methodology, although it would be interesting to know whether the disordered or mixed 
components are present among the computer-generated crystal structures.64 Further 
experimental work is ongoing: if successful, it will allow to determine why CSP failed to 
predict these forms and whether they could actually be predicted. 
 
4.5 Conclusion 
 
The CSP study on two tautomers of the antihelminthic drug mebendazole successfully 
reproduced the only two solved crystal structures, forms A and C. Form A was correctly 
predicted to be more thermodynamically stable than C, and it was found as the global 
minimum in Elatt without an estimate of polarisation and as the second most stable form, 
0.8 kJ·mol-1 above the global minimum, when the PCM was included. These results were 
confirmed by the experimental solid form screen, which found form A as the most 
thermodynamically stable and form C as a competitive crystal structure that can be 
produced under the right experimental conditions.  
 The solid form screen found the previously known but unsolved form B of 
mebendazole, as well as five new single-component forms. Unfortunately it was not 
possible to solve any of these crystal structures. Suitable single crystals could not be 
obtained, and only PXRD patterns could be produced. Quite worryingly, none of these 
PXRD patterns could be matched with those simulated from the CSP-generated crystal 
structures. 
 This study provides some insights that are very useful in the context of this thesis. 
First of all, it illustrates that CSP studies can provide useful information to 
experimentalists: the crystal energy landscape confirms that it is unlikely that a               
single-component crystal structure of mebendazole significantly more stable form than 
form A exists, and a ritonavir-like occurrence can be excluded. Furthermore, it correctly 
anticipates that mebendazole is not a promiscuous solvate former since it can pack well 
with itself. However, it also shows some of the limitations of current CSP methodologies: 
although the reasons for missing form B and the five new single-component forms are 
not known, this may have been caused by the need of limiting the search in terms of 
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conformational ranges and Z’ values. Furthermore, this combined CSP-experimental 
effort shows that every molecule is a new challenge: mebendazole revealed to be very 
difficult to crystallise making the experimental work inconclusive.  
 Finally this chapter illustrates how analysing the quality of a computer-generated 
crystal energy landscape using partial experimental information can be misleading: if the 
extra forms had not been discovered, this would have been considered a completely 
successful CSP study, since matches both the known solved forms of mebendazole were 
found among the most competitive computer-generated crystal structures. However, a 
thorough solid form screen revealed that some experimental forms were indeed missed, 
making this CSP study only partially successful. This is a well-known problem, as the 
possibility of unreported polymorphs has often cast a shadow of doubt on Blind Test 
results.64 This partial failure may indicate that computational methodologies must be 
made more cost-effective to allow a broader coverage of the multidimensional Elatt 
surface.  
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4.7 Appendix 
 
Appendix Table 4.1: Definition of the main torsion angles of the A- and C-tautomers of 
mebendazole shown in Figure 4.3. 
Torsion angle 
name 
Torsion angle definition 
Φ1 C18-C17-C14-C7 (A), C18-C17-C14-C8 (C) 
(C) Φ2 O15-C14-C7-C8 (A), O15-C14-C8-C7 (C) 
Φ3 N1-C2-N10-C11 (A and C) 
Φ4 C2-N10-C11-O12 (A and C) 
Φ5 N10-C11-O12-C13 (A and C) 
Φ6 C11-O12-C13-H13a (A and C) 
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Appendix Table 4.2: Values taken by the torsion angles in Figure 4.3 in the conformations 
of the two solved crystal structures of mebendazole.  
Torsion 
angle 
name 
Torsion angle values of form A conformation/° Torsion angle values of form C conformation/° 
Φ1 336.73 329.67 
Φ2 148.40 147.69 
Φ3 359.57 0.17 
Φ4 180.76 181.35 
Φ5 180.27 180.32 
Φ6 42.89 65.00 
 
Appendix Table 4.3: List of the 59 space groups considered in the crystal structure 
search performed with CrystalPredictor 1.8. 
P1 P1̅ P21 P21/c P21212 P212121 Pna21 Pca21 Pbca Pbcn 
C2/c Cc C2 Pc Cm P21/m C2/m P2/c C2221 Pmn21 
Cmc21 Aba2 Fdd2 Iba2 Pnna Pccn Pbcm Pnnm Pmmn Pnma 
Cmcm Cmca Fddd Ibam P41 P43 I4̅ P4/n P42/n I4/m 
I41/a P41212 P43212 P4̅21c I4̅2d P31 P32 R3 P3̅ R3̅ 
P3121 P3221 R3c R3̅C P61 P63 P63/m P213 PA3̅  
 
Appendix Table 4.4: Definition of the torsion and bond-angles of the two tautomers of 
mebendazole treated as independent CDFs in the final refinement stage with 
CrystalOptimizer. The atomic numbering of each tautomer is shown in Figure 4.6. 
  Torsion angle definition Bond-angle definition 
A-tautomer 
C18-C17-C14-C7, C21-C22-C17-C14, O15-C14-C7-C6, H1a-N1-
C2-N10, N1-C2-N10-C11, O16-C11-O2-C13, C2-N10-C11-O12. 
H10a-N10-C11-O12 
C22-C17-C14, C18-C17-C14, 
H1a-N1-C2, C2-N10-C11, H10a-
N10-C11, C11-O12-C13 
C-tautomer 
N10-C11-O2-C13, O12-C11-N10-C2, N1-C2-N10-C11, C14-C8-
C8-C4, C17-C14-C8-C7, C22-C17-C14-C8, O16-C11-O12-C13, 
H10a-N10-C11-O12, H13a-C13-O2-C11, H1a-N1-C2-N10 
C22-C17-C14, C18-C17-C14, 
C17-C14-C7, H1a-N1-C2, H10a-
N10-C11, C11-O12-C13 
 
                            
Appendix Figure 4.1: Overlay of the conformation of the experimental crystal structure, 
coloured by elements, and the closest isolated-molecule local minimum in 
conformational energy, in blue, of  (left)  form A, with and RMSD1 of 0.242 Å (right) form 
C, with and RMSD1 of 0.096 Å. 
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Appendix Figure 4.2: Summary plots of the crystal energy landscapes of                                
(a) the A-tautomer (b) the C-tautomer of mebendazole after recalculating ΔEintra and the 
charge density in a PCM with ε=3, showing all the crystal structures within 20 kJ·mol-1 of 
the global minimum in Elatt.  Each point on the landscape corresponds to a separate 
crystal structure, labelled according to its space group. The structure matching the 
respective experimental forms are circled, and those labelled in Figure 4.10 and Figure 
4.13 are indicated.  
A788 
A19 A50 
A37 A53 
A72 
A173 
C27 
C5, C10 C406 C23 
C73 
C248 
(a) 
(b) 
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Appendix Figure 4.3: Diffractograms of form B, as reported by Kumar et al. and 
Swanepoel et al. Each of the two patterns (in black) is also compared with the 
diffractograms that were obtained from the crystallisation experiments using 
dichloroethane (grey) and ethyl acetate (blue) as solvents.  
 
Appendix Figure 4.4: The five tautomers of mebendazole listed by Martins et al.34 Note 
that MBZ1 and MBZ2 correspond to the C- and A-tautomer respectively. MBZ3, MBZ4 and 
MBZ5 were not considered in this CSP study. 
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Appendix Table 4.5: Lattice energies, structural and crystallographic parameters after the 
full optimisations of CrystalOptimizer of the 211 computer-generated crystal structures 
of both tautomers of mebendazole in the crystal energy landscape in Figure 4.7  and 
whose .res files were provided to the experimental collaborators. The energies obtained 
re-optimising the intermolecular interactions with the PCM (see Figure 4.9 for the plot) 
are also shown. The structure matching experimental form A is highlighted in orange, the 
one matching experimental form C in green. 
Structu
re  
Elatt /kJ·mol-
1 
Densit
y/g·cm
3 
Packing 
coefficie
nt/% 
Space 
group 
Z' 
a/
Å 
b/Å c/Å α/° β/° γ/° 
Elatt with 
PCM/kJ·
mol-1 
A788 -183.02 1.408 72.03 P1̅ 1 5.3
5 
11.3
7 
12.7
9 
66.97 80.4
5 
77.24 -190.58 
A19 -181.84 1.432 73.16 C2/c 1 5.1
1 
13.1
0 
20.9
4 
94.11 90.0
0 
101.24 -189.19 
C27 -180.87 1.410 72.1 C2/c 1 5.1
2 
16.0
5 
17.8
2 
106.01 98.2
5 
90.00 -191.35 
C5 -180.48 1.413 72.21 P1̅ 1 5.0
7 
8.18 17.7
2 
83.52 85.9
6 
72.00 -190.32 
C10 -180.39 1.413 72.37 C2/c 1 5.0
9 
8.12 35.4
3 
93.57 90.0
0 
108.29 -190.53 
A50 -179.88 1.418 72.33 P1̅ 1 5.4
5 
10.7
2 
12.2
7 
91.93 101.
07 
99.77 -187.81 
A37 -178.94 1.418 72.44 P21/c 1 5.0
5 
15.9
2 
17.7
8 
104.62 90.0
0 
90.00 -186.09 
C23 -178.69 1.397 71.4 P21 2 5.1
0 
8.17 35.3
8 
90.00 90.0
0 
107.56 -188.58 
C73 -178.69 1.400 71.59 Cc 2 5.0
8 
8.16 35.5
4 
89.52 88.4
6 
71.86 -188.19 
C406 -178.34 1.400 71.58 Pna21 2 5.0
7 
16.1
4 
34.2
6 
90.00 90.0
0 
90.00 -188.65 
A53 -178.22 1.398 71.51 P21/c 1 4.1
4 
17.8
1 
20.8
0 
113.79 90.0
0 
90.00 -185.82 
C53 -177.55 1.358 69.72 P21/c 1 5.1
5 
8.14 36.2
1 
90.00 90.0
0 
108.08 -187.87 
C25 -177.53 1.380 70.49 C2/c 1 5.1
2 
8.15 35.9
6 
86.59 85.9
2 
71.68 -188.03 
A173 -177.36 1.399 71.43 P21 2 5.3
3 
12.5
2 
21.4
2 
90.00 90.0
0 
101.04 -184.54 
A72 -177.28 1.412 72.13 P21 1 4.0
3 
10.6
3 
16.3
3 
97.04 90.0
0 
90.00 -185.30 
A49 -177.23 1.394 71.11 P21/c 1 4.7
2 
14.7
3 
20.2
4 
90.45 90.0
0 
90.00 -185.02 
A78 -177.09 1.397 71.41 P21/c 1 4.0
6 
16.6
6 
21.0
7 
99.74 90.0
0 
90.00 -184.83 
A90 -177.05 1.372 69.98 C2/c 1 5.3
4 
11.4
1 
24.3
5 
84.57 83.7
0 
76.46 -185.10 
A291 -176.88 1.433 73.3 C2/c 1 7.4
3 
8.48 24.5
0 
83.22 81.2
8 
64.03 -184.13 
C248 -176.85 1.405 71.94 C2/c 1 5.2
9 
14.5
3 
19.5
1 
108.31 90.0
0 
100.48 -186.59 
A306 -176.76 1.423 72.7 P21/c 1 4.5
3 
10.2
5 
29.7
8 
90.00 93.4
6 
90.00 -184.82 
C46 -176.72 1.404 71.8 P2/c 1 5.0
9 
16.0
7 
17.4
2 
101.36 90.0
0 
90.00 -186.47 
C24 -176.67 1.387 70.8 C2/c 1 5.0
8 
16.1
6 
18.1
2 
106.04 98.0
6 
90.00 -186.89 
C115 -176.56 1.409 72.28 P21/c 1 4.5
9 
16.2
4 
19.5
2 
106.93 90.0
0 
90.00 -184.94 
C509 -176.42 1.371 70.13 P21/c 1 5.4
5 
14.8
8 
18.6
9 
109.11 90.0
0 
90.00 -185.24 
C583 -176.41 1.429 73.02 Pc 2 4.1
9 
12.5
7 
26.3
2 
98.13 90.0
0 
90.00 -183.88 
C106 -176.30 1.430 72.88 P21/c 1 4.0
4 
15.1
3 
22.5
4 
90.00 95.0
3 
90.00 -184.92 
A202 -176.30 1.378 70.53 P21/c 1 4.5
7 
12.0
7 
26.4
3 
102.22 90.0
0 
90.00 -183.85 
A143 -175.83 1.435 72.96 P1̅ 1 7.1
9 
8.60 12.8
8 
109.05 90.2
6 
113.30 -182.28 
A89 -175.70 1.403 71.58 P21/c 1 7.8
9 
8.40 21.1
8 
94.23 90.0
0 
90.00 -185.23 
C908 -175.59 1.399 71.48 C2/c 1 5.3
6 
13.9
9 
19.8
2 
105.63 90.0
0 
101.03 -184.31 
C244 -175.31 1.372 70.29 P21/c 1 5.2
1 
15.2
3 
19.5
1 
112.57 90.0
0 
90.00 -185.17 
C132 -175.12 1.413 72.11 P1̅ 1 4.0
5 
12.7
1 
13.7
1 
99.29 91.9
9 
94.86 -181.95 
A54 -174.94 1.430 72.61 P1̅ 1 7.5
3 
10.3
8 
10.5
4 
116.61 92.9
9 
107.47 -181.29 
A109 -174.86 1.395 71.14 C2/c 1 5.4
0 
12.4
3 
21.9
1 
79.40 82.9
2 
77.45 -182.37 
A71 -174.80 1.398 71.43 P21/c 1 4.8
5 
10.4
0 
27.8
1 
90.55 90.0
0 
90.00 -182.67 
C111 -174.77 1.445 74.31 P21/c 1 3.9
8 
17.4
3 
19.6
5 
90.00 90.0
0 
95.63 -179.98 
A604 -174.45 1.384 70.58 C2/c 1 3.8
8 
17.4
0 
21.3
6 
98.15 90.0
0 
96.40 -180.51 
A75 -174.38 1.392 71.56 P21/c 1 4.1
8 
11.9
5 
28.2
4 
90.00 91.1
9 
90.00 -183.18 
C199 -174.33 1.406 71.04 P1̅ 1 4.1
1 
12.8
0 
13.9
3 
72.45 89.7
3 
87.86 -181.32 
C220 -174.27 1.408 72.22 C2/c 1 3.9
7 
12.8
9 
27.9
1 
98.93 90.0
0 
98.85 -181.25 
A100 -174.22 1.392 71.04 P21/c 1 4.1
2 
16.0
0 
21.5
9 
98.45 90.0
0 
90.00 -182.36 
A119 -174.11 1.390 70.85 P21/c 1 4.0
2 
10.4
1 
33.9
6 
96.99 90.0
0 
90.00 -181.34 
A80 -174.07 1.392 70.43 P1̅ 1 4.0
2 
10.5
9 
16.9
2 
101.28 94.7
5 
90.65 -180.93 
C394 -174.00 1.405 71.57 P21/c 1 4.9
6 
12.8
8 
22.0
8 
97.93 90.0
0 
90.00 -181.51 
C114 -173.96 1.420 72.76 P1̅ 1 4.0
5 
13.4
4 
14.2
1 
114.90 92.2
5 
98.36 -181.12 
C112 -173.91 1.421 72.72 P21/c 1 3.9
4 
15.2
4 
23.3
9 
100.70 90.0
0 
90.00 -180.12 
C124 -173.90 1.411 72.31 P21/c 1 4.4
8 
15.3
9 
20.3
4 
90.00 90.0
0 
97.94 -182.51 
A95 -173.76 1.416 72.41 C2/c 1 4.7
8 
13.6
3 
21.6
5 
93.82 90.0
0 
100.10 -180.85 
C35 -173.72 1.378 70.13 P2/c 1 5.1
3 
16.0
2 
17.5
5 
99.31 90.0
0 
90.00 -183.28 
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C119 -173.70 1.427 72.58 P21/c 1 4.0
1 
14.8
8 
23.4
5 
101.02 90.0
0 
90.00 -180.67 
C483 -173.70 1.412 71.91 P21/c 1 3.9
2 
14.3
0 
25.1
2 
99.09 90.0
0 
90.00 -180.33 
C135 -173.69 1.346 68.86 Pbca 1 5.1
7 
16.0
1 
35.1
9 
90.00 90.0
0 
90.00 -183.67 
C923 -173.41 1.418 72.18 P21/c 1 4.5
9 
9.99 30.2
5 
93.73 90.0
0 
90.00 -182.05 
C694 -173.38 1.430 72.7 P21/c 1 3.9
7 
10.0
8 
34.3
1 
90.80 90.0
0 
90.00 -179.50 
C444 -173.29 1.398 71.43 P21 2 4.0
8 
12.7
4 
27.0
3 
90.00 90.0
0 
94.28 -180.66 
C330 -173.20 1.374 69.8 P21/c 1 4.4
5 
11.2
3 
28.6
0 
90.00 90.0
0 
90.08 -181.96 
C144 -173.13 1.403 71.98 P21/c 1 4.1
2 
15.6
5 
21.6
8 
90.63 90.0
0 
90.00 -179.48 
C397 -173.08 1.402 71.69 C2/c 1 4.0
0 
13.2
1 
26.8
4 
88.58 85.7
2 
81.28 -179.84 
A159 -173.07 1.395 70.84 P21/c 1 4.0
0 
10.7
6 
32.8
0 
95.67 90.0
0 
90.00 -180.41 
A137 -173.07 1.380 70.36 C2/c 1 3.9
2 
19.2
0 
20.9
2 
114.51 90.0
0 
95.85 -179.18 
A120 -172.89 1.385 70.57 P21/c 1 4.3
4 
16.2
0 
20.1
6 
92.28 90.0
0 
90.00 -180.07 
C884 -172.88 1.409 71.77 C2/c 1 3.9
4 
17.4
6 
20.5
8 
83.23 84.5
1 
83.52 -179.59 
A136 -172.71 1.378 70.35 P21/c 1 4.4
1 
10.8
9 
29.8
6 
90.00 90.0
0 
96.76 -181.05 
C642 -172.65 1.397 71.56 P21/c 1 4.4
9 
10.4
1 
30.0
9 
90.00 93.4
6 
90.00 -181.74 
A157 -172.55 1.399 71.42 C2/c 1 4.1
5 
17.0
2 
20.1
1 
88.22 84.0
8 
83.00 -179.33 
C602 -172.54 1.405 71.95 P21/c 1 3.9
4 
17.6
3 
20.2
7 
97.11 90.0
0 
90.00 -179.11 
A156 -172.24 1.389 70.72 P21/c 1 5.0
0 
10.6
5 
26.5
3 
92.86 90.0
0 
90.00 -179.93 
C194 -172.13 1.424 72.96 C2/c 1 3.9
6 
18.4
4 
19.6
6 
104.86 90.0
0 
96.16 -178.08 
C874 -171.99 1.397 71.53 P21/c 1 4.1
5 
12.6
1 
27.4
2 
101.54 90.0
0 
90.00 -178.95 
A132 -171.97 1.379 70.43 P21/c 1 5.1
1 
13.3
6 
21.1
4 
99.48 90.0
0 
90.00 -179.40 
C302 -171.88 1.415 72.59 P1̅ 1 5.0
0 
10.8
1 
14.0
4 
109.60 96.8
6 
99.23 -178.65 
A76 -171.87 1.403 71.58 P21/c 1 3.9
5 
10.6
5 
33.5
2 
96.91 90.0
0 
90.00 -179.11 
A85 -171.85 1.383 70.95 P21212
1 
1 4.3
3 
10.4
0 
31.5
2 
90.00 90.0
0 
90.00 -179.78 
C644 -171.84 1.410 71.69 P21/c 1 4.0
6 
10.0
5 
34.1
0 
90.00 92.8
7 
90.00 -178.68 
C657 -171.80 1.410 72.01 C2/c 1 3.9
3 
15.0
8 
23.7
3 
88.58 85.2
4 
82.51 -178.15 
A175 -171.71 1.399 71.35 C2 1 3.8
4 
10.6
0 
17.4
9 
97.30 96.3
0 
90.00 -176.86 
C59 -171.66 1.366 69.75 P21/c 1 5.1
4 
13.6
6 
20.4
5 
90.00 92.5
1 
90.00 -181.42 
C541 -171.65 1.393 70.75 P1̅ 1 5.0
4 
10.1
3 
14.5
4 
73.64 81.3
6 
87.73 -180.50 
A130 -171.62 1.392 71.19 P21/c 1 4.0
6 
10.5
0 
33.0
2 
90.00 90.0
0 
90.41 -178.93 
C48 -171.60 1.388 70.8 C2/c 1 7.9
8 
10.9
7 
17.8
1 
82.80 77.0
5 
68.67 -179.92 
C634 -171.54 1.395 71.32 P21/c 1 5.0
5 
15.3
2 
18.7
4 
103.87 90.0
0 
90.00 -180.24 
A682 -171.53 1.360 69.43 P21/c 1 5.4
6 
12.2
8 
21.9
2 
90.00 90.0
0 
101.18 -176.93 
A734 -171.38 1.339 68.41 C2/c 1 5.0
8 
16.9
7 
17.9
5 
74.12 81.8
6 
81.39 -179.66 
A803 -171.34 1.390 71.27 P1̅ 1 4.9
9 
8.25 17.9
7 
97.05 94.6
9 
104.47 -181.17 
A497 -171.17 1.387 70.97 C2/c 1 4.5
9 
13.5
5 
23.8
4 
104.26 90.0
0 
99.75 -177.38 
C190 -171.08 1.406 72.08 C2/c 1 4.2
5 
14.1
6 
24.2
8 
75.04 84.9
8 
81.36 -178.45 
A307 -171.05 1.388 71.05 P21 2 5.6
3 
8.31 30.7
5 
90.00 90.0
0 
101.10 -179.62 
C295 -171.05 1.387 70.9 C2/c 1 4.9
9 
15.8
0 
18.3
5 
85.01 82.1
8 
80.91 -178.06 
A218 -170.95 1.352 69.11 C2/c 1 5.3
2 
11.3
5 
24.9
2 
85.65 83.8
8 
76.45 -179.24 
C761 -170.87 1.392 71.23 P21/c 1 4.6
9 
10.0
2 
30.0
8 
90.00 90.0
0 
94.17 -179.73 
C75 -170.84 1.398 71.91 P21/c 1 3.9
5 
15.3
5 
23.3
0 
90.00 90.0
0 
96.79 -179.13 
C584 -170.77 1.417 72.53 C2/c 1 4.1
2 
18.2
0 
20.1
1 
112.43 90.0
0 
96.50 -176.73 
C838 -170.74 1.403 71.97 C2/c 1 5.1
9 
14.7
5 
18.5
7 
96.39 98.0
3 
90.00 -179.81 
A429 -170.73 1.372 69.49 P21/c 1 4.3
0 
10.7
8 
30.9
1 
90.00 92.2
0 
90.00 -178.10 
C777 -170.52 1.393 71.83 P2/c 1 4.1
4 
16.5
4 
20.7
6 
97.99 90.0
0 
90.00 -177.74 
C439 -170.52 1.396 71.43 P21/c 1 3.9
6 
19.0
9 
19.4
3 
107.04 90.0
0 
90.00 -177.40 
C465 -170.49 1.394 70.99 C2/c 1 3.9
6 
15.3
2 
23.9
6 
77.80 85.2
6 
82.57 -176.69 
C275 -170.47 1.407 72.17 P21/c 1 4.1
4 
17.0
9 
19.7
6 
90.00 94.6
4 
90.00 -176.54 
A179 -170.42 1.391 70.91 C2/c 1 5.2
7 
10.8
3 
25.6
6 
96.18 90.0
0 
104.08 -177.66 
A706 -170.35 1.389 70.62 P1̅ 1 5.5
6 
8.40 15.7
4 
81.41 80.0
1 
78.90 -178.03 
C771 -170.29 1.390 70.82 C2/c 1 3.9
7 
16.0
2 
22.8
6 
78.65 85.0
2 
82.89 -177.21 
C113 -170.22 1.368 69.82 C2/c 1 10.
94 
10.9
4 
12.4
8 
94.87 94.8
7 
104.48 -179.42 
A182 -170.12 1.361 69.5 C2/c 1 4.2
0 
11.1
2 
31.8
7 
80.39 86.2
2 
79.11 -177.72 
C174 -170.04 1.412 71.99 P1̅ 1 4.7
5 
9.85 15.2
7 
91.45 96.7
5 
101.28 -175.02 
C131 -170.03 1.393 71.23 P21/c 1 8.2
9 
10.8
5 
16.1
2 
90.00 103.
68 
90.00 -180.03 
C432 -170.00 1.403 71.87 C2/c 1 3.9
8 
18.5
3 
19.7
9 
105.54 90.0
0 
96.17 -175.90 
C893 -169.97 1.319 66.96 R3̅ 1 6.7
2 
19.7
1 
19.7
1 
118.73 96.5
3 
96.53 -177.38 
A184 -169.96 1.389 70.95 C2/c 1 4.6
8 
16.6
3 
19.1
6 
73.77 82.9
9 
81.91 -177.47 
A494 -169.83 1.389 70.81 P1̅ 1 5.6
9 
8.29 15.9
4 
75.18 80.6
3 
78.21 -177.51 
A435 -169.82 1.369 70.38 P21/c 1 7.4
8 
7.86 24.6
5 
90.00 98.3
9 
90.00 -177.10 
A88 -169.78 1.405 71.92 P21/c 1 4.9
7 
16.8
5 
17.6
6 
109.20 90.0
0 
90.00 -176.94 
C173 -169.74 1.393 71.37 Pbca 1 7.4
8 
11.2
4 
33.5
1 
90.00 90.0
0 
90.00 -178.59 
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A482 -169.73 1.394 71.58 P2/c 1 3.8
0 
10.6
3 
35.0
5 
96.78 90.0
0 
90.00 -174.75 
C396 -169.65 1.385 70.8 P21/c 1 4.2
0 
13.2
3 
25.9
9 
101.63 90.0
0 
90.00 -176.08 
A457 -169.52 1.368 69.84 C2/c 1 4.1
2 
18.4
2 
20.5
4 
67.93 84.2
4 
83.58 -176.30 
A142 -169.51 1.398 71.64 P21/c 1 3.9
0 
19.0
4 
20.8
7 
115.13 90.0
0 
90.00 -176.50 
C660 -169.42 1.367 69.85 C2/c 1 3.9
7 
13.1
1 
28.0
3 
84.46 85.9
4 
81.29 -176.36 
A167 -169.37 1.378 70.58 P21/c 1 4.2
7 
18.0
2 
19.9
2 
111.77 90.0
0 
90.00 -177.00 
A129 -169.37 1.385 71.18 P21/c 1 4.6
4 
11.6
3 
26.2
3 
90.00 90.7
1 
90.00 -177.78 
A147 -169.35 1.382 70.74 P21/c 1 4.4
5 
17.7
6 
19.0
7 
109.62 90.0
0 
90.00 -176.86 
A588 -169.35 1.382 71.13 P2/c 1 3.9
3 
16.9
3 
22.0
0 
104.33 90.0
0 
90.00 -176.87 
A194 -169.32 1.410 71.83 P1̅ 1 5.5
7 
8.40 15.5
8 
103.89 91.0
3 
100.19 -177.26 
C72 -169.31 1.403 71.98 P21/c 1 7.3
8 
11.2
9 
16.9
3 
90.00 97.8
3 
90.00 -176.83 
A253 -169.29 1.356 69.29 P21/c 1 5.3
8 
13.7
0 
19.7
9 
97.18 90.0
0 
90.00 -176.70 
C888 -169.29 1.379 71.06 P2/c 1 4.1
3 
16.1
7 
21.5
8 
99.66 90.0
0 
90.00 -176.12 
C594 -168.94 1.396 71.47 C2/c 1 3.9
3 
14.2
0 
25.5
1 
86.84 85.5
8 
82.04 -175.09 
C749 -168.93 1.367 69.94 P21/c 1 6.3
8 
11.5
6 
19.4
4 
90.00 90.2
4 
90.00 -177.67 
A177 -168.85 1.387 70.82 C2/c 1 3.8
9 
17.1
4 
21.6
0 
98.61 90.0
0 
96.51 -174.01 
A163 -168.78 1.374 70.13 C2/c 1 4.6
7 
14.3
6 
21.7
6 
96.99 90.0
0 
99.36 -176.70 
C740 -168.69 1.382 70.93 P21/c 1 4.0
8 
16.9
6 
20.5
5 
93.16 90.0
0 
90.00 -175.52 
A241 -168.63 1.389 70.98 C2/c 1 3.9
4 
18.5
3 
21.5
3 
64.74 84.7
5 
83.89 -174.65 
A490 -168.62 1.382 70.52 C2/c 1 3.9
7 
11.0
2 
33.4
0 
98.78 90.0
0 
100.38 -175.38 
A688 -168.57 1.347 68.92 C2/c 1 4.3
8 
16.2
0 
21.3
4 
103.68 90.0
0 
97.77 -175.99 
A812 -168.55 1.329 67.55 C2/c 1 6.6
5 
11.5
8 
20.7
3 
75.88 80.7
6 
73.30 -177.42 
A375 -168.51 1.397 71.19 C2/c 1 4.1
9 
13.4
3 
25.7
3 
100.71 90.0
0 
98.97 -175.48 
A695 -168.48 1.392 71.05 C2/c 1 4.1
1 
16.3
0 
22.0
8 
74.03 84.6
6 
82.76 -175.03 
A314 -168.43 1.398 71.35 P21 1 4.0
9 
13.0
2 
13.7
6 
106.56 90.0
0 
90.00 -175.80 
C766 -168.32 1.394 71.44 P21/c 1 4.1
5 
16.8
2 
21.0
4 
106.46 90.0
0 
90.00 -175.26 
C322 -168.31 1.423 72.84 P21/c 1 6.1
5 
11.2
3 
19.9
8 
91.63 90.0
0 
90.00 -174.49 
C545 -168.29 1.378 70.69 C2/c 1 5.2
6 
12.1
7 
23.1
2 
81.14 83.4
7 
77.52 -175.25 
A204 -168.28 1.351 68.76 P21/c 1 4.0
6 
12.6
4 
28.3
4 
90.00 90.0
0 
92.56 -176.68 
C154 -168.22 1.407 71.96 P21/c 1 4.3
7 
15.4
8 
20.5
9 
91.35 90.0
0 
90.00 -173.83 
C149 -168.17 1.403 71.77 P21/c 1 3.8
7 
15.5
5 
23.2
4 
90.00 90.0
0 
90.96 -176.54 
C116 -168.15 1.393 71.75 P21/c 1 6.1
1 
10.5
6 
22.1
1 
99.64 90.0
0 
90.00 -175.67 
A315 -168.13 1.341 68.07 P21/c 1 5.0
7 
13.8
0 
21.2
6 
100.73 90.0
0 
90.00 -175.59 
A614 -168.12 1.383 70.34 P21/c 1 4.0
3 
12.0
0 
29.8
0 
100.27 90.0
0 
90.00 -174.29 
C672 -168.06 1.407 72.06 P1̅ 1 7.0
6 
9.33 10.6
6 
88.44 84.0
1 
86.74 -175.67 
C797 -168.00 1.375 69.98 C2/c 1 4.0
0 
15.9
2 
22.6
9 
88.77 84.9
5 
82.79 -173.84 
C811 -167.98 1.367 70.04 P21/c 1 4.9
1 
14.2
6 
20.5
3 
94.00 90.0
0 
90.00 -176.01 
A658 -167.91 1.358 69.05 P21/c 1 3.8
3 
17.5
9 
21.6
0 
96.63 90.0
0 
90.00 -173.55 
C93 -167.86 1.398 71.38 C2/c 1 8.7
3 
9.16 19.9
8 
92.29 90.0
0 
118.45 -174.16 
A616 -167.83 1.342 68.66 C2/c 1 4.3
0 
17.9
5 
20.9
8 
65.72 84.1
3 
83.13 -175.44 
C165 -167.72 1.409 71.73 P1̅ 1 8.1
2 
8.98 10.2
2 
76.84 75.0
2 
80.32 -176.45 
C769 -167.66 1.397 71.55 P21/c 1 3.8
8 
18.4
5 
19.6
6 
90.00 93.5
3 
90.00 -173.10 
C95 -167.64 1.309 66.47 P21/c 1 4.9
9 
16.2
8 
18.5
3 
90.00 95.6
1 
90.00 -175.35 
A224 -167.50 1.309 66.62 P21/c 1 4.8
8 
11.9
1 
25.8
1 
93.48 90.0
0 
90.00 -174.54 
C434 -167.50 1.324 67.81 P21/c 1 5.9
2 
14.7
9 
17.5
4 
105.10 90.0
0 
90.00 -176.79 
A280 -167.46 1.375 70.07 C2/c 1 3.9
6 
15.4
1 
24.2
9 
103.73 90.0
0 
97.38 -174.18 
C574 -167.44 1.412 72.08 P1̅ 1 5.8
4 
10.6
9 
11.7
3 
99.74 103.
36 
96.09 -173.88 
A371 -167.24 1.377 70.26 P1̅ 1 7.5
4 
7.63 12.7
4 
102.90 94.7
3 
91.46 -173.77 
C529 -167.22 1.377 70.52 C2/c 1 4.8
1 
10.0
1 
30.5
1 
91.03 90.0
0 
103.90 -174.01 
C270 -167.10 1.331 68.15 R3̅ 1 4.7
8 
23.1
7 
23.1
7 
119.53 93.9
4 
93.94 -176.02 
A648 -166.88 1.319 66.92 P2/c 1 5.0
8 
11.8
5 
24.7
5 
92.88 90.0
0 
90.00 -174.13 
A463 -166.86 1.397 71.48 P1̅ 1 3.9
9 
13.1
7 
13.6
3 
100.04 95.0
4 
93.01 -170.97 
A758 -166.76 1.351 68.92 C2/c 1 4.1
7 
16.3
5 
21.6
1 
96.52 90.0
0 
97.33 -173.74 
A226 -166.64 1.356 68.97 C2/c 1 5.1
0 
13.5
4 
21.9
9 
76.68 83.3
4 
79.14 -173.86 
C546 -166.60 1.383 70.5 P21/c 1 6.5
1 
14.5
4 
15.1
3 
90.00 90.0
0 
98.40 -173.45 
A396 -166.57 1.350 68.27 P1̅ 1 4.0
1 
12.5
6 
15.1
3 
73.65 83.5
3 
89.77 -174.27 
A242 -166.56 1.422 72.27 P21/c 1 4.1
1 
15.9
5 
21.0
9 
93.95 90.0
0 
90.00 -173.81 
C74 -166.51 1.386 71.02 P21/c 1 9.4
8 
10.9
8 
14.0
1 
90.00 103.
77 
90.00 -176.99 
A415 -166.43 1.339 68.58 P21/c 1 7.3
8 
9.49 20.9
1 
91.71 90.0
0 
90.00 -174.44 
A205 -166.41 1.364 68.86 P1̅ 1 6.2
3 
9.04 13.7
3 
102.85 91.3
7 
106.68 -173.51 
C180 -166.38 1.389 70.9 P21/c 1 9.9
5 
11.9
7 
12.0
5 
90.00 90.0
0 
100.22 -176.17 
A217 -166.34 1.379 70.17 P21/c 1 4.8
6 
17.0
3 
17.8
5 
105.71 90.0
0 
90.00 -173.38 
A605 -166.25 1.357 69.4 P2/c 1 4.5
4 
17.2
2 
19.2
4 
106.21 90.0
0 
90.00 -173.06 
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C54 -166.23 1.397 71.57 P1̅ 1 7.5
7 
10.2
5 
10.8
6 
109.90 102.
76 
107.93 -172.68 
A244 -166.21 1.373 70.37 P21/c 1 5.1
8 
15.8
6 
17.5
4 
97.35 90.0
0 
90.00 -171.20 
C600 -166.15 1.335 68.03 C2/c 1 5.8
4 
13.0
7 
19.8
1 
94.49 90.0
0 
102.91 -174.76 
A329 -166.02 1.360 69.8 C2/c 1 6.2
1 
10.4
3 
23.5
4 
85.83 82.4
3 
72.70 -172.93 
A484 -166.01 1.371 69.87 C2/c 1 4.4
5 
11.1
4 
29.5
9 
95.77 90.0
0 
101.53 -173.44 
A509 -165.98 1.374 70.39 C2/c 1 3.9
4 
16.9
9 
21.8
1 
100.19 90.0
0 
96.66 -172.57 
A516 -165.94 1.389 70.66 C2/c 1 4.6
0 
11.1
2 
28.5
0 
97.72 90.0
0 
101.94 -173.09 
A610 -165.93 1.374 70.15 C2/c 1 4.1
5 
14.5
5 
24.2
9 
79.85 85.0
9 
81.79 -170.36 
A607 -165.79 1.337 68.28 C2/c 1 4.5
7 
11.0
0 
30.2
1 
99.07 90.0
0 
102.00 -174.33 
A504 -165.64 1.376 70.33 C2/c 1 3.8
2 
19.4
6 
21.5
3 
116.40 90.0
0 
95.63 -170.86 
C102 -165.61 1.387 70.61 P21/c 1 6.6
7 
14.5
6 
14.9
8 
103.56 90.0
0 
90.00 -174.67 
C895 -165.60 1.377 69.99 C2/c 1 5.9
6 
15.7
5 
16.0
2 
77.55 79.2
9 
79.10 -172.63 
A525 -165.55 1.332 67.8 P21/c 1 4.0
1 
15.5
1 
23.8
5 
96.83 90.0
0 
90.00 -172.29 
A579 -165.50 1.341 68.4 C2/c 1 4.5
8 
11.1
2 
29.3
1 
90.46 90.0
0 
101.89 -172.59 
A428 -165.50 1.415 72.53 C2 1 4.0
0 
13.3
8 
13.3
9 
102.06 98.6
0 
90.00 -169.75 
A808 -165.33 1.334 68.17 C2/c 1 3.9
8 
15.2
4 
24.6
9 
83.44 85.3
8 
82.50 -172.08 
A321 -165.22 1.378 70.36 C2 1 4.5
5 
11.1
2 
14.6
2 
82.86 81.0
4 
78.19 -172.91 
C183 -165.17 1.358 69.67 C2/c 1 4.6
3 
16.4
4 
19.3
6 
98.26 90.0
0 
98.10 -171.69 
A161 -164.96 1.393 71.41 P21/c 1 5.1
6 
9.25 29.5
3 
90.00 90.0
0 
90.22 -170.57 
A437 -164.90 1.392 71.03 P21/c 1 3.9
9 
13.2
8 
27.3
5 
103.76 90.0
0 
90.00 -172.34 
A637 -164.89 1.338 67.77 P2/c 1 4.7
3 
10.9
8 
28.3
8 
95.39 90.0
0 
90.00 -172.42 
A693 -164.88 1.335 67.94 C2/c 1 5.1
1 
14.2
6 
20.8
3 
81.38 82.9
6 
79.68 -172.30 
C805 -164.86 1.362 69.89 P42/n 1 6.7
5 
20.6
6 
20.6
6 
90.00 90.0
0 
90.00 -174.55 
A572 -164.82 1.364 69.52 C2 1 4.1
0 
11.1
8 
16.0
1 
95.22 90.0
0 
100.58 -172.05 
A704 -164.78 1.369 69.93 C2/c 1 6.1
6 
14.4
1 
18.0
0 
67.22 80.1
5 
77.66 -171.18 
A660 -164.68 1.328 67.84 P1̅ 1 6.0
5 
10.4
8 
12.6
6 
100.97 98.6
4 
106.29 -173.44 
CisC32 -164.51 1.416 71.03 P21/c 1 4.0
5 
16.0
2 
21.3
8 
90.00 93.2
0 
90.00 -176.38 
A243 -164.30 1.368 70.05 Pbca 1 5.4
9 
15.9
2 
32.8
1 
90.00 90.0
0 
90.00 -171.27 
A330 -164.21 1.361 69.53 P21/c 1 5.0
3 
17.3
7 
17.6
9 
111.35 90.0
0 
90.00 -168.74 
A511 -163.92 1.306 67.02 P21/c 1 4.0
6 
16.7
1 
22.2
5 
95.09 90.0
0 
90.00 -171.70 
C100 -163.63 1.388 72.32 P1̅ 1 6.4
3 
7.77 14.5
7 
76.79 85.9
6 
88.09 -171.72 
A823 -163.42 1.371 69.84 P21/c 1 5.3
0 
16.5
4 
16.8
3 
104.01 90.0
0 
90.00 -172.24 
A657 -163.39 1.404 72.21 Pna21 1 4.6
4 
10.1
0 
29.8
3 
90.00 90.0
0 
90.00 -170.41 
A581 -163.14 1.397 71.69 C2/c  1 3.9
0 
10.9
7 
33.7
2 
98.10 90.0
0 
100.23 -167.82 
A783 -163.09 1.358 69.49 P21/c 1 5.8
9 
13.0
8 
18.9
8 
90.00 90.0
0 
98.91 -170.09 
170.09 
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Chapter 5: Crystal structure informatics for 
defining the conformational search space of large 
flexible molecules 
 
5.1 Introduction 
 
The previous two chapters have shown that computational cost is a big issue for 
performing CSP on pharmaceutical-like molecules, as it increases drastically with 
molecular size and flexibility (see also Chapter 1.2.3). Producing the crystal energy 
landscape of molecule XXVI1 was twenty times more expensive than it was for two 
tautomers of mebendazole, even if an almost identical procedure was followed. The 
reason is that mebendazole is smaller than XXVI, and its main degrees of freedom can 
take fewer values; the latter was not obvious at the onset of these studies. Since most 
molecules in drug development are conformationally flexible,2 this is one of the factors 
hindering a routine utilisation of computational methods in industrial solid form screening. 
Thus finding methods to reduce the computational expense and its scaling with 
molecular size and flexibility would be important. 
 All CSP methods start with a crystal structure search (see Chapter 2.4.1), which 
aims to generate plausible packing arrangements of a molecule by finding all the most 
important local minima on the potential energy surface.1 In all successful CSP 
methodologies, the lattice energy (Elatt) surface is explored during the search.1, 3, 4 The 
Elatt search space is immense, and its size increases drastically with the number of 
flexible conformational degrees of freedom (CDFs).2, 5 It is fundamental that the 
conformations that occur in the most important Elatt minima are included in the search to 
guarantee completeness. These cannot be limited to the isolated-molecule local minima 
in conformational energy, since intermolecular interactions can significantly distort 
conformers6, 7 (as it was the case for molecule XXVI, see Chapter 3.3.1).  
 One possible solution is to perform a set of rigid searches for all the conformations 
that have an energy penalty small enough to be counterbalanced by improvements in 
intermolecular interactions.8 This approach can be effective in some cases,9, 10 but for a 
molecule like XXVI (or ritonavir) this would require an unfeasible number of searches.11 
An alternative approach is to treat some CDFs as explicit search variables.8, 12 In general, 
only low-barrier torsion angles need to be treated as flexible in the search, as semi-rigid 
dihedrals (such as those in phenyl rings), bond-angles and bond-lengths do not separate 
structures belonging to different Elatt minima (but they are important for performing 
accurate optimisations of the generated structures, see Chapter 6).12, 13 On the other 
hand if a torsion angle can only take a limited set of values within very limited ranges, 
such as an amide group that can only be in a cis or a trans configuration,14 a more 
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efficient approach is to perform separate searches in for all its possible values, which are 
deemed to define separate conformational regions (CRs).13, 15 
 Treating torsion angles as explicitly flexible in a search requires an accurate 
calculation of the energy penalty for their variation from the isolated molecule global 
minimum in conformational energy (i.e. ΔEintra).8, 12 This is because the use of cheap 
transferable force-fields can be inaccurate and limit the ability of a CSP method to locate 
all the most important local minima in Elatt16 (this occurred in an early study on aspirin).17 
Hence, in the most effective CSP methodologies electronic structure calculations are 
performed to estimate ΔEintra for varying the flexible torsion angles.1 This can be done 
implicitly through the use of ab initio calculations to establish suitable tailor-made force-
fields,18 or explicitly by performing ‘scans’ on the isolated molecule with electronic 
structure methods to create grids of ΔEintra values;8 the latter method is used in 
CrystalPredictor19 (see Chapter 2.4.1.2). However, both approaches are computationally 
expensive, in particular for very flexible molecules, and they often require a large amount 
of human time to set up the calculations.1, 20  
 This chapter seeks to simplify the definition of the conformational search space of 
flexible molecules using information retrieved from the Cambridge Structural Database 
(CSD),21 with the goal of reducing the computational cost of CSP searches without 
reducing their effectiveness in identifying potential polymorphs. After exploring what sort 
of data on conformational preferences can be retrieved from the CSD on small 
molecules, as an essential validation of the approach, this chapter illustrates the 
development and testing of a workflow that uses this information to set up CSP searches. 
This workflow reduces the number of ab initio calculations that are required to determine 
the flexibility ranges of the most important torsion angles and to generate plausible 
crystal structures. This approach was developed from the five pharmaceutical-like 
flexible molecules shown in Figure 5.4, which had been subject to previous CSP studies 
in the Price group performed with a standard methodology: molecule XXVI (see Chapter 
3),1 mebendazole (Chapter 4), GSK269984B,20 molecule XXIII1 and molecule XX.15, 22 It 
was then tested for its ability to generate the most important low-energy crystal structures 
of the same five molecules. Finally, the workflow was applied to succinic acid to test 
whether it could reproduce a newly discovered conformational polymorph (the γ form).23 
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5.2 Methods 
 
5.2.1 Preliminary analysis of CSD conformational information on small molecules 
 
5.2.1.1 Rotamer distributions 
 
Figure 5.1: Chemical diagrams of the small molecules used to investigate the ability of 
CSD information on geometric preferences to define the conformational search space. 
An initial test was performed on five small molecules (Figure 5.1), all of which had been 
subject to full CSP studies,24-27 to illustrate some types of conformational behaviours and 
how CSD information on torsion angle distributions could be applied in CSP. The aim 
was to verify whether CSD informatics tools provided information on the conformational 
space of some relatively simple molecules that is consistent with what had been 
determined using accurate ab initio methods, before testing them on some more 
challenging large and flexible targets. For each molecule, the rotamer distributions were 
retrieved from the CSD conformational libraries (see Chapter 2.6.3),28 using a stand-
alone programme. The retrieved distributions were also analysed via kernel density 
estimation (KDE) with the Von Mises kernel, using the method described in Chapter 
2.6.3.1.29 Figure 5.2 shows three examples of possible histograms and PDFs derived 
from the rotamer distributions. 
145 
 
 
Figure 5.2: Histograms (light purple bars) and Von Mises KDE PDFs (red lines) describing 
the torsion angle distributions of the dihedral angles indicated on each molecular 
diagram of (a) 5-Formyluracil (0° in the diagram) (b) Tazofelone (0° in the diagram) (c) 
Fenamic acid (0° in the diagram), with an overlay of the PDF for tolfenamic acid in green, 
showing the effect of the additional methyl and Cl substituents. 
 In all three cases, the insights from the rotamer distributions are similar to those 
derived from the ab initio scans performed on these molecules in the original CSP 
studies. For 5-formyluracil (Figure 5.2a), the distributions indicate that only two values 
are possible within very narrow ranges (i.e. 0 and 180).24 In tazofelone, there is quite a 
wide spread of possible values around both 90 and 270° (Figure 5.2b), while the 
remainder have very low probabilities.26 In the final example of the fenamates, the only 
low-barrier torsion angle (Figure 5.2c) can adopt any value in fenamic acid, but the 
methyl substitution in tolfenamic acid significantly reduces the probability of a crystalline 
conformation between 60 and 300 because of steric interactions.27  
 In summary, this initial test has shown that CSD torsion angle distributions can 
capture the conformational behaviour of these molecules consistently with their ab initio 
energy profiles.  
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5.2.1.2 The CSD Conformer Generator (CG) 
 
The CSD Conformer Generator (CG) uses the information from the rotamer distributions 
to generate plausible molecular conformations;30 its functioning is explained in Chapter 
2.6.4. The effectiveness of the CG was tested by verifying whether it could reproduce 
the molecular conformations of the experimentally-known single-component crystal 
structures of the molecules in Figure 5.1. Hence the CG, with its default settings for 
molecular clustering and maximum number of unusual torsion angles and without any 
limit in number of conformations and probability scores, was used on each of these 
molecules. It produced two conformations for 5-formyluracil, 37 for olanzapine, 10 for 
tazofelone, 67 for fenamic acid and 83 for tolfenamic acid. The full set of generated 
conformations was analysed to verify whether they contained matches to the 
experimental targets. The analysis was performed with the Crystal Packing Similarity 
tool31 (see Chapter 2.5.1) available through the CSD Python API (Chapter 2.6.5).21 All 
experimental crystalline conformations of the five small molecules were reproduced very 
well by the CG, with RMSD1 < 0.35 Å, as shown in Figure 5.3 and Table 5.1. 
 
Figure 5.3: Overlays of the experimental conformations of the molecules in Figure 5.1 
(coloured by elements) with their best matches produced by the CG (in blue). If the same 
CG conformation was the closest match of each molecule in the asymmetric unit of Z’>1 
crystal structures, the other experimental conformations are coloured in red or in yellow. 
Polymorphs with very similar conformations are shown only once. 
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Table 5.1: Quantification of the ability of CG to reproduce the experimental 
conformations, as shown in Figure 5.3. 
Label on 
Figure 5.3 
Crystal structure of molecule 
Generated 
conformations 
Ranking of 
most similar 
conformation  
RMSD1(Å) 
a 5-Formyluracil 2 2 0.019 
b Olanzapine forms I and II 37 1 0.151 
c Tazofelone forms I and II 10 5 0.337 
d, e Tazofelone form III (solid solution) " 4, 1 0.260, 0.123 
f Tolfenamic acid form 1 83 2 0.087 
g Tolfenamic acid form 2 “ 16 0.258 
h Tolfenamic acid form 3 (Z` = 2) “ 2, 2 0.219, 0.175 
i Tolfenamic acid form 4 (Z` = 3) “ 2, 2, 2 
0.277, 0.314, 
0.287 
j Tolfenamic acid form 5 (disordered) “ 15, 15 0.301,  0.228 
k, l Fenamic acid (Z` = 2)  67 2, 6 0.169, 0.185 
 
 This analysis revealed that the range of CG conformations covers, or even 
exceeds, the conformational search space considered in the original searches. Hence, 
a set of rigid searches would have captured the entire flexibility ranges of these small 
molecules. Furthermore an analysis of the rotamer distributions, e.g. those in Figure 5.2, 
would make the choice of which torsion angle/s should be treated as explicitly flexible to 
make searches more efficient straightforward.  
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5.2.2 Development of a workflow to generate the crystal structures of the five flexible 
molecules 
 
5.2.2.1 Extension of the use of conformational information on larger molecules 
 
Although the analysis in Chapter 5.1.1 showed that CSD conformational information 
could straightforwardly be applied to the small molecules in Figure 5.1, for larger and 
more flexible targets more significant challenges can be anticipated. In this chapter, the 
five molecules shown in Figure 5.4 were used to test the applicability of CSD 
conformational information to molecules of pharmaceutical interest. 
 
Figure 5.4: Chemical diagrams of the molecules used to test the applicability of CSD 
information to large and flexible targets, showing the torsion angles that are identified as 
flexible by the rotamer libraries and the number of distinct conformations generated by 
the CG. The additional angles not identified by the rotamers libraries are in green and 
define the position of polar hydrogen atoms. Atomic numbering can be found in 
Appendix Figure 5.1, and the definition of the torsion angles in Appendix Table 5.1. 
 The CG generated a significantly higher number of possible conformations than 
for the smaller molecules, as shown in Figure 5.4. The Crystal Packing Similarity tool 
was used to find the closest matches to the experimental conformations. The results can 
be found in Figure 5.5 and Table 5.2. 
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Figure 5.5: Overlays of the experimental conformations of the molecules in Figure 5.4 
(coloured by elements) with their best matches produced by the CG (in blue). 
 
Table 5.2: Quantification of the ability of CG to reproduce the experimental 
conformations, as shown in Figure 5.5. 
Label on 
Figure 5.5 
Crystal structure of molecule 
Generated 
conformations 
Ranking of most similar 
conformation 
RMSD1(Å) 
a XXVI 4947 685 0.386 
b XXIII form a 14269 440 0.683 
c XXIII form b “ 406 0.65 
d, e XXIII form c (Z` = 2) “ 657, 3160 0.66, 0.692 
f XXIII form d “ 406 0.192 
g, h XXIII form e (Z` = 2) “ 491, 411 0.235, 0.627 
I  XX 17374 15 0.419 
j  GSK269984B 9529 166 0.129 
k Mebendazole form A 91 2 0.157 
l Mebendazole form C 84 1 0.133 
 
 Compared to the results in Table 5.1, Table 5.2 shows that the reproductions of 
the conformations of the larger molecules were of poorer quality. Even when the RMSD1 
values are small, there are visual differences in the orientations of key peripheral bulky 
groups. This suggests that performing CSP searches with the closest CG-generated 
conformations being treated as rigid may not find some experimental structures because 
the exact Elatt local minima would not be reachable upon optimisation.2 Furthermore the 
large number of generated conformations means that many ab initio calculations would 
be required to select those that should be searched, given how poorly the CG probability-
based score correlates with conformational energy (see Appendix Figure 5.2). 
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Performing ab initio calculations and possibly rigid searches on thousands of 
conformations would be unfeasibly expensive.  
 A related issue is that some torsion angles affect the overall shape of the 
molecule more than others, as illustrated in Figure 5.6.11 Hence the effect of the variation 
of a torsion angle on the overall molecular shape, and so on its packing capability, should 
be considered in CSP.  
 
Figure 5.6: Visual comparison of the effects of changing by 30° (a) torsion angle Φ4 in 
molecule XXVI, which strongly affects molecular shape and (b) torsion angle Φ6 in 
molecule XXIII, which has a very small effect on the shape of the hydrogen bonded 
dimer, except in the proximity of the carboxylic acid functional groups. 
 In summary, for large and flexible molecules CSD conformational information 
cannot be used as it is to perform CSP searches, but a more complex workflow is 
required. 
 
5.2.2.2 The workflow 
 
The proposed workflow was developed from the molecules in Figure 5.4.11 The specific 
parameters of this workflow were heuristically determined, and may need adaption to 
different molecules, in particular if they are larger and more flexible. However, the aim is 
to propose a general approach to use information retrieved from the CSD to establish 
the most efficient treatment of conformational flexibility in the searches.  
 More specifically, the individual rotamer distributions fall into two classes. On the 
one hand the rotamer distributions can be tightly clustered around a few specific values 
(e.g. in 5-formyluracil, see Figure 5.2a), which will be picked by the CG. These angles 
can be treated as fixed in the searches, with different values defining separate CRs.13, 15 
Alternatively, there can be a wide range of possible values (e.g. in fenamic acid, see 
Figure 5.2c): these torsion angles must be considered as search variables.13 
Furthermore, the effect on molecular shape (Figure 5.6) needs to be accounted for in 
deciding how to treat a torsion angle: dihedrals that have a large shape impact should 
only be constrained if they can take few values within very narrow intervals, as even a 
small variation within a range could affect the packing possibilities of the molecule. 
 The workflow developed in this chapter includes several steps:  
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1) For each torsion angle, analyse the rotamer distributions and the effect on molecular 
shape.  After extracting the rotamer distributions from the knowledge-based libraries, 
histograms of the torsion angles in Figure 5.4 were plotted and superimposed with their 
PDFs calculated via Von Mises KDE using the Matplotlib32 Python33 package. The effect 
of each torsion angle on molecular shape was then analysed by ultra-fast shape 
recognition (USR, see Chapter 2.5.3),34 using the RDKit35 and USRCAT36 Python 
packages. The results of these analyses can be found in Appendix Figures 5.3-5.7 and 
Appendix Tables 5.2-5.6.   
 For torsion angles defining the positions of polar hydrogen atoms, which are very 
important in determining hydrogen bonding patterns,37 or any other angle identified by 
CG as potentially flexible but with insufficient data in the CSD, explicit ab initio 
conformational energy scans must be performed. This was the case for angles Φ7 in 
GSK269984B and Φ7 in XXIII, both of which define the position of polar hydrogen atoms. 
They were scanned with Gaussian 0938 at the PBE0 6-31G(d,p) level of theory. 
2) Assess the nature of each torsion angle. This analysis aims to discriminate between 
torsion angles to be treated as search variables and those that can be constrained to a 
set of CG values, defining separate CRs. The decision tree in Figure 5.7 was used for 
this purpose. 
 
Figure 5.7: Decision tree used to discriminate between constrained and explicitly flexible 
torsion angles on the basis of the PDF f() values and the changes in shape associated 
with their variation. 
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3) Determine the values or range of values for each torsion of angle. This involves: 
a) Determine representative values for torsion angles that will be fixed in the search.  A 
set of CG-generated conformations with different combinations of the constrained torsion 
angles needs to be selected, which define separate CRs. Each CR requires a separate 
sub-search. Since the CG has a complex algorithm for picking the values of each torsion 
angle, aimed at maximising diversity,30 many CG conformations do not have angles that 
are at the peaks of distributions. This diversity is important, but the number of 
conformations (and associated CRs) to be searched needs to be limited to keep the 
computational cost manageable. Thus, the decision tree shown in Figure 5.8 was used 
to determine appropriate separation thresholds, which divide the full 360° range into 
intervals that define the most significant maxima of the distribution. These thresholds 
were then fed into an automated Python script to select those CG-generated 
conformations that were worth considering as distinct CRs.  
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Figure 5.8: Decision tree used to choose the separation threshold of each torsion angle 
defining a separate CR from the PDF f()  and shape-matching characteristics.  
b) Specification of the ranges for the flexible torsion angles. The range of the torsion 
angles treated as search variables, and a suitable grid spacing for representing their 
energy behaviour, were selected using Mogul,39 as it produces more chemistry-specific 
distributions than the rotamer libraries.28 Since the CG removes any gross steric clash 
that can occur in large molecules,30 the torsion angle ranges produced by the CG can 
sometimes further reduce those observed in the Mogul distributions. The Mogul 
154 
 
distributions for the explicitly flexible torsion angles of the five molecules are shown in 
Appendix Figures 5.8-5.12. 
c) Add polar hydrogen torsion angles. The same principles of analysing the PDFs were 
applied to the ab initio torsion energy surfaces. Since the scans showed that torsion 
angles defining the position of polar hydrogren atoms (i.e. Φ7 in GSK269984B and in 
molecule XXIII, see Appendix Figures 5.13-5.17) had sharp energy minima, they were 
constrained to these values, which were added to the selected conformations.  
4) Eliminate conformational regions that are energetically implausible. The CG 
conformations representative of distinct CRs, with all the angles to be fixed during the 
search constrained at their initial, CG values, were optimised with Gaussian 09 at the 
PBE0 6-31G(d,p) level of theory. This optimisation of the flexible torsions and all the 
other bond-lengths, bond-angles and dihedrals not identified as flexible by CG was 
performed to calculate the energy of the nearest local minimum in conformational energy. 
Only CRs whose optimised conformational energy penalty (ΔEintra), relative to the most 
stable fully optimised gas-phase conformer, was plausible for solid-state conformations 
were kept after this stage. A recently found threshold of ΔEIntra
CR  ≤ 26 kJ·mol-1 was 
utilised.40  
 In summary, the workflow steps outlined thus far define the conformational space 
of the molecule as a set of CRs and angles that can adopt a specific range of possible 
values.  
5) Perform CSP searches using the remaining conformational regions. The searches 
were performed with CrystalPredictor 1.819 for each CR. Grids of ΔEintra values were 
calculated for the ranges and grid spacings determined in step 3b with Gaussian 09 at 
the PBE0 6-31G(d,p) level of theory. The dimensionality of the grids was reduced by 
identifying smaller surrogate molecules containing subsets of torsion angles when it was 
reasonable to assume that their ΔEintra values were not affected by the rest of the 
molecule.8, 12, 15 The chosen surrogate molecules are shown in Appendix Figures                 
5.18-5.22. They had hydrogen atoms or methyl groups added at their edges to avoid the 
presence of unphysical free bonds, and were large enough to represent the influence of 
the bonding environment on ΔEintra for the subset of torsion angles.  
 In the searches the ΔEintra values estimated from the grids were combined with the 
intermolecular energy (Uinter) calculated as a sum of an electrostatic component derived 
from fixed point charges (fitted from the charge densities of the optimised CRs) and a 
repulsion-dispersion component derived from the empirically fitted FIT potential.41 Z’=1 
Crystal structures were generated in the 59 most-common space groups in the CSD, 
which are listed in Appendix Table 5.7. The extent of the search was weighted according 
to the lowest energy CR. A total of 300,000 structures were generated in CRs with  
ΔEIntra
CR  ≤ 4 kJ·mol-1, 150,000 for those with 4 < ΔEIntra
CR  ≤ 17 kJ·mol-1and 50,000 for those 
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with 17< ΔEIntra
CR  ≤ 26 kJ·mol-1. By running the sub-searches in order of increasing ΔEIntra
CR , 
it was possible to track the current global Elatt minimum for the overall search.                         
Sub-searches that after generating at least 10,000 crystal structures had not produced 
any with a lattice energy within 25 kJ·mol-1 of the global minimum were terminated to 
save computational resources, with a high degree of confidence that the Uinter was 
unlikely to compensate for the ΔEintra penalty and generate thermodynamically 
competitive structures. This contributed to the saving in computational resources.  
 
5.2.2.3 Assessing the adequate coverage of conformational search space 
 
After completing the workflow, its effectiveness was assessed. The workflow could only 
be regarded as successful if all the “significant” crystal structures that would be analysed 
in the interpretation of the CSP study had been generated.11 These were selected as 
those matching the experimentally observed crystal structure/s of each molecule and the 
most competitive unobserved putative polymorphs (PPMs) found in the original CSP 
studies. For some molecules a few higher energy conformationally diverse                  
computer-generated crystal structures that were examined in the original CSP studies to 
exclude possible types of conformational polymorphism were also considered. 
 For molecule XXVI, the set of significant structures included all the 35 crystal 
structures within 10 kJ·mol-1 of the global minimum in the first list of predictions submitted 
by the Price group for the 6th Blind Test, including a match to the experimental structure 
(CSD refcode XAFQIH, see chapter 3), as well as one extra structure that was made 
highly competitive by polarisation in the second list.1 For molecule XXIII, it consisted of 
the 49 crystal structures within 10 kJ·mol-1 of the global minimum in the second list of 
predictions, including matches to experimental forms B (XAFPAY01) and D 
(XAFPAY03), three further structures in a different conformational region present in the 
second list and experimental form A (XAFPAY), which was not present in either 
submitted list; Z’=2 experimental structures were ignored.1 For GSK269984B, the 38 
crystal structures within 10 kJ·mol-1 of the global minimum, including a match to the 
experimental form (BIFHOP),20 which are listed in the publication were considered.20 For 
molecule XX, the 21 unique crystal structures within 10 kJ·mol-1 of the global minimum 
submitted in the extended list of predictions for the 5th Blind Test, which included a match 
to the experimentally known crystal structure (OBEQIX), were deemed to be significant, 
as well as a structure with a cis amide, which was submitted as one of the three main 
predictions.15, 22 Finally for mebendazole the significant structures were the 31 lowest 
energy crystal structures of both tautomers, including matches to the solved forms A 
(TUXPEJ)42 and C (YULGIW),43 together with the only competitive crystal structure with 
a cis amide configuration (see Chapter 4 for details). 
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 For each molecule, all the crystal structures generated by the workflow with Elatt 
values (as calculated by CrystalPredictor) within 40 kJ·mol-1 of the global minimum were 
checked to verify whether the significant crystal structures were present among them. 
This is on the conservative side of the spectra of ranges used to determine which 
CrystalPredictor-generated structures should be taken to the final refinement stage.1  
 The generated crystal structures were compared with the significant ones using 
the Crystal Packing Similarity tool available through the CSD Python API. Clusters of 15 
molecules were considered, with a 50% distance and a 40° angle tolerances. These 
values are larger than the default tolerances to account for the differences in the quality 
of the models used for generating the crystal structures and for the full optimisations in 
the original CSP studies. A fully optimised significant structure was considered as ‘found’ 
when a 15/15 molecule overlay was possible with at least one crystal structure generated 
with the new methodology. If the RMSD15 was smaller than 0.8 Å, which is the criterion 
used to test the success of the searches for the latest Blind Test,1 the structure was 
considered to have been ‘certainly found’ (i.e. a full optimisation was deemed to lead to 
an almost exact match).11 If the RMSD15 was larger than 0.8 Å, the structure was 
considered to have been ‘probably found’: it was deemed highly likely, but not certain, 
that the generated structure would optimise to the corresponding significant one.11 
Optimisations of these crystal structures are performed in Chapter 7. 
 
5.2.3 Testing the workflow on succinic acid 
 
After the development of the workflow, the Price group was challenged by the Blagden 
team at the University of Lincoln to predict a newly discovered conformational polymorph 
(γ form) of succinic acid they had produced during a co-crystallisation experiment aimed 
at purifying a peptide from a set of impurities.23 Before that discovery, two single-
components forms of succinic acid were known: stable β form (CSD refcode 
SUCACB0344 is the best experimental determination), and metastable α form (the 
highest-quality determination being CSD refcode SUCACB07).23, 45 The α and β forms 
both contain a planar conformation, while the new γ conformational polymorph contains 
a folded molecular geometry.23  Succinic acid is smaller and less flexible than the 
molecules in Figure 5.4 from which the workflow was developed. It had already been 
subject to a partial CSP study, which had however dismissed the possibility of a 
conformational polymorph existing.46 Its chemical diagram with the main torsion angles 
indicated is shown in Figure 5.9. 
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Figure 5.9: Chemical diagram and atomic numbering of succinic acid. The torsion angles 
identified as flexible by the CG are in black, while those in green define the position of 
polar hydrogen atoms. Their definition can be found in Appendix Table 5.8. 
 In order to verify whether the methodology developed in this chapter could 
generate form γ, the CG was used on succinic acid, generating 46 conformations, and 
the workflow steps outlined in Chapter 5.2.2.3 were performed. The results of the various 
steps of the workflow for succinic acid can be found in Appendix Table 5.9 and Appendix 
Figures 5.23-5.24.  
 Since succinic acid is not a very flexible molecule, with no torsion angle selected 
by the workflow for an explicitly flexible treatment, the number of structures generated 
with CrystalPredictor was halved compared to what had been done for the larger and 
more flexible molecules in Figure 5.4: for CRs with ΔEIntra
CR  ≤ 4 kJ·mol-1 150,000 structures 
were generated; 75,000 for those with 4 < ΔEIntra
CR  ≤ 17 kJ·mol-1and 25,000 for those with 
17 < ΔEIntra
CR  ≤ 26 kJ·mol-1.. 
 
5.3 Results and discussion 
 
5.3.1 Test of the workflow for the five large flexible molecules 
 
A summary of the results of the workflow for the molecules in Figure 5.4 is shown in 
Figure 5.10 and Table 5.3. 
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Figure 5.10: Summary of the application of the workflow on the molecules in Figure 5.4. 
The torsion angles in red were treated as flexible in the searches, covering the ranges 
given in degrees. Torsion angles in black were constrained to a set of CG values, with 
the values used in at least one search indicated; note that many combinations of these 
values were eliminated as energetically unfeasible (see Appendix Tables 5.10-5.15).  
Torsion angles in green were constrained to the indicated values having been 
determined from an ab initio conformational-energy scan. The tautomers A and C of 
mebendazole were treated in the same way (the motivation for this assumption is 
illustrated in Chapter 4).  
 
Table 5.3: Summary of the CSP studies and their results. 
Molecule 
# Selected 
CRs 
# ΔEintra (CR)  
# ~ crystal 
structures 
/ ·106 
Found? Saving in CPU 
hours, relative 
to original CSP 
studies 
0-
4  
4-
17  
17- 
26  
Yes Probably  No 
XXVI1 138 1 8 14 2.2 31 4 1 ~14,000 (-50%) 
GSK269984B20 51 1 7 10 1.9 28 6 4 not recorded 
XX15, 22 21 2 8 3 2 20 2 0 ~6,000 (-30%) 
XXIII1 127 3 6 7 2.1 37 12 4 ~14,000 (-70%) 
Mebendazole A 4 1 1 0 0.45  28 4 0 ~5,000 (-70%) 
Mebendazole C 4 1 0 1 0.35 
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 The workflow defined a number of CRs and explicitly flexible torsion angles. This 
breakdown is very dependent on the specific molecule, reflecting the level of flexibility and 
the shape effect of different torsion angles. For example, there are eight possible angles 
between the aromatic ring and amide groups in XXVI (i.e. angle Φ3a), but only one for 
mebendazole (i.e. Φ3), because of an internal hydrogen bond.  
 The reproduction of the significant crystal structures listed in Chapter 5.2.2.3 is 
summarised in Figure 5.11. More details can also be found in Appendix Tables 5.16-5.20. 
 
Figure 5.11. Plots of the significant CSP-generated crystal structures found in previous 
studies, classified as to whether they were found by the search workflow, of (a) molecule 
XXVI, (b) GSK269984B, (c) molecule XX, (d) molecule XXIII and (e) mebendazole. Higher 
energy structures were included for molecule XXVI (a structure whose stability was very 
dependent on the energy model), molecule XX and mebendazole (a competitive crystal 
structure with a cis amide for both molecules). Structures matching the experimentally 
known forms are indicated by open diamonds. 
 The workflow generated millions of crystal structures at a considerably reduced 
computational cost, as shown in Table 5.3. 
  Figure 5.11 evaluates whether the searches managed to reproduce the significant 
crystal structures, classifying the output of the original CSP studies as to whether the 
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workflow generated similar enough matches. The vast majority of the significant crystal 
structures, including those matching all the experimentally-characterised forms, were 
successfully generated. For molecule XX and mebendazole no significant crystal 
structure was missed, and only a few higher-energy PPMs were not generated for 
molecule XXVI, GSK269984B and molecule XXIII. This was not due to an inadequacy in 
the workflow, since the conformations contained in the missed structures were found in 
other structures that were generated in the searches. These few structures were 
probably missed because they are located in particularly narrow Elatt minima, which are 
rarely found47 by the pseudo-random element of the CrystalPredictor searches. The 
accuracy of the conformational model was also evidenced by most of the generated 
structures being good matches with the corresponding fully optimised significant 
structures (see Appendix Tables 5.16-5.20 for further details).  
 The use of the workflow decreased the computational cost by 30-70%, as shown 
in Table 5.3, although some of these savings would be due to the use of different 
computer clusters. This reduction came from replacing the initial ab initio conformational 
analyses on individual torsion angles with a fast assessment based on CSD informatics, 
from requiring fewer calculations to produce the ΔEintra grids, and from terminating some 
Crystal Predictor runs early in a systematic manner. Furthermore, this workflow takes 
less than an hour to set up, which is a considerable saving in terms of human time 
compared to other similar methods. 
 
5.3.2. Testing the workflow on succinic acid 
 
The results of the application of the workflow to succinic acid are summarised in Figure 
5.12 and Table 5.4. 
 
Figure 5.12: Summary of the application of the workflow to succinic acid. Torsion angles 
in black were constrained to a set of CG values, with the values used in at least one 
search indicated; many combinations of these values were eliminated as energetically 
unfeasible (see Appendix Table 5.21). Torsion angles in green were constrained to the 
indicated values having been determined from an ab initio conformational-energy scan. 
Since the two halves of the molecule are symmetric, only one combination 180°-0° values 
for the green torsion angles Φ1 and Φ5 was considered, as they would represent identical 
molecules upon switching.  
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Table 5.4: Summary of the succinic acid searches. 
# CG 
conformations 
# Selected 
CRs 
# CRs ΔEintra (CR) ≤ 26 
kJ·mol-1 # ~ generated structures/ 
·106 
CPU 
cost/hours 
0-4  4-17 17- 26  
46 72 1 10 15 0.42 ~600 
  
 A match to new conformational polymorph (γ form) was successfully found by the 
workflow. This is significant because the γ form contains a folded conformation, with a 
Φ3 value of 75.43° that is rare in the CSD (see Appendix Figure 5.23). A CSD survey of 
all the salts, co-crystals and solvates that contain succinic acid showed the folded 
conformations are indeed unusual, as they are found in only ~11% of the retrieved 
entries.23 It is promising that the workflow generated a match to a new polymorph that 
contains such an uncommon molecular geometry. The most stable β form, which 
contains the more common planar conformation (i.e. with Φ3=180.00°), was also 
successfully identified, while the α form was missed. However, the α form has a Z’ of two 
halves molecules,23, 46 and so it was outside the scope of this search. The results are 
summarised in Table 5.5.  
Table 5.5: Comparison of the crystal structures of succinic acid generated in the 
workflow and the two Z’=1 experimentally known polymorphs. 
Experimental 
form 
Found? 
Conformation 
number 
Ranking after 
search 
RMSD15 
β form YES 1 1 0.272 
γ form  YES 2 834 0.456 
  
 Although a parallel CSP study performed with a traditional CSP workflow was 
published in the paper describing the crystallisation of the γ form,23 this search showed 
that the workflow developed and tested in Chapter 5.2.2.2 can be effective even for a 
molecule that was not involved in its development. Succinic acid is a relatively small 
molecule, and it is important that a search workflow developed heuristically from larger 
targets was successful. Nonetheless, more testing on larger molecules that differ more 
from those that were considered in this work is needed. 
 
5.3.3 Discussion 
 
 The results illustrated in this chapter show that the conformational space that 
needs to be covered is very molecule-dependent. The interplay between the different 
torsion angles within a large and flexible molecule is complex: some combinations of 
values are restricted by steric clashes, or there can be specific correlations that allow 
large variations with little overall effect on the molecular shape. 
 The CSD Conformer Generator is effective at describing the likely conformational 
space of pharmaceutical-like molecules, but the vast number of conformations it 
generates makes a detailed analysis of both the individual torsion angle distributions and 
their effect on the overall molecular shape necessary. These analyses allow a setup of 
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a CSP study as a set of searches with some fixed torsion angles and/or some that are 
allowed to vary over defined ranges, vastly reducing the number of costly ab initio energy 
calculations required. This approach is effective: it generated most of the significant 
crystal structures of the five large and flexible molecules in Figure 5.4, including matches 
to all Z’=1 experimentally-characterised forms, with a large reduction in computational 
cost and minimal human effort. It also reproduced both Z’=1 polymorphs of succinic acid, 
including the newly discovered γ form with an unusual conformation.23 Very few 
significant structures were missed for the five test molecules (see Table 5.3 and 
Appendix Tables 5.16-5.20), and this was not due to an incomplete coverage of the 
conformational space. However the significant crystal structures were often poorly 
ranked among a plethora of alternatives because of the approximations in the 
CrystalPredictor Elatt model, and this poses important challenges for the final refinement 
stage of CSP. 
 Although the results presented in this chapter are promising, the workflow was only 
tested for its ability to reproduce the results of CSP studies based on the assumption 
that a conformation can plausibly occur in a stable crystal structure only if it has a low 
ΔEintra value as determined by ab initio calculations (see Chapter 2.4.1.1). However in 
larger molecules intermolecular dispersion effects, which favour planar conformations,40 
and differences in electrostatic contributions, such as switching between inter- and 
intramolecular hydrogen bonds,6 can stabilise molecular geometries with very high ΔEintra 
values. Hence as molecules get larger and more flexible the conformational energy                
cut-off values, such as the 26 kJ·mol-1 used here to determine whether a CR is likely to 
be observed in a crystal structure, might require adaption. It may also be that CSD 
information, capturing solid-state rather than isolated-molecule conformational 
preferences, reflects more than the relative thermodynamic stability of gas-phase 
conformations, e.g. which molecular geometries optimise intermolecular interactions or 
crystallisation kinetics.48, 49 
 Some further issues related to a large-scale application of this specific workflow 
can be anticipated. First of all, since the workflow is based on conformational information 
derived from molecular fragments, it may miss some unusual but potentially important 
conformations involving torsion angles that have few CSD entries. Moreover, the 
workflow could only be developed and validated from a limited number of CSP studies, 
as relatively few have been performed on molecules of the size of small pharmaceuticals. 
Thus it is doubtful whether this methodology could be extended to molecules like 
ritonavir: the current version of the CG on standard settings does not produce the 
molecular conformation of the most stable observed polymorph (form II) because of the 
unusual cis conformation of the carbamate group in combination with the other 20 flexible 
torsion angles.50 However, this does not necessarily mean that the workflow would lead 
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to an incomplete search, as the combination of constrained and explicitly flexible torsion 
angles may still include form II within its boundaries. Finally, all the assumptions made 
in this chapter to limit the use of human and computer resources (such as assuming 
Z’=1) risk missing some thermodynamically stable crystal structures.5, 51  
 Nonetheless, the results show that using CSD-derived information on geometrical 
preferences to define the conformational search space can be an efficient route to 
performing CSP searches on molecules of pharmaceutical interest. The use of shape 
matching criteria to determine which angles have a large effect on molecular shape, and 
the concept of dividing the angles into those which can take a wide range of values, or 
just a few probable ones defining separate CRs, are likely to be applicable to other CSP 
workflows and algorithms. Finally, the poor ranking of the significant crystal structures 
among many others that are of little practical interest shows how cost effective methods 
to optimise and re-rank the generated crystal structures are needed. This topic will be 
discussed in Chapter 7. 
 
5.4 Conclusion 
 
A workflow for using CSD conformational information to set up CSP searches was 
developed, which uses CSD torsion angle distributions, molecular shape analysis and a 
limited number of ab initio calculations to reduce the conformations produced by the CSD 
Conformer Generator into a set of sufficiently low-energy conformational regions, 
defining also which torsion angles should be treated as search variables within specified 
ranges. Using this workflow in conjunction with CrystalPredictor successfully generated 
most of the significant crystal structures of five large flexible molecules of pharmaceutical 
interest, including all the experimentally- characterised Z’=1 forms, at a 30-70% lower 
computational cost. It must be noted that some of the calculations were not performed 
on the same machines. A newly discovered conformational polymorph of succinic acid 
was also found, showing that the workflow can be successful for molecules not 
considered in its development. 
 The results illustrated in this chapter are very important in the context of this 
thesis. First of all, they show that the use of CSD conformational information is a viable 
way to limit the computational cost of setting up and performing CSP searches on large 
flexible molecules of pharmaceutical interest. This approach does not seem to limit the 
coverage of the conformational search space, as crystal structures with unusual 
molecular geometries were successfully generated, e.g. the γ form of succinic acid. 
Another important point is that CSD information cannot be used on its own in CSP for 
molecules of pharmaceutical interest, since the informatics tools generate an 
unmanageable number of conformational possibilities, and other factors, such as ab initio 
energies and shape effects, must be accounted for. Although the workflow is tailored to 
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CrystalPredictor, the ideas behind it are applicable to other CSP methodologies, as long 
as the necessary modifications to the parameters are brought. Finally, this chapter shows 
that speeding up searches is by no means sufficient to perform an effective CSP study: 
although the most important crystal structures were generated, they were often poorly 
ranked among a plethora of unimportant alternatives. This is due to the approximate Elatt 
model used to perform the CSP searches. Hence, an effective CSP methodology 
requires cost effective yet accurate methods to optimise and re-rank search-generated 
structures. The development of a methodology to achieve a fast but high-quality 
refinement of the thousands of crystal structures generated by the workflow for the 
molecules in Figure 5.4 is the main goal of Chapter 7.  
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5.6 Appendix 
 
 
Appendix Figure 5.1: Chemical diagrams of the molecules in Figure 5.4, with the atomic 
numbering that precisely identifies the rotatable torsion angles in Appendix Table 5.1. 
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Appendix Table 5.1: Atomic numbering definition of the key torsion angles shown in 
Appendix Figure 5.1. 
Label for XXVI Torsion Angle Definition 
Φ1a  35-34-32-33  
Φ2a 33-32-31-22 
Φ3a 32-21-22-21 
Φ1b 1-2-8-9 
Φ2b 9-8-10-11 
Φ3b 8-10-11-12 
Φ4 30-21-12-13 
Label for GSK269984B Torsion Angle Definition 
Φ1 17-18-19-20 
Φ2 12 -17-18-19 
Φ3 11-12-17-18 
Φ4 12-11-10-5 
Φ5 11-10-5-4 
Φ6 4-3-2-9 
Φ7 3-2-1-1a 
Label for XX Torsion Angle Definition 
Φ1 20-19-18-17 
Φ2 19-18-17-16 
Φ3 18-17-16-16 
Φ4 32-16-15-9 
Φ5 16-15-9-8 
Φ6 7-6-2-3 
Φ7 4-5-13-26 
Φ8 5-13-26-31 
Label for XXIII Torsion Angle Definition 
Φ1 6-5-9-10 
Φ2 5-9-10-11 
Φ3 9-10-11-12 
Φ4 13-14-17-18 
Φ5 14-17-18-19 
Φ6 18-19-26-26 
Φ7 19-24-25-25a 
Label for Mebendazole A, C Torsion Angle Definition 
Φ1 22-17-14-7 (A), 22-17-14-8 (C) 
Φ2 17-14-7-8 (A), 17-14-8-9 (C) 
Φ3 3-2-10-11 
Φ4 2-10-11-16 
Φ5 16-11-12-13 
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Appendix Figure 5.2: Plots of ΔEintra versus CG probability scores (explained in Chapter 
2.6.4) for the 200 most probably conformations of (a) Molecule XXVI (b) the A-tautomer of 
Mebendazole (c) the C-tautomer of Mebendazole (d) Molecule XXIII. This test shows that 
the CG probability score does not correlate well with ab initio ΔEintra values, and that 
some high-probability conformations have unfeasible conformational energies for               
solid-state candidates. This is probably because the CG does not capture the 
interactions between different fragments.30 
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Appendix Figure 5.3: Histograms (light purple bars) and PDFs (red lines) of the torsion 
angle distributions of molecule XXVI. 
 
Appendix Figure 5.4: Histograms (light purple bars) and PDFs (red lines) of the torsion 
angle distributions of GSK269984B. 
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Appendix Figure 5.5: Histograms (light purple bars) and PDFs (red lines) of the torsion 
angle distributions of molecule XX. 
Φ1 
 
Φ2 
Φ3 Φ4 
Φ5 Φ6 
Φ7 
Φ8 
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Appendix Figure 5.6: Histograms (light purple bars) and PDFs (red lines) of the torsion 
angle distributions of molecule XXIII. 
 
Appendix Figure 5.7: Histograms (light purple bars) and PDFs (red lines) of the 
torsion angle distributions of both tautomers of mebendazole. For Φ1 and Φ2, the 
rotamer libraries failed to generate individual distributions since they are coupled 
around C14 (see Appendix Figure 5.1). Hence the Mogul distributions in Appendix 
Figure 12 were used as a replacement, and they suggested that both Φ1 and Φ2 
should be treated as explicitly flexible in the searches. 
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Appendix Table 5.2: Shape matches for varying each torsion angle of molecule XXVI with 
30° steps with both the previous step and the starting conformation. The angles are 
normalised to a 0-360° range. The first value for each torsion angle corresponds to the 
initial value. 
Φ1a,2a/° 
% shape match 
with previous 
step 
% shape match with 
original conformation 
Φ2a,2b/° 
% shape match 
with previous 
step 
% shape match with 
original conformation 
214.37 / / 4.14 / / 
244.37 99.39 99.39 34.14 95.47 95.47 
274.37 99.60 99.04 64.14 96.53 92.30 
304.37 99.51 98.90 94.14 98.30 91.09 
334.37 96.26 96.39 124.14 98.75 92.06 
4.37 97.31 97.77 154.14 96.72 94.06 
34.37 97.48 98.55 184.14 95.70 96.18 
64.37 99.46 98.37 214.14 95.61 96.16 
94.37 99.31 98.23 244.14 96.42 93.00 
124.37 99.28 98.28 274.14 98.07 91.53 
154.37 99.50 98.62 304.14 98.86 92.41 
184.37 99.32 99.24 334.14 96.63 95.47 
Φ3a,3b/° 
% shape match 
with previous 
step 
% shape match with 
original conformation 
Φ4/° 
% shape match 
with previous 
step 
% shape match with 
original conformation 
222.46 / / 258 / / 
252.46 98.71 98.71 287.97 91.41 91.41 
282.46 98.41 97.31 317.97 93.60 86.04 
312.46 98.14 95.83 347.97 93.32 82.99 
342.46 98.19 94.40 17.97 96.53 80.93 
12.46 98.65 93.58 47.97 88.74 81.81 
42.46 98.90 93.54 77.97 88.27 82.76 
72.46 96.24 95.21 107.97 92.50 85.50 
102.46 98.39 94.86 137.97 76.01 77.20 
132.46 98.70 95.15 167.97 77.46 71.13 
162.46 96.79 97.82 197.97 93.17 73.82 
192.46 98.75 98.98 227.97 83.49 85.93 
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Appendix Table 5.3: Shape matches for varying each torsion angle of GSK269984B with 
30° steps with both the previous step and the starting conformation. The angles are 
normalised to a 0-360° range. The first value for each torsion angle corresponds to the 
initial value. 
Φ1/° 
% shape match 
with previous 
step 
% shape match with 
original conformation 
Φ2/° 
% shape match 
with previous 
step 
% shape match with 
original conformation 
181 / / 178.55 / / 
211 99.13 99.13 208.55 96.87 96.87 
241 98.94 98.31 238.55 92.07 92.06 
271 98.47 97.11 268.55 92.11 85.33 
301 98.09 95.98 298.55 95.07 82.12 
331 99.00 95.29 328.55 95.24 81.17 
1 99.01 95.88 358.55 97.28 80.20 
31 98.16 96.86 28.55 96.15 79.86 
61 98.51 97.67 58.55 94.11 79.63 
91 98.87 98.76 88.55 92.84 80.79 
121 98.90 99.53 118.55 93.03 83.86 
151 99.49 99.48 148.55 88.87 91.13 
Φ3/° 
% shape match 
with previous 
step 
% shape match with 
original conformation 
Φ4/° 
% shape match 
with previous 
step 
% shape match with 
original conformation 
182.96 / / 64.96 / / 
212.96 98.14 98.14 94.96 89.55 89.55 
242.96 97.44 95.70 124.96 90.89 82.19 
272.96 96.38 92.87 154.96 91.70 77.69 
302.96 96.07 89.60 184.96 92.79 75.11 
332.96 98.24 88.20 214.96 89.34 72.58 
2.96 97.20 90.34 244.96 94.72 74.44 
32.96 95.98 93.41 274.96 90.19 80.27 
62.96 96.61 96.58 304.96 86.80 89.57 
92.96 97.53 98.85 334.96 88.04 89.18 
122.96 98.49 99.42 4.96 93.68 84.48 
152.96 99.58 99.20 34.96 88.78 92.03 
Φ5/° 
% shape match 
with previous 
step 
% shape match with 
original conformation 
Φ6/° 
% shape match 
with previous 
step 
% shape match with 
original conformation 
214.27 / / 184.8 / / 
244.27 92.15 92.15 214.8 99.83 99.83 
274.27 96.75 90.94 244.8 96.88 96.72 
304.27 93.97 92.95 274.78 98.31 95.16 
334.27 92.08 90.42 304.78 99.04 95.14 
4.27 93.22 87.38 334.78 98.23 96.68 
34.27 95.29 87.47 4.78 96.68 99.70 
64.27 95.39 84.64 34.78 99.91 99.66 
94.27 96.64 83.85 64.78 97.22 97.28 
124.27 93.86 84.70 94.78 98.61 96.03 
154.27 90.66 89.01 124.78 99.35 95.99 
184.27 94.18 90.20 154.78 98.73 97.03 
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Appendix Table 5.4: Shape matches for varying each torsion angle of molecule XX with 
30° steps with both the previous step and the starting conformation. The angles are 
normalised to a 0-360° range. The first value for each torsion angle corresponds to the 
initial value.  
Φ1/° 
% shape match 
with previous 
step 
% shape match with 
original conformation 
Φ2/° 
% shape match 
with previous 
step 
% shape match with 
original conformation 
82.16 / / -105.82 / / 
112.16 96.73 96.73 -75.82 92.21 92.21 
142.16 99.00 95.80 -45.82 89.91 87.53 
172.16 98.38 96.51 -15.82 89.36 80.07 
202.16 96.84 99.38 14.18 88.41 73.23 
232.16 98.77 98.77 44.18 90.57 70.52 
262.16 98.54 99.74 74.18 91.14 69.33 
292.16 96.81 96.58 104.18 83.40 72.75 
322.16 99.16 95.82 134.18 87.45 72.05 
352.16 98.34 96.59 164.18 87.44 79.87 
22.16 96.77 99.21 194.18 90.05 84.41 
52.16 98.74 98.52 224.18 85.74 91.60 
Φ3/° 
% shape match 
with previous 
step 
% shape match with 
original conformation 
Φ4/° 
% shape match 
with previous 
step 
% shape match with 
original conformation 
6.3 / / 355.83 / / 
36.3 97.13 97.13 25.83 79.10 79.10 
66.3 96.04 95.35 55.83 77.91 75.17 
96.3 92.59 89.79 85.83 80.14 67.42 
126.3 91.09 82.54 115.83 84.26 60.41 
156.3 91.58 76.72 145.83 91.36 61.17 
186.3 90.58 71.42 175.83 88.85 65.04 
216.3 85.41 71.05 205.83 84.93 70.56 
246.3 94.06 74.17 235.83 77.86 72.66 
276.3 88.51 81.72 265.83 77.89 90.07 
306.3 91.30 88.15 295.83 91.79 91.39 
336.3 92.42 94.76 325.83 95.81 94.03 
Φ5/° 
% shape match 
with previous 
step 
% shape match with 
original conformation 
Φ6/° 
% shape match 
with previous 
step 
% shape match with 
original conformation 
0.09 / / 348.21 
 
/ / 
31.09 96.13 96.13 18.21 92.24 92.24 
61.09 94.90 91.49 48.21 92.39 85.74 
91.09 94.36 86.91 78.21 94.67 81.96 
121.09 94.09 82.95 108.21 97.81 81.01 
151.09 86.96 76.37 138.21 96.05 82.84 
181.09 93.73 75.67 168.21 94.17 85.94 
211.09 95.29 78.21 198.21 93.43 88.28 
241.09 91.33 83.22 228.21 93.73 89.06 
271.09 88.43 91.89 258.21 94.58 89.85 
301.09 95.82 94.58 288.21 95.07 91.18 
331.09 97.20 97.05 318.21 95.92 94.13 
Φ7/° 
% shape match 
with previous 
step 
% shape match with 
original conformation 
Φ8/° 
% shape match 
with previous 
step 
% shape match with 
original conformation 
286.42 / / 107.04 / / 
316.42 94.13 94.13 137.04 99.53 99.53 
346.42 95.92 91.18 167.04 99.39 98.95 
16.42 95.07 89.85 197.04 99.26 98.41 
46.42 94.58 89.06 227.04 98.65 97.32 
76.42 93.73 88.28 257.04 99.59 97.09 
106.42 93.43 85.94 287.04 99.62 97.42 
136.42 94.17 82.84 317.04 99.14 98.16 
166.42 96.05 81.01 347.04 99.02 98.85 
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196.42 97.81 81.96 17.04 99.24 99.37 
226.42 94.67 85.74 47.04 99.63 99.52 
256.42 92.39 92.24 77.04 99.56 99.85 
 
Appendix Table 5.5: Shape matches for varying each torsion angle of molecule XXIII with 
30° steps with both the previous step and the starting conformation. The angles are 
normalised to a 0-360° range. The first value for each torsion angle corresponds to the 
initial value.  
Φ1/° 
% shape match 
with previous 
step 
% shape match with 
original conformation 
Φ2/° 
% shape match 
with previous 
step 
% shape match with 
original conformation 
269.87 / / 188.84 / / 
299.87 98.29 98.29 218.84 92.11 92.11 
329.87 99.00 97.52 248.84 91.00 87.65 
359.87 98.03 97.24 278.84 90.13 80.41 
29.87 94.35 92.17 308.84 89.06 73.85 
59.87 98.59 93.13 338.84 90.73 68.96 
89.87 91.96 96.75 8.84 89.68 69.65 
119.87 97.26 94.30 38.84 86.73 72.40 
149.87 97.00 95.95 68.84 91.64 76.79 
179.87 95.29 95.52 98.84 89.29 84.32 
209.87 98.43 94.93 128.84 86.77 87.08 
239.87 96.75 97.57 158.84 88.76 96.55 
Φ3/° 
% shape match 
with previous 
step 
% shape match with 
original conformation 
Φ4/° 
% shape match 
with previous 
step 
% shape match with 
original conformation 
87.22 / / 132.45 / / 
117.22 97.54 97.54 162.45 97.83 97.83 
147.22 93.52 92.18 192.45 98.58 96.47 
177.22 98.58 92.72 222.45 93.77 92.15 
207.22 96.14 90.77 252.45 96.17 90.65 
237.22 97.74 92.21 282.45 95.55 92.97 
267.22 94.80 90.36 312.45 91.32 94.18 
297.22 93.37 96.45 342.45 98.04 95.97 
327.22 94.51 97.61 12.45 95.12 98.73 
357.22 92.81 92.50 42.45 91.06 91.07 
27.22 99.65 92.58 72.45 98.83 91.97 
57.22 98.67 93.28 102.45 93.00 97.35 
Φ5/° 
% shape match 
with previous 
step 
% shape match with 
original conformation 
Φ6/° 
% shape match 
with previous 
step 
% shape match with 
original conformation 
166.75 / / 4.47 / / 
196.75 97.29 97.29 34.47 98.40 98.40 
226.75 91.32 90.47 64.47 94.44 93.41 
256.75 97.13 88.35 94.47 99.77 93.23 
286.75 97.73 87.06 124.47 99.84 93.29 
316.75 97.72 86.89 154.47 93.84 97.17 
346.75 97.39 87.48 184.47 98.67 98.42 
16.75 97.57 88.88 214.47 98.66 97.19 
46.75 98.37 89.96 244.47 94.56 93.42 
76.75 98.33 90.68 274.47 99.88 93.41 
106.75 98.07 91.71 304.47 99.76 93.56 
136.75 97.81 92.99 334.47 93.68 98.59 
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Appendix Table 5.6: Shape matches for varying each torsion angle of mebendazole with 
30° steps with both the previous step and the starting conformation. The angles are 
normalised to a 0-360° range. The first value for each torsion angle corresponds to the 
initial value. 
Φ1/° 
% shape match 
with previous 
step 
% shape match with 
original conformation 
Φ2/° 
% shape match 
with previous 
step 
% shape match with 
original conformation 
166.19 / / 327.79 / / 
199.19 97.62 97.62 357.79 93.86 93.86 
229.19 97.59 95.35 27.79 88.55 85.12 
259.19 90.64 87.23 57.79 91.60 86.59 
289.19 88.47 95.96 87.79 91.08 90.66 
319.19 98.10 96.42 117.79 92.04 88.46 
349.19 97.77 96.20 147.79 95.51 85.08 
19.19 97.79 95.56 177.79 96.40 82.72 
49.19 98.32 94.59 207.79 97.04 81.73 
79.19 94.43 95.84 237.79 93.19 86.22 
109.19 99.32 96.47 267.79 94.90 90.05 
139.19 98.47 97.94 297.79 93.66 93.47 
Φ3/° 
% shape match 
with previous 
step 
% shape match with 
original conformation 
Φ4/° 
% shape match 
with previous 
step 
% shape match with 
original conformation 
176.61 / / 0.42 / / 
206.61 98.20 98.20 30.42 98.21 98.21 
236.61 97.81 96.08 60.42 96.89 95.61 
266.61 97.75 94.12 90.42 95.70 91.68 
296.61 97.00 91.71 120.42 94.81 88.35 
326.61 98.21 90.93 150.42 96.44 85.77 
356.61 97.14 91.57 180.42 95.59 86.03 
26.61 97.66 93.26 210.42 98.86 86.59 
56.61 97.49 94.45 240.42 96.88 86.81 
86.61 97.27 96.24 270.42 95.72 90.21 
116.61 99.28 96.63 300.42 95.32 94.31 
146.61 98.31 97.75 330.42 96.15 97.87 
Φ5/° 
% shape match 
with previous 
step 
% shape match with 
original conformation 
   
0.62 / /    
30.62 98.44 98.44    
60.62 97.42 95.95    
90.62 96.96 93.22    
120.62 96.30 90.10    
150.62 98.40 89.01    
180.62 99.06 89.22    
210.62 98.23 90.57    
240.62 97.40 92.74    
270.62 97.20 95.21    
300.62 97.57 97.18    
330.62 98.49 98.27    
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Appendix Figure 5.8: Mogul distributions used to select the ΔEintra grid dimensions for (a) 
Φ1a-1b and (b) Φ4 of molecule XXVI. 
 
Appendix Figure 5.9: Mogul distributions used to select the ΔEintra grid dimensions for (a) 
Φ1 (b) Φ4 and (c) Φ5 of GSK269984B 
(a) (b) 
(a) (b) 
(c) 
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Appendix Figure 5.10: Mogul distributions used to select the ΔEintra grid dimensions for 
(a) Φ1 (b) Φ2 (c) Φ5 (d) Φ6 and (e) Φ8 of molecule XX. 
 
Appendix Figure 5.11: Mogul distributions used to select the ΔEintra grid dimensions for 
(a) Φ1 (b) Φ3 (c) Φ4 of molecule XXIII. 
 
(a) (b) 
(c) (d) 
(e) 
(a) (b) 
(c) 
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Appendix Figure 5.12: Mogul distributions used to decide the flexible treatment and 
select the ΔEintra grid dimensions for (a) Φ1 (b) Φ2 of mebendazole. 
 
Appendix Figure 5.13: Fragment used to scan angle Φ7 in GSK269984B. 
 
Appendix Figure 5.14: Constrained angle scan of Φ7 in GSK269984B, with 30° steps, 
when the OH group is on the same side as the N atom in the fragment shown in Appendix 
Figure 5.13.  
 
 
 
(a) (b) 
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Appendix Figure 5.15: Constrained angle scan of Φ7 in GSK269984B, with 30° steps, 
when the OH group is on the opposite side of the N atom in the fragment shown in 
Appendix Figure 5.13. 
 
Appendix Figure 5.16: Fragment used to scan angle Φ7 in molecule XXIII. 
 
Appendix Figure 5.17: Constrained angle scan of Φ7 in molecule XXIII, with 30° steps, 
using the fragment shown in Appendix Figure 5.16.  
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Appendix Figure 5.18: (a) Surrogate molecule used to calculate the ΔEintra grids of Φ1a 
and Φ1b of molecule XXVI. (b) Whole molecule XXVI used to calculate the ΔEintra grid of 
sterically congested Φ4. 
 
Appendix Figure 5.19: Surrogate molecules used to calculate the ΔEintra grids of (a) Φ1 (b) 
Φ4 and Φ5 of GSK269984B. 
 
 
Appendix Figure 5.20: Surrogate molecules used to calculate the ΔEintra grids of (a) Φ1 
and Φ2 (b) Φ5 (c) Φ6 and (d) Φ8 of molecule XX. 
(a) (b) 
(a) (b) 
(a) (b) 
(c) (d) 
183 
 
 
Appendix Figure 5.21: Surrogate molecules used to calculate the ΔEintra grids of (a) Φ1 (b) 
Φ3 (c) Φ4 of molecule XXIII. 
 
Appendix Figure 5.22: Surrogate molecule used to calculate the ΔEintra grid of Φ1 and Φ2 
of both tautomers of mebendazole.  
 
Appendix Table 5.7: List of the 59 space groups considered in the searches. 
P1 P1̅ P21 P21/c P21212 P212121 Pna21 Pca21 Pbca Pbcn 
C2/c Cc C2 Pc Cm P21/m C2/m P2/c C2221 Pmn21 
Cmc21 Aba2 Fdd2 Iba2 Pnna Pccn Pbcm Pnnm Pmmn Pnma 
Cmcm Cmca Fddd Ibam P41 P43 I4̅ P4/n P42/n I4/m 
I41/a P41212 P43212 P4̅21c I4̅2d P31 P32 R3 P3̅ R3̅ 
P3121 P3221 R3c R3̅C P61 P63 P63/m P213 PA3̅  
 
Appendix Table 5.8: Atomic numbering definition of the key torsion angles of succinic 
acid shown in Figure 5.9. 
Label for XXVI Torsion Angle Definition 
Φ1 1a-1-2-4 
Φ2  3-2-4-5 
Φ3 2-4-5-6 
Φ4 4-5-6-8 
Φ5 5-6-7-7a 
 
 
Appendix Figure 5.23: Histograms (light purple bars) and Von Mises kernel density 
approximations (red lines) for torsion angle distributions of angles succinic acid.  
 
 
 
 
Φ2-Φ4 
 
Φ4 
Φ3 
 
Φ4 
(a) (b) (c) 
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Appendix Table 5.9: Shape matches for varying each torsion angle of succinic acid with 
30° steps with both the previous step and the starting conformation. The angles are 
normalised to a 0-360° range. The first value for each torsion angle corresponds to the 
initial value. 
Φ2/° 
% shape match with 
previous step 
% shape match with 
original conformation 
Φ3/° 
% shape match 
with previous 
step 
% shape match with 
original conformation 
10.76 / / 180 / / 
40.76 94.90 94.90 210 94.99 94.99 
70.76 96.84 92.05 240 92.15 87.87 
100.76 98.53 92.71 270 93.80 83.05 
130.76 94.09 91.83 300 94.43 79.41 
160.76 95.54 95.10 330 95.46 77.37 
190.76 99.13 94.52 0 97.72 76.31 
220.76 94.81 93.21 30 97.72 77.37 
250.76 93.66 93.15 60 95.46 79.41 
280.76 97.63 91.35 90 94.43 83.05 
310.76 97.00 94.00 120 93.80 87.88 
340.76 96.62 96.63 150 92.15 94.99 
Φ4/° 
% shape match with 
previous step 
% shape match with 
original conformation    
349.24 / /    
19.24 96.63 96.63    
49.24 96.62 94.01    
79.24 97.00 91.35    
109.24 97.63 93.15    
139.24 93.66 93.21    
169.24 94.81 94.52    
199.24 99.13 95.10    
229.24 95.54 91.83    
259.24 94.09 92.71    
289.24 98.53 92.05    
319.24 96.84 94.90    
 
 
Appendix Figure 5.24: Constrained angle scan of Φ1 in succinic acid, with 30° steps, 
using the whole molecule (Figure 5.9). This scan was considered to be valid for torsion 
angle Φ5 because of symmetry.  
 
 
 
185 
 
 
Appendix Table 5.10: Selected conformational regions and calculation of the associated 
ΔEintra value of molecule XXVI. The conformational regions highlighted in blue were taken 
to the search stage; some with 𝚫𝐄𝐈𝐧𝐭𝐫𝐚
𝐂𝐑  < 26 kJ·mol-1 were excluded because of an 
approximate molecular symmetry relationship; in those cases, the lower energy one was 
always chosen. 
CG conformation number Φ2a/° Φ3a/° Φ2b/° Φ3b/° ΔEintra 
1 -4 178 9 179 1.92 
25 0 212 -8 212 11.7 
26 -4 151 -8 151 11.63 
29 2 148 4 178 4.35 
30 ~ 41 for symmetry -2 212 -4 182 6.54 
31 ~ 29 for symmetry -2 178 2 148 4.47 
37 2 209 8 148 7.93 
38 ~ 37 for symmetry -2 151 -8 212 8.67 
41 2 178 2 209 5.54 
60 ~ 124 for symmetry 0 178 8 238 15.77 
61 0 182 -8 122 12.86 
89 -3 66 -9 181 20.98 
93 -4 209 8 118 16.42 
94 ~ 198 for symmetry 4 151 -8 242 21.14 
122 ~ 61 for symmetry 0 122 -4 182 12.93 
124 -1 238 0 178 15.76 
174 ~ 176 for symmetry 3 148 8 119 22.11 
175 2 238 4 209 20.27 
176 -2 122 -4 151 19.03 
186 ~ 1502 for symmetry 3 177 5 89 25.78 
187 -4 182 -4 272 26.34 
190 2 268 9 179 25.54 
198 2 238 2 148 19.63 
199 -2 122 -2 212 16.07 
218 -4 268 8 209 29.11 
219 -4 148 8 88 31.66 
224 ~ 175 for symmetry -2 212 -4 242 22.61 
232 0 65 0 212 23.61 
241 -4 177 8 297 30.71 
275 0 148 0 268 29.59 
277 2 209 8 88 18.32 
279 -2 212 -8 272 30.9 
294 0 298 3 177 31.31 
322 0 242 0 242 32.23 
323 -4 122 -4 122 32.72 
338 2 268 8 148 29.33 
353 ~ 89 for symmetry -4 179 8 59 22.16 
364 ~ 396 for symmetry -4 122 -8 242 25.54 
375 ~ 805 for symmetry -3 66 -8 242 21.01 
396 -2 242 -8 122 25.53 
407 0 148 8 297 33.26 
417 -1 88 2 148 22.96 
465 2 298 1 209 33.73 
466 -2 212 -8 301 34.75 
471 4 122 -8 272 36.93 
472 -4 238 8 88 21.61 
510 2 298 4 148 33.49 
516 4 93 0 123 34.34 
517 -4 272 -8 242 40.83 
556 0 238 4 268 38.7 
562 -2 272 -8 122 37.02 
601 -4 58 2 148 38.17 
609 4 123 -3 93 34.26 
186 
 
617 1 65 -8 272 31.18 
646 0 152 -2 62 36.58 
648 -4 239 8 297 43.3 
696 -4 268 8 268 47.07 
698 ~ 472 for symmetry -2 92 -4 242 22.23 
723 ~ 232 for symmetry 2 209 0 59 25.09 
730 ~ 277 for symmetry 4 91 -2 212 23.57 
741 1 298 4 239 43.27 
742 0 122 0 301 41.14 
754 -4 298 8 297 51.74 
796 4 298 8 118 42.16 
803 -4 117 8 59 37.67 
805 4 241 -8 63 20.96 
852 8 268 4 88 30.19 
886 0 58 4 117 37.75 
905 -10 61 -10 62 84.61 
1160 2 298 4 268 51.42 
1194 -2 272 -2 301 51.96 
1214 4 91 -8 91 38.87 
1502 -2 92 -9 181 23.87 
1534 -4 178 178 143 23.2 
1535 4 182 -178 217 30.07 
1767 -178 178 9 179 31.86 
1773 176 148 -5 182 27.63 
1826 -179 216 -4 182 30.17 
2000 -2 182 178 182 30.64 
2099 179 144 2 148 35.22 
2100 -179 216 -2 212 35.85 
2101 -175 213 2 148 33.17 
2102 174 147 -2 212 40.4 
2380 -179 177 2 209 36.19 
2381 179 183 -2 151 34.79 
2533 -179 216 -8 242 47.54 
2534 179 144 9 239 41.28 
2535 179 144 8 118 38.82 
2537 -174 213 8 118 40.85 
2776 -2 242 174 146 49.44 
2813 178 182 -8 242 46.44 
2814 179 183 -8 122 45.51 
2875 -4 212 175 236 43.66 
2876 0 151 175 236 38.68 
2954 -2 122 -180 213 40.05 
2972 4 212 174 147 40.27 
3058 2 238 -178 178 46.43 
3060 2 118 -178 178 48.81 
3188 2 209 -176 209 33.09 
3189 -2 151 174 146 33.95 
3192 1 123 179 147 45.88 
3213 -179 216 0 92 41.97 
3214 -179 216 0 272 54.2 
3308 -180 146 5 267 49.48 
3403 -180 146 5 91 43.72 
3421 2 238 179 233 53.41 
3445 -178 268 9 178 56.52 
3489 -174 213 8 297 53.99 
3518 -2 68 174 234 44.9 
3596 2 177 -178 268 56.33 
3682 -178 88 9 180 43.28 
3716 -179 149 11 63 44.79 
3717 -180 213 -8 63 43.97 
3833 2 180 -177 89 43.14 
3840 2 207 -178 270 64.2 
3841 177 257 2 205 53.53 
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3842 178 272 -2 151 60.4 
3912 -179 100 -8 211 39.19 
4007 0 150 -177 121 34.63 
4097 -175 92 2 148 41.38 
4098 -178 270 8 121 67.03 
4099 -178 271 8 239 78.72 
4109 5 300 -178 236 59.1 
4138 -4 122 -178 238 45.2 
4228 -2 122 178 272 50.67 
4229 -2 242 178 273 68.4 
4310 178 91 -8 241 53.02 
4395 2 238 -178 88 51.68 
4396 5 95 -172 124 46.35 
4774 2 148 -176 210 32.72 
4819 179 144 178 143 40.77 
4820 -179 216 -178 217 56.76 
4821 -174 213 178 143 46 
4822 174 147 -178 217 48.01 
4872 6 237 -178 119 43.25 
4899 2 209 -178 117 38.59 
4928 -178 238 2 122 45.03 
4941 -178 215 178 242 66.95 
 
Appendix Table 5.11: Selected conformational regions and calculation of the associated 
ΔEintra value of GSK269984B. The values of the polar hydrogen torsion angle highlighted 
in yellow were added manually, and those conformations that differ from the CG-
generated ones only in the values of this dihedral are indicated using a ‘_N’ notation. The 
conformational regions highlighted in blue were taken to the search stage; some with        
𝚫𝐄𝐈𝐧𝐭𝐫𝐚
𝐂𝐑  < 26 kJ·mol-1 were excluded because of an approximate molecular symmetry 
relationship; in those cases, the lower energy one was always chosen. 
CG conformation number Φ2/° Φ3/° Φ6/° Φ7/° ΔEintra 
1 180 180 180 0 0.07 
1_2 180 180 180 180 12.89 
11 0 180 180 180 14.02 
184 180 181 272 0 5.84 
184_2 180 181 272 180 21.64 
185 ~ 184 for symmetry 180 178 88 0 10.17 
185_2 ~ 184_2 for symmetry 180 178 88 180 25.75 
306 0 181 272 180 19.42 
307 ~ 306 for symmetry 0 178 88 180 19.56 
475 180 120 180 0 16.2 
475_2 180 120 180 180 22.57 
477 180 240 180 0 13.97 
477_2 180 240 180 180 22.39 
666 360 120 180 180 26.74 
668 0 240 182 180 26.92 
1694 180 75 181 0 23.31 
1694_2 180 75 181 180 37.41 
2018 180 285 179 0 20.48 
2018_2 180 285 179 180 34.7 
2302 360 75 181 180 43.91 
2655 0 285 179 180 39.89 
2730 ~ 2731 for symmetry 180 240 270 0 20.3 
2730_2 180 240 270 180 35.67 
2731 180 239 91 0 16.89 
2731_2 180 239 91 180 28.31 
2732 180 120 90 0 18.44 
2732_2 180 120 90 180 33.64 
3487 0 240 270 180 41.6 
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3488 0 121 269 180 42.66 
3489 0 120 90 180 39.97 
3491 360 238 91 180 31.57 
5036 180 124 300 0 16.92 
5036_2 180 124 300 180 32.57 
5162 180 287 267 0 25.91 
5162_2 180 287 267 180 37.21 
5974 180 71 91 0 24.6 
5974_2 180 71 91 180 39.48 
6136 0 287 267 180 41.77 
6810 180 120 240 0 24.51 
6810_2 180 71 91 180 38.58 
6875 0 71 91 180 45.49 
9131 180 91 33 0 27.33 
9131_2 180 91 33 180 34.39 
9132 180 271 327 0 29.88 
9132_2 180 271 327 180 42.18 
9267 180 242 32 0 26.04 
9267_2 180 242 32 180 38.83 
9327 0 91 33 180 34.81 
9329 360 271 327 180 46.87 
9395 360 242 32 180 41.9 
9458 0 123 327 180 60.49 
 
Appendix Table 5.12: Selected conformational regions and calculation of the associated 
ΔEintra value of molecule XX. The conformational regions highlighted in blue were taken 
to the search stage; some with 𝚫𝐄𝐈𝐧𝐭𝐫𝐚
𝐂𝐑  < 26 kJ·mol-1 were excluded because of an 
approximate molecular symmetry relationship; in those cases, the lower energy one was 
always chosen. 
CG conformation number Φ3/° Φ4/° Φ7/° ΔEintra 
1 180 180 270 1.45 
25 180 180 240 5.25 
78 180 180 300 3.34 
92 180 180 180 12.33 
245 180 357 270 11.68 
273 180 180 210 8.48 
413 180 180 330 15.50 
515 180 3 240 15.50 
745 180 357 300 13.79 
826 ~ 273 for symmetry 179 180 150 8.46 
1290 180 357 180 22.48 
2911 180 357 330 25.84 
3276 ~ 3739 for symmetry 180 357 150 18.56 
3739 180 357 210 18.55 
4480 ~ 245 for symmetry 180 357 90 11.69 
4974 ~ 2911 for symmetry 180 357 30 25.87 
7122 358 140 270 34.18 
9765 358 140 240 38.30 
10397 180 330 119 15.37 
14548 233 177 120 26.23 
16943 126 180 120 32.05 
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Appendix Table 5.13: Selected conformational regions and calculation of the associated 
ΔEintra value of molecule XXIII. The values of the polar hydrogen torsion angle highlighted 
in yellow were added manually. The conformational regions highlighted in blue were 
taken to the search stage; some with 𝚫𝐄𝐈𝐧𝐭𝐫𝐚
𝐂𝐑  < 26 kJ·mol-1 were excluded because of an 
approximate molecular symmetry relationship; in those cases the lower energy one was 
always chosen. 
CG conformation number Φ2/° Φ5/° Φ6/° Φ7/° ΔEintra 
1 180 164 360 180 0.57 
9 360 164 0 180 25.13 
17 180 164 180 180 16.66 
33 0 164 180 180 41.2 
49 60 164 0 180 1.15 
51 ~ 49 for symmetry 300 164 0 180 2.17 
65 0 229 360 180 32.68 
103 180 214 0 180 3.34 
145 ~ 147 for symmetry 60 164 180 180 17.56 
147 300 164 180 180 17.02 
172 0 229 180 180 45.8 
231 180 161 240 180 35.84 
232 180 161 120 180 43.69 
235 180 214 180 180 18.11 
256 180 117 360 180 16.07 
290 60 229 360 180 9.3 
309 180 270 0 180 32.67 
328 0 199 120 180 59.34 
329 0 199 240 180 67.29 
402 0 199 60 180 63.72 
403 0 199 300 180 54.51 
434 360 90 360 180 53.8 
464 180 64 2 180 47.28 
500 300 214 0 180 4.94 
512 180 117 180 180 27.25 
563 60 229 180 180 22.58 
613 180 269 180 180 38.59 
645 180 199 60 180 37.47 
646 180 199 300 180 44.14 
658 0 296 358 180 71.63 
712 0 117 180 180 51.65 
831 0 143 240 180 62.23 
893 60 199 120 180 36.3 
894 60 199 240 180 43.95 
897 300 199 120 180 48.44 
919 300 214 180 180 19.44 
949 60 117 360 180 16.42 
950 ~ 949 for symmetry 300 117 360 180 17.91 
1055 300 199 60 180 38.75 
1056 300 199 300 180 32.54 
1177 300 270 360 180 34.13 
1580 300 64 2 180 47.64 
1581 60 64 2 180 42.06 
1640 0 138 90 180 76.89 
1677 60 117 180 180 27.94 
1678 300 117 180 180 27.17 
1720 300 164 240 180 36.33 
1957 300 270 180 180 39.94 
2016 60 199 60 180 40.49 
2017 60 199 300 180 31.37 
2279 300 229 240 180 49.39 
2334 180 61 213 180 45.36 
2511 0 61 213 180 62.18 
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2512 0 299 147 180 69.56 
2527 180 207 240 180 44.01 
2530 180 229 120 180 39.45 
2661 60 296 358 180 48.52 
2915 180 131 300 180 46.17 
2916 180 131 60 180 35.38 
2926 300 146 90 180 52.46 
2932 60 143 90 180 53.14 
2933 60 143 270 180 55.14 
3001 0 270 240 180 83.92 
3020 0 117 300 180 76.46 
3098 180 300 300 180 54.68 
3099 180 61 60 180 54.68 
3169 180 300 120 180 52.81 
3170 180 63 118 180 66.95 
3468 0 90 60 180 64.76 
3469 0 270 300 180 72.65 
3489 0 90 120 180 77.15 
3882 0 270 60 180 85.38 
3948 ~ 3950 for symmetry 120 164 0 180 15.94 
3950 240 164 360 180 15.9 
4283 359 36 60 180 70.45 
4484 180 267 241 180 58.81 
4810 360 63 269 180 82.6 
4889 60 61 213 180 44.03 
4891 60 299 147 180 46.9 
4991 300 120 300 180 51.82 
5452 300 61 213 180 39.86 
5580 180 61 299 180 64.73 
5590 180 299 61 180 65.36 
5609 60 90 120 180 61.79 
5741 120 164 180 180 32.03 
5743 240 164 180 180 31.73 
6049 300 90 60 180 44.92 
6050 60 90 300 180 57.91 
6155 300 90 120 180 53.02 
6560 60 60 60 180 46.32 
6563 60 299 300 180 55.85 
6586 300 270 60 180 62.25 
6587 300 270 300 180 49.82 
6657 300 292 121 180 53.91 
7010 330 325 300 180 67.45 
7199 120 229 360 180 24.24 
7242 300 35 60 180 55.32 
7811 60 270 240 180 60.15 
8717 240 214 0 180 18.84 
8819 60 270 60 180 61.7 
9063 120 229 180 180 37.37 
9528 299 61 299 180 60.17 
10475 240 161 120 180 58.81 
10476 240 199 240 180 58.74 
10557 240 214 180 180 33.5 
10643 240 117 360 180 31.44 
10644 120 117 0 180 31.05 
10888 120 199 60 180 55.41 
10889 240 161 60 180 46.51 
10890 240 161 300 180 55.45 
11600 240 270 0 180 48.03 
11777 120 164 270 180 68.83 
11924 120 64 2 180 62.08 
11926 120 296 358 180 62.73 
11928 240 64 2 180 62.18 
12019 120 117 180 180 42.43 
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12024 240 117 180 180 42.54 
12045 120 164 120 180 58.88 
12267 240 270 180 180 53.82 
12351 293 297 242 180 66.85 
12628 240 229 120 180 54.52 
13511 120 210 120 180 51.8 
13512 120 210 240 180 59.61 
13514 240 150 240 180 51.53 
13625 120 150 60 180 47.08 
13628 240 229 300 180 50.56 
14103 240 214 60 180 57.34 
 
Appendix Table 5.14: Selected conformational regions and calculation of the associated 
ΔEintra value of the A-tautomer of mebendazole. The conformational regions highlighted 
in blue were taken to the search stage.  
CG conformation number Φ3/° Φ4/° Φ5/° ΔEintra 
1 180 360 0 0.00 
5 0 0.01 360 50.49 
35 184 186 360 16.25 
46 2 183 0 48.17 
 
Appendix Table 5.15: Selected conformational regions and calculation of the associated 
ΔEintra value of the C-tautomer of mebendazole. The conformational regions highlighted 
in blue were taken to the search stage. 
CG conformation number Φ3/° Φ4/° Φ5/° ΔEintra 
1 180 0 0 3.27 
5 0 0 0 56.54 
33 184 186 0 21.08 
41 2 183 360 52.89 
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Appendix Table 5.16: Comparison of the crystal structure search with the new workflow 
and the previous CSP results for molecule XXVI (Figure 5.11a). The structure highlighted 
in yellow is a match to the experimental form, the one in red was not found with the new 
method. When RMSD15 values are highlighted in blue, this indicates that the structure 
had been probably found in the search (i.e. RMSD15 > 0.8 Å). 
Structure 
name 
Found? 
Conformation 
number 
Previous CSP 
ranking 
Previous CSP 
lattice 
energy/kJ mol-1 
New method 
ranking after 
search 
RMSD15 
3525 YES 29 1 -206.86 1 0.506 
1600 YES 124 2 -206.37 251 0.695 
675 YES 124 3 -204.25 61 0.257 
38 YES 1 4 -202.71 122 0.597 
421 YES 124 5 -201.43 61 0.295 
3104 YES 805 6 -201.20 164 0.297 
615 YES 41 7 -200.58 72 0.426 
239 PROBABLY 1 8 -200.48 233 0.805 
2930 YES 29 9 -200.30 51 0.37 
354 YES 29 10 -199.98 71 0.377 
851 YES 29 11 -199.82 1071 0.442 
6460 YES 29 12 -199.74 7 0.666 
6335 YES 29 13 -199.41 10 0.579 
221 YES 29 14 -199.39 7 0.648 
2231 PROBABLY 29 15 -199.29 56 0.809 
2496 NO / 16 -198.93 / / 
185 YES 805 17 -198.75 159 0.325 
4201 PROBABLY 41 18 -198.65 670 1.223 
314 YES 29 19 -198.63 13 0.406 
508 YES 1 20 -198.57 31 0.505 
4946 YES 29 21 -198.48 56 0.342 
6879 YES 29 22 -198.35 632 0.43 
506 YES 29 23 -198.23 20 0.42 
4842 YES 29 24 -198.02 39 0.478 
43 YES 41 25 -197.84 26 0.467 
1236 YES 41 26 -197.71 33 0.387 
1537 YES 1 27 -197.69 21 0.43 
188 YES 61 28 -197.45 116 0.661 
5126 YES 1 29 -196.81 855 0.504 
444 YES 25 30 -196.74 42 0.683 
544 YES 29 31 -196.57 1071 0.408 
686 YES 29 32 -196.52 287 0.406 
89 PROBABLY 41 33 -196.42 614 0.841 
20 YES 29 34 -196.16 138 0.597 
83 YES 29 35 -196.04 3 0.546 
2591 YES 805 132 -189.83 1699 0.304 
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Appendix Table 5.17: Comparison of the crystal structure search with this new workflow 
and the previous CSP results for GSK269984B (Figure 5.11b in the main paper). The 
structure highlighted in yellow is a match to the experimental form, the ones in red were 
not found with the new method. When RMSD15 values are highlighted in blue, this 
indicates that the structure had been probably found in the search (i.e. RMSD15 > 0.8 Å). 
Structure 
name 
Found? 
Conformation 
number 
Previous 
CSP ranking 
Previous CSP 
lattice 
energy/kJ mol-1 
New method 
ranking after 
search 
RMSD15 
180Intra1
0 
YES 1 1 -180.68 46 0.129 
90InterB3
6 
YES 306 2 -180.15 5072 0.626 
180Inter
A11 
YES 1_2 3 -178.62 776 0.374 
180Inter
A8 
YES 1_2 4 -177.92 225 0.543 
180InterB
6 
YES 11 5 -177.42 354 0.32 
180Intra8 YES 1 6 -177.13 31 0.142 
180Intra3
8 
PROBABLY 1 7 -177.06 68 1.175 
180InterB
9 
YES 11 8 -176.88 942 0.282 
180Intra7
6 
YES 1 9 -176.44 1022 0.486 
180Inter
A22 
YES 1_2 10 -176.32 352 0.722 
90InterB6 NO / 11 -176.07 / / 
180Intra1
9 
YES 1 12 -176.02 87 0.211 
180Intra7
4 
YES 1 13 -175.68 2217 0.341 
180Intra4 YES 1 14 -175.64 38 0.355 
180Inter
A60 
YES 1_2 15 -175.60 1104 0.182 
180Intra2 YES 1 16 -175.52 1 0.344 
180Inter
A3 
NO / 17 -175.36 / / 
180Inter
A30 
YES 1_2 18 -175.29 1320 0.15 
180Intra8
3 
NO / 19 -175.28 / / 
180Intra5
6 
PROBABLY 1 20 -175.24 53 0.977 
180Inter
A7 
YES 1_2 21 -174.87 180 0.298 
90Intra31 YES 184 22 -174.80 7969 0.349 
180Intra3
2 
YES 1 23 -174.53 117 0.177 
180Inter
A18 
PROBABLY 1_2 24 -174.49 325 2.052 
180Intra9
2 
YES 1 25 -174.33 53 0.631 
180Inter
A12 
YES 1_2 26 -174.21 325 0.505 
180Inter
A29 
YES 1_2 27 -174.17 1499 0.172 
180InterB
10 
YES 11 28 -174.15 489 0.507 
90InterA
14 
NO / 29 -174.06 / / 
180Intra8
4 
PROBABLY 1 30 -174.01 926 1.437 
180Intra4
7 
YES 1 31 -173.96 125 0.294 
180Intra6
5 
YES 1 32 -173.87 50 0.118 
90InterA
32 
YES 184_2 33 -173.79 14162 0.362 
180Intra5 PROBABLY 1 34 -173.74 49 0.905 
180Intra2
8 
YES 1 35 -173.60 68 0.241 
180Inter
A26 
PROBABLY 1_2 36 -173.52 325 1.884 
180InterB
87 
YES 11 37 -173.50 1749 0.192 
180Intra5
7 
YES 1 38 -173.25 114 0.156 
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Appendix Table 5.18: Comparison of the crystal structure search with this new workflow 
and the previous CSP results for molecule XX (Figure 5.11c in the main paper). The 
structure highlighted in yellow is a match to the experimental form. When RMSD15 values 
are highlighted in blue, this indicates that the structure had been probably found in the 
search (i.e. RMSD15 > 0.8 Å). 
Structure 
name 
Found? 
Conformation 
number 
Previous CSP 
ranking 
Previous CSP 
lattice 
energy/kJ mol-1 
New method 
ranking after 
search 
RMSD15 
dfAa132 YES 1 1 -218.73 10 0.386 
dfAc102 YES 1 2 -217.95 161 0.264 
dfAa180 YES 1 3 -216.35 61 0.618 
dfAc14 YES 1 5 -213.14 70 0.308 
dfAc48 YES 1 10 -212.58 278 0.46 
dfAc19 YES 1 11 -212.30 
 
223 0.688 
dfAc7 YES 78 12 -211.47 14 0.365 
dfAc43 YES 78 14 -211.04 1740 0.778 
dfAc17 YES 1 15 -210.87 40 0.449 
dfAc172 YES 1 16 -210.76 58 0.572 
dfAc29 PROBABLY 1 17 -210.54 2154 1 
dfAb181 YES 78 22 -209.62 2428 0.79 
dfAd152 PROBABLY 78 23 -209.60 1596 1.012 
dfAc86 YES 1 24 -209.37 13 0.532 
dfAc67 YES 1 25 -209.25 94 0.167 
dfAa277 YES 1 27 -209.03 134 0.546 
dfAa4 YES 1 28 -208.97 2 0.376 
dfAa1 YES 1 29 -208.95 7 0.376 
dfAb161 YES 1 31 -208.86 49 0.26 
dfAb1 YES 1 32 -208.83 1 0.123 
dfAd79 YES 1 33 -208.80 602 0.444 
dfBa28 YES 245 47 -207.29 302 0.65 
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Appendix Table 5.19: Comparison of the crystal structure search with this new workflow 
and the previous CSP results for molecule XXIII (Figure 5.11d in the main paper). T 
 
he structures highlighted in yellow are matches to the experimental Z’=1 forms, the ones 
in red were not found with the new method. When RMSD15 values are highlighted in blue, 
this indicates that the structure had been probably found in the search                                     
(i.e. RMSD15 > 0.8 Å). 
Structure 
name 
Found? 
Conformation 
number 
Previous 
CSP ranking 
Previous CSP 
lattice 
energy/kJ mol-1 
New method 
ranking after 
search 
RMSD15 
A1361 YES 1 1 -212.68 11 0.222 
A70 YES 1 2 -211.02 10 0.309 
A6494 PROBABLY 1 3 -210.55 5375 1.394 
A691 YES 1 4 -209.30 46 0.767 
A3457 YES 1 5 -209.00 47 0.433 
A72 YES 1 6 -208.87 163 0.384 
A424 YES 1 7 -208.27 3 0.483 
A771 YES 1 8 -208.04 1 0.237 
A191 YES 103 9 -207.61 514 0.719 
A4890 YES 1 10 -207.22 24 0.746 
A5191 NO / 11 -207.16 / / 
A272 YES 1 12 -207.00 778 0.749 
A63 PROBABLY 1 13 -206.63 678 0.894 
A118 YES 1 14 -206.55 70 0.449 
A75 YES 1 15 -206.39 358 0.485 
A1413 YES 1 16 -206.35 13 0.375 
A2457 YES 1 17 -206.02 951 0.671 
A587 YES 1 18 -205.83 2821 0.422 
A2417 YES 1 19 -205.71 399 0.407 
A138 PROBABLY 1 20 -205.51 782 1.11 
A227 YES 1 21 -205.34 277 0.514 
A1949 PROBABLY 1 22 -205.07 497 1.114 
A3174 NO / 23 -204.92 / / 
A2054 NO / 24 -204.87 / / 
A3023 YES 103 25 -204.83 106 0.481 
A2311 YES 1 26 -204.82 5 0.343 
A3513 YES 1 27 -204.71 475 0.686 
A1109 YES 1 28 -204.69 2 0.447 
A894 PROBABLY 1 29 -204.61 1279 1.259 
A1422 YES 1 30 -204.53 377 0.488 
A1127 YES 1 31 -204.53 7 0.276 
A6634 PROBABLY 1 32 -204.34 3394 1.474 
A282 YES 1 33 -203.87 3838 0.322 
A323 PROBABLY 1 34 -203.83 199 0.807 
A2715 YES 1 35 -203.76 2489 0.537 
A24995 YES 1 36 -203.70 2983 0.42 
A3746 YES 1 37 -203.69 735 0.615 
A368 YES 1 38 -203.62 82 0.606 
A6738 NO / 39 -203.61 / / 
A4228 PROBABLY 1 40 -203.60 2304 1.073 
A1752 YES 1 41 -203.52 511 0.471 
A113 YES 1 42 -203.51 125 0.275 
A3750 YES 1 43 -203.49 584 0.256 
A505 YES 1 44 -203.41 1262 0.37 
A12658 YES 1 45 -203.12 626 0.31 
A1918 YES 1 46 -203.04 802 0.757 
A1411 PROBABLY 1 47 -202.96 350 0.855 
A5145 PROBABLY 1 48 -202.76 262 0.872 
A710 YES 1 49 -202.70 155 0.338 
B204 PROBABLY 49 66 -201.75 465 1.543 
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B60 YES 49 83 -201.03 2472 0.427 
B184 PROBABLY 49 100 -200.32 846 1.284 
Exptal A YES 103 (167) -199.08 4218 0.377 
  
Appendix Table 5.20: Comparison of the crystal structure search with this new workflow 
and the previous CSP results for mebendazole (Figure 5.11e in the main paper). The 
structures highlighted in yellow are matches to the solved forms. When RMSD15 values 
are highlighted in blue, this indicates that the structure had been probably found in the 
search (i.e. RMSD15 > 0.8 Å). 
Structure 
name 
Found? 
Conformation 
number 
Previous 
CSP ranking 
Previous CSP 
lattice 
energy/kJ mol-1 
New method 
ranking after 
search 
RMSD15 
A788 YES A1 1 -182.51 1 0.302 
A19 YES A1 2 -180.35 3 0.160 
C27 YES C1 3 -179.96 111 0.260 
C5 YES C1 4 -179.96 22 0.247 
C10 YES C1 5 -179.88 30 0.265 
A50 PROBABLY A1 6 -179.36 8 1.031 
A37 YES A1 7 -178.43 5 0.357 
C23 YES C1 8 -178.17 66 0.124 
C73 YES C1 9 -178.17 223 0.101 
C406 YES C1 10 -177.83 1313 0.159 
A53 YES A1 11 -177.70 12 0.590 
C53 YES C1 12 -177.03 123 0.242 
C25 YES C1 13 -177.01 60 0.241 
A173 YES A1 14 -176.84 119 0.418 
A72 YES A1 15 -176.76 6 0.312 
A49 PROBABLY A1 16 -176.72 4 1.066 
A78 YES A1 17 -176.58 46 0.310 
A90 YES A1 18 -176.54 23 0.326 
A291 YES A1 19 -176.37 284 0.289 
C248 YES C1 20 -176.33 129 0.210 
A306 YES A1 21 -176.24 87 0.311 
C46 YES C1 22 -176.21 201 0.243 
C24 YES C1 23 -176.15 111 0.266 
C115 YES C1 24 -176.04 105 0.440 
C509 PROBABLY C1 25 -175.90 128 1.857 
C583 YES C1 26 -175.89 360 0.353 
A202 YES A1 27 -175.79 51 0.603 
C106 YES C1 28 -175.78 56 0.235 
A143 YES A1 29 -175.31 178 0.429 
A89 YES A1 30 -175.18 29 0.247 
C908 YES C1 31 -175.08 206 0.513 
CCis32 PROBABLY C33 67 -164.51 1486 0.855 
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Appendix Table 5.21: Selected conformational regions and calculation of the associated 
intramolecular energy penalty of succinic acid. The values of the polar hydrogen torsion 
angles highlighted in yellow were added manually, and those conformations that differ 
from the CG-generated ones only in the values of these dihedrals are indicated using a 
‘_N’ notation. The conformational regions highlighted in blue were taken to the search 
stage. 
CG conformation number Φ1/° Φ2/° Φ3/° Φ4/° Φ5/° ΔEintra/kJ·mol-1 
1 180 0 180 0 180 1.92 
1_2 180 0 180 0 0 25.42 
1_3 0 0 180 0 0 48.45 
2 180 0 62 0 180 5.93 
2_2 180 0 62 0 0 32.49 
2_3 0 0 62 0 0 59.86 
4 180 0 180 180 180 9.12 
4_2 180 0 180 180 0 33.92 
4_3 0 0 180 180 0 69.42 
5 180 0 180 270 180 10.16 
5_2 180 0 180 270 0 35.20 
5_3 0 0 180 270 0 62.64 
7 180 178 295 359 180 9.13 
7_2 180 178 295 359 0 42.33 
7_3 0 178 295 359 0 69.74 
8 180 178 295 178 180 9.11 
8_2 180 359 295 178 0 34.65 
8_3 0 359 295 178 0 69.71 
9 180 269 63 1 180 24.27 
9_2 180 269 63 1 0 54.45 
9_3 0 269 63 1 0 84.13 
11 180 87 64 2 180 21.57 
11_2 180 87 64 2 0 21.48 
11_3 0 87 64 2 0 46.21 
13 180 180 180 180 180 15.97 
13_2 180 180 180 180 0 46.78 
13_3 0 180 180 180 0 76.27 
14 180 180 180 90 180 16.84 
14_2 180 180 180 90 0 46.45 
14_3 0 180 180 90 0 76.23 
16 180 270 180 270 180 18.74 
16_2 180 270 180 270 0 45.49 
16_3 0 270 180 270 0 78.39 
17 180 270 180 90 180 18.37 
17_2 180 270 180 90 0 44.19 
17_3 0 270 180 90 0 69.75 
23 180 178 296 150 180 13.24 
23_2 180 178 296 150 0 42.45 
23_3 0 178 296 150 0 72.68 
25 180 90 300 150 180 20.31 
25_2 180 90 300 150 0 48.85 
25_3 0 90 300 150 0 73.80 
27 180 89 62 211 180 21.63 
27_2 180 89 62 211 0 32.05 
27_3 0 89 62 211 0 80.92 
29 180 90 60 90 180 19.46 
29_2 180 90 60 90 0 44.81 
29_3 0 90 60 90 0 64.30 
30 180 90 300 90 180 20.08 
30_2 180 90 300 90 0 50.28 
30_3 0 90 300 90 0 82.27 
33 180 89 61 299 180 21.79 
33_2 180 89 61 299 0 47.42 
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33_3 0 89 61 299 0 75.11 
34 180 299 61 89 180 21.79 
34_2 180 299 61 89 0 50.13 
34_3 0 299 61 89 0 75.11 
37 180 30 90 120 180 13.25 
37_2 180 30 90 120 0 39.52 
37_3 0 30 90 120 0 59.04 
39 180 330 150 60 180 16.56 
39_2 180 330 150 60 0 41.39 
39_3 0 330 150 60 0 64.03 
41 180 240 150 330 180 15.88 
41_2 180 240 150 330 0 43.45 
41_3 0 240 150 330 0 72.22 
43 180 30 120 180 180 20.02 
43_2 180 30 120 180 0 44.70 
43_3 0 30 120 180 0 86.30 
45 180 30 120 270 180 24.10 
45_2 180 30 120 270 0 50.61 
45_3 0 30 120 270 0 78.78 
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Chapter 6: Molecular flexibility in crystal 
structures  
 
 6.1 Introduction 
 
The previous chapter was focused on the treatment of molecular flexibility in crystal 
structure searches. In this chapter the importance of treating flexibility in the final 
refinement stage of CSP studies (see Chapter 2.4.2 for background), a related but 
different problem, is assessed.  
 Upon crystallisation, the conformation of a flexible molecule always undergoes 
some adjustment from its closest isolated-molecule local minimum in conformational 
energy to improve the intermolecular interactions, Uinter (see Chapter 2.3.1.1 for a 
detailed discussion).1, 2 These improvements compensate for the increase in 
intramolecular energy (ΔEintra) associated with conformational adjustment.1 Hence, the 
accurate modelling of molecular flexibility is fundamental to guarantee a full coverage of 
the potential energy surface in CSP.3 However, while crystal structure searches aim only 
to locate all possible local minima in lattice energy (Elatt), the final refinement has the 
purpose of finding the most accurate geometry and energy for each local minimum.4-7 
Thus in a search only some very flexible torsion angles need to be treated as 
independent conformational degrees of freedom (CDFs).3, 6-10 Nonetheless, this 
approximation is too gross for the final refinement stage, where accuracy is of utmost 
importance: even minor changes in CDFs of limited flexibility, with a minor influence on 
molecular shape, can affect the balance between intra- and intermolecular interactions, 
in particular if they define the position of donors and acceptors in hydrogen bonded 
crystal structures.3, 6, 8  
 If the final refinement is performed with modelling approaches based on 
optimising the whole crystal structure (the Ψcrys method, see Chapter 2.3.2), then all the 
degrees of freedom are minimised, without any selection required.3, 11 On the other hand, 
Ψmol approaches (see Chapter 2.3.1) that calculate the wave-function of each molecular 
conformation require a selection of the CDFs to be treated as independent.3, 6, 8, 11 The 
remaining CDFs are considered not affected by intermolecular interactions.6,12 
CrystalOptimizer13 is an example of Elatt minimisation algorithm utilising the Ψmol 
approach; its functioning in described in Chapter 2.4.2.2. Its computational efficiency is 
due to the use of local approximate models (LAMs, see Chapter 2.4.1.2 for details), and 
this allows the optimisation of several independent CDFs, in contrast with earlier 
applications of the Ψmol approach where only a few flexible torsion angles around acyclic 
bonds, similar to those considered in the search,6, 8 could be explicitly optimised.6, 13 
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 Ideally, all CDFs should be considered as independent (i.e. a fully atomistic 
optimisation),6, 13 similarly to the Ψcrys approach. However, the computational cost 
increases with the number of CDFs treated as independent,6, 13 and fully atomistic 
optimisations are often unfeasibly expensive, in particular for large and flexible 
molecules. Hence the independent CDFs are generally limited to acyclic torsion angles 
(including methyl rotations that are ignored in the searches, see Chapter 4.2.2) and some 
bond-angles that are deemed to be affected by the solid-state environment; bond-lengths 
are usually treated as dependent CDFs (i.e. they take values that minimise the 
conformational energy of the isolated molecule for a set of values of the independent 
CDFs) 4, 6, 8, 13, 14 
 The importance of selecting a set of degrees of freedom that combines accuracy 
and cost efficiency is fundamental when the Ψmol method is used.6, 8, 13 However, there is 
no well-defined approach to perform this selection, and the user has to choose the 
independent CDFs for the final refinement stage of CSP. This choice is generally based 
on experience and/or chemical intuition, or on analysing the isolated-molecule behaviour 
of the CDFs, although in some cases fully-atomistic calculations on a set of crystal 
structures are performed to verify which torsion and bond-angles vary the most (this 
method was utilised in Chapter 4.2.3.1).4, 8, 15-18 The lack of clear rules for selecting the 
independent CDFs for the final refinement stage of CSP can be problematic. The set of 
independent CDFs could be sub-optimal and lead to inaccurate energies and 
geometries, possibly missing experimental forms, or to unnecessarily high computational 
costs.  
 In this chapter, three criteria for selecting the CDFs that can be the most affected 
by the crystalline environment, and that should be treated as independent in the final 
refinement stage of a CSP study, were tested on sets of 20 computer-generated crystal 
structures (some matching known experimental forms) of five flexible molecules. The 
results from using these three criteria were compared in terms of absolute and relative 
energies, reproduction of the experimental forms and computational cost with those 
obtained optimising the same crystal structures with the more accurate but expensive 
treatment of all torsion and bond-angles as independent CDFs. The first criterion was 
purely based on chemical intuition and consisted in the independent treatment in the 
optimisations of only the acyclic torsion angles. The second criterion was based on a set 
of rules derived from combining chemical intuition with experience from modelling crystal 
structures of small molecules; these rules are embedded in the AUTODOF19 programme 
and lead to the selection of the several torsion angles and a few bond-angles as 
independent CDFs.14, 20 Finally, the third criterion integrated the independent CDFs from 
AUTODOF with some intuitively rigid cyclic torsion angles, as well as some bond-angles, 
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which were found to vary significantly in the optimisations where they were all treated as 
independent. 
 
 6.2 Methods 
 
6.2.1 Choice of molecules and sample crystal structures 
 
The five molecules shown in Figure 6.1 were used to perform the analyses in this 
chapter: molecules XXIII and XXVI (whose CSP study is outlined in Chapter 3) from the 
sixth Blind Test,4 the two tautomers of mebendazole21 (see Chapter 4 for details of the 
CSP study), and naproxen, whose CSP study was undertaken in a work aimed at 
contrasting its racemic and enantiopure forms.18 Naproxen was chosen because of the 
presence of a rare non-planar naphthalene group in the known enantiopure crystal 
structure, which exemplifies how the solid-state environment can sometimes distort 
CDFs that are intuitively rigid.18 
 For each molecule, a set of 20 crystal structures generated in the respective CSP 
studies were used for this test. For molecules XXVI and XXIII, the 20 lowest energy 
crystal structures submitted in the first list of predictions for the sixth Blind Test (i.e. the 
20 most stable in Elatt after the final optimisations with CrystalOptimizer, without 
considering polarisation, temperature effects and diversity, see Chapter 3 and the 
publication4 for details) were considered; structure 1600 of molecule XXVI matches the 
only known experimental form (CSD22 refcode XAFQIH),4 while structure A70 of 
molecule XXIII matches experimental form B (CSD refcode XAFPAY01).4 For both 
tautomers of mebendazole, the 20-lowest energy crystal structures predicted in the CSP 
study (see Chapter 4 for details) were considered; structure A788 is a match to 
experimental form A (CSD refcode TUXPEJ),23 while structure C5 matches experimental 
form C (CSD refcode YULGIW).24 Finally for naproxen the 20-lowest energy crystal 
structures in the crystal energy landscape of the published CSP study were considered 
(the Z’=2 version of the global minimum was ignored);18 this set includes structure CO_1, 
which matches the known racemic form (CSD refcode PAPTUX is the best experimental 
determination),18 and structure af92, a match to the enantiopure form (CSD refcode 
COYRUD11 is the highest-quality determination).25 The starting points for all 
CrystalOptimizer minimisations were the same from which the final optimisations in the 
original CSP studies had been started, in order to avoid to begin from structures already 
completely converged. For molecule XXVI4 and the two tautomers of mebendazole21 the 
starting points were the output of an intermediate optimisation with a single-iteration of 
CrystalOptimizer, while for molecule XXIII4 and naproxen18 of a rigid-body minimisation 
of Uinter with DMACRYS.26 
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6.2.2 Benchmark calculations with all torsion and bond-angles as independent CDFs 
 
In order to perform an accurate analysis, a benchmark was needed against which the 
effectiveness of various approaches for selecting the independent CDFs could be tested 
in terms of absolute and relative lattice energies, computational cost and reproduction of 
the experimentally known forms. Data from original CSP studies were not considered 
appropriate for this test because the independent CDFs for the CrystalOptimizer 
optimisations had not been selected with consistent criteria. Hence, in order to produce 
an accurate and feasible benchmark, all the 100 crystal structures of the five molecules 
were optimised with CrystalOptimizer at the PBE0 6-31G(d,p) level of theory for both 
intramolecular interactions and charge density calculations treating all torsion and          
bond-angles (from now on the CDFsall) as independent CDFs. Bond-lengths were treated 
as dependent CDFs: their values are generally not affected by the solid-state 
environment because their distortion requires very high energies.13 
 
6.2.3 Treating only the acyclic torsion angles as independent CDFs  
 
The first selection criterion that was tested was the treatment of only the intuitively flexible 
torsion angles around acyclic bonds as independent CDFs (from now on the CDFstorsion); 
this corresponds with what was achievable in early optimisations with the Ψmol        
method.6, 13 Acyclic torsion angles are also generally used to define molecular flexibility 
in crystal structure searches,6, 8, 9 with the exception of methyl rotations. Methyl rotations 
are ignored in searches because of their negligible effect on ΔEintra and molecular shape, 
but refining their position can be important when more accurate optimisations are 
performed.3, 8 The CDFstorsion are shown in Figure 6.1 for each molecule, and their full 
definition is given in Appendix Figure 6.1 and Appendix Tables 6.1-6.5. 
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Figure 6.1: Chemical diagrams of the five molecules considered for this test. The black 
arrows indicate the CDFstorsion.  
 Note that the CDFstorsion of molecule XXVI correspond to the independent CDFs 
used in the final refinement stage of the original CSP study (see Chapter 3).4 
 All 100 crystal structures were optimised with CrystalOptimizer at the PBE0          
6-31G(d,p) level of theory for both intramolecular interactions and charge density 
calculations, as a function of the CDFstorsion.  
 
6.2.4 Treating the torsion and bond-angles selected with the AUTODOF programme as 
independent CDFs  
 
In a recent paper Nyman and Day proposed a set of rules to select the independent 
CDFs, which they used in a study on the importance of temperature effects on the 
properties of different polymorphs of the same molecules.20 These are: 
 “Covalent bond lengths are optimised without considering packing forces; 
 All angles and dihedrals containing a polar hydrogen atom (–OH, –NH, –SH) are 
optimised under the influence of packing forces; 
 All exocyclic bonds are considered rotatable and are optimised under the 
influence of crystal packing forces; 
  Dihedrals and angles in 3- and 4-membered rings are optimised without 
considering packing forces; 
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 Dihedrals and angles in 5- and 6-membered rings consisting of 3-coordinated 
carbon atoms and nitrogen in any combination are unaffected by packing forces, 
except dihedrals and angles that contain a polar hydrogen atom; 
 Dihedrals and angles in 5-membered rings containing 2-coordinated sulphur or 
oxygen atoms bonded to two 3-coordinated carbon atoms are optimised without 
considering packing forces; 
 Any remaining dihedrals are optimised with respect to packing forces.” 
 Note that the CDFs optimised “with respect to packing forces” are independent 
and those optimised “without considering packing forces” are dependent. These are the 
only criteria to select the independent CDFs in the final refinement stage of CSP studies 
with the Ψmol approach that are clearly codified in the literature, although they have never 
been tested against possible alternatives. These rules are based on a combination of 
chemical intuition, as acyclic torsion angles are treated as independent CDFs and torsion 
angles in rigid rings as dependent, and experience derived from modelling small crystal 
structures, as all torsion and bond-angles that contain polar hydrogen atoms, whose 
position is key to accurately describe hydrogen bond geometries,14 are explicitly 
optimised. AUTODOF19, 20 is a Python27 programme that can be used to automatically 
apply these rules to a given molecule. The independent CDFs chosen by AUTODOF 
(from now on the CDFsAUTODOF) for each of the five molecules are shown in Figure 6.2, 
and their full definition is given in Appendix Figure 6.1 and Appendix Tables 6.1-6.5. 
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Figure 6.2: Chemical diagram of the five molecules considered for this test, showing the 
torsion angles and bond-angles treated as independent in the CrystalOptimizer 
optimisation with the CDFsAUTODOF. Black arrows indicate the torsion angles that are also 
present in the CDFstorsion and that are selected according to chemical intuition, while red 
arrows and red arcs indicate the torsion and bond-angles added by AUTODOF as they 
include polar hydrogen atoms.  
 Comparing the independent CDFs in Figure 6.1 and Figure 6.2, it is clear that all 
the torsion angles in the CDFtorsion are present in the CDFsAUTODOF, which indicates how 
AUTODOF chooses the independent CDFs in line with what suggested by chemical 
intuition. However, there are a few additions. In particular, the CDFsAUTODOF include a 
handful of bond-angles around polar hydrogen atoms, as well as some extra torsion 
angles, most of which have the same central atoms as others intuitively flexible (this is 
indicated in Figure 6.2 by double arrows around the same bonds), with the exception of 
one torsion angle around a cyclic bond in the two tautomers of mebendazole.  
 All 100 crystal structures were optimised with CrystalOptimizer at the               
PBE0 6-31G(d,p) level of theory for both intramolecular interactions and charge density 
calculations, as a function of CDFsAUTODOF.  
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6.2.5 Integrating the CDFsAUTODOF with extra torsion and bond-angles. 
 
6.2.5.1 Determining which CDFs can vary to optimise intermolecular interactions 
 
The results of the benchmark optimisations with the CDFsall were analysed to determine 
which CDFs had their values significantly distorted to improve the balance between intra- 
and intermolecular interactions. In particular, for each molecule all the torsion angles that 
varied by at least 5° in one or more crystal structures, and all the bond-angles that varied 
at least by 1° were recorded. Bond-angles including non-polar hydrogen atoms were 
ignored, and only one instance of torsion angles with the same central atoms was 
considered. The results of this analysis are shown in Figure 6.3. 
 
Figure 6.3: Chemical diagrams of the five molecules considered for this test. The torsion 
angles indicated by black arrows and the bond-angles indicated by red arcs were present 
in the CDFsAUTODOF and varied significantly in at least one crystal structure optimised with 
CrystalOptimizer with the CDFsall. Green arrows and arcs indicate torsion and bond-
angles not included in the CDFsAUTODOF but that varied significantly in at least one crystal 
structure, while those in turquoise are included in the CDFsAUTODOF but did not vary 
significantly in any crystal structure. 
 
6.2.5.2 Comparison with CDFsAUTODOF and integration with extra CDFs 
 
 From Figure 6.3 it is clear that most torsion and bond-angles in the CDFsAUTODOF 
do respond significantly to packing forces in the sample of crystal structures that was 
considered. The only exceptions (indicated in turquoise in Figure 6.3) are the torsion 
angle in the carboxyl group of naproxen and the bond-angle around the amine group in 
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the     C-tautomer of mebendazole (although another bond-angle with the same central 
N atom is present in Figure 6.3). With the exception of that bond-angle, all the other 
CDFs that are included in the CDFsAUTODOF but that are absent in the CDFstorsion varied 
significantly in the benchmark optimisations with the CDFsall. This shows how for these 
molecules the combination of chemical intuition and experience on modelling crystal 
structures of small molecules forms a solid base for selecting the independent CDFs. 
However, the CDFsAUTODOF do not include several intuitively rigid torsion and bond-angles 
(indicated in green in Figure 6.3) that can undergo large distortions when optimised 
under the influence of packing forces. Analysing Figure 6.3, they can be grouped into 
three main categories: 
1) Torsion angles in 5 or 6-membered aromatic rings or 5-membered rings 
consisting of 3-coordinated carbon atoms and nitrogen in any combination, in 
which one of the central atoms is bonded to a cyclic or acyclic substituent 
containing more than one non-H atom.  
2) Bond-angles between atoms in 5 or 6-membered aromatic rings or 5-membered 
rings consisting of 3-coordinated carbon atoms and nitrogen in any combination 
and an acyclic substituent containing more than one non-H atom. 
3) Bond-angles between atoms in two consecutive acyclic flexible bonds. 
 CDFs belonging to these three categories were manually added to the set of 
independent CDFs selected by AUTODOF, forming the CDFsAUTODOF+ that are shown in 
Figure 6.4. Only one torsion angle around the same bond was added to the CDFsAUTODOF, 
and only one bond-angle per central atom; the full definition of the CDFsAUTODOF+ is given 
in Appendix Figure 6.1 and Appendix Tables 6.1-6.5.  
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Figure 6.4: Chemical diagrams of the five molecules considered for this test, showing the 
torsion and bond-angles treated as independent in the CrystalOptimizer optimisation 
with the CDFsAUTODOF+. The torsion angles indicated by red and black arrows and bond-
angles indicate by red arcs were present in the CDFsAUTODOF.  Blue arrows and arcs 
indicate the torsion and bond-angles that were manually added as they belong to one of 
the three categories of intuitively rigid CDFs that varied significantly in the 
CrystalOptimizer minimisations performed with the CDFsall.  
 All 100 crystal structures were optimised with CrystalOptimizer at the PBE0 6-
31G(d,p) level of theory for both intramolecular interactions and charge density 
calculations as a function of the CDFsAUTODOF+. 
 
 6.3 Results and Discussion 
 
6.3.1 Absolute lattice energies 
 
The quality of the various sets of independent CDFs, and of the approaches for selecting 
them, was firstly assessed by their ability to reproduce the Elatt values obtained in the 
benchmark optimisations with the CDFsall. Comparisons between the lattice energies 
obtained with each selection approach and in the benchmark optimisations for the 20 
crystal structures of the five molecules are shown in Figure 6.5 and Figure 6.6; these 
data are also summarised in Table 6.1 and shown more extensively in Appendix Tables 
6.6-6.10.  
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Figure 6.5: Comparison between the lattice energies obtained after full optimisations with 
CrystalOptimizer with the various sets of independent CDFs and those with the CDFsall 
for the 20 crystal structures of (a) molecule XXVI (b) molecule XXIII (c) the A-tautomer of 
mebendazole (d) the C-tautomer of mebendazole and (e) naproxen. For each molecule, 
the lattice energies are plotted as the difference with the Elatt value of the global 
minimum in the benchmark optimisations with the CDFsall. The black lines indicate the 
lattice energies obtained in the optimisations with the CDFsall, and the structures 
matching the experimentally-characterised forms are indicated. See Appendix Tables 6.6-
6.10 for more detailed results. The presence of crystal structures with energies lower 
than those obtained with the CDFsall is probably due to the tolerances in the 
convergence criteria of the optimisations. 
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Figure 6.6: Comparison between the lattice energies obtained after full optimisations with 
CrystalOptimizer with the various sets of independent CDFs and those with the CDFsall 
for the 20 crystal structures of (a) molecule XXVI (b) molecule XXIII (c) the A-tautomer of 
mebendazole (d) the C-tautomer of mebendazole and (e) naproxen. For each crystal 
structure, the energy is shown as the difference with that obtained in the benchmark 
optimisations with the CDFsall for the same structure. The crystal structures that match 
experimentally-characterised forms are circled. See Appendix Tables 6.6-6.10 for more 
detailed results. The presence of crystal structures with energies lower than those 
obtained with the CDFsall is probably due to the tolerances in the convergence criteria of 
the optimisations. 
 
Table 6.1: Summary of the results shown in Figure 6.5, Figure 6.6 and Appendix Tables 
6.6-6.10, showing for each molecule the number of torsion and bond-angles treated as 
independent CDFs, as well the average relative and absolute deviations in Elatt compared 
with the optimisations with the CDFsall. 
  CDFall CDFtorsion CDFAUTODOF CDFAUTODOF+ 
Molecule 
Torsion, 
bond-
angles 
Torsion 
bond-
angles 
Mean, mean 
absolute 
ΔElatt/kJ·mol-1 
Torsion, 
bond-
angles 
Mean, mean 
absolute 
ΔElatt/kJ·mol-1 
Torsion, 
bond-
angles 
Mean, mean 
absolute 
ΔElatt/kJ·mol-1 
XXVI 59, 60 7, 0 6.87, 6.87 9, 2 5.3, 5.3 17, 10 2.96, 2.96 
XXIII 40, 41 7, 0 3.62, 3.62 8, 2 3.05, 3.05 13, 10 1.47, 1.43 
Mebendazole A 32, 33 6, 0 3.17, 3.17 8, 2 2.14, 2.14 11, 8 1.73, 1.73 
Mebendazole C 32, 33 6, 0 1.61, 1.65 8, 2 1.25, 1.30 11, 8 0.73, 0.75 
Naproxen 28, 29 6, 0 1.60, 1.60 6, 1 1.34, 1.34 9, 6 0.42, 0.60 
   MEAN 3.40, 3.41 MEAN 2.65, 2.66 MEAN 1.47, 1.51 
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 Results in Figure 6.5, Figure 6.6 and Appendix Tables 6.6-6.10 clearly show that 
the energies calculated in the benchmark optimisations with the CDFsall were lower than 
for any alternative, with only a few exceptions that are probably due to the tolerances 
that are used by CrystalOptimizer to determine the convergence of a minimisation.13 The 
lattice energy differences for treating various sets of CDFs as independent varied 
drastically for different crystal structures of the same molecule. However, this does not 
seem to be associated with specific structural or packing characteristic, but it can be 
ascribed to subtle and unpredictable balances between intra- and intermolecular 
interactions. 
 Looking at Table 6.1, it is clear that the optimisations with the CDFstorsion produced 
energies of poor quality compared to the benchmark calculations, with an average 
increase in Elatt of ~3.4 kJ·mol-1 and with a maximum increase of ~6.9 kJ·mol-1 for 
molecule XXVI. Using the CDFsAUTODOF slightly improved the energies, as the average 
increase in Elatt was reduced to ~2.7 kJ·mol-1 and to ~5.3 kJ·mol-1 for XXVI. Finally, the 
addition of some intuitively rigid torsion and bond-angles within the CDFsAUTODOF+ 
decreased the discrepancies to an average of ~1.5 kJ·mol-1, and to ~3 kJ·mol-1 for 
molecule XXVI. However, none of the attempted selection criteria could exactly 
reproduce the energies obtained with the CDFsall.  
 These results show that it is important to optimise some intuitively rigid CDFs to 
obtain optimal Elatt values. It also appears that even CDFs with a small influence on 
molecular shape, like bond-angles or cyclic torsion angles, can affect the overall balance 
of intra- and intermolecular interactions. Furthermore, this limited analysis on five flexible 
molecules seems to suggest that neglecting intuitively rigid CDFs becomes more 
detrimental as molecules get larger. As shown in Table 6.1, the number of torsion and 
bond-angles in the CDFstorsion, which are purely selected from intuition, and in the 
CDFsAUTODOF, which are chosen from a combination of intuition and experience derived 
from modelling small molecules, is similar for the five molecules. However, the difference 
becomes larger when some additional intuitively rigid torsion and bond-angles are added 
in the CDFsAUTODOF+, which suggests that large and flexible molecules tend to have a 
higher proportion of CDFs that are ignored when selection criteria based exclusively (or 
mostly) on chemical intuition are adopted. Furthermore, Table 6.1 shows that the 
increase of Elatt compared to the benchmark calculations with the CDFsall is broadly 
related to the number of CDFs that are not treated as independent. Hence as molecules 
get larger obtaining the best possible energies upon optimisations with the Ψmol model 
becomes more problematic: the inclusion of many more independent CDFs is required, 
but even the most comprehensive selection approach still produces results that are of 
worse quality than for smaller molecules. 
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 Although explicitly optimising more CDFs produces lower Elatt values, it also shifts 
the balance between inter- and intramolecular interactions. Table 6.2 shows the average 
values of the intramolecular energy penalty (ΔEintra) obtained for each molecule with the 
various sets of independent CDFs. 
Table 6.2: Average ΔEintra for the 20 crystal structures of each molecule when different 
criteria for selecting the independent CDFs in the CrystalOptimizer optimisations were 
adopted. 
 Mean ΔEintra for the optimisations with different CDFsall/ kJ·mol-1 
Molecule CDFsall CDFstorsion CDFsall CDFsAUTODOF+ 
XXVI 14.29 11.02 10.81 12.16 
XXIII 9.27 7.72 7.86 8.27 
Mebendazole A 3.96 2.78 2.84 3.18 
Mebendazole C 4.30 2.69 2.98 3.15 
Naproxen 2.50 1.04 1.25 2.05 
MEAN 6.86 5.05 5.15 5.76 
 
 These data clearly show that crystal structures optimised with more independent 
CDFs have higher average values for ΔEintra. This implies that the explicit optimisation of 
more CDFs causes a larger degree of conformational adjustment than when they are 
considered as dependent.13 These distortions increase ΔEintra, but this is more than 
compensated by better intermolecular interactions (with an associated decrease in 
Uinter),1 like improved electrostatics or better dispersion interactions due to denser 
packings.2, 3 Indeed, crystal structures optimised with more independent CDFs were 
denser, as shown in Appendix Tables 6.11-6.15. 
 In summary, this analysis shows how choosing the independent CDFs with 
criteria derived exclusively (i.e. the CDFstorsion) or mostly (i.e. the CDFsAUTODOF) from 
chemical intuition leads to a sub-optimal balance of intra- and intermolecular interactions, 
and this problem becomes more relevant for larger molecules, as they have a larger 
proportion of CDFs that are ignored by these approaches. Integrating the sets of 
independent CDFs derived mostly from chemical intuition with some intuitively rigid 
CDFs that underwent significant distortions in the benchmark calculations with the 
CDFsall leads to smaller Elatt deviations. Hence, the CDFsAUTODOF+ appear to be the most 
adequate set of independent CDFs among those that were tested, although no approach 
was accurate enough to exactly reproduce the Elatt values obtained in the benchmark 
calculations. This becomes more problematic as a function of molecular size. This 
indicates that separating CDFs into dependent and independent is an unideal 
approximation and that a CSP methodology for refining crystal structures should optimise 
all molecular degrees of freedom.3, 6 
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6.3.2 Reproduction and ranking of the experimentally known crystal structures 
 
As already mentioned in Chapter 6.2.1, the sample of 100 crystal structures contained 
six matches to experimentally-characterised forms, which are indicated in Figure 6.6 and 
Appendix Tables 6.6-6.10. Table 6.3 summarises how the crystal structures matching 
the experimental forms were ranked for each molecule in terms of Elatt, as well as the 15-
molecule root mean square deviation (RMSD15) of the overlays with the experimental 
crystal structures and the RMSD1 of the overlays with the experimental conformations. 
Table 6.3: For each molecule, the energy ranking in terms of Elatt of the crystal structures 
matching the experimental forms, the quality of the reproduction of the experimental 
crystal structures (RMSD15) and the quality of the reproduction of the experimental 
conformations (RMSD1) when different criteria for selecting the independent CDFs in the 
CrystalOptimizer optimisations were adopted. 
  
Optimisations with the 
CDFall 
Optimisations with the 
CDFtorsion 
Optimisations with 
CDFAUTODOF 
Optimisations with 
CDFAUTODOF+ 
Molecule 
(CSD refcode) 
Rank 
RMSD15, 
RMSD1/Å 
Rank 
RMSD15, 
RMSD1/Å 
Rank 
RMSD15, 
RMSD1/Å 
Rank 
RMSD15, 
RMSD1/Å 
XXVI 
(XAQHIF) 
1 0.292, 0.115 2 0.259, 0.125 1 0.344, 0.138 1 0.306, 0.108 
XXIII form B 
(XAFPAY01) 
2 0.303, 0.133 1 0.364, 0.155 2 0.362, 0.152 2 0.312, 0.133 
Mebendazole 
A (TUXPEJ) 
2 0.333, 0.140 1 0.301, 0.133 1 0.301, 0.122 1 0.311, 0.124 
Mebendazole 
C (YULGIW) 
3 0.265, 0.041 2 0.287, 0.071 3 0.284, 0.068 2 0.259, 0.042 
Naproxen 
(PAPTUX, 
racemic) 
1 0.711, 0.165 2 0.973, 0.211 2 0.974, 0.206 1 0.780, 0.167 
Naproxen 
(COYRUD11, 
enantiopure ) 
9 0.275, 0.048 12 0.458, 0.119 12 0.478, 0.129 10 0.300, 0.057 
  MEAN 0.363, 0.107 MEAN 0.440, 0.136 MEAN 0.457, 0.136 MEAN 0.378, 0.105 
 
 No method could accurately reproduce all the experimental forms; the worst 
reproduction was for the racemic form of naproxen, and this is probably due to a poor 
starting point for the optimisation, as the RMSD15 value between PAPTUX and the fully 
minimised computer-generated crystal structure was also high in the original CSP 
study.18 It is impossible to determine what differentiates the experimental forms from the 
crystal structures optimised with the different sets of independent CDFs, since the 
structural differences cannot be spotted visually. However, a perfect reproduction of the 
experimental forms cannot be expected: the Elatt optimisations are in fact carried out at 
0 K, but all the experimental crystal structures were characterised at room temperature, 
with the exception of YULGIW that was determined at 150 K. Temperature differences 
modify crystal structures because of thermal expansion,28, 29 thus even an extremely 
accurate model cannot exactly reproduce experimental forms characterised at higher 
temperatures.  
  Even accounting for the temperature differences, these results are somewhat 
surprising, since the reproduction of the experimental crystal structures was not clearly 
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affected by the number of CDFs treated as independent in the optimisations. This differs 
from the outcome of the initial test of CrystalOptimizer, where better reproductions were 
achieved when more CDFs were explicitly optimised.13 The only examples for which the 
reproduction of the experimental crystal structures was significantly affected by the set 
of independent CDFs were the two forms of naproxen. For its enantiopure form 
(COYRUD11), the best representation of both the molecular conformation and the crystal 
structure was obtained treating some intuitively rigid torsion angles as independent CDFs 
because of the unusual bend of the naphthalene ring.18  Table 6.4 compares the values 
of the torsion angle between the two aromatic rings in the naphthalene group in the 
conformations of the enantiopure crystal structure of naproxen, COYRUD11, and of the 
computer-generated structure matching it, af92, after the optimisations with the different 
sets of independent CDFs. 
Table 6.4: Value of the torsion angle between the two aromatic rings in the naphthalene 
group in the enantiopure crystal structure of naproxen (CSD refcode COYRUD11) and in 
structure af92 when different criteria for selecting the independent CDFs in the 
CrystalOptimizer optimisations were adopted. 
Conformation 
Torsion angle between the aromatic rings in the 
naphthalene group/° 
Experimental crystal structure (COYRUD11) 174.34 
Structure af92 after the optimisation with the CDFsall 173.63 
Structure af92 after the optimisation with the CDFtorsion 179.86 
Structure af92 after the optimisation with the CDFAUTODOF 179.87 
Structure af92 after the optimisation with the CDFAUTODOF+ 173.14 
 
 The best reproduction of the torsion angle was achieved in the benchmark 
optimisation with the CDFsall, closely followed by CDFsAUTODOF+, where treating one 
torsion angle between the aromatic rings as independent was sufficient to reproduce a 
bent naphthalene group. The intuitive rigid treatment of the aromatic rings in the 
optimisations with the CDFstorsion and the CDFsAUTODOF wrongly produced planar 
naphthalene. 
 On the other hand, the poor reproduction of the racemic form with the CDFstorsion 
and CDFsAUTODOF was not due to this issue, since naphthalene is planar in PAPTUX,18 
but to other subtle differences that affect the balance of intra- and intermolecular 
interactions.  For the other molecules, the differences were small and probably not 
significant considering the temperature effects described above; however, it is surprising 
how optimising only the CDFstorsion produced the best reproduction of the experimental 
forms of molecule XXVI and mebendazole form A. It is also interesting to note that the 
optimisations with the CDFsAUTODOF+ reproduced very well the experimental 
conformations, as they have the lowest mean RMSD1 values in Table 6.3, confirming 
that this is a reliable approach for selecting the independent CDFs. 
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 The relative stability of the crystal structures matching the experimental forms 
relative to the other competitors was less affected by the set of independent CDFs than 
the absolute energies, suggesting that the energy differences tend to cancel out. The 
addition of at least some intuitively rigid torsion and bond-angles within the CDFsAUTODOF+ 
was needed to place the structure matching the racemic form of naproxen as the global 
minimum in Elatt. This also improved the ranking of the enantiopure form of naproxen, 
which however was always found to be the most stable homochiral crystal structure (as 
shown in Appendix Table 6.10), as well as metastable with respect to the racemic form, 
consistently with experimental studies.18 For molecule XXVI, the experience-based 
addition of some torsion and bond-angles containing polar hydrogen atoms in the 
CDFsAUTODOF was needed to place the experimentally known form of XXVI as the global 
minimum in Elatt, as it was ranked second in the optimisations with the purely intuition-
based CDFstorsion (like in the original CSP study, see Chapter 3.3.2.2). On the other hand, 
for the A-tautomer of mebendazole one structure becomes slightly more stable than the 
experimentally known form when the optimisations are performed with the CDFsall. 
 In summary, the differences in terms of reproduction of the experimental forms 
and their relative stabilities are less affected by the choice of the independent CDFs than 
the absolute Elatt values. Nonetheless, among the three sets of CDFs selected with 
different approaches, the CDFsAUTODOF+ appear once again to be the most adequate, as 
they produce results of very similar quality to the benchmark optimisations with the 
CDFsall. 
 
6.3.3 Comparison of computational cost 
 
Table 6.5: Average computational cost per crystal structure for performing the 
optimisations with the different sets of independent CDFs. 
 Average cost of the optimisations performed with different CDFs /CPU hours 
Molecule CDFsall CDFstorsion CDFsAUTODOF CDFsAUTODOF+ 
XXVI 131 70 61 65 
XXIII 46 10 10 19 
Mebendazole A 39 5 6 9 
Mebendazole C 60 22 28 28 
Naproxen 22 5 5 5 
 
For all molecules, the optimisations with the CDFsall were the most computationally 
expensive. As shown in Figure 6.7, the CPU cost increases with the number of 
independent CDFs, consistently with what had been noticed in the initial testing of 
CrystalOptimizer.13 
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Figure 6.7: For each molecule, average CPU cost of the optimisations as a function of the 
number of independent CDFs. 
 For this limited number of data point, Figure 6.7 suggests that each independent 
CDF increases the computational cost by an average of 0.4-0.6 CPU hours per crystal 
structure. This cost increase would make the explicit optimisation of the CDFsall 
unaffordable when thousands of crystal structures need to be minimised, in particular for 
large and flexible molecules. On the other hand, optimising the crystal structures with 
the CDFsAUTODOF+ does not significantly increase the overall CPU cost compared to the 
approaches based exclusively or mostly on chemical intuition. Since optimisations with 
the CDFsAUTODOF+ produce better energies and geometries, it can be concluded that this 
selection approach provides the best balance between accuracy and computational 
feasibility within the Ψmol framework among those that were tested in this study, although 
it still includes some unideal approximations.  
 
6.3.4 CSD validation of the findings of this analysis 
 
The data shown so far have illustrated that the explicit optimisation of only the CDFs that 
are flexible according to intuition and/or experience from modelling small model 
molecules is not sufficient. In particular, three categories of intuitively rigid torsion and 
bond-angles (listed in Chapter 6.2.5.2) seem to vary significantly in the optimisations with 
the CDFsall. The addition of independent CDFs belonging to these three categories in 
the CDFsAUTODOF+ improves the reproduction of the energies compared to the benchmark 
optimisations with the CDFsall. However, this may just be an artefact of the 
CrystalOptimizer energy model, as Table 6.3 shows that increasing the number of 
independent CDFs does not improve the reproduction of the experimental forms to the 
same extent to which it decrease the lattice energies (as shown in Table 6.1 and 
Appendix Tables 6.6-6.10). Hence, to verify whether the distortion of these three 
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categories of intuitively rigid CDFs is realistic, a CSD survey was performed. For each 
category listed in Chapter 6.2.5.2, crystal structures containing the fragments shown in 
Figure 6.8a-c respectively were extracted with Conquest.30 In order to increase the 
confidence in the results, only organic, non-ionic crystal structures without disorder or 
errors and with an R-factor smaller than 5% were considered. Furthermore the search 
was limited to the CSD entries within the ‘best R-factor’31 list to limit the double-count of 
redeterminations of identical crystal structures. 
 
Figure 6.8: Fragments used to perform the CSD surveys with Conquest. The black arrow 
represents a torsion angle, red arcs bond-angles. Z indicates any non-H atom, while the 
‘a’ subscript indicates that the atom is acyclic. Fragments (a), (b) and (c) represent 
categories 1-3 of intuitively rigid CDFs respectively (see section 6.2.5.2). 
 For the second category (Figure 6.8b) only 6-membered aromatic rings were 
considered, since rare 5-membered rings that are aromatic and/or consist of                              
3-coordinated carbon atoms and nitrogen in any combination have different idealised 
values for the bond-angles. The values of all torsion and bond-angles in the CSD 
structures containing these fragments were extracted. 
 Conquest searches were also performed with the fragments in Figure 6.9 to 
extract the values taken by the torsion and bond-angles in rigid rings when none of the 
central atoms is bonded to a heavy substituent, which in the optimisations with the 
CDFsall are not significantly distorted by packing forces (see Figure 6.3). 
 
Figure 6.9: Fragments used to perform the CSD surveys with Conquest, representing 
torsion and bond-angles in rigid rings in the absence of heavy substituents in the central 
atoms. The black arrow represents a torsion angle, the red arc a bond-angle. Z indicates 
any non-H atom, X any atom, while the ‘1’ subscript indicates that the atom forms only 
one bond. 
 Note that the fragments in Figure 6.9 exclude some relevant configurations, like 
angles with central 2-coordinated nitrogen atoms, or methyl substituents. Nevertheless, 
these were the broadest possible criteria using the Conquest search parameters. 
 Figure 6.10 and Figure 6.11 show the CSD distribution of the values of torsion 
angle in Figure 6.8a and Figure 6.9a respectively. 
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Figure 6.10: Histogram showing the CSD distribution of the values of the torsion angle in 
the fragment in Figure 6.8a. 
 
Figure 6.11: Histogram showing the CSD distribution of the values of the torsion angle in 
the fragment in Figure 6.9a. 
 Although the torsion angle values in both distributions are tightly clustered around 
the idealised value of 0°, there is a spread of possible values around both maxima. 
Although this is not sufficient to justify a flexible treatment of aromatic torsion angles in 
a CSP search (see Chapter 5),10 the histograms show that some deviations from the 
distribution maximum are possible in the solid-state. However, the presence of a 
substituent with more than one non-H atom in one of the central atoms increases the 
flexibility range, confirming the results obtained in this chapter. In the presence of a 
heavy substituent in one of the central atoms, ~3% of the torsion angles are outside the 
-5° to 5° range, while this occurs in only ~0.4% of the entries in its absence. Figure 6.10 
and Figure 6.11 show that the most realistic option is to treat all torsion angles in rigid 
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rings as independent variables, but they also confirm that the explicitly flexible treatment 
of torsion angles in rigid rings is more important when one of the central atoms is bonded 
to a heavy substituent. 
 Figure 6.12 shows the CSD distribution of the values of the bond-angle in Figure 
6.8b, while Figure 6.13 shows the distribution for the bond-angle in Figure 6.9b. 
 
Figure 6.12: Histogram showing the CSD distribution of the values of the bond-angle in 
the fragment in Figure 6.8b. 
 
Figure 6.13: Histogram showing the CSD distribution of the values of the bond-angle in 
the fragment in Figure 6.9b. 
 Both distributions are clustered around the idealised bond-angle value of 120°, 
but in both cases there is a spread of possible values around this maximum. However, 
this spread is larger for the bond-angles between rigid rings and heavy substituents. 
While ~66% of the values of bond-angles between rigid rings and heavy substituents 
deviate by more than 1° from the maximum in the distribution, this is true only in ~35% 
of cases when no heavy substituent is connected to the rigid ring. Figure 6.12 and Figure 
220 
 
6.13 illustrate that treating all bond-angles in rigid rings as explicitly flexible in the 
optimisations is the most realistic solution, but they also confirm that the presence of a 
heavy substituent increases the likelihood of a bond-angle deviating from the most 
common value. 
 Finally Figure 6.14 shows the CSD distributions of the values of the bond-angle 
in Figure 6.8c, i.e. between atoms in two adjacent acyclic flexible bonds.  
 
Figure 6.14: Histogram showing the CSD distribution of the values of the bond-angle in 
the fragment in Figure 6.8c. 
 Figure 6.14 shows that these bond-angles can take a broad range of values. 
Hence, this sort of CDFs can show a lot of variation in response to packing forces, and 
should be treated as independent in the optimisations, confirming the findings of the 
computational analysis. 
 In summary, these CSD surveys show that all torsion and bond-angles, even the 
most rigid ones, can take a range of values in the solid-state to adjust to packing forces 
and so should be treated as variables when optimising crystal structures. Nonetheless, 
their degree of flexibility varies. In particular, the intuitively rigid torsion and bond-angles 
identified in Chapter 6.2.5.2 seem to be more affected by packing than others that did 
not significantly vary in the benchmark optimisations with the CDFsall, confirming that the 
findings of the calculations performed in this study are not just an artefact of the Elatt 
model.  
 
6.4 Conclusion 
 
Crystal Optimizer optimisations of 100 generated crystal structures of five flexible 
molecules were performed treating different sets of CDFs as independent to study which 
torsion and bond-angles can vary significantly to respond to packing. Optimisations with 
the intuition-based CDFstorsion and the intuition and experience-based CDFsAUTODOF 
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produced results of low quality compared to the ideal but computationally expensive 
benchmark minimisations where all torsion and bond-angles were treated as 
independent CDFs, in particular in terms of absolute lattice energies. This showed that 
some extra CDFs need to be considered to produce better Elatt values. Analysing the 
results of the benchmark optimisations with the CDFsall three categories of intuitively 
rigidly CDFs were found to vary significantly: torsion angles in rigid rings where one of 
the central atom is bonded to a heavy substituent, bond-angles between rigid rings and 
heavy substituents and bond-angle between atoms in two adjacent acyclic flexible 
bonds. Adding these three categories of torsion and bond-angles to the CDFAUTODOF, 
forming the CDFsAUTODOF+, produced lower Elatt values at a reasonable computational 
cost. The importance of treating at least these intuitively rigid CDFs as independent in 
the final refinement stage of CSP was confirmed by a CSD analysis showing that they 
take a relatively broad range of values in experimentally-determined crystal structures. 
 Several insights that are very relevant to the overall purpose of this thesis are 
provided by this analysis. The explicit optimisation of all torsion and bond-angles in the 
final refinement stage of CSP is the most accurate solution within the Ψmol framework, 
but it is too computationally expensive. Hence an effective selection criterion for 
independent CDFs is needed, and the approach used to select the CDFsAUTODOF+ seems 
to provide a good balance between accuracy and cost.  
 A fundamental weakness of the Ψmol model is also shown: limiting the explicitly 
flexible CDFs in crystal structure optimisations to keep the computational expense 
manageable is a necessary but unideal and not completely realistic approximation.6 In 
fact the CSD surveys show that even the most rigid CDFs can take limited but                 
non-insignificant flexibility ranges of values, and no selection approach was capable to 
reproduce the energies of the benchmark minimisations with the CDFsall. Hence, the 
Ψcrys model is more realistic as it treats all molecular CDFs as optimisation variables; 
however, similarly to utilising the CDFsall within the Ψmol model, it is very computationally 
demanding.32 As already outlined in Chapter 3, using a very accurate but cost ineffective 
methodology in the final refinement stage of CSP, when hundreds or thousands of crystal 
structures need to be optimised, can lead to failures when large and flexible molecules 
of pharmaceutical interest are targeted. Hence, the use of cheaper Ψcrys models that can 
explicitly optimise all intermolecular interactions and molecular CDFs at the same time 
would be the best solution to perform accurate, realistic but computationally affordable 
optimisations. This possibility is explored in detail in Chapter 7. 
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6.6 Appendix 
 
Appendix Figure 6.1: Chemical diagrams of the five molecules considered in this test, 
showing the atomic numbering that is used in Appendix Tables 6.1-6.5 to precisely define 
the torsion and bond-angles. 
 
 
Appendix Table 6.1: Definition of the torsion and bond-angles of molecule XXVI treated 
as independent CDFs with when different selection approaches were adopted. 
  Torsion angle definition Bond-angle definition 
CDFstorsion 
31-32-34-35, 22-31-32-34, 21-22-31-32, 11-12-21-
22, 8-10-11-12, 2-8-10-11, 1-2-8-10 
/ 
Added to the 
CSDsAUTODOF 
31a-31-22-21, 2-8-10-10a 31a-31-22, 8-10-10a 
Added to the 
CSDsAUTODOF+ 
38-39-34-35, 21-12-11-10, 25-30-21-22, 28-29-30-
21, 15-14-13-12, 14-13-12-21, 20-11-12-21, 4-3-2-8 
32-34-35, 23-22-31, 12-21-22, 10-11-12, 
1-2-8, 11-12-21, 34-32-31, 2-8-10 
 
Appendix Table 6.2: Definition of the torsion and bond-angles of molecule XXIII treated 
as independent CDFs with when different selection approaches were adopted. 
  Torsion angle definition Bond-angle definition 
CDFstorsion 
11-10-9-5, 12-11-10-9, 10-9-5-6, 18-17-14-15, 23-18-17-14, 
26-24-19-18, 25a-25-24-19 
/ 
Added to the 
CSDsAUTODOF 
17a-17-14-15 17a-17-14, 25a-25-24 
Added to the 
CSDsAUTODOF+ 
1-6-5-9,  13-12-11-10, 17-14-15-16, 22-23-18-17, 24-19-18-
17 
6-5-9, 16-11-10, 17-14-13, 23-18-
17, 24-19-18, 5-9-10, 9-10-11, 25-
24-19 
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Appendix Table 6.3: Definition of the torsion and bond-angles of the A-tautomer of 
mebendazole treated as independent CDFs with when different selection approaches 
were adopted. 
  Torsion angle definition Bond-angle definition 
CDFstorsion 
10-11-12-13, 2-10-11-12, 1-2-10-11, 17-14-7-
6, 22-17-14-7, 13a-13-12-11 
/ 
Added to the 
CSDsAUTODOF 
1a-1-2-10, 10a-10-11-12 1a-1-2, 10a-10-11 
Added to the 
CSDsAUTODOF+ 
7-6-5-1, 19-18-17-14, 9-8-7-6 
22-17-14, 14-7-6, 1-2-10, 17-14-7, 10-11-
12, 11-12-13 
 
Appendix Table 6.4: Definition of the torsion and bond-angles of the C-tautomer of 
mebendazole treated as independent CDFs with when different selection approaches 
were adopted. 
  Torsion angle definition Bond-angle definition 
CDFstorsion 
10-11-12-13, 2-10-11-12, 1-2-10-11, 17-14-8-7, 22-
17-14-8, 13a-13-12-11 
/ 
Added to the 
CSDsAUTODOF 
1a-1-2-10, 10a-10-11-12 1a-1-2, 10a-10-11 
Added to the 
CSDsAUTODOF+ 
19-18-17-14, 14-8-9-4, 8-9-4-5 
17-18-14, 14-8-7, 1-2-10, 17-14-8, 
10-11-12, 11-12-13 
 
Appendix Table 6.5: Definition of the torsion and bond-angles of naproxen treated as 
independent CDFs with when different selection approaches were adopted. 
  Torsion angle definition Bond-angle definition 
CDFstorsion 
15-13-14-14a, 7-6-13-14, 16-15-13-14, 12-11-1-10, 
12a-12-11-1, 16a-16-15-13 
/ 
Added to the 
CSDsAUTODOF 
/ 16a-16-15 
Added to the 
CSDsAUTODOF+ 
11-1-2-3, 8-7-6-13, 2-3-4-5 
11-1-10, 7-6-13, 12-11-1, 6-3-14, 16-
15-13 
 
Appendix Table 6.6: Elatt values of the 20 crystal structures of molecule XXVI when 
different criteria for selecting the independent CDFs in the CrystalOptimizer 
optimisations were adopted, relative to the global minimum in the benchmark 
optimisations with the CDFsall. The crystal structure matching the known form (XAFQIH) 
is highlighted in orange. 
 ΔElatt for the optimisations with different CDFs/ kJ·mol-1 
Name of the structure 
from the original CSP 
study 
CDFsall CDFstorsion CDFsAUTODOF CDFsAUTODOF+ 
1600 0.00 6.33 3.28 1.91 
2231 0.57 12.54 10.11 4.05 
675 0.65 7.85 6.71 4.05 
3525 1.16 4.98 4.65 2.51 
239 2.08 11.42 11.56 4.53 
2930 3.64 19.57 7.46 5.11 
4946 4.08 22.01 20.42 16.76 
615 4.23 15.58 11.24 5.47 
38 4.98 9.78 9.21 6.72 
2496 5.37 12.57 10.76 7.93 
508 5.99 13.43 11.65 8.88 
6460 6.62 12.11 10.00 8.81 
3104 7.58 10.75 10.77 9.74 
6335 7.75 12.54 11.90 9.68 
226 
 
851 8.69 12.06 11.71 11.11 
314 8.88 13.37 14.13 10.97 
354 8.95 11.88 12.08 10.54 
185 9.16 13.20 13.24 11.41 
221 9.97 13.05 12.72 11.46 
4201 10.54 13.25 13.27 12.37 
 
Appendix Table 6.7: Elatt values of the 20 crystal structures of molecule XXIII when 
different criteria for selecting the independent CDFs in the CrystalOptimizer 
optimisations were adopted, relative to the global minimum in the benchmark 
optimisations with the CDFsall. The crystal structure matching known form B (XAFPAY01) 
is highlighted in orange. 
 ΔElatt for the optimisations with different CDFs/ kJ·mol-1 
Name of the structure 
from the original CSP study 
CDFsall CDFstorsion CDFsAUTODOF CDFsAUTODOF+ 
A2073 0.00 3.35 2.64 1.29 
A70 0.01 3.34 2.67 1.34 
A51 0.93 6.53 5.67 2.29 
A424 1.70 8.77 8.48 8.43 
A1361 2.09 4.12 3.78 2.58 
A691 2.11 3.69 3.40 2.86 
A5191 2.18 5.58 5.27 3.33 
A771 2.90 4.53 4.26 3.07 
A72 3.00 5.65 5.35 4.10 
A4890 3.24 5.41 4.90 4.16 
A63 3.57 6.99 6.34 4.46 
A118 3.65 6.38 5.84 4.30 
A2112 3.72 6.41 5.83 4.41 
A894 4.05 9.76 12.81 6.02 
A75 4.28 5.33 5.06 4.89 
A191 4.34 7.06 6.60 5.33 
A272 4.45 10.95 10.52 8.09 
A1413 4.62 5.58 5.38 4.68 
A1752 5.45 13.46 7.44 6.58 
A3457 16.47 22.34 21.55 19.89 
 
Appendix Table 6.8: Elatt values of the 20 crystal structures of the A-tautomer of 
mebendazole when different criteria for selecting the independent CDFs in the 
CrystalOptimizer optimisations were adopted, relative to the global minimum in the 
benchmark optimisations with the CDFsall. The crystal structure matching known form A 
(TUXPEJ) is highlighted in orange. 
 ΔElatt for the optimisations with different CDFs/ kJ·mol-1 
Name of the structure 
from the original CSP study 
CDFsall CDFstorsion CDFsAUTODOF CDFsAUTODOF+ 
19 0.00 4.39 2.86 2.45 
788 0.11 3.15 1.38 1.17 
37 2.00 6.87 5.15 4.94 
50 2.72 5.25 3.92 3.89 
291 3.00 8.49 7.90 5.98 
143 3.47 8.62 8.05 6.84 
109 4.02 11.69 9.66 9.06 
173 4.91 8.85 6.73 6.65 
90 5.25 8.80 6.99 6.66 
72 5.29 9.65 6.60 6.59 
49 5.37 6.97 6.82 6.63 
89 5.45 9.13 8.61 7.65 
53 5.63 5.82 5.86 5.99 
227 
 
54 5.90 9.53 8.77 7.76 
306 6.30 8.69 7.89 7.49 
78 6.34 6.73 6.72 6.82 
202 6.90 8.28 8.12 7.90 
75 7.92 9.78 9.63 9.21 
71 8.68 11.06 9.71 9.37 
604 8.96 9.84 9.70 9.85 
 
Appendix Table 6.9: Elatt values of the 20 crystal structures of the C-tautomer of 
mebendazole when different criteria for selecting the independent CDFs in the 
CrystalOptimizer optimisations were adopted, relative to the global minimum in the 
benchmark optimisations with the CDFsall.  The crystal structure matching known form C 
(YULGIW) is highlighted in orange. 
 ΔElatt for the optimisations with different CDFs/ kJ·mol-1 
Name of the structure 
from the original CSP study 
CDFsall CDFstorsion CDFsAUTODOF CDFsAUTODOF+ 
27 0.00 2.20 1.91 1.18 
10 1.02 2.83 2.03 1.94 
5 1.20 2.80 2.15 1.74 
406 2.26 4.63 4.28 3.50 
23 2.77 4.47 3.80 3.67 
73 3.02 4.39 3.67 3.67 
248 3.83 6.38 5.79 4.73 
24 3.84 6.41 6.17 5.07 
115 3.93 6.31 6.04 4.99 
46 4.02 7.15 6.64 5.23 
25 4.35 5.49 4.84 4.79 
53 4.37 5.52 4.85 4.92 
908 4.59 7.05 6.81 5.41 
106 4.87 6.14 6.19 5.61 
583 5.22 6.41 6.34 5.57 
244 5.78 7.61 7.47 6.55 
199 7.04 8.26 8.05 8.02 
111 7.08 7.74 7.64 7.32 
132 7.47 7.21 7.15 7.33 
220 8.20 8.09 8.09 8.26 
 
Appendix Table 6.10: : Elatt values of the 20 crystal structures of naproxen when different 
criteria for selecting the independent CDFs in the CrystalOptimizer optimisations were 
adopted, relative to the global minimum in the benchmark optimisations with the CDFsall. 
The crystal structure matching the known racemic form (PAPTUX) is highlighted in 
orange, while the crystal structure matching the known enantiopure form (COYRUD11) is 
highlighted in green. 
 ΔElatt for the optimisations with different CDFs/ kJ·mol-1 
Name of the structure 
from the original CSP study 
CDFsall CDFstorsion CDFsAUTODOF CDFsAUTODOF+ 
CO_1 0.00 2.37 1.97 0.65 
ak57 0.60 1.51 1.07 1.00 
fc15 2.55 3.42 3.11 2.96 
am85 2.88 4.39 4.06 3.59 
fb24 5.30 6.66 6.57 5.44 
ak35 5.40 6.33 6.27 5.91 
fc100 5.96 7.43 7.29 6.46 
ab9 6.00 6.63 6.31 6.23 
af92 6.28 9.47 9.10 7.10 
228 
 
fa31 6.54 7.02 6.82 6.85 
ak63 6.86 9.75 9.49 7.58 
am133 6.89 7.87 7.40 7.50 
fc125 7.46 10.40 10.09 8.09 
fc119 7.75 8.17 7.98 8.03 
cc56 8.71 9.65 9.52 9.34 
fa104 9.21 12.95 12.84 9.84 
ca102 9.45 9.73 9.67 7.68 
aq49 9.64 11.51 11.14 10.38 
bh18 9.73 15.61 15.39 11.17 
ah12 10.29 11.58 11.42 10.90 
 
Appendix Table 6.11: Packing coefficient of the 20 crystal structures of molecule XXVI 
when different criteria for selecting the independent CDFs in the CrystalOptimizer 
optimisations were adopted. The crystal structure matching the known form (XAFQIH) is 
highlighted in orange. 
 Packing coefficient for the optimisations with different CDFs/% 
Name of the structure 
from the original CSP study 
CDFsall CDFstorsion CDFsAUTODOF CDFsAUTODOF+ 
1600 67.31 67.47 67.4 67.25 
2231 69.17 68.53 68.03 68.73 
675 69.44 68.57 68.72 69.07 
3525 69.05 68.33 68.41 68.7 
239 69.58 68.2 68.08 68.83 
2930 69.4 68.25 68.92 69.34 
4946 69.81 66.18 66.42 67.23 
615 67.95 66.14 66.83 67.45 
38 68.25 67.41 67.52 67.86 
2496 69.37 67.56 67.95 68.47 
508 69.27 68.57 68.7 68.91 
6460 66.85 65.72 66 66.19 
3104 71.07 70.48 70.54 70.65 
6335 68.35 67.61 67.45 67.85 
851 67.25 66.7 66.68 66.78 
314 67.86 65.84 65.9 67.15 
354 67.89 67.01 66.93 67.32 
185 71.41 70.7 70.63 71.02 
221 67.38 66.57 66.53 66.96 
4201 68.49 67.95 67.89 68.09 
MEAN 68.76 67.69 67.78 68.19 
 
Appendix Table 6.12: Packing coefficient of the 20 crystal structures of molecule XXIII 
when different criteria for selecting the independent CDFs in the CrystalOptimizer 
optimisations were adopted. The crystal structure matching known form B (XAFPAY01) 
is highlighted in orange. 
 Packing coefficient for the optimisations with different CDFs/% 
Name of the structure 
from the original CSP study 
CDFsall CDFstorsion CDFsAUTODOF CDFsAUTODOF+ 
A2073 71.63 71.04 71.08 71.26 
A70 71.89 71.29 71.34 71.5 
A51 70.23 68.03 68.6 69.84 
A424 70.32 70.73 70.78 70.79 
A1361 71.52 70.87 70.86 71.27 
A691 69.83 69.35 69.33 69.55 
A5191 70.78 70.32 70.30 70.57 
A4890 72.59 72.23 72.27 72.46 
A72 71.20 70.51 70.54 70.97 
A771 71.57 71.10 71.08 71.43 
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A63 70.89 70.92 70.91 70.76 
A118 70.39 70.03 70.03 70.28 
A2112 70.87 70.49 70.53 70.68 
A894 70.61 69.5 67.55 70.10 
A191 71.21 70.96 71.01 71.14 
A1413 69.68 69.49 69.45 69.47 
A75 71.73 68.48 68.59 69.15 
A272 71.82 71.52 71.55 71.66 
A1752 70.16 66.91 69.05 69.56 
A3457 68.97 66.57 66.67 67.46 
MEAN 70.89 70.02 70.08 70.50 
 
Appendix Table 6.13: Packing coefficient of the 20 crystal structures of the A-tautomer of 
mebendazole when different criteria for selecting the independent CDFs in the 
CrystalOptimizer optimisations were adopted. The crystal structure matching known 
form A (TUXPEJ) is highlighted in orange. 
 Packing coefficient for the optimisations with different CDFs/% 
Name of the structure 
from the original CSP study 
CDFsall CDFstorsion CDFsAUTODOF CDFsAUTODOF+ 
19 73.93 72.61 72.78 72.83 
788 72.38 71.72 71.88 72.01 
37 73.26 72.03 72.22 72.24 
50 72.57 71.83 72.07 72.13 
291 73.65 72.88 73.03 73.34 
143 74.17 72.82 72.94 73.72 
109 71.82 70.66 70.73 71.07 
173 72.40 71.21 71.39 71.43 
90 70.69 69.82 70.06 70.35 
72 72.28 72.11 72.20 72.09 
49 71.65 71.05 71.13 71.14 
89 72.25 71.75 71.81 72.18 
53 71.63 71.52 71.50 71.77 
54 73.02 72.43 72.40 72.36 
306 72.77 72.30 72.56 72.74 
78 71.52 71.55 71.54 71.42 
202 70.72 70.29 70.28 70.56 
75 71.70 71.46 71.52 71.59 
71 71.56 71.35 71.34 71.27 
604 70.60 70.52 70.52 70.41 
MEAN 72.23 71.60 71.70 71.83 
 
Appendix Table 6.14: Packing coefficient of the 20 crystal structures of the C-tautomer of 
mebendazole when different criteria for selecting the independent CDFs in the 
CrystalOptimizer optimisations were adopted. The crystal structure matching known 
form C (YULGIW) is highlighted in orange. 
 Packing coefficient for the optimisations with different CDFs/% 
Name of the structure 
from the original CSP study 
CDFsall CDFstorsion CDFsAUTODOF CDFsAUTODOF+ 
27 72.63 71.75 71.79 72.04 
10 72.71 72.03 72.26 72.32 
5 72.63 71.9 72.04 72.22 
406 72.22 71.23 71.37 71.58 
23 71.96 71.16 71.28 71.37 
73 71.81 71.25 71.39 71.43 
248 72.24 71.53 71.65 71.87 
24 71.53 70.46 70.49 70.83 
115 72.32 72.22 72.30 72.23 
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46 72.49 71.28 71.38 71.85 
25 70.80 70.17 70.29 70.49 
53 69.98 69.60 69.70 69.64 
908 71.98 71.44 71.47 71.73 
106 73.19 72.75 72.80 72.85 
583 73.27 72.63 72.68 72.97 
244 72.04 72.07 72.03 71.89 
199 71.62 70.84 70.88 70.87 
111 74.41 74.12 74.19 74.30 
132 72.26 72.11 72.12 72.18 
220 72.37 72.17 72.17 72.45 
MEAN 72.22 71.64 71.71 71.86 
 
Appendix Table 6.15: Packing coefficient of the 20 crystal structures of naproxen when 
different criteria for selecting the independent CDFs in the CrystalOptimizer 
optimisations were adopted. The crystal structure matching the known racemic form 
(PAPTUX) is highlighted in orange, while the crystal structure matching the known 
enantiopure form (COYRUD11) is highlighted in green. 
 Packing coefficient for the optimisations with different CDFs/% 
Name of the structure 
from the original CSP study 
CDFsall CDFstorsion CDFsAUTODOF CDFsAUTODOF+ 
CO_1 71.83 70.93 70.96 71.68 
ak57 72.12 71.69 71.65 71.94 
fc15 70.56 70.15 70.20 70.49 
am85 71.44 70.60 70.60 71.15 
fb24 70.53 70.24 70.28 70.64 
ak35 69.80 69.40 69.39 69.34 
fc100 70.26 69.81 69.80 70.06 
ab9 69.89 69.46 69.72 69.73 
af92 69.64 68.13 68.25 69.22 
fa31 69.77 69.51 69.59 69.59 
ak63 68.04 66.93 66.97 67.90 
am133 68.45 68.2 68.14 68.32 
fc125 68.44 66.91 67.02 68.21 
fc119 69.14 69.02 69.01 69.05 
cc56 70.07 69.46 69.45 69.64 
fa104 69.00 66.41 66.57 68.62 
ca102 68.82 68.56 68.57 69.09 
aq49 68.33 67.54 67.58 68.01 
bh18 69.24 65.63 65.70 68.80 
ah12 68.45 67.82 67.65 68.14 
MEAN 69.69 68.82 68.86 69.48 
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Chapter 7: Use of density functional tight-binding 
(DFTB) as an intermediate optimisation method 
and for free energy estimation 
 
7.1 Introduction 
 
7.1.1 The importance of intermediate optimisations in the final refinement stage of CSP 
  
In Chapter 5, a workflow for using CSD information to speed up CSP searches was 
developed.1 Although most of the significant crystal structures from previous CSP studies 
(i.e. that were thermodynamically competitive after the final optimisations),2-5 including 
all those matching the experimentally-characterised Z’=1 forms, were successfully 
generated at a reduced computational cost, they were often poorly ranked among a 
plethora of alternatives of little practical interest.  
 This is a well-known problem: the lattice energy (Elatt) values are generally 
computed in the searches with approximate models, and are rarely accurate enough to 
provide reliable energy rankings (see also Chapter 2.4).2, 6, 7 This poses significant 
challenges to the final refinement stage of CSP: because of the poor Elatt ranking output 
by the search, thousands of generated crystal structures must be optimised and                
re-ranked to produce an accurate crystal energy landscape.6, 7 Since the final refinement 
requires the use of high-quality expensive models, such as periodic electronic structure 
calculations with the Ψcrys methods on all crystal structures,8-11  or the calculation of a 
high-quality wave-function for each molecular conformation in the crystals (the Ψmol  
method, se chapter 2.3.1),12-14 the computational cost can easily explode if too many 
search-generated structures have to be refined.7, 15 
 A possible solution to this problem is performing an intermediate optimisation, 
which can bridge the gap between the cheap and simple models used in the searches 
and the more accurate and expensive ones that are required in the final refinement of 
the generated crystal structures.2, 7, 16 For flexible molecules, several intermediate 
optimisation methods are used in CSP, such as minimising some torsion angles with a 
transferable force-field to improve the molecular conformations,17, 18 performing single-
point energy calculations with a more accurate description of the intra- and 
intermolecular interactions19, 20 or partial Elatt optimisations (as it was done in Chapters 3 
and 4).2, 7 This chapter attempts to test one possible cheap yet accurate method to 
perform intermediate optimisations with the goal of speeding up the final refinement 
stage of a CSP procedure, which could be practicable for expanding computational 
studies to larger and more flexible molecules. 
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7.1.2 Advantages of periodic semi-empirical method 
 
 In Chapter 6 it has been shown how refining search-generated crystal structures 
with the Ψmol method (see Chapter 2.3.1) has the inherent weakness of requiring the 
selection of the conformational degrees of freedom (CDFs) that are to be explicitly 
optimised under the influence of packing forces.21 Ideally all torsion and bond-angles 
should be treated as explicit variables for each crystal structure (bond-lengths can be 
safely ignored).6, 21 However, since hundreds or thousands of search-generated crystal 
structures often need to be refined, this would be unaffordable for large and flexible 
molecules as the computational cost increases with the number of explicitly optimised 
CDFs.21 Although an effective criterion for selecting the explicitly flexible CDFs was 
outlined in Chapter 6, no practically affordable method could reproduce the energies 
obtained upon optimising all torsion and bond-angles. Using Ψcrys methods (see Chapter 
2.3.2) is more realistic, as all atomic positions are optimised at once.22 The most 
commonly used Ψcrys method in CSP is dispersion-corrected density functional theory, 
DFT-D (Chapter 2.3.2.1).2, 10 However, the need of balancing the intra- and 
intermolecular interactions makes DFT-D with any functional and dispersion correction 
that can give worthwhile accuracy very demanding.6, 16  
 Within the Ψcrys framework, periodic semi-empirical quantum-mechanical 
methods (see Chapter 2.3.2.2) can be a significantly less costly alternative.16, 23, 24 Given 
their approximate Hamiltonian, they cannot be used to produce an accurate final crystal 
energy landscape. This chapter tests whether optimisations with density functional tight 
binding methods (DFTB3-D3, see chapter 2.3.2.2.1 for the theory behind it), which are 
up to three orders of magnitude cheaper than DFT-D,16 can be used as an intermediate  
step in CSP, to be followed by a final calculation of Elatt with more accurate models.  
 Another shortcoming of DFT-D and other Ψcrys methods is that the calculation of 
all the molecular and lattice phonon modes to determine the vibrational component of 
free energy is very computationally demanding (note that with the Ψmol method only the 
rigid-body lattice modes are calculated, see Chapter 2.3.3.1).2, 9, 14 Hence another aim of 
this chapter is to verify the ability of DFTB3-D3 to affordably estimate the vibrational 
component of free energy within the harmonic approximation (see Chapter 2.3.3). 
 In the first portion of this chapter, the suitability of DFTB3-D3 as an intermediate 
optimisation method is tested for its ability to improve the geometries and the energy 
rankings of the thousands of crystal structures generated in the searches that were 
carried out in Chapter 5 on five large and flexible molecules.1 The quality of the 
intermediate DFTB3-D3 optimisations is also assessed by performing a final calculation 
of Elatt with a higher-quality wave-function starting from their output. Finally, free energy 
estimates are performed on some of the most competitive crystal structures to test 
whether DFTB3-D3 can be used to carry out fast and reliable phonon calculations. 
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7.2 Methods 
 
7.2.1 DFTB3-D3 intermediate optimisation of all the search-generated structures 
 
The starting point for the refinement procedure tested in this chapter was the set of 
unique crystal structures within 40 kJ·mol-1 of the global minimum in CrystalPredictor25 
lattice energy that had been generated with the search workflow described in Chapter 
5.2.2.2. This set consisted of 9,215 search-generated crystal structures for molecule 
XXVI, 16,744 for GSK269984B, 28,249 for molecule XXIII, 26,650 for molecule XX, 
4,165 for the A-tautomer of mebendazole and 4,284 for its C-tautomer.  
 These crystal structures were optimised with DFTB3-D3, using the programme 
dftb+,26 which required the symmetry of each crystal structure to be reduced to the P1 
space group. The 3OB Slater-Koster files27, 28 were used for the DFTB3 transferable 
parameters, and the missing dispersion interactions were corrected with the atom-
pairwise D3 scheme.29 The D3 damping parameters were chosen as those that minimise 
the errors in centre-of-mass distances of a set of small molecular dimers (S66).30 The 
DFTB3-D3 optimisations were performed with a quasi-Newton scheme as implemented 
in the CRYSTAL14 programme,31 using thresholds of 0.12 a.u. and 0.003 a.u. for root-
mean square (RMS) displacement and RMS gradient respectively.   
 Once all the minimisations were completed, the symmetry of all the crystal 
structures that had been successfully optimised was reintroduced with Platon.32 
Successively, they were clustered to remove duplicates using the Crystal Packing 
Similarity tool33 (see Chapter 2.5.1) available through the CSD Python API (Chapter 
2.6.5).34 Structures were considered as duplicates if they had an energy difference 
smaller than 5 kJ·mol-1, a density difference smaller than 0.1 g·cm-3 and if it was possible 
to match 15/15 molecules, with 20% distance and 20° angle tolerances, with a root mean 
square deviation (RMSD15) smaller than 0.5 Å. When the structures had different 
numbers of molecules in the asymmetric unit cell (Z’), the RMSD15 threshold was reduced 
to 0.1 Å, to avoid the removal of isostructural polymorphs35 with different Z’ and in 
different space groups (see Chapter 8.1 for details).  
 
7.2.2 Final re-ranking using an improved molecular wave-function 
 
The energy ranking calculated with DFTB3-D3 was very different from that computed 
with the Ψmol model with atomic point charges used by CrystalPredictor, and the Elatt 
values had a larger spread than after the search. The distributions of the Elatt values 
before and after the DFTB3-D3 optimisations are shown for each molecule in Appendix 
Figures 7.1-7.6.   
 The high relative energies of the structures matching the experimental forms 
showed that, contrary to the original hope, DFTB3-D3 had not produced a more accurate 
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energy ranking. Since the Elatt values after the intermediate optimisations were clearly 
inadequate, they could not be used to significantly limit the number of crystal structures 
to be taken to the last step of the refinement procedure. However, the intermediate 
minimisations were successful at improving the reproductions of the known experimental 
forms (see Table 7.1). In particular, DFTB3-D3 drastically improved the quality of the 
reproduction of the crystalline conformations, and this was exploited by reverting to the 
Ψmol approach used in the crystal structure generation stage, but with a more accurate 
evaluation of both ΔEintra and Uinter.  
 For all the DFTB3-D3 optimised crystal structures, the wave-function of each 
molecular conformation was calculated at the PBE0 6-31G(d,p) level of theory using 
Gaussian09,36 and distributed multipoles were derived from the charge density using 
GDMA 2.237 (see Chapter 2.3.1.2.2 for details). Finally the intermolecular interactions 
were optimised with DMACRYS38 (see Chapter 2.4.2.1), with the repulsion-dispersion 
component calculated with the empirically-fitted FIT potential.39 The crystal structures 
optimised with this specific method, denoted Ψ𝑚𝑜𝑙
𝑃𝐵𝐸0+𝐹𝐼𝑇,15 were ranked in terms of Elatt. 
ΔEintra was estimated as the difference between the energies of each molecular 
conformation contained in the crystal structures and the PBE0 6-31G(d,p) energy, 
calculated with Gaussian09, of the DFTB3-D3 optimised isolated-molecule global 
minimum conformer. This was used to avoid the absolute values of Elatt being affected 
by a ΔEintra component calculated relative to a conformer optimised with a different wave-
function. Note that this method of calculating ΔEintra does not change the relative energy 
ranking of the computer-generated crystal structures, which is the most important output 
of CSP studies.  
 Given the unreliability of the DFTB3-D3 Elatt ranking, all the unique crystal 
structures within a large window of 50 kJ·mol-1 of the global minimum were optimised 
with the Ψ𝑚𝑜𝑙
𝑃𝐵𝐸0+𝐹𝐼𝑇 method. Despite using a large energy cut-off, its application and the 
removal of duplicates after the DFTB3-D3 optimisations reduced the number of 
structures by a molecule-dependent proportion, which is broken down in Appendix Table 
7.1. A total of 3,346 crystal structures for molecule XXVI, 5,328 for GSK269984B, 13,490 
for molecule XXIII, 19,146 for molecule XX, 3,078 for the A-tautomer of mebendazole 
and 3,352 for its C-tautomer underwent these final optimisations. 
 For each molecule, all the crystal structures within 50 kJ·mol-1 of the global 
minimum in Ψ𝑚𝑜𝑙
𝑃𝐵𝐸0+𝐹𝐼𝑇 Elatt were clustered to remove duplicates. The same clustering 
method and parameters as after the DFTB3-D3 optimisations were utilised, with the only 
difference being that the maximum RMSD15 for two structures to be considered as 
duplicates was raised from 0.5 to 1.0 Å. A stricter threshold had been used when 
performing clustering after the intermediate optimisations to avoid the removal of 
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structures that were deemed to be sufficiently different to converge to different Elatt 
minima in the subsequent stage. 
 
7.2.3 DFTB3-D3 phonon calculations to compute free energies 
 
DFTB3-D3 phonon calculations were performed on few diverse CSP-generated crystal 
structures with low relative Elatt values after the Ψ𝑚𝑜𝑙
𝑃𝐵𝐸0+𝐹𝐼𝑇 optimisations, as well as on 
those matching the experimentally-characterised forms, to verify whether this semi-
empirical method can cheaply and reliably compute the vibrational component of free 
energy (Fvib, see Chapter 2.3.3). Free energy calculations were also performed on the 
two known Z’=2 forms of molecule XXIII,2 which were outside the scope of the Z’=1 
searches performed in Chapter 5; experimental forms C (CSD refcode XAFPAY02) and 
E (XAFPAY04) were optimised with DFTB3-D3 and then with the Ψ𝑚𝑜𝑙
𝑃𝐵𝐸0+𝐹𝐼𝑇 method, and 
then their phonon modes were calculated.  
 The crystal structures output by the Ψ𝑚𝑜𝑙
𝑃𝐵𝐸0+𝐹𝐼𝑇 optimisations had to be                            
re-minimised with DFTB3-D3 before performing phonon calculations using symmetric 
finite displacements. These re-minimisations required one order of magnitude tighter 
thresholds than the intermediate DFTB3-D3 optimisations. The Brillouin zone sampling 
was initially formed by constructing supercells with minimum cell length of 10 Å,40 but 
some were expanded to ensure that a similar number of atoms were included in each 
supercell to enhance error compensation.  
   
7.2.4 Assessment of the results 
 
The results of the crystal structure refinement procedure were assessed by whether the 
experimental forms and the significant computer-generated crystal structures from the 
original CSP studies had been reproduced, as well as by the quality of the reproductions 
and the relative energies of the matches. Two structures were considered to match if the 
Crystal Packing Similarity tool could overlay 15/15 molecules wit 20% distance and 20° 
angle tolerances. In a few cases the tolerances had to be slightly increased to find 
matches with some of the computer-generated significant crystal structures. 
 Some CrystalOptimizer21 (see Chapter 2.4.2.2) minimisations were also 
performed to verify how the geometries and energies obtained after the optimisations 
with DFTB3-D3 and Ψ𝑚𝑜𝑙
𝑃𝐵𝐸0+𝐹𝐼𝑇 compared with those obtained with a more 
computationally expensive Ψmol method. Thus the search-generated crystal structures 
that upon optimisation ended up matching the experimental forms and the significant 
computer-generated crystal structures from the original CSP studies were re-minimised 
with CrystalOptimizer at the PBE0 6-31G(d,p) level of theory for both intramolecular 
interactions and charge density calculations. The CDFs identified by the AUTODOF 
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programme (see Chapter 6.2.4),41 which are shown in Appendix Figure 7.7, were treated 
as explicit CrystalOptimizer variables. AUTODOF was used because it required a small 
amount of human time to setup the calculations and for the affordable computational cost 
of the resulting optimisations, despite its weaknesses (see Chapter 6).  
 Furthermore, the Fvib values obtained with DFTB3-D3 were compared with those 
obtained using the Ψ𝑚𝑜𝑙
𝑃𝐵𝐸0+𝐹𝐼𝑇 model. Rigid-body harmonic phonon calculations were 
performed with DMACRYS on the same crystal structure for which DFTB3-D3 Fvib values 
had been computed. Supercells were constructed using the methodology proposed by 
Nyman and Day,42 with a target k-point distance of 0.12 Å−1 (see Chapter 2.3.3.1). This 
approach assumes that all the molecular modes make an almost identical contribution 
to Fvib,42, 43 in contrast to the DFTB3-D3 calculations that allow the coupling of the 
molecular and lattice modes. 
  
7.3 Results and discussion 
 
7.3.1 Structures matching the experimentally known forms 
 
7.3.1.1 Quality of the reproductions 
 
The quality of reproduction of each solved experimental Z’=1 crystal structure of the five 
molecules and of the molecular conformations within them are shown in Table 7.1. The 
comparisons were performed with the lowest energy matching crystal structures after the  
DFTB3-D3 and Ψ𝑚𝑜𝑙
𝑃𝐵𝐸0+𝐹𝐼𝑇 optimisations. These reproductions are contrasted with those 
achieved upon performing more demanding CrystalOptimizer re-minimisations. 
Table 7.1: Accuracy of the reproductions of the experimental crystal structures (RMSD15) 
and experimental conformations (RMSD1, see Table 7.2 for a visual comparison). Note 
that the molecular conformations were treated as rigid in the final 𝚿𝒎𝒐𝒍
𝑷𝑩𝑬𝟎+𝑭𝑰𝑻 
optimisations with DMACRYS, and so the RMSD1 values were not affected. 
 
Reproduction of the experimental 
conformations (RMSD1) 
Reproduction of the experimental crystal lattices 
(RMSD15) 
Molecule 
(CSD refcode) 
search 
/Å 
DFTB3-
D3/Å 
CrystalOptimi
zer/Å 
search/
Å 
DFTB3-
D3/Å 
𝚿𝒎𝒐𝒍
𝑷𝑩𝑬𝟎+𝑭𝑰𝑻/Å 
CrystalOptimi
zer/Å 
XXVI 
(XAFQIH) 
0.200 0.133 0.123 0.533 0.425 0.376 0.294 
GSK269984B 
(BIFHOP) 
0.093 0.071 0.094 0.219 0.329 0.212 0.210 
XXIII (A, 
XAFPAY) 
0.236 0.216 0.212 0.689 0.680 0.663 0.443 
XXIII  (B, 
XAFPAY01) 
0.278 0.180 0.159 0.626 0.528 0.415 0.373 
XXIII  (D, 
XAFPAY03) 
0.310 0.278 0.237 0.511 0.544 0.583 0.530 
XX (OBEQIX) 0.227 0.137 0.101 0.455 0.469 0.390 0.218 
Mebendazole 
A (TUXPEJ) 
0.201 0.176 0.143 0.465 0.408 0.402 0.321 
Mebendazole 
C (YULGIW) 
0.096 0.067 0.066 0.825 0.763 0.313 0.280 
AVERAGE  0.205 0.157 0.142 0.540 0.518 0.419 0.334 
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 Table 7.2 shows visually how well each experimental conformation was 
reproduced with the various methods. 
Table 7.2: For each molecule, overlay of the experimental molecular conformation/s 
(coloured by element) with the conformation/s contained in the lowest-energy matching 
crystal structure after the DFTB3-D3 optimisations (in red), and after the CrystalOptimizer 
re-minimisations (in blue). The RMSD1 for overlaying the experimental and optimised 
conformations are also indicated. Hydrogen atoms are not shown for clarity. 
   
Molecule XXVI (XAFQIH), DFTB3-D3 RMSD1 = 0.133 Å, 
CrystalOptimizer RMSD1 = 0.123 Å 
GSK269984B (BIFHOP), DFTB3-D3 
RMSD1 = 0.071 Å, CrystalOptimizer 
RMSD1 = 0.094 Å 
 
 
Molecule XX (OBEQIX), DFTB3-D3 RMSD1 = 0.137 Å, 
CrystalOptimizer RMSD1 = 0.101 Å 
Molecule XXIII form A (XAFPAY), 
DFTB3-D3 RMSD1 = 0.216 Å, 
CrystalOptimizer RMSD1 = 0.212 Å 
  
Molecule XXIII form B (XAFPAY01), DFTB3-D3 RMSD1 = 
0.180 Å, CrystalOptimizer RMSD1 = 0.159 Å 
Molecule XXIII form D (XAFPAY03), 
DFTB3-D3 RMSD1 = 0.278 Å, 
CrystalOptimizer RMSD1 = 0.237 Å 
  
Mebendazole form A (TUXPEJ), DFTB3-D3 RMSD1 = 
0.176 Å, CrystalOptimizer RMSD1 =  0.143 Å 
Mebendazole form C (YULGIW), 
DFTB3-D3 RMSD1 = 0.067 Å, 
CrystalOptimizer RMSD1 = 0.066 Å 
 DFTB3-D3 optimisations were effective at improving all the molecular 
conformations from the search-generated crystal structures, with a 23% reduction in the 
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average RMSD1. The improvement in the overall crystal packing was more variable, with 
some becoming slightly worse and some slightly better, with a mere 4% improvement in 
the average RMSD15. Keeping the conformations rigid but optimising the intermolecular 
interactions with a higher quality wave-function improved the reproductions even further, 
leading to an overall reduction of the average RMSD15 of 22% after the Ψ𝑚𝑜𝑙
𝑃𝐵𝐸0+𝐹𝐼𝑇 
minimisations.  
 Both the molecular and crystalline geometries were of a slightly worse quality 
than those obtained after the CrystalOptimizer re-minimisations, which improved the 
average RMSD1 by 31% and an average RMSD15 by 38%. However, the intermediate 
DFTB3-D3 refinements followed by the Ψ𝑚𝑜𝑙
𝑃𝐵𝐸0+𝐹𝐼𝑇 optimisations could be carried out at 
a much lower computational cost and yet successfully reproduce the experimental crystal 
structures. 
 
7.3.1.2 Relative Elatt rankings 
 
The energy ranking of the crystal structures matching the experimentally known forms 
and their stability relative to the global minimum in Elatt at each stage of the refinement 
procedure are shown in Table 7.3, and compared to those obtained in the original 
studies. Visual representations of the crystal energy landscapes obtained after the 
optimisations with the Ψ𝑚𝑜𝑙
𝑃𝐵𝐸0+𝐹𝐼𝑇method are shown in Figure 7.1. 
Table 7.3: Energy ranking and energy difference with the global minimum at each stage 
of the refinement of the crystal structures matching the solved experimental forms. 
These values are compared with their ranking in the original CSP studies. Note that the 
crystal structures of the two tautomers of mebendazole are ranked together. 
Molecule (CSD 
refcode) 
Ranking 
after 
search 
ΔElatt 
after 
search 
/kJ mol-1 
Ranking 
after 
DFTB3-
D3 
ΔElatt after 
DFTB3-
D3/kJ 
mol-1 
Ranking 
after 
𝚿𝒎𝒐𝒍
𝑷𝑩𝑬𝟎+𝑭𝑰𝑻 
ΔElatt after 
𝚿𝒎𝒐𝒍
𝑷𝑩𝑬𝟎+𝑭𝑰𝑻
/kJ mol-1 
Ranking 
in 
original 
CSP 
study 
ΔElatt in 
original 
CSP 
study/kJ 
mol-1 
XXVI (XAFQIH) 262 20.5 208 25.44 2 1.96 2 0.49 
GSK269984B 
(BIFHOP) 
54 6.63 1803 37.2 1 0 1 0 
XXIII (A, 
XAFPAY) 
4311 20.57 3670 33.8 232 12.31 280 13.52 
XXIII  (B, 
XAFPAY01) 
55 7.72 805 23.49 3 0.82 1 0 
XXIII  (D, 
XAFPAY03) 
1318 16.28 3748 33.99 114 10.25 85 9.21 
XX (OBEQIX) 10 3.86 10 2.94 1 0 1 0 
Mebendazole A 
(TUXPEJ) 
2 1.37 14 4.32 1 0 1 0 
Mebendazole C 
(YULGIW) 
92 9.64 101 8.96 15 5.78 4 2.55 
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Figure 7.1: Plots of the crystal energy landscapes obtained after the final optimisations 
with the 𝚿𝒎𝒐𝒍
𝑷𝑩𝑬𝟎+𝑭𝑰𝑻method of (a) molecule XXVI (b) GSK269984B (c) molecule XX (d) 
molecule XXIII and (e) mebendazole. Each point on the plots corresponds to a separate 
crystal structure, labelled according to its space group. The structures matching the 
known experimental forms are indicated. The relative energies of the Z’=2 polymorphs of 
XXIII (XAFPAY02 for form C and XAFPAY04 for form E),2 which were outside the scope of 
the searches performed in Chapter 5, were calculated independently and are only shown 
in Figure 7.3. 
 Table 7.3 shows that DFTB3-D3 energies are inadequate for CSP and in most 
cases the experimental crystal structures are ranked worse than after the searches. On 
the other hand, the final optimisations of just Uinter (i.e. keeping the DFTB3-D3 optimised 
molecular conformations rigid) with the Ψ𝑚𝑜𝑙
𝑃𝐵𝐸0+𝐹𝐼𝑇model drastically improved the relative 
energies. The crystal structures matching the experimental forms were ranked similarly 
to the original CSP studies, which had been performed with more expensive methods. 
For three experimental crystal structures (molecule XX, GSK269984B, and 
mebendazole form A) a match was the global minimum. Matches to experimental form 
B of molecule XXIII, form C of mebendazole and XXVI were all within a few kJ·mol-1 of 
the global minimum, while the structures representing forms A and D of molecule XXIII 
were higher in energy, although still within a sensible energy window considering the 
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issues with predicting the stability of the polymorphs of XXIII with any method (see 
Chapter 7.3.5).2   
 Given the modest improvements they brought to the reproductions of the 
experimental crystal structures, and the poor Elatt ranking, the DFTB3-D3 intermediate 
optimisations may appear to not have been important to obtain the promising results 
shown in Table 7.3 and Figure 7.1. To verify whether this was really the case, for the 100 
lowest energy crystal structures of each molecule (except for molecule XXIII where 250 
were optimised to include all three matches to the known forms), the search-generated 
structures were optimised directly with the Ψ𝑚𝑜𝑙
𝑃𝐵𝐸0+𝐹𝐼𝑇model using DMACRYS, without 
performing the intermediate DFTB3-D3 optimisations. Table 7.4 shows the results. 
Table 7.4: Comparison of the relative energies of the structures matching the 
experimental forms shown in Table 7.3 with those obtained after optimising the same 
search-generated structures directly with the 𝚿𝒎𝒐𝒍
𝑷𝑩𝑬𝟎+𝑭𝑰𝑻model, i.e. without performing the 
intermediate DFTB3-D3 optimisations. 
Experimental crystal 
structure (CSD refcode) 
ΔElatt after 𝚿𝒎𝒐𝒍
𝑷𝑩𝑬𝟎+𝑭𝑰𝑻  with 
DFTB3-D3 intermediate 
optimisation/kJ mol-1 
 ΔElatt after 𝚿𝒎𝒐𝒍
𝑷𝑩𝑬𝟎+𝑭𝑰𝑻 without 
DFTB3-D3 intermediate 
optimisation/kJ mol-1 
XXVI (XAFQIH) 1.96 51.67 
GSK269984B (BIFHOP) 0 0 
XXIII A (XAFPAY) 12.31 17.25 
XXIII B (XAFPAY01) 0.82 10.51 
XXIII D (XAFPAY03) 10.25 14.58 
XX (OBEQIZ) 0 13.13 
Mebendazole A (TUXPEJ)* 0 0 
Mebendazole C (YULGIW)* 5.78 12.78 
 With the exceptions of GSK269984B and the A-tautomer of mebendazole, the 
relative energies of the structures matching the known experimental forms were 
significantly higher in the absence of the intermediate DFTB3-D3 optimisations. The 
values in Table 7.4 could have been worse if the same analysis had been carried out on 
all the thousands of structures that had been optimised with DFTB3-D3 and Ψ𝑚𝑜𝑙
𝑃𝐵𝐸0+𝐹𝐼𝑇 
(see Chapter 7.2.2). The importance of the DFTB3-D3 optimisations is particularly 
evident for XXVI, the largest and most flexible molecule: the match to the experimental 
form becomes so energetically unfavourable in the absence of the intermediate step that 
it would be discarded as an irrelevant crystal structure in a CSP study. The most probable 
explanation is that the geometries of the search-generated structures were poor, 
because of the approximate models used by CrystalPredictor.25 However, the                
DFTB3-D3 intermediate optimisations of all the intra- and intermolecular degrees of 
freedom produce better starting points for the cheap final optimisations of just the 
intermolecular interactions with an improved wave-function. In the absence of this 
intermediate step, expensive optimisations of both intra- and intermolecular degrees of 
freedom with a high-quality wave-function (e.g. with CrystalOptimizer) are required. This 
confirms that performing an intermediate DFTB3-D3 optimisation of search-generated 
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crystal structures can limit the overall computational cost without worsening the quality 
of the results. 
 
7.3.2 The other significant crystal structures 
 
A question that arises is whether the refinement methodology produced not only matches 
to the known experimental forms but also to the other as yet unfound significant crystal 
structures found in the original CSP studies (see Chapter 5.2.2.3 for details). As shown 
in Appendix Tables 7.2-7.6, the vast majority of these structures were reproduced by the 
refinement procedure: out of the 180 targeted PPMs for the five molecules, only 21 were 
not found in the set of Ψ𝑚𝑜𝑙
𝑃𝐵𝐸0+𝐹𝐼𝑇 optimised crystal structures. However, in eight of those 
cases they were already missing after the search, and for a further nine the generated 
structures were poor matches that had been classified as ‘probably found’ in Chapter 5. 
Only four significant structures that had been considered as ‘certainly found’ after the 
searches were lost in the refinement, and these are either towards the high energy end 
of the sample, or similar types of packing are present in the crystal energy landscape.  
 Nonetheless, some of the matches to the significant structures had high relative 
energies, above 20 kJ·mol-1 of the global minimum, and/or had poor overlays with those 
found in the original CSP studies. This can reflect a huge sensitivity to the starting points 
of the optimisations and to subtle changes in conformation, particularly when hydrogen 
bonds can be intra- or intermolecular as in GSK269984B.5 This is further highlighted by 
how the relative energies and the geometries were often different from the original CSP 
studies in both the DFTB3-D3 and Ψ𝑚𝑜𝑙
𝑃𝐵𝐸0+𝐹𝐼𝑇 optimisations and in the CrystalOptimizer 
re-minimisations.  
 Since the great majority of these crystal structures have not yet been 
experimentally found, it is impossible to determine which of these energies and 
geometries are more realistic. However, it is a success of the refinement methodology 
used in this chapter that most of the competitive structures found in the original CSP 
studies were reproduced as low energy and at a reduced computational cost. 
 
7.3.3 Phonon calculations 
 
The calculation of phonons by DFTB3-D3 methods proved difficult to automate. The 
recipe of only needing supercells to have a minimum length of 10 Å proved insufficient 
to converge the Brillouin sampling so that the difference in Fvib between structures could 
be converged below 1 kJ·mol-1. However, expanding some supercells to guarantee that 
a similar number of atoms was present in each improved the convergence. 
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Figure 7.2: For some key CSP-generated crystal structures of each molecule, the relative 
vibrational contributions ΔFvib, which can be added to Elatt to calculate the Helmholtz free 
energy (A, see Equation 2.37). For each molecule, ΔFvib is calculated relative to the 
structure which is the Elatt global minimum after the 𝚿𝒎𝒐𝒍
𝑷𝑩𝑬𝟎+𝑭𝑰𝑻 optimisations, for which 
ΔFvib = 0. The structures matching the experimentally known forms are indicated in 
green. The rigid-body modes are pure lattice modes, calculated with the 𝚿𝒎𝒐𝒍
𝑷𝑩𝑬𝟎+𝑭𝑰𝑻 model 
using DMACRYS. Full details about the crystal structures and their energies can be 
found in Appendix Table 7.7. 
 Overall, the DFTB3-D3 phonons do not cause significant re-ranking; the most 
notable exception is for molecule XXVI, where the experimental crystal structure 
becomes lower in free energy than the Elatt global minimum (see Appendix Table 7.7). 
 It is clear that the inclusion of all the molecular and lattice modes in the DFTB3-
D3 calculations leads to a wider range of free energy differences than when only the 
rigid-body phonons are considered. This is because the packing forces in different 
polymorphs can affect the lowest frequency (i.e. the most flexible) molecular phonon 
modes, which makes the calculation of the coupling of intra- and intermolecular modes 
important to compute accurate free energy differences. Hence the rigid-body phonons 
calculated with the Ψ𝑚𝑜𝑙
𝑃𝐵𝐸0+𝐹𝐼𝑇 method described in Chapter 7.2.4 can be unrealistic for 
large and flexible molecules as they ignore this coupling.  
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7.3.4 Computational cost 
 
Table 7.5: Comparison between the computational costs needed to optimise and re-rank 
the search-generated structures in the original CSP studies and with the refinement 
method outlined in this chapter. See Appendix Table 7.8 for a breakdown of the 
computational cost of the latter. 
Molecule Saving in CPU hours % difference 
XXVI ~220,000 -90 
 
 
GSK269984B Not recorded / 
XX ~70,000 -70 
XXIII ~40,000 -70 
Mebendazole  ~2,000 -30 
Table 7.5 shows that the savings in computational cost with the refinement procedure 
used in this study were large.  The smallest savings (~30%) were for the two tautomers 
of mebendazole, which is the least complex molecule in terms of size and conformational 
flexibility, and the greatest were for molecule XXVI (~90%). Some of this reduction in 
computational cost would be due to the use of different computer clusters, but the 
savings from replacing CrystalOptimizer and sometimes intermediate optimisations with 
DFTB3-D3 followed by Ψ𝑚𝑜𝑙
𝑃𝐵𝐸0+𝐹𝐼𝑇 calculations are drastic and increase with molecular 
size and flexibility. This is very important in the context of this thesis, as it seems that 
introducing an intermediate DFTB3-D3 optimisation step could aid the scaling of CSP 
studies to molecules of pharmaceutical interest. 
 The DFTB3-D3 phonon calculations were much more expensive than the 
Ψ𝑚𝑜𝑙
𝑃𝐵𝐸0+𝐹𝐼𝑇 ones, as shown in Appendix Table 7.8. However, DFTB3-D3 computes both 
the lattice and molecular modes at a reasonable computational cost, while in the Ψmol 
method the latter are assumed not to vary between different polymorphs. On the other 
hand, calculating all the phonon modes with DFT-D for several crystal structures is often 
unfeasibly expensive.2, 44 
   
7.3.5 Discussion 
 
This chapter pioneers the use of DFTB methods for CSP studies of pharmaceuticals. 
Full DFTB3-D3 optimisations seem to be effective as an intermediate step in the final 
refinement stage of CSP. Although they provide unreliable energy rankings, they improve 
the geometries of both the crystal structures and the molecular conformations. In 
particular, the results shown in Table 7.1 and Table 7.2 suggest that DFTB3-D3 is of 
similar accuracy to CrystalOptimizer optimisations in reproducing the experimental 
conformations, as judged by RMSD1 values. The only exception is form D of molecule 
XXIII, where the optimisations have found a visually different conformation from the 
experimental one because of a poor search-generated starting point. 
 This intermediate refinement step provides a good starting point for a final 
calculation of Elatt with an improved wave-function, which in this study was performed via 
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an optimisation of the intermolecular interactions with the Ψ𝑚𝑜𝑙
𝑃𝐵𝐸0+𝐹𝐼𝑇 model using 
DMACRYS. This procedure led to slightly worse reproductions of the experimental 
crystal structures in terms of RMSD15 compared to the CrystalOptimizer optimisations, 
but to energy rankings similar to those obtained in the original CSP studies at a lower 
computational cost (see Table 7.5).  
 The cost savings brought by the intermediate DFTB3-D3 optimisations are 
important for extending CSP to the large and flexible molecules in pharmaceutical 
development. DFTB3-D3 scales as N·ln(N) , in contrast to N3 for periodic DFT-D 
methods,26 where N is the number of atoms in the unit cell. Furthermore, the cost of the 
Ψmol optimisations with CrystalOptimizer scales badly with the number of CDFs that are 
treated as explicit variables (see Chapter 6.3.3).21  
 The disappointment is that the relative energies produced by DFTB3-D3 are too 
poor (see Appendix Figures 7.1-7.6) to allow a confident, drastic reduction in the number 
of structures to be investigated with more accurate methods. This is probably due to the 
theoretical limitations of this methodology.24, 45 It appears that despite the clear 
advantages of optimising all intra- and intermolecular degrees of freedom at once, 
accurate crystal energy landscape cannot be calculated with a simplified wave-function. 
The long-range electrostatic interactions are described by atomic charges in both 
DFTB3-D3 and in the crystal generation stage, but by atomic multipoles in the final 
energy evaluation, and the quality of the electrostatic model is very critical in CSP, 
particularly in the presence of hydrogen bonds;46 this may explain why the final energy 
ranking appears to be much more accurate than the initial and intermediate ones. 
However, the improvement in the crystalline geometries and in particular in the molecular 
conformations brought by DFTB3-D3 optimisations was fundamental to perform accurate 
calculations with the Ψ𝑚𝑜𝑙
𝑃𝐵𝐸0+𝐹𝐼𝑇 model, as shown in Table 7.4. 
 The phonon calculations with the Ψcrys approach, which can be affordably 
performed for several crystal structures only using DFTB3-D3, are conceptually different 
from those performed with the rigid-body Ψmol method42 in allowing the coupling of the 
molecular and lattice modes. This leads to an even larger spread of Fvib values than using 
the rigid-body model (see Figure 7.2), which is already comparable with polymorphic 
energy differences,42, 43 raising the question as to whether thermal effects are likely to be 
more significant in determining the relative thermodynamic stability of pharmaceutical 
polymorphs than they are for more rigid molecules, particularly in the presence of large 
conformational and density differences. DFTB3-D3 has the potential of making the 
modelling of all phonon contributions to free energies more widespread in CSP. The 
DFTB3-D3 Fvib values can be added to Elatt values calculated with the Ψmol method (like 
in this chapter) or with an accurate Ψcrys method like DFT-D. However, some 
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benchmarking against experimental data (e.g. by Terahertz time-domain spectroscopy)47 
is needed to test the actual accuracy of the DFTB3-D3 phonon calculations. 
 Furthermore, thermal expansion is likely to be important for both absolute44 and 
relative free energies.14, 43, 48 Although this phenomenon can be modelled with the     
quasi-harmonic approximation,43 the validity of this approach is questionable for large 
molecules where methyl groups may be rotating and phenyl rings may have different 
large amplitude of motions, depending on the packing. Hence, the potential energy 
surface should be explored more explicitly, for example by molecular dynamics 
simulations,49 as none of the methodologies currently available can fully describe all the 
possible thermal effects that can affect crystal structures and their relative free energy 
ranking.   
 Among the five molecules considered in this chapter, polymorphic molecule XXIII 
poses the most significant challenges to CSP methodologies. Looking at Figure 7.1d it 
is clear that although the three Z’=1 polymorphs are all successfully reproduced by the 
refinement methodology and are ranked among the most competitive crystal structures, 
nothing differentiates them from a plethora of alternatives. Only form B is close to the 
bottom of the crystal energy landscape, while forms A and D are above 10 kJ·mol-1 of 
the global minimum together with several unfound competitors. Two further Z’=2 
polymorphs have been characterised experimentally. Although they were outside the 
scope of the searches, their experimental crystal structures were optimised with             
DFTB3-D3 and Ψ𝑚𝑜𝑙
𝑃𝐵𝐸0+𝐹𝐼𝑇 to calculate the relative energy rankings of the structures 
matching to the five known forms. A comparison with the energy rankings obtained using 
different models in the 6th Blind Test2 is shown in Figure 7.3. It is clear that the relative 
stabilities of the known forms of molecule XXIII are very sensitive to the energy model. 
This highlights the challenges of producing an accurate stability ranking between 
polymorphs, and more CSP studies performed in collaboration with experimentalists in 
industry and academia are needed to provide benchmarks and improve the models. 
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Figure 7.3: Relative energies of the five polymorphs of molecule XXIII calculated in this 
study compared with those reported by the participants of the 6th Blind Test. Note that 
values linked by dashed lines denote changes from adding free energy estimates. The 
number in parentheses corresponds to the group identifier, with R denoting participants 
who only optimised crystal structures generated by others.2 
 
7.4 Conclusion 
 
An intermediate optimisation with the Ψcrys semi-empirical quantum-mechanical method 
DFTB3-D3 revealed to be suitable for reducing the computational cost of the final 
refinement stage of CSP of five large and flexible molecules. Although DFTB3-D3 does 
not produce a sufficiently accurate Elatt energy ranking, it improves the geometrical 
representation of the crystal structures and in particular of the molecular conformations, 
and it outputs good starting points for better energy calculations to be carried out with a 
more accurate wave-function. In this chapter, this final evaluation of Elatt was performed 
by optimising the intermolecular interactions with the Ψ𝑚𝑜𝑙
𝑃𝐵𝐸0+𝐹𝐼𝑇model, which produced 
results comparable in quality to those obtained in the original CSP studies but at a largely 
reduced computational cost. On top of producing accurate matches to the experimental 
forms, and placing them close to the bottom of the crystal energy landscapes, this 
refinement methodology was also successful at reproducing most of the significant as 
yet unfound crystal structures found in the original CSP studies. It is likely that accurate 
crystal energy landscapes could also be produced following the DFTB3-D3 optimisations 
with other methods to accurately evaluate Elatt, e.g. single-point DFT-D calculations, 
although some testing is required. Furthermore DFTB3-D3 can perform affordable 
calculations of both the molecular and lattice phonon modes, which can be used to 
calculate the vibrational component of free energy. These calculations suggest that the 
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thermal effects may cause more significant re-ranking for flexible pharmaceuticals than 
for smaller, more rigid molecules.  
 These results are very important in the context of this thesis. First of all,       
DFTB3-D3 seems to be suitable to bridge the gap between the cheap approximate 
models used in the searches and the expensive accurate models needed to produce an 
accurate final crystal energy landscape. A combination of this refinement approach (or 
suitable alternatives based on the same principles) with the search workflow described 
in Chapter 5 could produce a complete CSP method cheaper than other competitors and 
more scalable to larger and more flexible targets, but of similar accuracy.  
 Furthermore, this study has confirmed that crystal structure vibrations can have 
important effects on the relative stability of polymorphs, and that the vibrational 
component of free energy depends not only on the lattice but also on the molecular 
modes, whose neglecting in Ψmol methods42 can be the source of inaccuracies.              
DFTB3-D3 allows an affordable calculation of all phonon modes, and the resulting Fvib 
can be combined with Elatt computed with higher-quality models to produce a relatively 
cheap estimate of the Helmholtz free energy. However, some benchmarking of the 
DFTB3-D3 Fvib values is needed. 
 Finally, this study confirms that the difficulty of a CSP study is very                    
molecule-dependent and not easily predictable. Two similarly linear extended molecules 
like XX and XXIII have very different crystal energy landscapes: while the prediction of 
the only known crystal structure of the first is straightforward, the latter has a complex 
polymorphic behaviour that reveals how current models still face significant challenges 
in determining the set of thermodynamically competitive crystal structures, let alone in 
predicting how predicted forms could be experimentally produced. CSP is far from a 
solved problem. Although the work discussed in this chapter is a step towards extending 
CSP studies to more molecules of pharmaceutical interest, significant developments are 
needed before computational modelling can predict which crystal structures would form 
under specific experimental conditions. 
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7.6 Appendix 
 
  
Appendix Figure 7.1: Plot showing the energy distribution of the computer-generated 
crystal structures of molecule XXVI at the various stages of the CSP refinement 
procedure outlined in this chapter.  
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Appendix Figure 7.2: Plot showing the energy distribution of the computer-generated 
crystal structures of GSK269984B at the various stages of the CSP refinement procedure 
outlined in this chapter.  
 
Appendix Figure 7.3: Plot showing the energy distribution of the computer-generated 
crystal structures of molecule XX at the various stages of the CSP refinement procedure 
outlined in this chapter.  
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Appendix Figure 7.4: Plot showing the energy distribution of the computer-generated 
crystal structures of molecule XXIII at the various stages of the CSP refinement 
procedure outlined in this chapter.  
 
Appendix Figure 7.5: Plot showing the energy distribution of the computer-generated 
crystal structures of the A-tautomer of mebendazole at the various stages of the CSP 
refinement procedure outlined in this chapter.  
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Appendix Figure 7.6: Plot showing the energy distribution of the computer-generated 
crystal structures of the C-tautomer of mebendazole at the various stages of the CSP 
refinement procedure outlined in this chapter.  
 
Appendix Table 7.1: For each molecule, origin of the reduction in the number of crystal 
structures that were taken to the final optimisation with the 𝚿𝒎𝒐𝒍
𝑷𝑩𝑬𝟎+𝑭𝑰𝑻 model. 
  
# 
structures 
of mol. 
XXVI 
#structures of 
GSK269984B   
# structures 
of mol. XXIII 
# structures  
of molecule 
XX 
# structures 
of mbz A-
tautomer 
# structures 
of mbz C-
tautomer 
Original 
CrystalPredictor 
structures 
9215 16744 28249 26650 4165 4284 
Removing 
structures 
becoming 
duplicates with 
DFTB3-D3  
8821 16569 27866 26278 4147 4267 
Removing wrong 
molecules* 
8583 16270 27866 26098 4124 4238 
Clustering DFTB3-
D3 with looser 
criteria 
7534 13829 23682 19251 3083 3362 
Applying the 50 
kJ·mol-1 cut-off to 
DFTB3-D3 
energies 
3346 5238 13490 19146 3078 3352 
*In a few cases the DFTB3-D3 optimisations wrongly changed the covalent bonding of the molecule. 
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Appendix Figure 7.7: Chemical diagram of each molecule considered in this study, with 
indicated torsion angles (black arrows) and bond-angles (red arcs) treated as 
independent degrees of freedom in the CrystalOptimizer re-minimisations of some key 
search-generated crystal structures. The optimised CDFs were selected by AUTODOF.41  
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Appendix Table 7.2: Reproduction and ranking of the matches to the significant crystal 
structures of molecule XXVI that were found in the original CSP study. The structure 
highlighted in green matches the experimental form. The significant crystal structures for 
which a good match was not found are classified: in blue where they were not found by 
the search, in turquoise where they had a poor match in the search, and in red where 
structures were missed despite having a good match in the search. The structures in 
orange were found after 𝚿𝒎𝒐𝒍
𝑷𝑩𝑬𝟎+𝑭𝑰𝑻 at ΔElatt > 20 kJ·mol-1. In a few cases, the distance and 
angle tolerances had to be increased to 30% and 30° respectively to obtain a match, and 
the RMSD15 values for these structures are shown in italics. 
Structure 
name 
Found ? 
Old CSP  
rank 
Ranking 
after 
𝚿𝒎𝒐𝒍
𝑷𝑩𝑬𝟎+𝑭𝑰𝑻 
Old CSP 
study ΔElatt 
/kJ·mol-1 
𝚿𝒎𝒐𝒍
𝑷𝑩𝑬𝟎+𝑭𝑰𝑻 
ΔElatt 
/kJ·mol-1 
RMSD15 
after 
𝚿𝒎𝒐𝒍
𝑷𝑩𝑬𝟎+𝑭𝑰𝑻  
CrystalOpti
mizer ΔElatt 
/kJ·mol-1 
3525 YES 1 7 0.00 6.03 0.48 0.23 
1600 YES 2 2 0.49 1.96 0.528 0.00 
675 YES 3 10 2.60 6.97 0.284 3.45 
38 YES 4 4 4.15 4.45 0.195 5.17 
421 YES 5 10 5.43 6.97 0.286 3.43 
3104 YES 6 33 5.65 10.90 0.178 6.63 
615 YES 7 91 6.28 16.12 0.37 6.79 
239 YES 8 29 6.38 10.63 0.389 6.94 
2930 YES 9 161 6.56 18.99 0.421 3.70 
354 YES 10 147 6.88 18.58 0.398 8.31 
851 YES (high energy) 11 272 7.04 22.54 0.359 7.43 
6460 YES 12 31 7.11 10.79 0.931 8.26 
6335 YES 13 100 7.45 16.41 0.452 8.15 
221 YES 14 31 7.46 10.79 0.483 8.29 
2231 YES 15 5 7.57 4.77 0.33 6.32 
2496 NOT IN SEARCH 16 \ 7.93 \ \ \ 
185 YES (high energy) 17 369 8.10 24.61 0.621 9.05 
4201 POOR IN SEARCH 18 \ 8.21 \ \ \ 
314 YES 19 23 8.22 9.83 0.322 10.55 
508 YES 20 132 8.29 18.02 0.298 7.16 
4946 YES 21 165 19.14 16.30 0.475 5.09 
6879 YES 22 115 8.51 17.18 0.229 10.33 
506 YES 23 59 8.62 13.98 0.481 10.05 
4842 YES 24 46 8.83 12.85 0.645 7.03 
43 YES 25 3 9.02 4.35 0.439 9.03 
1236 YES 26 8 9.15 6.24 0.318 9.48 
1537 YES 27 12 9.16 7.76 0.334 9.73 
188 YES 28 14 9.41 8.39 0.942 9.47 
5126 YES 29 180 10.05 19.77 0.513 10.54 
444 YES 30 6 10.12 4.92 0.137 9.64 
544 YES (high energy) 31 272 10.28 22.54 0.377 7.44 
686 YES 32 25 10.34 9.86 0.211 10.78 
89 POOR IN SEARCH 33 \ 10.44 \ \ \ 
20 YES 34 70 10.69 14.78 0.932 \ 
83 YES 35 88 10.82 15.93 0.398 10.74 
2591 NO 132 \ 17.03 \ \ \ 
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Appendix Table 7.3: Reproduction and ranking of the matches to the significant crystal 
structures of GSK269984B that were found in the original CSP study. The structure 
highlighted in green matches the experimental form. The significant crystal structures for 
which a good match was not found are classified: in blue where they were not found by 
the search, in turquoise where they had a poor match in the search, and in red where 
structures were missed despite having a good match in the search. The structures in 
orange were found after 𝚿𝒎𝒐𝒍
𝑷𝑩𝑬𝟎+𝑭𝑰𝑻 at ΔElatt > 20 kJ·mol-1. In a few cases, the distance and 
angle tolerances had to be increased to 30% and 30° respectively to obtain a match, and 
the RMSD15 values for these structures are shown in italics. 
Structure 
name 
Found ? 
Old 
CSP  
rank 
Ranking 
after 
𝚿𝒎𝒐𝒍
𝑷𝑩𝑬𝟎+𝑭𝑰𝑻 
Old CSP 
study 
ΔElatt 
/kJ·mol-1 
𝚿𝒎𝒐𝒍
𝑷𝑩𝑬𝟎+𝑭𝑰𝑻 
ΔElatt 
/kJ·mol-1 
RMSD15 
after 
𝚿𝒎𝒐𝒍
𝑷𝑩𝑬𝟎+𝑭𝑰𝑻  
CrystalOpti
mizer ΔElatt 
/kJ·mol-1 
180Intra10 YES 1 1 0.00 0.00 0.135 0.00 
90InterB36 YES (high energy) 2 684 0.53 22.50 0.525 17.13 
180InterA11 YES (high energy) 3 543 2.06 20.84 0.407 16.72 
180InterA8 YES 4 17 2.76 7.59 0.581 10.83 
180InterB6 YES (high energy) 5 820 3.26 23.91 0.34 19.79 
180Intra8 YES 6 179 3.55 15.50 0.375 8.56 
180Intra38 POOR IN SEARCH 7 \ 3.62 \ \ \ 
180InterB9 YES 8 278 3.80 17.36 0.394 8.58 
180Intra76 YES 9 98 4.24 13.15 0.47 8.51 
180InterA22 YES 10 269 4.36 17.24 0.726 17.97 
90InterB6 NOT IN SEARCH 11 \ 4.61 \ \ \ 
180Intra19 YES 12 23 4.66 8.28 0.189 10.27 
180Intra74 YES 13 34 5.00 9.38 0.366 9.42 
180Intra4 YES 14 42 5.04 9.93 0.385 9.26 
180InterA60 YES 15 404 5.08 19.19 0.161 16.73 
180Intra2 YES 16 6 5.16 5.28 0.204 6.85 
180InterA3 NOT IN SEARCH 17 \ 5.32 \ \ \ 
180InterA30 YES 18 329 5.39 18.30 0.094 17.62 
180Intra83 NOT IN SEARCH 19 \ 5.40 \ \ \ 
180Intra56 POOR IN SEARCH 20 \ 5.44 \ \ \ 
180InterA7 YES 21 417 5.81 19.34 0.428 17.44 
90Intra31 YES 22 464 5.88 19.81 0.368 16.86 
180Intra32 YES 23 169 6.15 15.25 0.18 12.68 
180InterA18 POOR IN SEARCH 24 \ 6.19 \ \ \ 
180Intra92 YES 25 49 6.35 10.40 0.932 8.34 
180InterA12 YES 26 483 6.47 19.97 0.355 18.20 
180InterA29 YES (high energy) 27 765 6.51 23.34 0.298 19.19 
180InterB10 YES (high energy) 28 1418 6.53 29.12 0.471 21.50 
90InterA14 NOT IN SEARCH 29 \ 6.62 \ \ \ 
180Intra84 YES 30 61 6.67 11.15 0.258 8.54 
180Intra47 YES 31 77 6.72 12.05 0.162 11.28 
180Intra65 YES 32 28 6.81 8.78 0.116 12.00 
90InterA32 YES (high energy) 33 1412 6.89 29.09 0.26 24.66 
180Intra5 YES 34 56 6.94 10.99 0.329 11.61 
180Intra28 YES 35 21 7.08 8.06 0.208 11.36 
180InterA26 YES 36 483 7.16 19.97 1.441 18.28 
180InterB87 YES (high energy) 37 1051 7.18 26.08 0.265 20.29 
180Intra57 YES 38 24 7.43 8.50 0.764 12.21 
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Appendix Table 7.4: Reproduction and ranking of the matches to the significant crystal 
structures of molecule XX that were found in the original CSP study. The structure 
highlighted in green matches the experimental form. The structures in red were missed 
despite having a good match in the search. The structures in orange were found after 
𝚿𝒎𝒐𝒍
𝑷𝑩𝑬𝟎+𝑭𝑰𝑻 at ΔElatt > 20 kJ·mol-1. In a few cases, the distance and angle tolerances had to 
be increased to 30% and 30° respectively to obtain a match, and the RMSD15 values for 
these structures are shown in italics. 
Structure 
name 
Found ? 
Old 
CSP  
rank 
Ranking 
after 
𝚿𝒎𝒐𝒍
𝑷𝑩𝑬𝟎+𝑭𝑰𝑻 
Old CSP 
study ΔElatt 
/kJ·mol-1 
𝚿𝒎𝒐𝒍
𝑷𝑩𝑬𝟎+𝑭𝑰𝑻 
ΔElatt 
/kJ·mol-1 
RMSD15 
after 
𝚿𝒎𝒐𝒍
𝑷𝑩𝑬𝟎+𝑭𝑰𝑻  
CrystalOpti
mizer ΔElatt 
/kJ·mol-1 
dfAa132 YES 1 1 0.00 0.00 0.308 0.00 
dfAc102 YES 2 2 0.78 2.98 0.217 2.16 
dfAa180 YES 3 5 2.38 8.08 0.357 3.01 
dfAc14 YES 5 7 5.59 9.34 0.19 5.37 
dfAc48 YES 10 3 6.15 4.91 0.429 8.83 
dfAc19 
 
YES 6 6 6.42 9.13 0.658 5.87 
dfAc7 YES 12 14 7.26 9.97 0.186 8.12 
dfAc43 NO 14 \ 7.69 \ \ \ 
dfAc17 YES 15 9 7.86 9.72 0.307 10.97 
dfAc172 YES 16 25 7.97 11.53 0.528 7.76 
dfAc29 YES 17 129 8.19 15.70 0.49 6.93 
dfAb181 YES (high energy) 22 1135 9.12 24.00 0.671 10.14 
dfAd152 YES 23 314 9.13 18.96 0.839 8.33 
dfAc86 YES 24 13 9.36 9.92 0.329 8.91 
dfAc67 YES 25 20 9.48 11.14 0.142 9.39 
dfAa277 YES 27 43 9.70 12.85 0.16 9.12 
dfAa4 YES 28 54 9.76 13.50 0.579 10.44 
dfAa1 YES 29 115 9.78 15.51 0.419 11.51 
dfAb161 YES 31 59 9.88 13.74 0.395 9.51 
dfAb1 YES 32 34 9.90 12.41 0.245 10.20 
dfAd79 YES 33 112 9.93 15.43 0.346 8.20 
dfBa28 NO 47 \ 11.44 \ \ \ 
 
Appendix Table 7.5: Reproduction and ranking of the matches to the significant crystal 
structures of molecule XXIII that were found in the original CSP study. The structures 
highlighted in green match the experimental forms. The significant crystal structures for 
which a good match was not found are classified: in blue where they were not found by 
the search, in turquoise where they had a poor match in the search, and in red where 
structures were missed despite having a good match in the search. The structures in 
orange were found after 𝚿𝒎𝒐𝒍
𝑷𝑩𝑬𝟎+𝑭𝑰𝑻 at ΔElatt > 20 kJ·mol-1.  In a few cases, the distance and 
angle tolerances had to be increased to 30% and 30° respectively to obtain a match, and 
the RMSD15 values for these structures are shown in italics. 
Structure 
name 
Found ? 
Old 
CSP  
rank 
Ranking 
after 
𝚿𝒎𝒐𝒍
𝑷𝑩𝑬𝟎+𝑭𝑰𝑻 
Old CSP 
study ΔElatt 
/kJ·mol-1 
𝚿𝒎𝒐𝒍
𝑷𝑩𝑬𝟎+𝑭𝑰𝑻 
ΔElatt 
/kJ·mol-1 
RMSD15 
after 
𝚿𝒎𝒐𝒍
𝑷𝑩𝑬𝟎+𝑭𝑰𝑻  
CrystalOpti
mizer ΔElatt 
/kJ·mol-1 
A1361 YES 1 1 0.00 0.00 0.117 1.27 
A70 YES 2 3 1.66 0.83 0.168 0.00 
A6494 POOR IN SEARCH 3 \ 2.13 \ \ \ 
A691 YES 4 5 3.38 1.46 0.293 0.21 
A3457 YES 5 7 3.68 2.04 0.312 1.40 
A72 YES 6 24 3.81 5.47 0.355 2.15 
A424 YES 7 6 4.41 1.81 0.253 1.64 
A771 YES 8 4 4.64 0.85 0.173 1.20 
A191 NO 9 \ 5.07 \ \ \ 
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A4890 YES 10 66 5.46 8.35 0.703 9.04 
A5191 NOT IN SEARCH 11 \ 5.52 \ \ \ 
A272 YES 12 35 5.68 6.53 0.664 6.17 
A63 POOR IN SEARCH 13 \ 6.05 \ \ \ 
A118 YES 14 2 6.13 0.17 0.281 2.69 
A75 YES 15 27 6.29 5.73 0.58 2.17 
A1413 YES 16 12 6.33 3.59 0.133 2.28 
A2457 YES 17 34 6.66 6.41 0.594 11.13 
A587 YES 18 59 6.85 7.93 0.358 7.41 
A2417 YES 19 40 6.97 6.91 0.434 8.25 
A138 YES 20 111 7.17 10.02 0.594 5.36 
A227 YES 21 52 7.34 7.64 0.3 5.20 
A1949 YES 22 279 7.61 13.00 1.107 5.34 
A3174 NOT IN SEARCH 23 \ 7.76 \ \ \ 
A2054 NOT IN SEARCH 24 \ 7.81 \ \ \ 
A3023 YES 25 153 7.85 10.89 0.27 6.96 
A2311 YES 26 216 7.86 12.04 0.233 11.15 
A3513 YES 27 82 7.97 9.09 0.52 8.47 
A1109 YES 28 231 7.99 12.30 0.424 6.74 
A894 POOR IN SEARCH 29 \ 8.07 \ \ \ 
A1422 YES 30 68 8.15 8.44 0.603 9.77 
A1127 YES 31 99 8.15 9.74 0.376 7.05 
A6634 POOR IN SEARCH 32 \ 8.34 \ \ \ 
A282 YES 33 155 8.81 10.93 0.213 13.68 
A323 YES 34 85 8.85 9.16 0.865 8.96 
A2715 YES 35 141 8.92 10.68 0.226 10.99 
A24995 YES 36 55 8.98 7.79 0.248 7.23 
A3746 NO 37 233 8.99 12.34 0.618 5.26 
A368 YES 38 239 9.06 12.36 0.509 7.76 
A6738 YES 39 1080 9.07 19.28 1.009 11.00 
A4228 YES 40 93 9.08 9.58 0.533 4.59 
A1752 YES 41 13 9.16 3.87 0.227 4.26 
A113 YES 42 31 9.17 6.02 0.315 4.49 
A3750 YES 43 87 9.19 9.21 0.198 12.60 
A505 YES 44 217 9.27 12.06 0.314 11.16 
A12658 YES 45 61 9.56 7.96 0.224 6.78 
A1918 YES 46 37 9.64 6.69 0.797 7.99 
A1411 YES 47 950 9.72 18.49 1.035 20.35 
A5145 YES 48 711 9.92 16.92 0.674 7.48 
A710 YES 49 302 9.98 13.37 0.677 12.31 
B204 YES 66 401 10.93 14.45 0.672 5.39 
B60 YES 83 160 11.65 11.04 0.441 8.80 
B184 YES (high energy) 100 1379 12.36 20.69 0.717 10.22 
Exptal A YES (167
) 
232 13.60 12.31 0.664 10.78 
 
Appendix Table 7.6: Reproduction and ranking of the matches to the significant crystal 
structures of mebendazole that were found in the original CSP study. The structures 
highlighted in green match the experimental forms. The structures in orange were found 
after 𝚿𝒎𝒐𝒍
𝑷𝑩𝑬𝟎+𝑭𝑰𝑻 at ΔElatt > 20 kJ·mol-1. In a few cases, the distance and angle tolerances had 
to be increased to 30% and 30° respectively to obtain a match, and the RMSD15 values for 
these structures are shown in italics. 
Structure 
name 
Found ? 
Old 
CSP  
rank 
Ranking 
after 
𝚿𝒎𝒐𝒍
𝑷𝑩𝑬𝟎+𝑭𝑰𝑻 
Old CSP 
study ΔElatt 
/kJ·mol-1 
𝚿𝒎𝒐𝒍
𝑷𝑩𝑬𝟎+𝑭𝑰𝑻 
ΔElatt 
/kJ·mol-1 
RMSD15 
after 
𝚿𝒎𝒐𝒍
𝑷𝑩𝑬𝟎+𝑭𝑰𝑻  
CrystalOpti
mizer ΔElatt 
/kJ·mol-1 
A788 YES 1 1 0.00 0.00 0.164 0.00 
A19 YES 2 2 2.15 0.85 0.258 \ 
C27 YES 3 3 2.54 1.79 0.128 2.66 
C5 YES 4 15 2.54 5.78 0.142 2.51 
C10 YES 5 6 2.63 3.51 0.103 2.31 
A50 YES 6 10 3.15 4.65 0.795 4.69 
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A37 YES 7 5 4.07 2.11 0.234 4.41 
C23 YES 8 36 4.33 7.89 0.255 6.12 
C73 YES 9 51 4.33 9.63 0.219 7.95 
C406 YES 10 93 4.68 11.62 0.172 12.75 
A53 YES 11 11 4.81 4.75 0.347 4.67 
C53 YES 12 35 5.48 7.74 0.121 5.25 
C25 YES 13 18 5.50 6.57 0.097 5.22 
A173 YES 14 126 5.66 12.80 0.333 10.69 
A72 YES 15 101 5.75 11.90 0.214 5.79 
A49 YES 16 17 5.79 6.52 0.88 6.18 
A78 YES 17 12 5.93 5.34 0.097 5.73 
A90 YES 18 7 5.97 3.53 0.193 5.67 
A291 YES 19 23 6.14 7.13 0.273 6.85 
C248 YES 20 29 6.17 7.47 0.166 6.03 
A306 YES 21 91 6.27 11.53 0.413 6.53 
C46 YES 22 25 6.30 7.20 0.106 7.08 
C24 YES 23 22 6.36 7.04 0.228 6.69 
C115 YES 24 37 6.47 7.91 0.32 6.50 
C509 YES 25 72 6.61 10.60 0.374 6.81 
C583 YES 26 448 6.62 19.25 0.304 14.60 
A202 YES 27 20 6.72 6.78 0.764 7.78 
C106 YES 28 53 6.72 9.65 0.506 6.62 
A143 YES 29 28 7.19 7.36 0.19 6.94 
A89 YES 30 40 7.33 8.42 0.17 7.33 
C908 YES 31 43 7.42 8.77 0.296 7.51 
CCis32 YES (high energy) 67 578 18.00 20.86 0.106 18.82 
 
 
 
Appendix Table 7.7: Structures selected for phonon calculations for each molecule. For 
each structure the identifier is indicated, together with its density and Elatt after the 
optimisations with the 𝚿𝒎𝒐𝒍
𝑷𝑩𝑬𝟎+𝑭𝑰𝑻 model, the variations in Fvib and in the Helmholtz free 
energies (ΔA), calculated using the rigid body and the DFTB3-D3 models, relative to the 
global minimum in Elatt, and the supercell used to calculate the DFTB3-D3 phonons. 
Structures matching the experimentally known forms are indicated in green and as yet 
unobserved Elatt minima are in orange. Note that forms C and E of XXIII were not present 
in the search, since they are Z’=2, and were optimised independently for comparison 
purposes. The first letter in the identifier of the mebendazole crystal structures indicates 
whether they contained the A or C tautomers. 
Molecule XXVI 
Structure 
name 
Density
/g·cm-3 
Elatt 
/kJ·mol-1 
ΔFvib rigid 
body/kJ·mol-1 
ΔA rigid 
body 
/kJ·mol-1 
ΔFvib DFTB3-
D3/kJ·mol-1 
ΔA DFTB3-
D3/kJ·mol-1 
DFTB3-D3 
supercell 
C26_863 1.388 -211.84 0.00 0 0.00 0 222 
C124_2 1.331 -209.88 -0.31 1.65 -3.36 -1.40 222 
C1_134 1.333 -207.39 -0.24 4.21 -3.16 1.29 111 
C41_619 1.361 -205.82 -0.87 5.15 -4.78 1.25 222 
C805_7 1.393 -200.95 0.24 11.14 2.03 12.93 222 
GSK269984B 
Structure 
name  
Density
/g·cm-3 
Elatt 
/kJ·mol-1 
ΔFvib rigid 
body/kJ·mol-1 
ΔA rigid 
body 
/kJ·mol-1 
ΔFvib DFTB3-
D3/kJ·mol-1 
ΔA DFTB3-
D3/kJ·mol-1 
DFTB3-D3 
supercell 
C1_60 1.497 -173.71 0.00 0 0 0 222 
C1_240 1.494 -171.17 -1.71 0.83 3.23 5.78 222 
C1_1165 1.506 -170.14 -1.72 1.86 2.15 5.72 222 
C1_685 1.479 -169.86 0.30 4.15 -3.18 0.67 211 
C1_2_1 1.484 -165.01 2.09 10.79 0.01 8.71 141 
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Molecule XX 
Structure 
name  
Density
/g·cm-3 
Elatt 
/kJ·mol-1 
ΔFvib rigid 
body/kJ·mol-1 
ΔA rigid 
body 
/kJ·mol-1 
ΔFvib DFTB3-
D3/kJ·mol-1 
ΔA DFTB3-
D3/kJ·mol-1 
DFTB3-D3 
supercell 
C1_9 1.382 -218.52 0.00 0 0 0 111 
C1_60 1.330 -215.54 -1.05 1.93 6.32 9.30 411 
C1_250 1.393 -213.61 1.43 6.34 2.86 7.77 121 
C78_1191 1.315 -211.12 1.63 9.03 2.37 9.78 121 
C78_28 1.347 -210.45 -0.53 7.54 -2.60 5.48 111 
C245_91 1.328 -199.71 -0.30 18.5 0.57 19.39 111 
Molecule XXIII 
Structure 
name  
Density
/g·cm-3 
Elatt 
/kJ·mol-1 
ΔFvib rigid 
body/kJ·mol-1 
ΔA rigid 
body 
/kJ·mol-1 
ΔFvib DFTB3-
D3/kJ·mol-1 
ΔA DFTB3-
D3/kJ·mol-1 
DFTB3-D3 
supercell 
C1_13 1.387 -179.40 0.00 0 0 0 212 
C1_60 1.394 -179.22 -0.25 -0.08 -0.95 -0.78 222 
C1_43 1.402 -178.57 -0.80 0.03 -0.50 0.32 231 
C103_31 1.410 -178.55 0.70 1.55 0.86 1.71 311 
C1_889 1.342 -169.14 -2.46 7.81 -2.79 7.47 221 
C49_1002 1.411 -169.09 -0.60 9.71 -1.90 8.41 221 
C103_847 1.345 -167.08 -1.15 11.17 0.86 13.17 221 
Form C 1.402 -172.28 -1.21 5.91 -1.33 5.79 221 
Form E 1.366 -170.88 -1.36 7.16 -2.44 6.07 221 
Mebendazole 
Structure 
name  
Density
/g·cm-3 
Elatt 
/kJ·mol-1 
ΔFvib rigid 
body/kJ·mol-1 
ΔA rigid 
body 
/kJ·mol-1 
ΔFvib DFTB3-
D3/kJ·mol-1 
ΔA DFTB3-
D3/kJ·mol-1 
DFTB3-D3 
supercell 
A_C1_5 1.395 -176.73 0.00 0 0 0 221 
A_C1_47 1.406 -175.87 0.14 1.00 -1.14 -0.29 211 
A_C1_6 1.430 -174.91 1.43 3.25 0.77 2.58 111 
C_C1_39 1.395 -174.94 0.63 2.42 -3.72 -1.93 111 
C_C1_28 1.397 -170.94 0.28 6.06 -1.63 4.15 221 
C_C1_227
0 
1.370 -169.96 -0.29 6.48 -3.38 3.39 211 
 
Appendix Table 7.8: Breakdown of the computational cost for refining and re-ranking the 
CrystalPredictor generated crystal structures of each molecule with the method 
described in this chapter. The cost of the phonon calculations is not included in the total, 
to have a more meaningful comparison with the original CSP studies where only Elatt 
values had been calculated.2-5 
  XXVI GSK269984B XXIII XX Mebendazole 
DFTB Optimisation cost/ hours 10,927 4,829 8,386 12,723 2,215 
DFTB clustering cost/ hours 109 156 618 1,306 37 
DMACRYS Optimisation cost/ hours 4,426 2,911 6,903 14,674 2,300 
Total cost/ hours 15,462 7,896 15,907 28,703 4,552 
DFTB3-D3 phonon calculations/hours 
 
1,844 344 984 512 99 
Rigid body phonon calculations/hours 
 
5 3 9 6 7 
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Chapter 8: The intricacies of discriminating 
between polymorphs and duplicates. 
 
8.1 Introduction 
 
A problem of CSP studies is that most search algorithms tend to generate the same 
crystal structure several times.1-3 This is true especially for the less accurate models used 
for crystal structure generation, which tend to have a rough energy surface, with more 
minima than more accurate periodic models.4 Since CSP studies aim to find all the 
plausible distinct polymorphs of a molecule, the presence of duplicate crystal structures 
is detrimental to the assessment of the results of a CSP study, as well as to its overall 
efficiency given the waste of computational resources in performing several calculations 
on the same crystal structure.2, 3, 5, 6 On the other hand, there is a danger in removing as 
duplicates similar crystal structures that may correspond to different polymorphs.7 
Throwing away an experimental crystal structure as a duplicate would turn a successful 
CSP study into a failure. 
  A number of approaches have been developed to remove duplicates, a process 
known as clustering.3, 5, 8-10 All these methods share the underlying problem that there is 
not a clear quantitative degree of dissimilarity that can be used to distinguish polymorphs 
from variations of the same crystalline form.7, 11 Clustering approaches are all based on 
arbitrary thresholds, mostly derived from human experience and intuition.10 For this 
reason, finding some quantitative parameters to assess whether two crystal structures 
are duplicates or polymorphs would be very important in CSP. This could also be used 
by experimentalists who are in doubt about how to classify the crystal structures they 
crystallise, as well as for database analyses and surveys. But can thresholds actually be 
found? 
 The main problem is that there is some ambiguity regarding what actually 
constitutes a polymorph.12-15 The most widely accepted definition of polymorph is still the 
one given by McCrone in 1965: “A polymorph is a solid crystalline phase of a given 
compound resulting from the possibility of at least two different arrangements of the 
molecules of that compound in the solid-state”.16 Other definitions have been proposed, 
but they have not changed the general view of the phenomenon, and Bernstein pointed 
out that they often create more confusion than clarity.17 McCrone’s definition is important 
in stating a polymorph is not necessarily a different crystal structure, but a different 
phase, which is defined by IUPAC as “an entity of a material system which is uniform in 
chemical composition and physical state.”18 Hence two polymorphs are essentially two 
solid-states exhibiting different physical properties, but sharing the same liquid and 
vapour states.17, 19 This has the fundamental implication that, although some structural 
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dissimilarity is needed to have a phase change (and hence a polymorph),20 it must just 
be large enough to cause some deviation in the solid-state physical properties. These 
differences can be rather small in many cases, and the term “isostructural polymorphs” 
has been coined to describe distinct phases with a strong degree of structural 
similarity.12, 21 Although Gavezzotti stated that subtle modulations without any significant 
change in crystal structures should not be termed as polymorphs,13 the polymorphic 
nature of almost identical crystal structures has in several cases been unequivocally 
established by discovering phase transitions with experimental techniques like 
differential scanning calorimetry (DSC)12, magnetic susceptibility measurements,22 
neutron diffraction,23 Raman Spectroscopy,24 or by changes in properties of the solid.25 
In the absence of a clearly identified phase transition, the distinction lines get blurry, and 
the identification of isostructural polymorphs can often be dependent on a personal 
interpretation by the crystallographer. Isostructural polymorphs are a major challenge in 
understanding the structural differences that separate polymorphs from duplicates.  
 To complicate the matter even further, a different crystal structure is not 
necessarily a different polymorph.20, 26 The same polymorph produced in a different 
experiment could have a slightly different molecular arrangement, particularly if it is 
characterised at different temperatures and pressures. Thermal expansion can change 
unit cell dimensions, and the differences can be remarkable over large temperature 
ranges; furthermore, this lattice expansion can often be anisotropic and lead to 
differences in packing without any phase transition occurring.20, 27, 28 The amount of 
structural change caused by variations in pressure can be even larger.26 Hence, several 
ambiguous cases exist, in which quantitative structural parameters may not be sufficient 
to separate polymorphs from redeterminations; it is possible that different determinations 
of the same phase could be more structurally different by certain measures than some 
polymorphs.  
 However, these ambiguities are known to be rare, and in most cases identical 
phases characterised under different conditions are structurally similar, while 
polymorphs have very different and easily distinguishable packings, if not 
conformations.11, 29 Furthermore, it can be safely assumed that two crystal structures of 
the same molecule with very different packing arrangements, i.e. with their atoms 
occupying very different positions within the lattice, are polymorphs, since large structural 
differences are associated with large differences in properties.30, 31 Hence, it is worth 
investigating the differences that can be generally found in polymorphs, with the aim of 
determining criteria that in the great majority of cases can separate polymorphs from 
duplicates. At a first glance, it may appear that the computation of lattice energies, 
enthalpies or free energies would be adequate for this purpose: while duplicates should 
optimise to the same energy minimum, polymorphs should optimise to different minima. 
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However, the energy surface described even by the most accurate theoretical models is 
not perfectly realistic,32 and polymorphs often have very small energy differences, within 
the range of accuracy of the calculations.33 This problem becomes even more serious 
for isostructural polymorphs forming upon phase transitions with temperature and/or 
pressure, since the two phases could belong to different free energy minima but to the 
same lattice energy minimum (i.e. at 0 K and 0 GPa), or one form could be a higher 
symmetry phase averaging over several lower symmetry Elatt minima.1 The detection of 
this sort of differences is beyond the capability of the available modelling methods, which 
makes the discrimination of any polymorph from duplicates purely on energy grounds 
very complicated.10 Several other methods have been proposed to separate polymorphs 
from duplicates,15 such as fingerprints based on energies of molecule-molecule pairs13, 
configurational  distances between crystal structures34 or analysis of the Hirshfield 
surfaces.35, 36 However, they all lack quantitative thresholds, and the user has to decide 
where to draw the boundary between polymorphs and duplicates.  
 In this work, the focus is on the differences in 3-dimensional structural 
coordinates and crystallographic parameters between crystal structures. From the 
analysis outlined above, it is clear how the only possible approach for finding clustering 
criteria is a heuristic one, based on analysing what sort of differences are common 
between polymorphs and what similarities are common between duplicates. A few 
failures in identifying isostructural polymorphs, or different modulations of the same 
crystal structures, are expected. While these failures would probably not be problematic 
in CSP, for experimental studies the clustering criteria can be treated more flexibly: they 
can give an idea of what sort of differences can suggest the presence of polymorphs or 
duplicates, while more ambiguous cases can be investigated more in depth with the 
appropriate experimental techniques. 
 The Cambridge Structural Database (CSD),37 which contains more than 900,000 
experimentally-determined crystal structures, is an obvious choice for performing this 
heuristic analysis. In the CSD, every distinct chemical compound is characterised by a 
six-letter ‘refcode’, and there are thousands of compounds for which multiple crystal 
structures have been deposited. Enantiopure and racemic compounds of the same 
molecules are different in the liquid phase and so belong to different refcode families.38 
The different crystal structures within the same refcode family are not necessarily 
polymorphs, but can also be multiple redeterminations or refinements of the same crystal 
structures. Polymorphic crystal structures are often flagged in the CSD: different 
polymorphs are flagged differently, while duplicates share the same flag.27, 38 However, 
not all polymorphs are flagged, since this depends on whether the polymorphic nature of 
the molecule was mentioned in the original publication.27 Furthermore, polymorph flags 
are not always specific: some clearly indicate what polymorph each crystal structure 
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corresponds to (for example flagging polymorphs as polymorph I, II etc.), while others 
are more generic (for example ‘monoclinic’, ‘P21/c’). In this chapter, it is assumed that 
each identical flag characterises the same polymorphs and vice versa, independently of 
its specificity, unless a manual check reveals otherwise. 
Given the imperfect nature of the polymorph flags, the CCDC has tried to find 
ways to distinguish polymorphs and redeterminations that is independent of whether the 
crystallographers mentioned the polymorphic nature of the deposited crystal structures. 
These efforts have led to the creation with every release of the CSD of the ‘best R-factor’ 
list.38 This subset of the CSD is selected through an algorithm that uses simulated PXRD 
similarities39 (see Chapter 2.5.2) to remove all the redeterminations from the CSD, 
leaving only the unique crystal structures with the best R-factor. Hence, every refcode 
family with more than one crystal structure in the ‘best R-factor’ list should be 
polymorphic. Also, disordered or wrong crystal structures are removed, which should 
guarantee that each crystal structure in the ‘best R-factor’ list is ordered and of high 
quality. This list, or variations built with a similar method, have been utilised in several 
high-quality studies on crystalline polymorphism.29, 30, 40  
However, since PXRD similarities alone do not seem to solve the clustering 
problem in CSP,7 the ‘best R-factor’ list was just used to heuristically determine  a set of 
differences that are common in most polymorphic pairs and hence can be used as criteria 
to discriminate between polymorphs and duplicates. These same criteria were then 
applied on the entire CSD to test their effectiveness. Finally an efficient clustering 
algorithm based on the CSD Python API37 (see Chapter 2.6.5) and implementing all of 
these criteria was written for use in CSP studies, accounting for the different types of 
problems that can be encountered in computational studies compared to database 
analysis. This algorithm was tested on a set of CSP-generated crystal structures of 
molecule XXVI (see Chapter 3) and mebendazole (see Chapter 4). 
 
8.2 Methods 
 
8.2.1 Analysis of the ‘best R-factor list’ to determine the differentiation criteria 
 
Conquest 1.1941 (see Chapter 2.6.1) was used to retrieve the 499,981 crystal structures 
in the ‘best R-factor’ list. Successively, all the refcode families with only one entry were 
removed, leaving 10,042 crystal structures of 4,748 compounds. These were grouped in 
6,007 possible polymorphic pairs; two crystal structures of the same compound formed 
one pair, three crystal structures formed two pairs etc. No limitation in the number of 
molecular components was introduced. Only crystal structures of organic molecules 
determined at ambient pressures were kept; this was because even small pressure 
differences can cause large structural variations.26, 42 This resulted in 3,925 pairs of 
crystal structures. This sample included polymorphs determined at different 
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temperatures, since temperature differences tend to have a smaller structural effect than 
pressure differences.43, 44 
 The next important choice was whether to trust the methodology used to form the 
list and consider all of those pairs as actual polymorphs, or if further limitations were 
required. The ‘best R-factor list’ is known to contain a small but not insignificant number 
of false polymorphs, i.e. pairs of crystal structures that appear to be polymorphs but that 
are effectively duplicates, and false duplicates, i.e. pairs of crystal structures that are 
polymorphs but look like duplicates.38 This is because the list is compiled using PXRD 
similarity, which can sometimes be misleading. To check how prevalent this 
phenomenon may be, the PXRD similarities were tested for their ability to reveal the 
degree of structural similarity. For each of the 3,925 pairs, the CSD Python API was used 
to estimate both the simulated PXRD similarities (with its default settings) and to perform 
structural overlays. Clusters of 15 molecules were overlaid using the Crystal Packing 
Similarity tool (see Chapter 2.5.1),45 with 20% distance and a 20° angle tolerances. The 
position of hydrogen atoms was ignored since it is often uncertain in                      
experimentally-determined crystal structures.29, 46 Figure 8.1 shows how the PXRD 
similarity compares with the number of molecules that were successfully overlaid for the 
3,925 pairs of crystal structures. 
 
Figure 8.1: Comparison of the PXRD similarity and the number of molecules matched 
(out of 15) for the 3,925 pairs of crystal structures under consideration. 
 Crystal structures for which more molecules can be overlaid tend to show higher 
PXRD similarities. However, the relationship is far from perfect, and structures with high 
or low PXRD similarities can be found across the whole spectrum of numbers of overlaid 
molecules. This generalises the worrying findings of an earlier study limited to 
isostructural hydrates.47 Some fully matching crystal structures exhibit PXRD similarities 
smaller than 0.80 and very different ones have similarities above 0.99. This weakness 
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suggests that not all the 3,925 pairs can be safely considered as polymorphic, and also 
makes it likely that the ‘best R-factor’ list does not contain all the possible pairs of 
polymorphs within the CSD. Hence, since certainty about the nature of the crystalline 
pairs is fundamental for the effectiveness of the analysis, it was decided to further limit 
the analysis only to those pairs with both crystal structures flagged as polymorphic. This 
limited the data set to 3,371 pairs. In 3,331 pairs the flags were different, while 40 pairs 
they were identical. Those 40 pairs were manually analysed. In 16 of those cases the 
flag was found to be wrong (e.g. AZELAC04-AZELAC15) and those polymorphic pairs 
were kept, while in 24 cases (see Appendix Table 8.1 for details) they were determined 
to be duplicates, and were removed from the data set, leaving 3,347 pairs. 
 The next step was to analyse the remaining polymorphic pairs to heuristically find 
what sort of differences they generally share. The first check was on the possibility to 
overlay all the molecules within 15-molecule clusters. For most of those pairs it was not 
possible, since in 3,288 cases a full 15-molecule overlay was not achieved, leaving 59 
pairs of fully overlaid polymorphs. This showed that for most polymorphic pairs 15/15 
molecule overlays fail, so structural differences are very common, as expected, and are 
a very effective criterion to recognise polymorphs. However, the possibility of overlaying 
15/15 molecule is not sufficient, and further criteria are needed to recognise a minority 
of structurally similar polymorphs. An analysis of the 59 remaining polymorphic pairs 
revealed that in 43 of these cases polymorphs have at least one of these crystallographic 
differences: 
- A different number of molecules in the unit cell (Z) 
- The same number of molecules in the unit cell (Z) and the same number of 
molecules in the asymmetric unit cell (Z’), but a different space group 
- The same number of molecules in the unit cell (Z) and the same space group, 
but a different number of molecules in the asymmetric unit cell (Z’) 
 Only for 16 pairs of crystal structures was it possible to perform both a 15/15 
overlay and not find any of the crystallographic differences above. 
  It was noted that polymorphs with different Z’ and space group tended to be more 
similar (i.e. to have smaller RMSD15 values) than those with the same Z’ and space 
group. This is probably because phase transitions between structurally similar 
polymorphs are often associated with a loss of symmetry elements and an associated 
increase in the number of molecules in the asymmetric unit.12, 13, 23, 48 In 5 out of the 6 
polymorphic pairs of structures with the same space group and Z’ RMSD15 was larger 
than 0.5 Å, and in 8 out of 10 pairs with different space group and Z’ it was larger than 
0.1 Å. Hence, including these RMSD15 differences leaves only three pairs of polymorphs 
(see Appendix Table 8.2 for details), which cannot be separated with any sensible 
structural or crystallographic criterion.  
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 Since the differences in terms of number of molecules overlaid, crystallographic 
parameters and RMSD15 between crystal structures that were heuristically found in this 
analysis are effective in recognising the great majority of polymorphic pairs in the ‘best 
R-factor’ list, they were considered as effective criteria to separate polymorphs from 
duplicates. The results of this analysis and the set of developed criteria are summarised 
in the decision tree in Figure 8.2. 
 
Figure 8.2: Decision tree to discriminate whether two organic crystal structures 
characterised at similar pressures are duplicates or polymorphs. 
 
8.2.2 Testing the criteria on the whole CSD 
 
The criteria determined from the analysis of the difference between the polymorphic pairs 
in the ‘best R-factor’ list were then applied on the entire CSD to test if they were effective 
at separating polymorphs from duplicates. The full CSD is ideal because, differently from 
the ‘best R-factor’ list, it purposely includes both duplicates and polymorphs.38 Also, this 
sample of structures is not limited to a selection of high-quality entries like the ‘best R-
factor’ list, and can reveal if the approach is suited to recognise polymorphs even in the 
presence of poorer determinations. 
 The 876,747 individual crystal structures in the 2017 release of the CSD were the 
starting point for this analysis. They were reduced by selecting only organic, not 
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disordered, with determined 3D coordinates structures determined at ambient pressure. 
For an objective assessment of the criteria, only polymorph-flagged crystal structures 
were retained. Since misassignments of refcodes do occasionally occur,27, 38 crystal 
structures were grouped according to their compound rather than just by refcode. Hence, 
structures were first grouped according to their chemical formulae; only those with at 
least two entries with the same chemical formula were kept. D and H atoms were 
considered as equivalent. The crystal structures were then grouped according to the 
isomer they contained. To do that, the Crystal Packing Similarity tool was used to perform 
1-molecule overlays between all the crystal structures with the same chemical formulae; 
when a match was not possible this indicated that the crystal structures contained 
different compounds. Although effective in most cases, this method carried the risk of 
grouping together racemates, stereoisomers and multi-component compounds with a 
common molecule. Hence all the groups containing more than one refcode family were 
manually checked to remove these occurrences.  
 This initial grouping resulted in 3,110 families of compounds containing 8,978 
polymorph-flagged crystal structures; in the great majority of cases these compound 
families matched refcode families, with few exceptions due to chirality or 
misassignments. The crystal structures in each of the 3,110 families were ordered 
according to their R-factors and clustered using an algorithm, implemented in Python, 
which followed the decision tree shown in Figure 8.2. The overlays were performed with 
the Crystal Packing Similarity tool and once again hydrogen atoms were ignored. Crystal 
structures were clustered in ascending order of R-factor, by comparing each entry with 
those within the same family already identified as belonging to a separate cluster. 
 The outcome was this analysis was the identification of 6,550 clusters of crystal 
structures, and each cluster should contain a separate polymorph. More than one crystal 
structure was present in 1,130 clusters; multiple crystal structures in the same cluster 
should be duplicates. This set of results was checked for the presence of false 
polymorphs and false duplicates. The assumption was made that if the polymorph flag 
and the clustering results coincided then the answer was correct and no further validation 
was undertaken.  
 To identify the false duplicates, the 1,130 clusters containing more than one 
crystal structure were checked to verify whether they contained entries with different 
polymorph flags. This was the case for 280 clusters, containing 930 crystal structure, 
which were checked manually to verify whether the flag was correct, or the discrepancy 
was caused by errors. The observed errors in the polymorph flags were: 
- Typos or different writings of the same flag (e.g. ‘1 Polymorph’ and ‘Polymorph 
1’). This type of error was the most common. 
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- The CSD polymorph flags present in the CSD are inconsistent with the 
publication/s.  
- The publication/s do not mention that a structure with a different polymorph flag 
is actually a different polymorph. 
- The publication/s state that one crystal structure is just a redetermination with a 
more accurate symmetry. This occurred rarely and it was the least common type 
of error. 
 In 239 clusters the presence of different polymorph flags was due to one of these 
errors, leaving 41 containing false duplicates (see Appendix Tables 8.4-8.5 for details), 
i.e. different polymorphs wrongly classified as duplicate using the criteria in Figure 8.2. 
Chapter 8.3.2.2 discusses the origin of these false duplicates. 
 On the other hand, to identify the false polymorphs all the crystal structures in the 
same input compound group and output in different clusters were checked to verify 
whether they had the same polymorph flag. This was the case for 122 pairs of structures. 
A further manual check was performed on all those pairs, and in 41 cases the polymorph 
flag was found to be wrong, meaning the structures were actual polymorphs, leaving 81 
pairs of false polymorphs, i.e. duplicates wrongly classified as polymorphs. These are 
listed in Appendix Table 8.3 and their origin is discussed in Chapter 8.3.2.3. 
 
8.2.3 Clustering CSP-generated structures 
 
The final step of this analysis was to test the criteria in Figure 8.2 on CSP-generated 
crystal structures. First of all a clustering algorithm, based on the CSD Python API tools, 
was written for use in CSP, and then it was tested on crystal structures generated in the 
CSP searches of molecule XXVI and mebendazole (see Chapters 3 and 4). 
 
8.2.3.1 Algorithm to perform the clustering 
 
Clustering CSP-generated crystal structures requires an algorithm that is more 
sophisticated than the one used to cluster CSD structures. First of all, the problem is 
different, since in the CSD there are only few experimentally-determined crystal 
structures for each compound, while a CSP study often generates thousands of 
candidates for a given molecule. Computational cost can be problematic and must be 
tackled effectively, by parallelising the task between multiple processors and/or limiting 
the number of comparisons to a feasible number. Furthermore, the position of hydrogen 
atoms is accurately determined in CSP, and in some cases it can be important in fully 
understanding the spectrum of possible crystal structures, as exemplified by gallic acid.49 
Finally, CSP studies provide information about the energy of crystal structures, as well 
as a number of structural characteristic, such as density and unit cell parameters at 
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constant temperatures and pressures, that the user may want to consider when 
performing the clustering procedure. 
 Hence a clustering algorithm for use in CSP has to be effective, flexible and 
computationally efficient. The algorithm that was written for this purpose analyses 
structural and crystallographic differences between crystal structures. It takes into 
account all the criteria in Figure 8.2 but the user can decide the number of molecules to 
be overlaid (x), the distance and angle tolerances for the overlays, whether or not to 
account for the position of hydrogen atoms, and the maximum RMSDx differences, in the 
presence of the same or different space groups, for structures with x/x molecules 
matching to be considered as duplicates. In order to improve the computational efficiency 
and give the user more flexibility, it is also possible to choose the maximum differences 
in calculated energy, density and unit cell parameters (i.e. unit cell lengths and angles) 
for two structures to be overlaid, as well as a minimum PXRD similarity. This clustering 
algorithm can work in parallel to take advantage of multi-core computer clusters; the user 
decides the number of processors that he wants to utilise. Finally a path to a crystal 
structure containing the correct molecule can be specified for removing those              
computer-generated structures with unrealistic close contacts, whose presence is 
common in CSP searches of flexible molecules due to the failings of the codes, usually 
caused by the minimisation going past the maximum in the exp-6 repulsion-dispersion 
potential.50 The algorithm functions as follows: 
1) Two input files are read; the first contains the user-defined criteria listed above 
and the second one contains a list of the crystal structures to be analysed, their 
energies and their densities. The structures are ordered according to their 
energies. The full set is broken down into several smaller sub-sets, each 
containing the same number of crystal structures. The number of sub-sets 
corresponds to the number of processors specified in the first input file.  
2) Each of these sub-sets is clustered in parallel, using the Python multiprocessing 
library. In each sub-set, the crystal structures are analysed from the lowest 
energy one upwards.  
 If the user has chosen the option, a first check is performed to verify 
whether the molecule in the crystal structure is correct. An overlay with the 
crystal structure containing the right molecule is attempted, with a                  
1-molecule shell size. If the overlay fails, the crystal structure contains the 
wrong molecular geometry, and it is removed.  
 Secondly, the actual clustering step is performed. Each crystal structure in 
the sub-set is compared, in reversed energy order, with each form already 
identified as unique. This list of unique forms is one of the outputs of the 
clustering analysis. If the differences in terms of energy, density or unit-cell 
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parameters between two crystal structures are above the thresholds 
specified in the input, or if the crystallographic criteria in Figure 8.2 are not 
met, they are not compared. If all those criteria are met, then PXRD 
similarity is identified using the CSD Python API, and if it is above the          
user-defined threshold, then the Crystal Packing Similarity Tool is used to 
overlay the crystal structures. If the tool manages to overlay each molecule 
within the cluster with an RMSDx value lower than the thresholds specified 
in the input, then the structure is considered to be a duplicate and thrown 
out of the sub-set, otherwise it is added to the list of unique crystal 
structures. The method for deciding whether two crystal structures belong 
to different clusters or if they are duplicates is summarised in Figure 8.3. 
The process is then repeated until each crystal structure within the sub-set 
has been analysed. A list of structures that have already been compared in 
this first clustering cycle is saved, in order to avoid wasting computational 
resources performing identical comparisons in the following step. 
3) The outputs of the clustering analyses performed on each processor are 
connected, and the unique crystal structures found in the previous step are 
combined to form a new group of sub-sets. Two groups of unique crystal 
structures are combined only if the energy difference between the lowest energy 
crystal structure in the higher-energy sub-sets and the highest-energy crystal 
structure in the lower-energy sub-set is smaller than the user-defined energy 
difference threshold. Once these new sub-sets have been generated, they are 
assigned to different processors and clustered in parallel in the same manner as 
for the original sub-sets (see Figure 8.3 for a summary). Two crystal structures 
are compared only if they had not already been contrasted in step 2. Once a          
sub-set has been fully analysed, the output is saved and a new sub-set is sent 
for clustering to the same processor. This process is repeated until all the         
sub-sets have been fully analysed.  
4) Clustering is finally complete and the user is provided with a set of outputs: a list 
of duplicate and wrong crystal structures, as well as a spreadsheet containing the 
unique crystal structures, which can be used as an input for further clustering.  
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Figure 8.3: Schematics of the criteria used in the algorithm to decide whether two 
computer-generated crystal structures are duplicates or belong to different clusters. The 
blue boxes indicate steps where the user can define the thresholds for success or 
failure, while the green boxes represent hard-coded criteria. 
 
8.2.3.2 Testing the algorithm and the criteria on CSP structures 
 
The algorithm described above was tested the 9,400 search-generated crystal structures 
of molecule XXVI, the 855 of the A-tautomer of mebendazole, and the 964 of its                        
C-tautomer that were taken forward to the successive refinement stages. Given the large 
size of these samples, the criteria shown in Figure 8.2 were integrated with some 
limitations in order to limit the computational cost: structures were compared only if their 
energies did not differ by more than 8 kJ·mol-1, their densities by not more than                          
0.1 g·cm-3, and if they had PXRD similarities larger than 0.900.  
 The results were analysed and compared with those obtained in the original CSP 
studies, where no clustering of the search-generated crystal structures had been 
undertaken besides the one automatically performed by CrystalPredictor (see Chapters 
3.2.2 and 4.2.2). The goal was to verify whether this clustering method and criteria can 
effectively reduce the number of generated structures to be taken to the refinement 
stage, limiting in this way the number of calculations to be performed on what are 
effectively identical crystal structures but without throwing away matches to the 
experimental form/s or other signicant PPMs. The potential savings of this clustering step 
were estimated by calculating how much computational cost would have been saved in 
the original CSP studies if the crystal structures removed by this clustering analysis had 
not been refined. 
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8.3 Results and Discussion 
 
8.3.1 Determination of the clustering criteria from the ‘best R-factor’ list 
  
An analysis of the polymorphic pairs in the ‘best R-factor’ list allowed to find the most 
common structural and crystallographic differences. These differences appear to be 
present independently of the number of components in the crystal structure, as well as 
of the size of the molecule/s under consideration. The few failures (i.e. false polymorphs 
and false duplicates) are indeed for single-component crystal structures of relatively 
small molecules.  
 The impossibility of performing 15/15 overlays is the most common difference, as 
shown in in Figure 8.4. 
 
Figure 8.4: Distribution of the number of molecules that could be overlaid for the 3,347 
pairs of polymorphs. They correspond to the 3,371 pairs of crystal structures considered, 
excluding the 24 identified as duplicates. 
 Only ~1.8% of flagged polymorphic pairs have a 15-molecule match, and in ~82% 
of cases five or fewer molecules can actually be overlaid, indicating a high degree of 
structural dissimilarity. The polymorphic pairs without any of the crystallographic 
differences (i.e. different Z, same space group and different Z’, or different space group 
and same Z’) are more common, around ~29% of the total. However, only ~0.5% of the 
polymorphic pairs have both a 15/15 molecule overlay and have none of the 
crystallographic differences. Putting a limit on RMSD15 values reduces this percentage to 
~0.1%, with only three pairs of false duplicates (see Appendix Table 8.2) in the ‘best R-
factor’ list passing all the tests in Figure 8.2. Furthermore, out of the 24 pairs of flagged 
duplicates, 20 meet all the criteria in Figure 8.2, with only four being failures, which can 
be classified as false polymorphs. These are listed in Appendix Table 8.1. 
274 
 
 An analysis of the few pairs of crystal structure whose nature is not identified by 
the heuristically developed approach reveals interesting information. All the three pairs 
of false duplicates (refcodes DIMETH01-DIMETH06, LIHXUW01-LIHXUW02 and 
MOSTIX-MOSTIX01, more details in Appendix Table 8.2) were determined at different 
temperatures, and they were subject to a phase transition occurring within that 
temperature range. In Figure 8.5 an overlay of the crystal structures of DIMETH01 and 
DIMETH06 shows how similar the crystal structures of distinct polymorphs can be when 
a phase transition with temperature occurs. 
 
Figure 8.5: 15-molecule overlay between the crystal structures of DIMETH01 (coloured by 
elements) and DIMETH06 (in green). The RMSD15 is 0.226 Å. The publication clearly states 
that they are different polymorphs.51 
 Hence, phase transitions appear to be problematic, and in a few cases they can 
cause changes of properties with barely noticeable structural changes. In the view of a 
CSP study, this is not particularly concerning, since crystal structures are generated and 
compared under the same conditions, generally at 0 K and 0 GPa.1, 2, 52 On the other 
hand, for crystal structures experimentally determined at different temperatures or 
pressures ambiguous cases can occur, and DSC measurements or other experimental 
validations may be required.  
 Out of the four pairs of false polymorphs (see the highlighted entries in Appendix 
Table 8.1), one was not identified because the structures failed to meet the 15/15 
molecule overlay criterion and three because they failed to meet the RMSD15 thresholds. 
The only case where the 15/15 molecule overlay was not achieved was for                  
FORMAC-FORMAC01, where the crystal structures are nearly identical if single and 
double bonds are not distinguished, while being very different if bond types are 
accounted for, as illustrated in Figure 8.6. FORMAC does not have the position of 
hydrogen atoms determined, so in this case the error is probably due to the Crystal 
Packing Similarity tool incorrectly defining the double bond in the carboxyl group. This is 
a problem related to the history of crystallography, since FORMAC is a determination 
from 1953, and the lack of hydrogen position is a common feature of old CSD entries.38 
Changing the settings of the Crystal Packing Similarity to ‘Ignore each atom’s hydrogen 
count’ and ‘Ignore each atom’s bond count’ produces a 15/15 overlay with an RMSD15 
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of just 0.065 Å. However, a routine use of these settings is not suitable, since 
comparisons would not be restricted to crystal structures of the same compounds; for 
example, tautomers would not be distinguished. Furthermore, not accounting for bond 
types when comparing crystal structures generated in a CSP study would hinder the 
detection of possible static disorder.1, 7 
             
Figure 8.6: Comparison between the crystal structures of FORMAC (left) and FORMAC01 
(right).  
 Out of the three pairs of duplicates not identified because they exceed the 
RMSD15 thresholds, two (GLYCIN16-GLYCIN82 and GLYCIN71-GLYCIN81) are 
redeterminations where one crystal structure was determined in the P1 space groups, 
despite its real symmetry being consistent with its counterpart. Since the crystal 
structures had been incorrectly reported in a different space group and with a different 
Z’, the methodology in Figure 8.2 applies a different similarity threshold (0.1 rather than 
0.5 Å, see Chapter 8.2.1 for the motivation of this difference), which is exceeded in both 
cases. Although this should not be a problem in CSP, where symmetry is generally 
imposed when a crystal structure is generated, this shows that the RMSD15 thresholds 
can in some cases lead to the presence of false polymorphs. For the other false 
polymorph (HOJQII-HOJQII01) the two structures have the same space group and Z’, 
but a very large RMSD15 value of ~0.77 Å, significantly above the 0.5 Å threshold. 
However a more careful analysis of the publication reveals that the crystal structure of 
HOJQII01 was determined at 2.5 GPa,53 although this is not flagged in the CSD. This 
shows how careful analysis of database information data is often needed, since the CSD 
contains some errors, and also illustrates how much structural change pressure can 
cause without inducing phase transformation. This effect is much larger than it is for 
temperature, which at least in this test does not cause the presence of false polymorphs. 
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8.3.2 Test on the whole CSD 
 
8.3.2.1 Overall results on the entire CSD 
 
The algorithm based on the decision tree in Figure 8.2 produced 6,550 clusters of crystal 
structures, in most cases matching the polymorph flags given by the experimentalists. 
Overall, the algorithm identified 4,197 pairs of crystal structures of the same compounds 
belonging to different clusters, which should be polymorphs. It has also identified 8,200 
pairs of structure belonging to the same clusters, which should be 
duplicates/redeterminations. Although not all those pairs of duplicates were directly 
compared with one another, it can be assumed that since they all match with the same 
crystal structure, then they all match with one another (i.e. if structure 2 and structure 3 
both meet all the similarity criteria when compared to structure 1, then it is assumed 
structures 2 and 3 would meet all the criteria if compared with one another). The overall 
outcome of the analysis is summarised in Figure 8.7. 
 
Figure 8.7: Summary of the results of the analysis of the polymorph-flagged CSD crystal 
structures. The pairs of false polymorphs are listed in Appendix Table 8.3 and the pairs 
of false duplicates in Appendix Table 8.4. 
 The methodology is successful in the great majority of cases, with ~98% of the 
pairs of structures in different clusters being actual polymorphs and ~97% of the pairs of 
structures in the same clusters being actual duplicates. This analysis confirms that 
polymorphs are usually structurally different: for 3,911 of the 4,163 polymorph pairs (i.e. 
the 4,116 found pairs of polymorphs and the 47 missed ones listed in Appendix Table 
8.5) it was impossible to overlay 15/15 molecules. Of the 252 pairs with a 15/15 overlay, 
only 128 do not have any of the crystallographic differences; 47 of those 128 do not have 
the RMSD15 differences and are output as false duplicates. 
 On the other hand, very few of the structures that fail to meet any of these criteria 
are found to be duplicates: only ~1.4% of the pairs of structures for which a 15/15 overlay 
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is impossible, although this may be overestimated because of some of the problems 
highlighted in Chapter 8.3.2.2, and only ~1% of the structures that do not meet the 
crystallographic criteria are duplicates. Furthermore, out of the structures for which a 
15/15 overlay is possible but exceed the RMSD15 thresholds, ~9% are duplicates. This 
means that the heuristically developed RMSD15 thresholds are effective in the majority 
of cases. Figure 8.8 summarises the overall analysis for each step of the decision tree 
in Figure 8.2.  
 
Figure 8.8: Summary of the results of the test on the polymorph-flagged CSD crystal 
structures for each step of the methodology in Figure 8.2. 
 The next question is whether the degree of success of the decision tree depends 
on the characteristic of the compounds present in the crystal structures. Table 8.1 shows 
a breakdown of the compounds in the crystal structures that were considered in this 
work, in terms of the number of components, flexibility and size. A crystal structure was 
considered to contain a ‘large’ molecule if the molecule or the largest molecular 
component (for multi-component compounds) contained more than 18 heavy atoms, a 
criterion used in previous studies on polymorphism,30 and ‘small’ otherwise. Furthermore, 
it was considered as ‘flexible’ if the molecule or the largest molecular component had at 
least one rotatable bond, as defined by Mogul,54 and ‘rigid’ otherwise. 
Table 8.1: Breakdown of the results of the analysis on polymorphism, in terms of the 
number of molecular components and the molecular properties. 
  Number of components Flexibility Size 
  
Single-
component 
Multi-
component 
Flexible Rigid Small Large 
Total number 
of compounds 
2,452 658 2,641  469 2,039 1,071 
Compounds 
containing false 
polymorphs 
50 (~2.0%) 16 (~2.4%) 49 (~1.8%) 17 (~3.6%) 34 (~1.7%) 32 (~3.0%) 
Compounds 
containing false 
duplicates 
30 (~1.2%) 11 (~1.7%) 30 (~1.1%) 11 (~2.3%) 27 (~1.3%) 14 (~1.3%) 
 
 An analysis of these data reveals that the percentage of compounds containing 
at least one pair of false duplicates and/or false polymorphs seems to be almost 
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independent of the number of molecular components (although they are both slightly 
over-represented among multi-component compounds), indicating that criteria in Figure 
8.2 are equally effective in discriminating polymorphs from duplicates in single-
component and multi-component crystal structures. On the other hand, compounds 
containing rigid-molecules are slightly over-represented in both false polymorphs and 
false duplicates. The over-representation of rigid molecules in false duplicates may be 
caused by the fewer degrees of freedom, which can make them exhibit similar crystal 
structures even in the presence of different phases;12 although slightly tighter RMSD15 
thresholds may help for rigid molecules, the discrepancy is small and probably not 
statistically significant. On the other hand, the over-representation of rigid molecules 
within compounds containing false polymorphs is counterintuitive and probably due to 
historical reasons: ~26% of the lowest R-factor crystal structures of the rigid compounds 
were characterised before 1980, compared to the ~14% of the whole set, and for older 
entries errors tend to be more prevalent. Finally, it is surprising that there is no correlation 
between molecular size and number of false duplicates, since one may expect that 
smaller molecules can exhibit smaller differences for similar but distinct polymorphs. On 
the other hand, larger molecules are over-represented among false polymorphs, which 
is sensible since the presence of more atoms means that duplicates may have slightly 
larger structural differences than smaller molecules. Once again, although more relaxed 
RMSD15 thresholds may help for larger molecules, these small differences are probably 
not significant enough. Hence, the criteria outlined in Figure 8.2 appear to be broadly 
applicable and are effective in the great majority of cases for any sort of compound.  
 In summary, although certain properties associate with a higher proportion or 
false polymorphs and/or false duplicates, the overall number of compounds containing 
at least one error is always between ~3-6% for any molecular characteristic and number 
of components. The decision tree in Figure 8.2 is effective in discriminating the majority 
of ambiguous cases, independently of the characteristic of the compounds. The next 
sections will analyse the few failures and their causes. 
 
8.3.2.2 Identification of false duplicates and their causes 
 
A total of 41 families of compounds containing false duplicates were identified. Out of 
those 41 families, in 39 two polymorphs were present within each family, in one case 
three polymorphs were present and in one case four. This results in 47 unfound 
polymorphic pairs, forming 212 pairs of false duplicates (this number includes pairs of 
duplicates of these 47 polymorphs), which are listed in Appendix Tables 8.4 and 8.5. 
Analysing these false duplicates in details, it was found that in only one case 
(ZZZHQU01-ZZZHQU02) the polymorphic nature was not identified because of the 
inadequacy of the 15-molecule overlay itself, since there are longer-range differences, 
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as shown by the possibility of matching only 23 molecules within a larger 30-molecule 
shell. This is very promising, and it appears that 15-molecule clusters are almost always 
adequate and that there is no need to use larger and more computationally demanding 
packing shells. In the remaining 211 pairs, the structures were nearly identical. In 27 of 
47 unfound polymorphic pairs the publication reports that the polymorphic difference was 
caused by a phase transition happening at a given temperature, and in 6 pairs to a phase 
transition happening with pressure (although the crystal structures were determined at 0 
GPa).55 This confirms what had been found in the analysis of the ‘best R-factor’ list, i.e. 
that phase transitions can cause polymorphic changes with very small structural 
differences, making them the biggest source of false duplicates. The remaining 14 cases 
are more ambiguous, no phase transition is described despite the publications stating 
presence of different phases. This shows that the distinction between experimental 
polymorphs and duplicates can in some cases be difficult and subject to the interpretation 
of the crystallographer.  
 
8.3.2.3 Identification of false polymorphs and their causes 
 
A total of 81 pairs of false polymorphs were identified; this number might be 
underestimated, since crystal structures classified as polymorphs but with identical 
polymorph flags may have not been identified because of some of the possible errors in 
the flags that are listed in Chapter 8.2.2.  
 In 35 pairs the crystal structures would meet all three criteria in the decision tree 
if double and single bonds were not distinguished. In 23 of those pairs one of the crystal 
structures does not have the hydrogen atoms explicitly indicated, which may cause 
errors in the automatic determination of the double-bonds, like in the example shown in 
Figure 8.6. On the other hand, an interesting pair of false polymorphs in which hydrogen 
atoms of both crystal structures are indicated is DBEZLM01-DBEZLM05, shown in 
Figure 8.9. The different position of the hydrogen atoms and the double bonds may be 
due to an uncertainty possibly caused by tautomeric disorder, although this is not 
mentioned in the publication. Tautomeric disorder is explicitly mentioned for QQQFDJ19 
and QQQFDJ20,56 indicating how this phenomenon can cause some ambiguous cases. 
 
Figure 8.9: 1-molecule overlay of the crystal structures of DBEZLM01 (coloured by 
elements) and DBEZLM05 (in green). See Appendix Table 8.3 for details. 
 Out of the remaining 46 pairs of false polymorphs, in 22 cases the algorithm did 
not match 15/15 molecules. A further 11 pairs were considered polymorphic because 
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they differed in the crystallographic parameters, and in 13 cases because they met both 
the overlay and crystallographic criteria but had RMSD15 values above the thresholds.  
 Out of the 22 cases where the Crystal Packing Similarity tool failed to produce a 
15/15 match, 13 were due to the 20% distance and a 20° angle tolerances being too 
tight, and increasing the tolerances to 40% and 40° respectively found a full overlay; 
generally in those pairs one of the crystal structures is a poor determination, often with 
some wrong covalent bonds, as exemplified in Figure 8.10 for the intuitively wrong phenyl 
rings of ANTCYB11, compared to the correct ones of ANTCYB13. 
            
Figure 8.10: Molecular conformations contained in (left) ANTCYB11 and (right) 
ANTCYB13. See Appendix Table 8.3 for details. The phenyl rings in ANTCYB11 are 
intuitively wrong.  
 Hence, in a limited number of cases poor determinations can make discriminating 
polymorphs from duplicates complicated. However, increasing the tolerances would be 
counterproductive since this could generate more false duplicates.  
 A further seven cases were caused by the presence of disorder in the hydrogen 
atoms. In the presence of disorder, the overlay often fails since the Crystal Packing 
Similarity tool cannot physically match the suppressed atoms. In the algorithm utilised 
for this test, crystal structures are compared only with the lowest R-factor counterpart 
within each cluster. For those seven pairs, the overlay fails with the crystal structure with 
the lowest R-factor entry within the cluster, but all the criteria are met when a comparison 
is attempted with other duplicates of that structure. Of the remaining two cases, one was 
caused by one crystal structure within the pair having a wrong molecular geometry 
(TFMETH, with a large 15% R-factor, and TFMETH02) and one by the Crystal Packing 
similarity tool showing a 3/15 molecule overlay despite a visually perfect match for 
NOETNA01-NOETNA02. Those problems signal the need of being cautious when poor 
or disordered crystal structures are compared. 
 Nine of the 11 pairs of duplicates with the crystallographic differences that 
according to the criteria in Figure 8.2 indicate the presence of polymorphs contained 
symmetric molecules. More specifically, one crystal structure had a lattice symmetry 
element correspondent to a molecular symmetry element, while the counterpart did not 
have it; this leads to different Z values. The pair formed by BENZID04-BENDIZ08, shown 
in Figure 8.11, is an example of this: BENZID04 has an inversion centre at the symmetric 
centre of the molecule that is absent in BENZID08. Hence BENZID04 has a Z value of 1 
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and BENZID08 of 2, although they are both in the P1̅ space group and have nearly 
identical crystal structures.  
    
Figure 8.11: Molecule and symmetry elements of (right) BENZID04 and (left) BENZID08. 
See Appendix Table 8.3 for details. Those crystal structures are both in the P?̅? space 
group and a 15/15 molecule overlay is possible with an RMSD15 of 0.181 Å. The yellow 
dots represent crystalline inversion centres, and in BENZID04 one of the inversion centre 
is located half the way through the central C-C bond. 
 This shows that symmetric molecules can sometimes be challenging, and that 
they may need careful consideration. One possible solution could be not to consider Z 
values when comparing crystal structures; however, this would lead to several more false 
duplicates. The other two pairs of false polymorphs caused by crystallographic 
differences are OCRSOL-OCRSOL01 and GLYCIN16-DOLBIR09: these structures have 
the same Z and Z’ value, but OCRSOL and DOLBIR09 are in the P31 space group, while 
OCRSOL01 and GLYCIN16 are in P32. This highlights how the determination of 
crystalline symmetry can in some cases be arbitrary, which can cause problems in the 
separation of polymorphs from duplicates. 
 Out of the 13 pairs of false polymorphs caused by the RMSD15 thresholds, in four 
cases the Crystal Packing Similarity tool gave unrealistically high RMSD15 values, 
despite visually excellent matches, probably because of errors in the overlays 
themselves. One example is DXYLEN14-DXYLEN15, shown in Figure 8.12. 
 
Figure 8.12: 15-molecule overlay of DXYLEN14 (coloured by elements) and DXYLEN15 (in 
green). See Appendix Table 8.3 for details. Despite a clearly excellent agreement, the tool 
returns an unrealistic RMSD15 of 2.335 Å. This has to be due to an error in the Crystal 
Packing Similarity tool. 
 Of the remaining nine pairs of false polymorphs, six pairs had different Z’ and 
space group and an RMSD15 value slightly larger than the 0.1 Å threshold, while three 
282 
 
had identical Z’ and space group and an RMSD15 slightly above the 0.5 Å threshold. 
These few cases once again fall into that category of ambiguity, where there is a degree 
of ambivalence on whether crystal structures may be polymorphic. In five of these nine 
pairs the crystal structures were determined at different temperatures. Loosening the 
RMSD15 thresholds would once again be dangerous since it could produce more false 
duplicates. However, despite those few failures, the heuristically-determined RMSD15 
thresholds appear to be effective in most cases, as shown in Figure 8.7 and Figure 8.8. 
 
8.3.2.4 Polymorphic differences and possible alternative methodologies 
 
The results of the analysis on the whole CSD are very similar to those from the ‘best              
R-factor list’, from which the methodology in Figure 8.2 was heuristically developed, 
although the percentage of false duplicates is slightly higher. However, most of those 
false duplicates are not present in the ‘best R-factor list’ because of their high level of 
simulated PXRD similarity (as shown in Figure 8.14), which would have not allowed their 
identification as separate polymorphs,38 and because some of them are old entries with 
poor R-factors. On the other hand, comparing the number of false polymorphs would be 
misleading, since the ‘best R-factor list’ contains very few flagged duplicates.  
 Although in the great majority of cases polymorphs have very different crystal 
structures and duplicates nearly identical ones, there are several polymorphic pairs with 
very similar crystal structures, and some duplicates with rather different packings; the 
most extreme examples found in this study are BIZWAJ01-BIZWAJ02 and SUWMIG-
SUWMIG03, which are shown in Figure 8.13. 
 
Figure 8.13: 15-molecule overlays of (above) BIZWAI01 and BIZWAI02, with an RMSD15 of 
just 0.007 Å, despite being explicitly indicated as polymorphs in the publication57 (below) 
SUWMIG and SUWMIG03, which require looser 40% distance and 40° angle tolerances to 
obtain a 15/15 overlay with an RMSD15 of 1.16 Å, despite being explicitly indicated as 
redeterminations in the publication.58 
Polymorphs with similar crystal structures are more frequent than duplicates with 
dissimilar packings. In fact, out of the 78 pairs of false polymorphs, the majority are not 
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identifiable as duplicates either because of errors in the experimental data and in the 
overlaying tools or short-comings of the adopted clustering methodology. There are only 
a handful of ambiguous cases due to the actual crystalline packing. On the other hand, 
out of the 212 pairs of polymorphs found in the same clusters, only one was not identified 
because of short-comings in the clustering methodology, while the other 211 are different 
phases with very similar crystal structures. The majority of those problematic 
polymorphic pairs are associated with phase transitions with temperature or pressure. 
Although phase transition seem to be associated with only a small fraction (~10%) of the 
total number of polymorphs in the CSD,59 they represent a much larger portion (~70%) 
of the false duplicates identified in this study. Overall it is highly unlikely that very 
structurally similar crystal structures are polymorphic, in particular when determined at 
the same temperature and pressure; hence, structurally similar CSP-generated 
structures can be safely clustered with a low chance of removing potential polymorphs.  
 Using the criteria in Figure 8.2 for performing a clustering analysis seems to be 
more effective than utilising simulated PXRD similarities. Figure 8.14 shows the 
distribution of the simulated PXRD similarities for the pairs structures identified as 
duplicates (including the false polymorphs) and polymorphs (including the false 
duplicates) in this study 
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Figure 8.14: Histograms showing the simulated PXRD similarities of (above) the 
polymorphic pairs identified; the false duplicates are indicated by orange bars (below) 
the pairs of duplicates identified; false polymorphs are indicated by orange bars. 
 Duplicates clearly have much higher simulated PXRD similarities than 
polymorphs, which is expected since duplicates tend to have very similar crystal 
structures and polymorphs very different ones. However, there are large numbers of 
polymorphs with high simulated PXRD similarities and vice versa, confirming the results 
shown in Figure 8.1. The method used to compile the ‘best R-factor’ considers as definite 
duplicates structures with a simulated PXRD similarity above 0.990,38 and 336 
polymorphic pairs of crystal structures would be considered as duplicates (i.e. they would 
be false duplicates), compared to the 212 in this study; as shown by the orange bars in 
Figure 8.14, simulated PXRD similarities would have failed to identify as polymorphs 
most of the false duplicates produced by the clustering methodology in Figure 8.2. On 
the other hand, 1,114 pairs of duplicates would be considered as certain polymorphs, 
285 
 
since they have a PXRD similarity smaller than 0.970 (i.e. they would be false 
polymorphs), compared to the 81 in this study. However, this may be an exaggeration 
since the simulated PXRD similarities calculated here are not exactly consistent with 
those used to produce the ‘best R-factor’ list, as they are not compared to those 
calculated with a reduced unit cell, the volumes are not normalised and the similarities 
are not adjusted for temperature and/or pressure differences.38 Also, 372 pairs of 
polymorphs and 1,717 pairs of duplicates have a simulated PXRD similarity between 
0.970 and 0.990 that would qualify them as unknown.38 However they are classified, this 
would likely further increase both false polymorphs and false duplicates. On the other 
hand, simulated PXRD similarities often succeed to recognise some of the duplicates 
that were mistakenly identified as polymorphs using the method in Figure 8.2 because 
of differences in double bonds, experimental errors or errors in the overlay tools. 
 Overall, the heuristic methodology identifies wrongly ~2% of the structures it 
classifies as polymorphs and ~3% of the structures it classifies as duplicates, while 
applying the simulated PXRD similarity-based criteria used to compile the ‘best R-factor’ 
list these percentages increase to ~4% for duplicates and ~26% of polymorphs. Although 
the final number is probably exaggerated, both percentage would likely be increased by 
classifying structures falling into the ambiguous category in terms of PXRD similarity. 
Hence, the method utilised in this chapter appears to be more reliable as a whole. 
 
8.3.3 Test on CSP-generated structures 
 
The results of clustering the generated crystal structures of molecule XXVI and the two 
tautomers of mebendazole are shown in Figure 8.15-17 and Table 8.2. 
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Figure 8.15: Lattice energy vs density plot obtained after the search with CrystalPredictor 
of molecule XXVI (above) before and (below) after clustering. 
 
 
Figure 8.16: Lattice energy vs density plot obtained after the search with CrystalPredictor 
of the A-tautomer of mebendazole (above) before and (below) after clustering. 
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Figure 8.17: Lattice energy vs density plot obtained after the search with CrystalPredictor 
of the C-tautomer of mebendazole (above) before and (below) after clustering. 
 
Table 8.2: Summary of the results of clustering the search-generated crystal structures 
of molecule XXVI and the two tautomers of mebendazole. 
Molecule 
# generated 
structures 
# 
duplicates  
# wrong 
structures  
% of 
structures 
eliminated 
# lost 
minima (% 
of 
duplicates) 
Clustering 
cost 
/CPU hours 
Estimated 
saving 
/CPU 
hours 
XXVI 9,400 2,580 2,623 55 623 (24%) 1,625  88,000 
Meb. A 855 437 0 51 29 (7%) 5  1,250 
Meb. C 964 496 0 51 43 (9%) 6  1,060 
 
 Clustering removed a large portion of CSP-generated structures for all three 
molecules. If the structures removed by this clustering analysis had not been taken to 
the final refinement stage of the original CSP studies, this would have led to important 
cost savings. The estimated savings are much larger than the computational cost 
required to perform the clustering step, and amount to approximately 30-40% of the 
computational expense for the final refinement stage, which is shown in Table 3.3 for 
molecule XXVI and Table 4.2 for mebendazole. Hence this could be an advantageous 
intermediate stage within a CSP workflow. 
 However, undertaking this extra step can be dangerous, since a significant 
proportion of the removed structures (7 to 24% in these three cases) did not optimise to 
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the same minimum as the structures they were considered duplicates of. This is a known 
problem associated with removing presumptive duplicates at early stages of CSP 
studies.3 In this case, this loss is probably due to the Elatt model in CrystalPredictor being 
different from the one used in CrystalOptimizer,60 which was used to refine the generated 
crystal structures. The extent to which changing the energy surface can take similar 
structures to different end-points is shown in Figure 8.18 for CSP-generated structures 
2494 and 2495 of molecule XXVI. 
  
Figure 8.18: Overlay of structures 2494 and 2495 (right) after the search, where it is 
possible to overlay 15/15 molecules with an RMSD15 of 0.006 (left) after the single-
iteration of CrystalOptimizer, where it is only possible to overlay 5/15 molecules. 
Molecules of 2494 are coloured by elements, while for 2495 matched molecules are 
coloured in green, non-matched molecules in red. 
 Hence there is no guarantee that two crystal structures that are duplicates at one 
stage of the CSP workflow will remain duplicates at later stages. Although for these three 
molecules the structures matching the experimental forms were not thrown away, it 
appears to be risky to remove duplicates produced exploring a poor energy surface 
before refinement with a more accurate one.  
 The decision of whether or not to undertake a clustering step comes down to the 
priority of the CSP study itself. If what is prioritised is the generation of a very accurate 
crystal energy landscape, and time or CPU cost constraints are not a problem, it is 
probably best to optimise all the search-generated structures within a certain energy 
window. On the other hand, if the resources are limited, then the risk of losing some 
potentially important minima may be accepted if clustering search-generated structures 
significantly reduces number of expensive optimisations. The larger and more flexible 
the molecule is, the more the decrease in CPU cost can become convenient and worth 
the partial loss in accuracy; however, this limited analysis seems to suggest that the 
number of lost minima could increase with molecular size.  
 An alternative solution is the use of tighter constraints in terms of energy or 
density differences, PXRD similarity or unit-cell parameters, or even the RMSD15 
thresholds to discriminate between duplicates and polymorphs, which could be adapted 
depending on the size and flexibility of the molecule. Although this would reduce the cost 
of the clustering step and the risk of removing crystal structures that would optimise to 
289 
 
separate minima, the number of identified duplicates would also decrease, limiting the 
savings in computational cost and the value of the intermediate clustering step. 
 
8.4 Conclusion 
 
An analysis of the CSD ‘best R-factor list’ allowed to define a set of criteria that can be 
used to separate the great majority of duplicates from polymorphs. A more complete test 
on the polymorph-flagged crystal structures in the CSD revealed that these criteria work 
in ~98% of cases. The ~2% of few failures are either due to errors in the experimental 
entries or in the overlaying tools, or to the presence of ambiguous pairs of crystal 
structures; the latter are generally associated with phase-transitions with temperature or 
pressure. In many cases, the ambiguity requires a certain level of human judgment to 
decide whether two structures are polymorphic or not,11 or more accurate experimental 
measurements. However, most polymorphs and duplicates are easy to distinguish, and 
these ambiguous cases are exceptions rather than the rule. 
 The development of a new clustering script and the application of these criteria 
to a set of the search-generated crystal structures of molecule XXVI and the two 
tautomers of mebendazole shows that removing duplicates at early stages of a CSP 
procedure can be both cost-effective and risky: the large number of removed crystal 
structures vastly reduces the computational cost of later refinement stages, but several 
structures that optimise to distinct minima are eliminated, limiting completeness. 
 This chapter provides several insights that are useful within the overall context of 
this thesis. First of all, removing duplicates produced after the generation stage can be 
important in reducing the computational cost of CSP studies on large molecules; 
however, a compromise must be found, since there is a risk of removing structures that 
are effectively distinct minima. Comparing and removing only structures that are similar 
not only in crystal structure but also in energy, density, unit cell parameters or PXRD 
similarity could reduce such risks, but would also reduce the worth of the clustering 
procedure itself. Secondly, the CSD analysis has produced some widely applicable 
criteria for separating polymorphs from duplicates that are not drastically affected by 
molecular size or flexibility, as well as the number of components in the crystal structures. 
Finally, the risk of similar crystal structures forming separate polymorphic phases is 
extremely small, in particular if they are obtained or predicted under the same conditions. 
Although this risk cannot be ruled out, this study increases the confidence that a careful 
analysis of CSP-generated crystal structures can identify a set of distinct PPMs. 
 
8.5 References 
 
1. Price, S. L., Predicting crystal structures of organic compounds. Chemical Society 
Reviews 2014, 43 (7), 2098-2111. 
290 
 
2. Reilly, A. M.; Cooper, R. I.; Adjiman, C. S.; Bhattacharya, S.; Boese, A. D.; Brandenburg, 
J. G.; Bygrave, P. J.; Bylsma, R.; Campbell, J. E.; Car, R.; Case, D. H.; Chadha, R.; Cole, J. C.; 
Cosburn, K.; Cuppen, H. M.; Curtis, F.; Day, G. M.; DiStasio Jr, R. A.; Dzyabchenko, A.; van Eijck, 
B. P.; Elking, D. M.; van den Ende, J. A.; Facelli, J. C.; Ferraro, M. B.; Fusti-Molnar, L.; Gatsiou, 
C.-A.; Gee, T. S.; de Gelder, R.; Ghiringhelli, L. M.; Goto, H.; Grimme, S.; Guo, R.; Hofmann, D. 
W. M.; Hoja, J.; Hylton, R. K.; Iuzzolino, L.; Jankiewicz, W.; de Jong, D. T.; Kendrick, J.; de Klerk, 
N. J. J.; Ko, H.-Y.; Kuleshova, L. N.; Li, X.; Lohani, S.; Leusen, F. J. J.; Lund, A. M.; Lv, J.; Ma, 
Y.; Marom, N.; Masunov, A. E.; McCabe, P.; McMahon, D. P.; Meekes, H.; Metz, M. P.; Misquitta, 
A. J.; Mohamed, S.; Monserrat, B.; Needs, R. J.; Neumann, M. A.; Nyman, J.; Obata, S.; 
Oberhofer, H.; Oganov, A. R.; Orendt, A. M.; Pagola, G. I.; Pantelides, C. C.; Pickard, C. J.; 
Podeszwa, R.; Price, L. S.; Price, S. L.; Pulido, A.; Read, M. G.; Reuter, K.; Schneider, E.; 
Schober, C.; Shields, G. P.; Singh, P.; Sugden, I. J.; Szalewicz, K.; Taylor, C. R.; Tkatchenko, A.; 
Tuckerman, M. E.; Vacarro, F.; Vasileiadis, M.; Vazquez-Mayagoitia, A.; Vogt, L.; Wang, Y.; 
Watson, R. E.; de Wijs, G. A.; Yang, J. Z.; Zhu, Q.; Groom, C. R., Report on the sixth blind test 
of organic crystal-structure prediction methods. Acta Crystallographica Section B - Structural 
Science 2016. 
3. van Eijck, B. P.; Kroon, J., Fast clustering of equivalent structures in crystal structure 
prediction. Journal of Computational Chemistry 1997, 18 (8), 1036-1042. 
4. Ghasemi, S. A.; Amsler, M.; Hennig, R. G.; Roy, S.; Goedecker, S.; Lenosky, T. J.; 
Umrigar, C. J.; Genovese, L.; Morishita, T.; Nishio, K., Energy landscape of silicon systems and 
its description by force fields, tight binding schemes, density functional methods, and quantum 
Monte Carlo methods. Physical Review B 2010, 81 (21), 214107. 
5. Verwer, P.; Leusen, F. J. J., Computer Simulation to Predict Possible Polymorphs. In 
Reviews in Computational Chemistry Volume 12, Lipkowitz, K. B.; Boyd, D. B., Eds. John Wiley 
and Sons Inc.: New York, 1998; pp 327-365. 
6. Day, G. M., Current approaches to predicting molecular organic crystal structures. 
Crystallography Reviews 2011, 17 (1), 3-52. 
7. Copley, R. C. B.; Barnett, S. A.; Karamertzanis, P. G.; Harris, K. D. M.; Kariuki, B. M.; Xu, 
M. C.; Nickels, E. A.; Lancaster, R. W.; Price, S. L., Predictable disorder versus polymorphism in 
the rationalization of structural diversity: A multidisciplinary study of eniluracil. Crystal Growth & 
Design 2008, 8 (9), 3474-3481. 
8. Case, D.; Campbell, J.; Bygrave, P.; Day, G., Convergence Properties of Crystal 
Structure Prediction by Quasi-Random Sampling. Journal of Chemical Theory and Computation 
2016, 12 (2), 910-924. 
9. Hofmann, D. W. M.; Kuleshova, L., New similarity index for crystal structure determination 
from X-ray powder diagrams. Journal of Applied Crystallography 2005, 38, 861-866. 
10. Valle, M.; Oganov, A. R. In Crystal structures classifier for an evolutionary algorithm 
structure predictor, 2008 IEEE Symposium on Visual Analytics Science and Technology, 19-24 
Oct. 2008; 2008; pp 11-18. 
11. Desiraju, G. R., Polymorphism: The same and not quite the same. Crystal Growth & 
Design 2008, 8 (1), 3-5. 
12. Coles, S. J.; Threlfall, T. L.; Tizzard, G. J., The Same but Different: Isostructural 
Polymorphs and the Case of 3-Chloromandelic Acid. Crystal Growth & Design 2014, 14 (4), 1623-
1628. 
13. Gavezzotti, A., A solid-state chemist's view of the crystal polymorphism of organic 
compounds. Journal of Pharmaceutical Sciences 2007, 96 (9), 2232-2241. 
14. Bernstein, J.; Dunitz, J. D.; Gavezzotti, A., Polymorphic Perversity: Crystal Structures 
with Many Symmetry-Independent Molecules in the Unit Cell. Crystal Growth & Design 2008, 8 
(6), 2011-2018. 
15. Bernstein, J., Polymorphism - A Perspective. Crystal Growth & Design 2011, 11 (3), 632-
650. 
16. McCrone, W. C., Polymorphism. In Physics and Chemistry of the Organic Solid-state, 
Fox, D.; Labes, M. M.; Weissberger, A., Eds. Wiley Interscience: New York, 1965; Vol. II, pp 725-
767. 
17. Bernstein, J., Polymorphism in Molecular Crystals. Clarendon Press: Oxford, 2002. 
18. McNaught, A. D.; Wilkinson, A., IUPAC. Compendium of Chemical Terminology, 2nd ed. 
(the "Gold Book"). WileyBlackwell; 2nd Revised edition edition. 
19. Stahly, G. P., Diversity in single- and multiple-component crystals. The search for and 
prevalence of polymorphs and cocrystals. Crystal Growth & Design 2007, 7 (6), 1007-1026. 
20. Threlfall, T. L.; Gelbrich, T., The crystal structure of methyl paraben at 118 K does not 
represent a new polymorph. Crystal Growth & Design 2007, 7 (11), 2297-2297. 
21. Fabian, L.; Kalman, A., Isostructurality in one and two dimensions: isostructurality of 
polymorphs. Acta Crystallographica Section B - Structural Science 2004, 60, 547-558. 
291 
 
22. Beer, L.; Brusso, J. L.; Cordes, A. W.; Haddon, R. C.; Itkis, M. E.; Kirschbaum, K.; 
MacGregor, D. S.; Oakley, R. T.; Pinkerton, A. A.; Reed, R. W., Resonance-Stabilized 1,2,3-
Dithiazolo-1,2,3-dithiazolyls as Neutral π-Radical Conductors. Journal of the American Chemical 
Society 2002, 124 (32), 9498-9509. 
23. Barnett, S. A.; Broder, C. K.; Shankland, K.; David, W. I. F.; Ibberson, R. M.; Tocher, D. 
A., Single-crystal X-ray and neutron powder diffraction investigation of the phase transition in 
tetrachlorobenzene. Acta Crystallographica Section B - Structural Science 2006, 62, 287-295. 
24. Torrie, B. H.; Anderson, A.; Andrews, B.; Laurin, D. G.; White, J. K.; Zung, W. W. E., 
Raman and far‐infrared spectra of crystalline methylene iodide. Journal of Raman Spectroscopy 
2005, 18 (3), 215-220. 
25. Silvestru, A.; Haiduc, I.; Ebert, K. H.; Breunig, H. J., Novel Coordination Pattern of 
Dithiophosphorus Ligands. Crystal and Molecular Structure of 
(Diphenylphosphinodithioato)phenyltellurium(II), PhTeS2PPh2. Supramolecular Association 
through Monodentate Biconnective Dithiophosphorus Ligands. Inorganic Chemistry 1994, 33 (7), 
1253-1254. 
26. Abbas, N.; Oswald, I.; Pulham, C., Accessing Mefenamic Acid Form II through High-
Pressure Recrystallisation. Pharmaceutics 2017, 9 (2). 
27. van de Streek, J.; Motherwell, S., Searching the Cambridge Structural Database for 
polymorphs. Acta Crystallographica Section B - Structural Science 2005, 61, 504-510. 
28. Stephenson, G., Anisotropic lattice contraction in pharmaceuticals: The influence of cryo-
crystallography on calculated powder diffraction patterns. Journal of Pharmaceutical Sciences 
2006, 95 (4), 821-827. 
29. Cruz-Cabeza, A. J.; Bernstein, J., Conformational Polymorphism. Chemical Reviews 
2014, 114 (4), 2170-2191. 
30. Cruz-Cabeza, A. J.; Reutzel-Edens, S. M.; Bernstein, J., Facts and fictions about 
polymorphism. Chemical Society Reviews 2015, 44, 8619-8635. 
31. Storey, R. A.; Ym‚n, I., Solid-state characterization of pharmaceuticals. Wiley: Chichester, 
2012. 
32. Yang, J.; Hu, W.; Usvyat, D.; Matthews, D.; Schutz, M.; Chan, H., Ab initio determination 
of the lattice energy in crystalline benzene to sub-kilojoule per mole accuracy. Science 2014, 345 
(6197), 640-643. 
33. Nyman, J.; Day, G. M., Static and lattice vibrational energy differences between 
polymorphs. Crystengcomm 2015, 17 (28), 5154-5165. 
34. Zhu, L.; Amsler, M.; Fuhrer, T.; Schaefer, B.; Faraji, S.; Rostami, S.; Ghasemi, S. A.; 
Sadeghi, A.; Grauzinyte, M.; Wolverton, C.; Goedecker, S., A fingerprint based metric for 
measuring similarities of crystalline structures. Journal of Chemical Physics 2016, 144 (3). 
35. Spackman, M. A.; Jayatilaka, D., Hirshfeld surface analysis. CrystEngComm 2009, 11 
(1), 19-32. 
36. Carter, D. J.; Raiteri, P.; Barnard, K. R.; Gielink, R.; Mocerino, M.; Skelton, B. W.; 
Vaughan, J. G.; Ogden, M. I.; Rohl, A. L., Difference Hirshfeld fingerprint plots: a tool for studying 
polymorphs. CrystEngComm 2017, 19 (16), 2207-2215. 
37. Groom, C. R.; Bruno, I. J.; Lightfoot, M. P.; Ward, S. C., The Cambridge Structural 
Database. Acta Crystallographica Section B-Structural Science Crystal Engineering and Materials 
2016, 72, 171-179. 
38. van de Streek, J., Searching the Cambridge Structural Database for the 'best' 
representative of each unique polymorph. Acta Crystallographica Section B - Structural Science 
2006, 62, 567-579. 
39. de Gelder, R.; Wehrens, R.; Hageman, J. A., A generalized expression for the similarity 
of spectra: Application to powder diffraction pattern classification. Journal of Computational 
Chemistry 2001, 22 (3), 273-289. 
40. Nyman, J.; Day, G., Static and lattice vibrational energy differences between polymorphs. 
Crystengcomm 2015, 17 (28), 5154-5165. 
41. Bruno, I. J.; Cole, J. C.; Edgington, P. R.; Kessler, M.; Macrae, C. F.; McCabe, P.; 
Pearson, J.; Taylor, R., New software for searching the Cambridge Structural Database and 
visualizing crystal structures. Acta Crystallographica Section B - Structural Science 2002, 58, 389-
397. 
42. Moggach, S.; Parsons, S.; Wood, P., High-pressure polymorphism in amino acids. 2008; 
Vol. 14, p 143-184. 
43. Budd, L.; Ibberson, R.; Marshall, W.; Parsons, S., The effect of temperature and pressure 
on the crystal structure of piperidine. Chemistry Central Journal 2015, 9. 
44. Boldyreva, E. V.; Shakhtshneider, T. P.; Vasilchenko, M. A.; Ahsbahs, H.; Uchtmann, H., 
Anisotropic crystal structure distortion of the monoclinic polymorph of acetaminophen at high 
292 
 
hydrostatic pressures. Acta Crystallographica Section B - Structural Science 2000, 56 (2), 299-
309. 
45. Chisholm, J. A.; Motherwell, S., COMPACK: a program for identifying crystal structure 
similarity using distances. Journal of Applied Crystallography 2005, 38, 228-231. 
46. Taylor, R.; Cole, J.; Korb, O.; McCabe, P., Knowledge-Based Libraries for Predicting the 
Geometric Preferences of Druglike Molecules. Journal of Chemical Information and Modeling 
2014, 54 (9), 2500-2514. 
47. Wood, P. A.; Oliveira, M. A.; Zink, A.; Hickey, M. B., Isostructurality in pharmaceutical 
salts: How often and how similar? CrystEngComm 2012, 14 (7), 2413-2421. 
48. Leitch, A. A.; Reed, R. W.; Robertson, C. M.; Britten, J. F.; Yu, X.; Secco, R. A.; Oakley, 
R. T., An Alternating π-Stacked Bisdithiazolyl Radical Conductor. Journal of the American 
Chemical Society 2007, 129 (25), 7903-7914. 
49. Braun, D. E.; Bhardwaj, R. M.; Florence, A. J.; Tocher, D. A.; Price, S. L., Complex 
Polymorphic System of Gallic Acid-Five Monohydrates, Three Anhydrates, and over 20 Solvates. 
Crystal Growth & Design 2013, 13 (1), 19-23. 
50. Iuzzolino, L.; Reilly, A. M.; McCabe, P.; Price, S. L., Use of Crystal Structure Informatics 
for Defining the Conformational Space Needed for Predicting Crystal Structures of 
Pharmaceutical Molecules. Journal of Chemical Theory and Computation 2017, 13 (10), 5163-
5171. 
51. Prystupa, D. A.; Torrie, B. H.; Powell, B. M.; Gerlach, P. N., Crystal structures of 
methylene bromide and methylene iodide. Molecular Physics 1989, 68 (4), 835-851. 
52. Price, S. L.; Reutzel-Edens, S. M., The potential of computed crystal energy landscapes 
to aid solid form development. Drug Discovery Today 2016. 
53. Lekin, K.; Phan, H.; Winter, S. M.; Wong, J. W. L.; Leitch, A. A.; Laniel, D.; Yong, W.; 
Secco, R. A.; Tse, J. S.; Desgreniers, S.; Dube, P. A.; Shatruk, M.; Oakley, R. T., Heat, Pressure 
and Light-Induced Interconversion of Bisdithiazolyl Radicals and Dimers. Journal of the American 
Chemical Society 2014, 136 (22), 8050-8062. 
54. Bruno, I. J.; Cole, J. C.; Kessler, M.; Luo, J.; Motherwell, W. D. S.; Purkis, L. H.; Smith, 
B. R.; Taylor, R.; Cooper, R. I.; Harris, S. E.; Orpen, A. G., Retrieval of Crystallographically-
Derived Molecular Geometry Information. Journal of Chemical Information and Computer 
Sciences 2004, 44 (6), 2133-2144. 
55. Takamizawa, S.; Takasaki, Y., Superelastic Shape Recovery of Mechanically Twinned 
3,5-Difluorobenzoic Acid Crystals. Angewandte Chemie-International Edition 2015, 54 (16), 4815-
4817. 
56. Moré, R.; Busse, G.; Hallmann, J.; Paulmann, C.; Scholz, M.; Techert, S., 
Photodimerization of Crystalline 9-Anthracenecarboxylic Acid: A Nontopotactic Autocatalytic 
Transformation. The Journal of Physical Chemistry C 2010, 114 (9), 4142-4148. 
57. Airoldi, A.; Bettoni, P.; Donnola, M.; Calestani, G.; Rizzoli, C., Crystal structure of 
zwitterionic 3-(2-hydroxy-2-phosphonato-2-phosphonoethyl)imidazo 1,2-a -pyridin-1-ium 
monohydrate (minodronic acid monohydrate): a redetermination. Acta Crystallographica Section 
E-Crystallographic Communications 2015, 71, 51-+. 
58. Tojo, K.; Mizuguchi, J., Refinement of the crystal structure of beta-3,4 : 9,10-
perylenetetracarboxylic dianhydride, C24H8O6, at 223 K. Zeitschrift Fur Kristallographie-New 
Crystal Structures 2002, 217 (2), 255-256. 
59. Kersten, K.; Kaur, R.; Matzger, A., Survey and analysis of crystal polymorphism in organic 
structures. Iucrj 2018, 5, 124-129. 
60. Kazantsev, A. V.; Karamertzanis, P. G.; Adjiman, C. S.; Pantelides, C. C., 
CrystalOptimizer. An efficient Algorithm for Lattice Energy Minimisation of Organic Crystal using 
Isolated-Molecule Quantum Mechanical Calculations. In Molecular System Engineering, Adjiman, 
C. S.; Galindo, A., Eds. WILEY-VCH Verlag GmbH & Co.: Weinheim, 2010; Vol. 6, pp 1-42. 
 
 
 
 
 
 
 
 
 
 
 
 
 
293 
 
8.6 Appendix 
 
Appendix Table 8.1: The 24 pairs of duplicate crystal structures in the ‘best R-factor’ list. 
The four highlighted in yellow are false polymorphs (i.e. duplicates wrongly identified as 
polymorphs) using the decision tree in Figure 8.2. 
Structure 1 Structure 2 Overlaid molecules/ out of 15 RMSD15 Comment 
PYRAZI01 PYRAZI 15 0.070 / 
NTBZAM10 NTBZAM01 15 0.106 / 
NIJHUJ03 NIJHUJ01 15 0.108 / 
TIPWIY07 TIPWIY06 15 0.110 / 
VEGNAX02 VEGNAX 15 0.115 / 
FACRIK06 FACRIK05 15 0.128 / 
TMPPIO13 TMPPIO01 15 0.141 / 
ACEMID03 ACEMID01 15 0.144 / 
MENSEE01 MENSEE 15 0.145 / 
GLYCIN82 GLYCIN16 15 0.147 above RMSD15 threshold 
TIPWIY07 TIPWIY 15 0.155 / 
FUYVUQ03 FUYVUQ01 15 0.157 / 
DCLBEN06 DCLBEN02 15 0.162 / 
GLYCIN81 GLYCIN71 15 0.173 above RMSD15 threshold 
CHAPEP10 CHAPEP02 15 0.177 / 
HACTPH15 HACTPH11 15 0.230 / 
HIXHIF03 HIXHIF02 15 0.231 / 
TIPWIY06 TIPWIY 15 0.263 / 
NMBYAN22 NMBYAN01 15 0.274 / 
MUROXA02 MUROXA01 15 0.341 / 
DIFVET02 DIFVET 15 0.471 / 
HOJQII01 HOJQII 15 0.767 different pressure 
DCLBEN07 DCLBEN01 15 0.098 / 
FORMAC01 FORMAC 1 0.036 different double bond 
 
Appendix Table 8.2: The three pairs of false duplicates (i.e. polymorphs wrongly 
identified as duplicates) left after applying the heuristically developed criteria in Figure 
8.2 to the ‘best R-factor’ list.  
Structure 1 Structure 2 Overlaid molecules/ out of 15 RMSD15 Comment 
DIMETH06 DIMETH01 15 0.226 Phase transition with temperature 
LIHXUW02 LIHXUW01 15 0.095 Phase transition with temperature 
MOSTIX01 MOSTIX 15 0.498 Phase transition with temperature 
 
Appendix Table 8.3: The 78 pairs of false polymorphs (i.e. duplicates wrongly identified 
as polymorphs) found after applying the criteria in Figure 8.2 to the polymorph-flagged 
crystal structures in the CSD.  The pairs highlighted in green are examples mentioned in 
the chapter. 
Structure 1 Structure 2 
Overlaid 
molecules/ 
out of 15 
RMSD15 Comment 
PDABZA PDABZA01 7 / different double bond 
ACRLAC02 ACRLAC01 1 / different double bond 
VEKSOT VEKSOT01 1 / different double bond 
ZZZZCB04 ZZZZCB03 5 / different double bond 
AMBNAC12 AMBNAC 3 / different double bond 
DXYLEN15 DXYLEN14 15 2.335 Wrong RMSD15 
ANTCYB11 ANTCYB13 9 / same with higher tolerances 
HEVXUB HEVXUB03 2 / different double bond 
MBPHOL15 MBPHOL14 failed / failed because overlaid only with lowest R-factor 
MBPHOL02 MBPHOL15 failed / failed because overlaid only with lowest R-factor 
MBPHOL02 MBPHOL14 failed / failed because overlaid only with lowest R-factor 
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ZZZNQS08 ZZZNQS09 7 / different double bond 
BENZID04 BENZID08 15 0.181 different Z because of molecular symmetry 
MONTIS02 MONTIS01 4 / same with higher tolerances 
BZDMAZ01 BZDMAZ02 1 / different double bond 
BETANC BETANC01 2 / different double bond 
MBZPNA12 MBZPNA13 failed / failed because overlaid only with lowest R-factor 
NMBYAN25 NMBYAN26 failed / failed because overlaid only with lowest R-factor 
BIPHEN06 BIPHEN08 15 0.091 different Z because of molecular symmetry 
PYRDNO10 PYRDNO11 15 0.017 different Z because of molecular symmetry 
CASHOT CASHOT02 7 / same with higher tolerances 
CBENPH CBENPH01 15 0.519 above RMSD15 threshold 
CILHIO02 CILHIO10 15 1.503 Wrong RMSD15 
COMXAD03 COMXAD05 7 / different double bond 
OCRSOL OCRSOL01 15 0.100 same Z and Z', different space group 
QQQFDJ04 QQQFDJ19 3 / different double bond 
QQQFDJ20 QQQFDJ04 3 / different double bond 
HAVBIQ06 HAVBIQ02 1 / different double bond 
DAWFUE02 DAWFUE01 15 0.680 above RMSD15 threshold 
DAWGAL DAWGAL02 15 0.756 above RMSD15 threshold 
DAZABZ10 DAZABZ02 7 / different double bond 
DBEZLM05 DBEZLM01 1 / different double bond 
DHNAPH17 DHNAPH 7 / different double bond 
DIVHOF01 DIVHOF 10 / different double bond 
DIXNIH02 DIXNIH03 15 0.105 different Z because of molecular symmetry 
SUCACB10 SUCACB03 3 / different double bond 
PIMELA13 PIMELA02 3 / different double bond 
PIMELA PIMELA13 1 / different double bond 
PIMELA PIMELA02 1 / different double bond 
GLYCIN71 GLYCIN81 15 0.173 above RMSD15 threshold 
GLYCIN82 DOLBIR09 15 0.144 above RMSD15 threshold 
GLYCIN16 DOLBIR09 15 0.017 same Z and Z', different space group 
GLYCIN82 GLYCIN16 15 0.147 above RMSD15 threshold 
EDTAXX02 EDTAXX01 1 / different double bond 
LGLUAC LGLUAC11 1 / different double bond 
FORMAC FORMAC01 1 / different double bond 
FOXNEL01 FOXNEL10 15 2.615 Wrong RMSD15 
FUCTIG03 FUCTIG02 15 0.068 different Z because of molecular symmetry 
INDMET01 INDMET03 2 / different double bond 
PRONAC01 PRONAC 1 / different double bond 
KASXUY02 KASXUY01 6 / different double bond 
KTCYQM KTCYQM01 15 0.127 different Z because of molecular symmetry 
SIKLIH06 SIKLIH07 1 / different double bond 
LUTDUR LUTDUR02 9 / same with higher tolerances 
MCHTEP17 MCHTEP06 7 / same with higher tolerances 
XENXUL01 XENXUL02 3 / different double bond 
NIJHUJ NIJHUJ01 15 0.008 different Z because of molecular symmetry 
NOETNA02 NOETNA01 3 / same but error in the overlay 
OXACDH03 OXACDH 7 / different double bond 
OXACDH13 OXACDH03 7 / different double bond 
OXACDH13 OXACDH 7 / different double bond 
OXIBZN10 OXIBZN02 15 0.116 above RMSD15 threshold 
PEYMIQ04 PEYMIQ02 failed / failed because overlaid only with lowest R-factor 
PHTHCY07 PHTHCY12 failed / different double bond 
PHENOL01 PHENOL03 15 0.287 above RMSD15 threshold 
SABCII SABCII02 15 0.213 different Z because of molecular symmetry 
SRFORA06 SRFORA07 9 / same with higher tolerances 
SUWMIG02 SUWMIG01 7 / same with higher tolerances 
SUWMIG03 SUWMIG 4 / 
same with higher tolerances, most structurally 
dissimilar duplicate 
TASCUM02 TASCUM03 12 / same with higher tolerances 
TEDAPC01 TEDAPC29 7 / different double bond 
TEDAPC06 TEDAPC22 7 / different double bond 
TETDAM01 TETDAM 15 0.127 above RMSD15 threshold 
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TFMETH TFMETH02 3 / same but very poor reproduction 
TGLYSU23 TGLYSU22 failed / failed because overlaid only with lowest R-factor 
TGLYSU20 TGLYSU23 7 / same with higher tolerances 
TGLYSU20 TGLYSU22 7 / same with higher tolerances 
TGLYSU TGLYSU16 7 / different double bond 
TIYQAU TIYQAU02 11 / same with higher tolerances 
TIZWAA01 TIZWAA02 15 0.005 different Z because of molecular symmetry 
XINRUH01 XINRUH 15 3.306 Wrong RMSD15 
 
Appendix Table 8.4: The 212 pairs of false duplicates (i.e. polymorphs wrongly identified 
as duplicates) found after applying the criteria in Figure 8.2 to the polymorph-flagged 
crystal structures in the CSD. These include several pairs of duplicates of the 47 missed 
polymorph pairs listed in Appendix Table 8.5. The pairs highlighted in green are 
examples mentioned in the chapter. 
Structure 1 Structure 2 Comment Structure 1 Structure 2 Comment 
QQQAUJ03 QQQAUJ05 / DOWVOC DOWVOC32 
Phase transition with 
temperature 
QQQAUJ03 QQQAUJ06 / DOWVOC DOWVOC35 
Phase transition with 
temperature 
AHOXLH02 AHOXLH 
Phase transition with 
temperature 
DOWVOC DOWVOC30 
Phase transition with 
temperature 
AKIJIP AKIJIP01 / DOWVOC DOWVOC34 
Phase transition with 
temperature 
MEDLUE12 MEDLUE15 
Phase transition with 
temperature 
DOWVOC DOWVOC33 
Phase transition with 
temperature 
MEDLUE12 MEDLUE19 
Phase transition with 
temperature 
DOWVOC DOWVOC28 
Phase transition with 
temperature 
MEDLUE12 MEDLUE16 
Phase transition with 
temperature 
DOWVOC DOWVOC38 
Phase transition with 
temperature 
MEDLUE12 MEDLUE 
Phase transition with 
temperature 
DOWVOC DOWVOC37 
Phase transition with 
temperature 
MEDLUE12 MEDLUE18 
Phase transition with 
temperature 
DOWVOC DOWVOC36 
Phase transition with 
temperature 
MEDLUE12 MEDLUE17 
Phase transition with 
temperature 
DOWVOC DOWVOC31 
Phase transition with 
temperature 
MEDLUE11 MEDLUE15 
Phase transition with 
temperature 
GAKNAH GAKNAH02 
Phase transition with 
temperature 
MEDLUE11 MEDLUE19 
Phase transition with 
temperature 
GAKNAH01 GAKNAH02 
Phase transition with 
temperature 
MEDLUE11 MEDLUE16 
Phase transition with 
temperature 
EZIZAP EZIZAP01 
Phase transition with 
temperature 
MEDLUE11 MEDLUE 
Phase transition with 
temperature 
ZZZHQU02 ZZZHQU01 
Different for 30-
molecule shell 
MEDLUE11 MEDLUE18 
Phase transition with 
temperature 
FIBYIY FIBYIY01 / 
MEDLUE11 MEDLUE17 
Phase transition with 
temperature 
GERZAG02 GERZAG03 
Phase transition with 
temperature 
MEDLUE10 MEDLUE15 
Phase transition with 
temperature 
PIDGOZ03 PIDGOZ01 
Phase transition with 
pressure 
MEDLUE10 MEDLUE19 
Phase transition with 
temperature 
PIDGOZ05 PIDGOZ03 
Phase transition with 
pressure 
MEDLUE10 MEDLUE16 
Phase transition with 
temperature 
PIDGOZ05 PIDGOZ01 
Phase transition with 
pressure 
MEDLUE10 MEDLUE 
Phase transition with 
temperature 
PIDGOZ02 PIDGOZ05 
Phase transition with 
pressure 
MEDLUE10 MEDLUE18 
Phase transition with 
temperature 
PIDGOZ02 PIDGOZ03 
Phase transition with 
pressure 
MEDLUE10 MEDLUE17 
Phase transition with 
temperature 
PIDGOZ04 PIDGOZ02 
Phase transition with 
pressure 
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MEDLUE09 MEDLUE15 
Phase transition with 
temperature 
PIDGOZ04 PIDGOZ05 
Phase transition with 
pressure 
MEDLUE09 MEDLUE19 
Phase transition with 
temperature 
PIDGOZ04 PIDGOZ03 
Phase transition with 
pressure 
MEDLUE09 MEDLUE16 
Phase transition with 
temperature 
PIDGOZ04 PIDGOZ01 
Phase transition with 
pressure 
MEDLUE09 MEDLUE 
Phase transition with 
temperature 
SINZIY01 SINZIY 
Phase transition with 
temperature 
MEDLUE09 MEDLUE18 
Phase transition with 
temperature 
HECXAO01 HECXAO 
Phase transition with 
temperature 
MEDLUE09 MEDLUE17 
Phase transition with 
temperature 
IJUXEQ01 IJUXEQ 
Phase transition with 
temperature 
DXYLEN22 DXYLEN21 
Phase transition with 
temperature 
TAYTUI TAYTUI01 / 
DXYLEN22 DXYLEN14 
Phase transition with 
temperature 
TAYTUI TAYTUI02 / 
DXYLEN19 DXYLEN22 
Phase transition with 
temperature 
KIBBUS01 KIBBUS / 
DXYLEN20 DXYLEN19 
Phase transition with 
temperature 
LIHXUW01 LIHXUW02 
Phase transition with 
temperature 
DXYLEN20 DXYLEN21 
Phase transition with 
temperature 
MAMPUM0
1 
MAMPUM0
2 
Phase transition with 
temperature 
DXYLEN20 DXYLEN14 
Phase transition with 
temperature 
MOBBAH02 MOBBAH / 
DXYLEN24 DXYLEN15 
Phase transition with 
temperature 
MOSTIX MOSTIX01 
Phase transition with 
temperature 
DXYLEN23 DXYLEN15 
Phase transition with 
temperature 
OPUPOG OPUNIY / 
DXYLEN13 DXYLEN15 
Phase transition with 
temperature 
UFOCAU01 UFOCAU / 
DXYLEN17 DXYLEN13 
Phase transition with 
temperature 
QUBPIN01 QUBPIN 
Phase transition with 
temperature 
DXYLEN17 DXYLEN23 
Phase transition with 
temperature 
QUBPIN03 QUBPIN01 
Phase transition with 
temperature 
DXYLEN17 DXYLEN24 
Phase transition with 
temperature 
QUBPIN03 QUBPIN 
Phase transition with 
temperature 
DXYLEN18 DXYLEN17 
Phase transition with 
temperature 
RBHTCA01 RBHTCA02 / 
DXYLEN18 DXYLEN15 
Phase transition with 
temperature 
RBHTCA RBHTCA02 / 
DXYLEN16 DXYLEN17 
Phase transition with 
temperature 
ROKQUF01 ROKQUF02 
Phase transition with 
temperature 
DXYLEN16 DXYLEN15 
Phase transition with 
temperature 
ROKQUF ROKQUF01 
Phase transition with 
temperature 
PRMDIN01 PRMDIN02 
Phase transition with 
temperature 
RUCJUV04 RUCJUV01 / 
PRMDIN07 PRMDIN01 
Phase transition with 
temperature 
SARCAC SARCAC01 
Phase transition with 
temperature 
PRMDIN04 PRMDIN01 
Phase transition with 
temperature 
TETBBZ TETBBZ04 
Phase transition with 
temperature 
PRMDIN06 PRMDIN01 
Phase transition with 
temperature 
TETBBZ TETBBZ03 
Phase transition with 
temperature 
PRMDIN05 PRMDIN01 
Phase transition with 
temperature 
TETBBZ TETBBZ02 
Phase transition with 
temperature 
PRMDIN03 PRMDIN01 
Phase transition with 
temperature 
TETBBZ01 TETBBZ 
Phase transition with 
temperature 
PRMDIN PRMDIN01 
Phase transition with 
temperature 
UBUQIR04 UBUQIR03 
Phase transition with 
temperature 
BARBAD07 BARBAD10 
Phase transition with 
temperature 
UBUQIR05 UBUQIR03 
Phase transition with 
temperature 
BARBAD07 BARBAD11 
Phase transition with 
temperature 
UBUQIR06 UBUQIR03 
Phase transition with 
temperature 
BARBAD07 BARBAD13 
Phase transition with 
temperature 
UBUQIR08 UBUQIR03 
Phase transition with 
temperature 
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BARBAD07 BARBAD14 
Phase transition with 
temperature 
UBUQIR07 UBUQIR03 
Phase transition with 
temperature 
BARBAD07 BARBAD15 
Phase transition with 
temperature 
UBUQIR13 UBUQIR07 
Phase transition with 
temperature 
BARBAD12 BARBAD07 
Phase transition with 
temperature 
UBUQIR13 UBUQIR08 
Phase transition with 
temperature 
BARBAD09 BARBAD12 
Phase transition with 
temperature 
UBUQIR13 UBUQIR06 
Phase transition with 
temperature 
BARBAD09 BARBAD10 
Phase transition with 
temperature 
UBUQIR13 UBUQIR05 
Phase transition with 
temperature 
BARBAD09 BARBAD11 
Phase transition with 
temperature 
UBUQIR13 UBUQIR04 
Phase transition with 
temperature 
BARBAD09 BARBAD13 
Phase transition with 
temperature 
UBUQIR14 UBUQIR13 
Phase transition with 
temperature 
BARBAD09 BARBAD14 
Phase transition with 
temperature 
UBUQIR14 UBUQIR03 
Phase transition with 
temperature 
BARBAD09 BARBAD15 
Phase transition with 
temperature 
UBUQIR01 UBUQIR13 
Phase transition with 
temperature 
BARBAD08 BARBAD12 
Phase transition with 
temperature 
UBUQIR01 UBUQIR03 
Phase transition with 
temperature 
BARBAD08 BARBAD10 
Phase transition with 
temperature 
UBUQIR09 UBUQIR01 
Phase transition with 
temperature 
BARBAD08 BARBAD11 
Phase transition with 
temperature 
UBUQIR09 UBUQIR14 
Phase transition with 
temperature 
BARBAD08 BARBAD13 
Phase transition with 
temperature 
UBUQIR09 UBUQIR07 
Phase transition with 
temperature 
BARBAD08 BARBAD14 
Phase transition with 
temperature 
UBUQIR09 UBUQIR08 
Phase transition with 
temperature 
BARBAD08 BARBAD15 
Phase transition with 
temperature 
UBUQIR09 UBUQIR06 
Phase transition with 
temperature 
BARBAD06 BARBAD12 
Phase transition with 
temperature 
UBUQIR09 UBUQIR05 
Phase transition with 
temperature 
BARBAD06 BARBAD10 
Phase transition with 
temperature 
UBUQIR09 UBUQIR04 
Phase transition with 
temperature 
BARBAD06 BARBAD11 
Phase transition with 
temperature 
UBUQIR10 UBUQIR01 
Phase transition with 
temperature 
BARBAD06 BARBAD13 
Phase transition with 
temperature 
UBUQIR10 UBUQIR14 
Phase transition with 
temperature 
BARBAD06 BARBAD14 
Phase transition with 
temperature 
UBUQIR10 UBUQIR07 
Phase transition with 
temperature 
BARBAD06 BARBAD15 
Phase transition with 
temperature 
UBUQIR10 UBUQIR08 
Phase transition with 
temperature 
BARBAD01 BARBAD06 
Phase transition with 
temperature 
UBUQIR10 UBUQIR06 
Phase transition with 
temperature 
BARBAD01 BARBAD08 
Phase transition with 
temperature 
UBUQIR10 UBUQIR05 
Phase transition with 
temperature 
BARBAD01 BARBAD09 
Phase transition with 
temperature 
UBUQIR10 UBUQIR04 
Phase transition with 
temperature 
BARBAD01 BARBAD07 
Phase transition with 
temperature 
UBUQIR12 UBUQIR01 
Phase transition with 
temperature 
BARBAD BARBAD06 
Phase transition with 
temperature 
UBUQIR12 UBUQIR14 
Phase transition with 
temperature 
BARBAD BARBAD08 
Phase transition with 
temperature 
UBUQIR12 UBUQIR07 
Phase transition with 
temperature 
BARBAD BARBAD09 
Phase transition with 
temperature 
UBUQIR12 UBUQIR08 
Phase transition with 
temperature 
BARBAD BARBAD07 
Phase transition with 
temperature 
UBUQIR12 UBUQIR06 
Phase transition with 
temperature 
BIZWAI01 BIZWAI02 
Most structurally 
similar polymorph 
UBUQIR12 UBUQIR05 
Phase transition with 
temperature 
SUCROS16 SUCROS17 
Phase transition with 
temperature 
UBUQIR12 UBUQIR04 
Phase transition with 
temperature 
HOLVAG HOLVAG01 
Phase transition with 
temperature 
UBUQIR11 UBUQIR01 
Phase transition with 
temperature 
298 
 
CAZLAR02 CAZLAR01 
Phase transition with 
temperature 
UBUQIR11 UBUQIR14 
Phase transition with 
temperature 
CAZLAR CAZLAR02 
Phase transition with 
temperature 
UBUQIR11 UBUQIR07 
Phase transition with 
temperature 
CELWIB04 CELWIB03 
Phase transition with 
temperature 
UBUQIR11 UBUQIR08 
Phase transition with 
temperature 
CHNAPQ CHNAPQ01 / UBUQIR11 UBUQIR06 
Phase transition with 
temperature 
DCLNAP DCLNAP02 / UBUQIR11 UBUQIR05 
Phase transition with 
temperature 
DECYIU01 DECYIU / UBUQIR11 UBUQIR04 
Phase transition with 
temperature 
DIMETH01 DIMETH06 
Phase transition with 
temperature 
UBUQIR UBUQIR11 
Phase transition with 
temperature 
DIMETH10 DIMETH06 
Phase transition with 
temperature 
UBUQIR UBUQIR12 
Phase transition with 
temperature 
DOWVOC40 DOWVOC38 
Phase transition with 
temperature 
UBUQIR UBUQIR10 
Phase transition with 
temperature 
DOWVOC40 DOWVOC37 
Phase transition with 
temperature 
UBUQIR UBUQIR09 
Phase transition with 
temperature 
DOWVOC40 DOWVOC36 
Phase transition with 
temperature 
UBUQIR UBUQIR13 
Phase transition with 
temperature 
DOWVOC40 DOWVOC31 
Phase transition with 
temperature 
UBUQIR UBUQIR03 
Phase transition with 
temperature 
DOWVOC28 DOWVOC40 
Phase transition with 
temperature 
UBUQIR02 UBUQIR 
Phase transition with 
temperature 
DOWVOC33 DOWVOC40 
Phase transition with 
temperature 
UBUQIR02 UBUQIR01 
Phase transition with 
temperature 
DOWVOC34 DOWVOC40 
Phase transition with 
temperature 
UBUQIR02 UBUQIR14 
Phase transition with 
temperature 
DOWVOC30 DOWVOC40 
Phase transition with 
temperature 
UBUQIR02 UBUQIR07 
Phase transition with 
temperature 
DOWVOC35 DOWVOC40 
Phase transition with 
temperature 
UBUQIR02 UBUQIR08 
Phase transition with 
temperature 
DOWVOC32 DOWVOC40 
Phase transition with 
temperature 
UBUQIR02 UBUQIR06 
Phase transition with 
temperature 
DOWVOC39 DOWVOC40 
Phase transition with 
temperature 
UBUQIR02 UBUQIR05 
Phase transition with 
temperature 
DOWVOC DOWVOC39 
Phase transition with 
temperature 
UBUQIR02 UBUQIR04 
Phase transition with 
temperature 
 
Appendix Table 8.5: The 47 pairs that are the best representative of each polymorph pair 
among the false duplicates in Appendix Table 4. The pairs highlighted in green are 
examples mentioned in the chapter. 
Structure 1 Structure 2 
Overlaid molecules/ out 
of 15 
RMSD15 Comment 
AHOXLH02 AHOXLH 15 0.082 Phase transition with temperature 
AKIJIP AKIJIP01 15 0.046 / 
MEDLUE12 MEDLUE17 15 0.045 Phase transition with temperature 
DXYLEN22 DXYLEN14 15 0.082 Phase transition with temperature 
PRMDIN01 PRMDIN02 15 0.097 Phase transition with temperature 
BARBAD07 BARBAD15 15 0.072 Phase transition with temperature 
BIZWAI01 BIZWAI02 15 0.007 Most structurally similar polymorph 
SUCROS16 SUCROS17 15 0.043 Phase transition with temperature 
HOLVAG HOLVAG01 15 0.114 Phase transition with temperature 
CAZLAR02 CAZLAR01 15 0.062 Phase transition with temperature 
CELWIB04 CELWIB03 15 0.045 Phase transition with temperature 
CHNAPQ CHNAPQ01 15 0.054 / 
DCLNAP DCLNAP02 15 0.115 / 
DECYIU01 DECYIU 15 0.320 / 
DIMETH01 DIMETH06 15 0.226 Phase transition with temperature 
DOWVOC40 DOWVOC31 15 0.075 Phase transition with temperature 
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GAKNAH GAKNAH02 15 0.138 Phase transition with temperature 
EZIZAP EZIZAP01 15 0.274 Phase transition with temperature 
ZZZHQU02 ZZZHQU01 15 0.123 
Different but not shown with 15 
molecules 
FIBYIY FIBYIY01 15 0.013 / 
GERZAG02 GERZAG03 15 0.070 Phase transition with temperature 
PIDGOZ03 PIDGOZ01 15 0.133 Phase transition with pressure 
PIDGOZ05 PIDGOZ03 15 0.013 Phase transition with pressure 
PIDGOZ05 PIDGOZ01 15 0.129 Phase transition with pressure 
PIDGOZ04 PIDGOZ05 15 0.015 Phase transition with pressure 
PIDGOZ04 PIDGOZ03 15 0.017 Phase transition with pressure 
PIDGOZ04 PIDGOZ01 15 0.130 Phase transition with pressure 
SINZIY01 SINZIY 15 0.058 Phase transition with temperature 
HECXAO01 HECXAO 15 0.120 Phase transition with temperature 
IJUXEQ01 IJUXEQ 15 0.130 Phase transition with temperature 
TAYTUI TAYTUI02 15 0.295 / 
KIBBUS01 KIBBUS 15 0.059 / 
LIHXUW01 LIHXUW02 15 0.095 Phase transition with temperature 
MAMPUM0
1 
MAMPUM0
2 
15 0.058 Phase transition with temperature 
MOBBAH02 MOBBAH 15 0.180 / 
MOSTIX MOSTIX01 15 0.498 Phase transition with temperature 
OPUNIY OPUPOG 15 0.087 / 
UFOCAU01 UFOCAU 15 0.039 / 
QUBPIN01 QUBPIN 15 0.068 Phase transition with temperature 
QUBPIN03 QUBPIN01 15 0.066 Phase transition with temperature 
QUBPIN03 QUBPIN 15 0.021 Phase transition with temperature 
RBHTCA02 RBHTCA01 15 0.016 / 
ROKQUF01 ROKQUF02 15 0.238 Phase transition with temperature 
RUCJUV04 RUCJUV01 15 0.039 / 
SARCAC SARCAC01 15 0.078 Phase transition with temperature 
TETBBZ TETBBZ02 15 0.483 Phase transition with temperature 
UBUQIR04 UBUQIR03 15 0.165 Phase transition with temperature 
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Chapter 9: Overall conclusion and future work 
 
9.1 Can CSP be routinely used to complement polymorphs screens? 
  
Chapters 3 and 4 have described the state-of-the-art of CSP studies on large and flexible 
molecules. In Chapter 3 the only solved crystal structure of molecule XXVI was 
successfully predicted in the context of the 6th Blind Test of organic CSP.1 In Chapter 4 
a CSP study successfully found the only two solved forms of the antihelminthic drug 
mebendazole,2, 3 in the right stability order, but it produced no match to the powder 
patterns of other six single-component crystal structures that were produced in a parallel 
academic experimental solid form screening effort.  However, these new forms have not 
been solved yet, and it is impossible to assess whether they were not found because 
they were outside the scope of the computational study or because of flaws in the CSP 
procedure. These two studies confirm that CSP can be successful under blind conditions 
and a useful complement to an experimental effort. The routine industrial use of CSP 
would be highly desirable as it can establish the completeness of experimental 
polymorph screens, avoiding the cost of performing unnecessary experiments but also 
warning about potential risks.4 
 However, the results shown in these two chapters also outline some weaknesses 
that make the applicability of CSP to the very large and flexible molecules the 
pharmaceutical industry mostly works with problematic. First of all these two studies 
reveal that CPU cost scales badly with size and level of flexibility:5, 6 generating a crystal 
energy landscape of molecule XXVI was more than twenty times more expensive than it 
was for mebendazole. As pharmaceutical molecules are often larger and more flexible 
than XXVI, this hinders a routine use of CSP in pharmaceutical polymorph screening. 
Current methodologies cannot be scaled to a molecule like ritonavir.6 Moreover the high 
computational expense required to perform CSP limits the coverage of the search even 
for relatively easy targets like mebendazole, as shown in Chapter 4. For example, CSP 
studies can only affordably predict crystal structures with Z’=1 and, in a few cases, with 
Z’=2, though Z’=2 searches generally include severe space group limitations and rigid 
cut-offs in terms of number of structures generated to limit the cost.1 They are also 
generally limited to single-component crystal structures, while thorough polymorph 
screens cover other solid forms like hydrates or co-crystals.5, 6 Finally, even with these 
limitations, CSP studies often produce very congested crystal energy landscapes,7 with 
no clear indication of which crystal structure/s are actually obtainable and of the 
experiments needed to produce them. The interpretation of CSP results is complicated 
by several low-energy crystal structures being very similar, without a clear way to 
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determine whether they are potential polymorphs, duplicates that are artefacts of the 
energy model or different components of a disordered phase. 
 
9.2 How can CSP be extended to large and flexible molecules of pharmaceutical 
interest? 
 
From what has been said so far, it is clear that methodological improvements are needed 
to make the application of CSP to larger and more flexible molecules, as well as a more 
complete coverage of the search space, affordable. In Chapter 5 a workflow that uses 
Cambridge Structural Database (CSD)8 conformational information to define the 
molecular flexibility range and to perform crystal structure searches was developed from 
and tested on five large and flexible molecules.9 This method successfully reproduced 
the great majority of the most significant crystal structures from the original CSP studies, 
including those matching all the experimentally known forms, at a reduced computational 
cost. A newly discovered polymorph of succinic acid with an unusual conformation10 was 
also successfully generated, indicating that the workflow can also be applied to 
molecules not included in its development. These results illustrate that CSD-derived 
knowledge-based conformational information can be used in CSP. The workflow 
parameters in Chapter 5 will probably need to be adapted to apply CSD-retrieved data 
to other molecules and/or CSP algorithms, and more efficient ways to use this 
information may also be discovered. 
 Chapter 6 and 7 deal with the complex issue of refining crystal structures 
generated in a CSP search. Chapter 6 shows how limiting the conformational degrees 
of freedom (CDFs) treated as explicit variables in crystal structure optimisations is not a 
completely realistic approach for pharmaceutical-like molecules. However, as thousands 
of generated crystal structures often need to be taken to the final refinement stage of 
CSP because of the approximate search models, for large and flexible molecules 
expensive full optimisations with the Ψmol method treating all torsion and bond-angles as 
explicit variables (bond-lengths can be ignored)11 would be unaffordable. The alternative 
solution of performing all the optimisations with Ψcrys methods like DFT-D,12 which 
optimise all intra- and intermolecular degrees of freedom without requiring an explicit 
selection, is once again too expensive for minimising hundreds or thousands of crystal 
structures. Hence, in Chapter 7 the affordable Ψcrys semi-empirical dispersion corrected 
density functional tight-binding (DFTB3-D3) method13 was used to perform full 
intermediate optimisations of all intra- and intermolecular degrees of freedom of the 
structures generated in Chapter 5, followed by an optimisation of only the intermolecular 
interactions with a molecular wave-function calculated at the PBE0 6-31G(d,p) level of 
theory. This produced crystal energy landscapes of similar quality to the original CSP 
studies, with all experimentally known forms found within a sensible energy window for 
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polymorphism, but at a reduced cost.14 These results show that a cheap intermediate 
optimisation followed by a more accurate final evaluation of Elatt is an effective approach 
to perform crystal structure refinement. The good scaling of cost with molecular size and 
level of flexibility suggests that these methods could be scalable to molecules of 
pharmaceutical interest. Moreover, DFTB3-D3 allows to affordably calculate all 
molecular and lattice phonon modes, which cause a larger spread of free energy values 
than the rigid-body lattice modes alone.  
 Finally, in Chapter 8 a CSD survey was performed to identify some structural and 
crystallographic similarity thresholds that can separate redeterminations from 
polymorphs. These thresholds are successful in ~98% of cases. Many of the failures are 
due to structural ambiguities generally associated with phase transitions with 
temperature and/or pressure. A clustering algorithm that can apply these criteria to                 
CSP-generated crystal structures was written. This is important to expand CSP studies 
to larger and more flexible molecules: understanding which structures could be actual 
polymorphs as opposed to artefacts of the models is important to limit the crystal energy 
landscape to plausible polymorphs or components of disordered phases. 
 
9.3 Possible future developments 
 
The work performed in this thesis has outlined some of the strengths and weaknesses 
of current CSP methodologies. Ways to solve some of the limitations of CSP, in particular 
the high computational cost and its poor scaling with molecular size and flexibility, have 
been proposed. However, more work is needed in several directions. 
 One of the main issues of CSP is the trade-off between computational cost and 
accuracy. This is particularly evident in CSP searches, where speed is fundamental to 
cover the search space within a feasible time-scale.15 However, the use of approximate 
models (e.g. the point charges in CrystalPredictor)16 for limiting cost has important       
draw-backs: the energy ranking output by the search is often inaccurate, as shown in 
Chapters 3-5, and thousands of expensive refinements of the generated crystal 
structures must often be carried out to select all potentially important crystal structures. 
This can severely limit the ability to use the most accurate models in the final refinement 
stage and to fully cover all packing possibilities. Furthermore, the use of simplified search 
models can result in important crystal structures being missed altogether if they are not 
minima in the approximate potential energy surface.15 Hence search methods should be 
improved, and the potential energy surface explored in the searches should resemble 
more that of the final refinement methods. This would increase the confidence that the 
searches have not missed important crystal structures, and it would limit the number of 
candidates to be taken to the final refinement stage since there would be smaller 
discrepancies between the relative energy rankings. This general idea is already 
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implemented in GRACE,17 where a tailor-made force field is fitted that mimics DFT-D 
results. However, fitting to ab initio data is itself a very expensive process, in particular 
for large molecules,1 and more efficient methods need to be found. In the recent Faraday 
Discussion on CSP several groups working on inorganic molecules have applied 
machine learning algorithms to crystal structure searches with very promising           
results.18, 19 The organic community should follow on these ideas, finding good training 
sets and comparing results with those obtained with the most accurate models. Chapter 
5 has shown that CSD information on geometric preferences can be effectively utilised 
to define the conformational search space that needs to be covered by CSP searches. 
Thus knowledge-based data may be used as a training set to produce machine learning 
hypotheses that accurately describe molecular flexibility and that could be applied in the 
crystal structure generation stage of CSP. Different CSP approaches are ultimately 
distinguished by the search methods: although some in-house refinement algorithms 
have been developed (e.g. CrystalOptimizer,11 used in this thesis), several accurate 
quantum-chemistry codes exist20-23 that can perform the same task to various degrees 
of efficiency. In my opinion, the biggest breakthrough in CSP will come from the 
development of better search methods that affordably cover a sufficient portion of a fairly 
accurate potential energy surface. 
 Until improved search algorithms are available, it will be necessary to use some 
approximations in the refinement stage, in particular for large and flexible molecules 
where fully optimising hundreds or thousands of generated crystal structures with the 
most accurate models is not feasible.24 Chapter 7 shows that a possible solution is to 
perform an intermediate optimisation with DFTB3-D3. However, the energy ranking 
output by DFTB3-D3 is not reliable. Developments in DFTB algorithms that could correct 
for some of the weaknesses outlined in Chapter 2.3.2.2.1, the use of alternative semi-
empirical approaches13 or the development of more accurate force fields25 could all help 
to speed up refinement without compromising accuracy. Machine learning could once 
again be very useful for this purpose, and it has shown some potential in computing 
accurate energies within a crystal structure refinement procedure.26 
 Another aspect that requires improvements is the calculation of free energies. 
Chapter 7 has shown that calculating both lattice and molecular phonon modes with a 
Ψcrys method that allows their coupling can cause more re-ranking of Elatt values than the 
rigid-body lattice modes alone. Accurate free energy calculations should thus be 
performed with high-quality Ψcrys methods, which are currently too expensive to be 
applied to a large portion of the crystal energy landscape. Furthermore, using the 
harmonic approximation does not account for anharmonic effects that may occur in the 
lattice,27 even when the quasi-harmonic correction is applied.28 Molecular dynamics 
simulations could be a step towards solving this problem,10 as they explore the potential 
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energy surface more explicitly, but this would require the development of very accurate 
potentials that can describe all intra- and intermolecular interactions. Machine learning 
could once again be employed for developing these potentials.  
 Finally, the issue of analysing the crystal energy landscape and extracting useful 
information remains fundamental. In Chapter 8 CSD mining has provided information 
that can be used for separating polymorphs from redeterminations. More developments 
however will be required to understand which Elatt minima would actually survive at finite 
temperatures, either as unique free energy minima or as components of disordered 
phases, to predict the properties of computer-generated crystal structures and to direct 
experimentalists towards the crystallisation of new forms.4 This will require a more 
thorough understanding of temperature effects and of crystallisation kinetics. Molecular 
dynamics could be used to improve our understanding of both phenomena,4 but 
affordable and accurate potentials are needed.  
 In summary, CSP is far from a solved problem. Although very accurate and widely 
available algorithms to refine crystal structures exist, they cannot be routinely used in 
CSP because of their high computational expense and their poor scaling with molecular 
size and flexibility. Developing more accurate yet affordable search methodologies could 
be a fundamental breakthrough for CSP, and it could allow a more complete coverage 
of the search space. Intermediate refinement methods that are more efficient at bridging 
the gap between the searches and final optimisations could be identified, and more 
accurate ways to analyse the crystal energy landscape, to calculate free energies and to 
predict crystallisation kinetics are needed. Any improvement of models and procedures 
will require a solid collaboration with experimentalists to obtain accurate benchmarks, 
such as energy differences between polymorphs or phonon modes, which can be used 
to drive developments and validate results.  
 This thesis has brought some advancements in these directions, and has 
provided some hints about what may be done in the near future. The scientific and 
financial incentives are strong enough to proceed in these directions. 
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